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Abstract 
In this thesis, a set of defined media was developed for a novel strategy to produce 
recombinant proteins using an autoinduction method and for an innovative protocol to 
generate recombinant proteins with specific labels.  
A novel defined autoinduction medium was developed using a mixture of glucose, glycerol, 
and lactose as carbon substrates and ammonium as the sole nitrogen source. This medium 
was tested in 96-well microtiter plates, test tubes, shake flasks and 15 liter bioreactor for 
the production of different proteins achieving an average yield of 500 mg L
−1 
product. 
Based on the developed defined medium, a simple protocol for producing heavy isotope 
labeled proteins was developed. Label incorporation into the target protein reached 99%, 
97% and about 75% for 
15
N, 
13
C, and 
2
H, respectively. This protocol is also applicable for 
selenomethionine (Se-Met) labeling, leading to Se-Met incorporation of 70% or 90% using 
prototrophic or methionine auxotrophic E. coli strains, respectively.  
The cultivation performances, e.g. target protein solubility and productivity, in defined and 
complex media are different. Subsequently, proteomic analyses were performed to reveal 
the physiological differences between E. coli grown in defined and complex media to 
reveal the hidden bottleneck of recombinant protein production. 
The regulation basis of acetate overflow metabolism under nutrient-rich conditions was 
first investigated: when precursors and reducing equivalents generated by the central 
metabolic pathways (CMPs) are sufficient for the cell growth, E. coli will simultaneously 
reduce the synthesis of proteins in the tricarboxylic acid cycle (TCA cycle) to decrease the 
generation of reducing equivalents and precursors. This leads to the increased formation of 
acetate. 
Insufficient nutrient triggers a self-protection mechanism: the transport systems and by-
products assimilation pathways are elevated for absorbing the limited nutrient in the 
environment. Many degradation processes are up-regulated to recycle the intracellular 
components that are no longer required. The proteins involved in eliminating the reactive 
oxygen species (ROS) and DNA protection are greatly increased. Conversely, proteins in 
transcription and translation processes are down-regulated, which can provide extra 
resources towards fine-tuning the whole proteome for long term starvation. 
This self-protection mechanism breaks down completely when E. coli is forced to 
overproduce recombinant protein: chaperones are up-regulated simultaneously. The 
relative amounts of transcription and translation related proteins remain constant. The 
transport systems, CMPs, by-product metabolism, proteins for degradations, eliminating 
ROS and DNA protection, are down-regulated. This causes an overall breakdown in 
cellular regulation and physiology. 
Keywords: Escherichia coli, Recombinant protein production, Proteomics 
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Zusammenfassung 
In dieser Arbeit wurde eine neue Strategie entwickelt, um rekombinante Proteine in 
definierten Medien zu produzieren. Diese Methode basiert auf der Nutzung von 
autoinduzierenden Medien und einem neuen innovativen Protokoll, um spezifisch 
markierte rekombinante Proteine zu erzeugen. 
Das neu entwickelte definierte Medium besteht aus Glukose, Glycerol und Laktose als 
Kohlenstoffquelle, sowie Ammonium als einziger Stickstoffquelle. Das Medium wurde in 
96-well Mikrotiterplatten, Reagenzgläsern, Schüttelkolben und in 15 Liter Bioreaktoren 
auf die effiziente Produktion unterschiedlicher Proteine getestet und es wurden 
durchschnittliche Produktkonzentrationen von 500 mg L
−1 
erzielt. 
Basierend auf dem entwickelten Medium wurde des Weiteren ein einfaches Protokoll zur 
Produktion von mit schweren Isotopen markierten Proteinen erstellt. Dabei wurde eine 
Ausbeute an markiertem Zielprotein von 99 %, 97 % und um die 75 % bei 
15
N, 
13
C, und 
2
H 
erreicht. Das Protokoll findet außerdem Anwendung bei der Produktion von mit 
Selenomethionin (Se-Met) markierten Proteinen mit Ausbeuten von 70 % oder 90 % in 
prototrophen oder Methionin-auxotrophen E. coli Stämmen. 
Die Ergebnisse der Proteinproduktion, z.B. Löslichkeit des Zielproteins und Produktivität 
im definierten und komplexen Medium, sind unterschiedlich. Um die physiologischen 
Unterschiede vom Wachstum von E. coli im definierten und komplexen Medium 
aufzuklären und versteckte Engpässe der rekombinanten Proteinproduktion zu enthüllen, 
wurde eine Proteomanalyse durchgeführt.  
Die Regulierung des Acetat-Überflussmetabolismus („Crabtree-Effekt“) unter 
nährstoffreichen Bedingungen wurde bei E. coli untersucht. Unter diesen Bedingungen 
können Vorläufermoleküle und reduzierende Äquivalente in den zentralen 
Stoffwechselwegen in ausreichender Menge generiert werden. Daraus folgend reduziert 
E. coli die Synthese von Proteinen aus dem Tricarbonsäurezyklus und reduziert somit auch 
die Generierung von Vorläufermolekülen und reduzierenden Äquivalenten. 
Unzureichende Nährstoffversorgung führt zu einem Selbstschutzsystem; Proteine aus den 
Transportsystemen und zum Abbau von Nebenprodukten sind erhöht, um die limitierende 
Nährstoffversorgung aus der Umwelt zu kompensieren. Viele Abbauprozesse sind 
hochreguliert, um intrazelluläre Komponenten zu recyceln, welche nicht länger benötigt 
werden. Die Synthese der Proteine, die an der Eliminierung von reaktiven 
Sauerstoffspezies (z.B. Sauerstoffradikalen) und dem Schutz der DNA beteiligt sind, ist 
stark erhöht. Auf der anderen Seite sind Proteine, die in Transkriptions- und 
Translationsprozessen eine Rolle spielen, herunterreguliert, wodurch zusätzliche 
Ressourcen für das fine tuning des Proteoms in Hinsicht auf eine lange Hungerperiode zur 
Verfügung stehen. 
 V 
Eine weitere Proteomanalyse zeigt, dass Selbstschutzmechanismen komplett ausgehebelt 
werden, wenn E. coli zur Überexpression von rekombinantem Protein gezwungen wird: 
Chaperone werden gleichzeitig hochreguliert. Die relative Menge der an der Transkription 
und Translation beteiligten Proteine bleibt dagegen konstant. Hingegen werden Proteine 
die für den Transport und die zentralen Stoffwechselwege, die Bildung und den Abbau von 
Nebenprodukten und andere Degradationsproteine, sowie Proteine für den Abbau reaktiver 
Sauerstoffspezies und den Schutz der DNA herunter reguliert. Diese Tatsache führt zu 
einem Zusammenbruch der Regulation des Stoffwechsels und der Physiologie. 
Stichwörter: Escherichia coli, Rekombinante Proteinproduktion, Proteomik 
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1 Introduction 
1.1 Thesis objective 
Recombinant DNA techniques combined with bioprocess engineering allows many 
therapeutic and diagnostic proteins to be produced in large quantities in genetically 
modified microorganisms. The gram-negative bacterium Escherichia coli is the most 
popular choice and is widely used in pharmaceutical industries and academic institutions. 
This thesis deals with the following objectives: first a set of novel easy-to-use defined 
media was developed to produce recombinant protein by an autoinduction method and to 
generate recombinant proteins with specific labels; secondly two proteomic analyses were 
performed to reveal the molecular differences of E. coli grown in defined and complex 
media under protein production and non-production conditions. Based on the proteomic 
comparisons, three fundamental cellular reactions were investigated: the regulation of 
acetate overflow metabolism in E. coli under nutrient-rich conditions; the global response 
of E. coli to nutrient deficiency and depletion; and the global metabolic response in E. coli 
during recombinant protein overproduction.  
Inducible E. coli expression systems, e.g. isopropyl β-D-1-thiogalactopyranoside (IPTG) 
[1]-, arabinose [2]-, temperature [3]- inducible systems, are commonly used to produce 
recombinant proteins. Operational procedures of the conventional inducible protein 
expression systems are often complicated and tedious: cultivation is always performed in 
two phases (the growth phase and production phase); and the induction must be employed 
at an appropriate growth stage. Development of a single batch cultivation by autoinduction 
without monitoring the cell growth and starting induction will significantly reduce the 
manual handling during recombinant protein production. 
E. coli expression systems provide a platform for the production of specifically labeled 
proteins for structure determination [4, 5]. An efficient and simple protocol for generating 
labeled proteins is very important for structural biologists. So there is great demand for 
protein labeling protocols which are easy to implement and lead to sufficient amount of 
protein with high-label incorporation at an acceptable cost. 
Recombinant protein production is mainly performed in complex medium [6-11] and 
defined (minimal) medium [12, 13]. Both media have their unique qualities which are 
suitable for different applications. Clearing the physiological differences of E. coli grown 
in complex and defined media will greatly help researchers to choose the appropriate 
medium for their specific tasks and may reveal the hidden bottleneck of recombinant 
protein production. 
When E. coli grows at a high rate, acetate is the major by-product [14-16]. Since it has a 
negative impact on cell growth and protein production [17-21], clarification of the 
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molecular mechanism of acetate overflow metabolism is of great importance. 
The investigation of the metabolic burden observed during overexpression of heterologous 
genes has been extensively studied from the macroscopic view [22-24], but from the 
microscopic view (particularly at the proteome level) it is still ambiguous. A 
comprehensive proteomic analysis would significantly help to understand the global 
metabolic response during recombinant protein overproduction. 
1.2 Thesis structure 
The experimental work of this thesis is divided into two chapters (Chapter 2 and 3) as 
shown in Fig. 1.1 
 
Fig. 1.1 Thesis structure 
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Chapter 2 consists of two sections: in the first section, a simple defined autoinduction 
medium for high-level recombinant protein production using T7-based E. coli expression 
systems is developed. In the second section, based on the defined medium, an optimized 
procedure to generate heavy isotope and selenomethionine-labeled proteins for structure 
determination is established using E. coli-based expression systems.  
Chapter 2 observes that the use of defined medium elicites several advantages, e.g. higher 
biomass and better reproducibility. However there is a small increase in inclusion body 
formation and a prolonged production time compared with the cultivation in complex 
medium. Subsequently, chapter 3 shows two proteomic analyses, using two-dimensional 
gel electrophoresis and mass spectrometry. These were performed to reveal the 
physiological differences of E. coli grown in defined and complex media under 
recombinant protein production and non-production conditions. 
In chapter 3, three fundamental biological mechanisms in E. coli were investigated. In the 
first section, the molecular mechanism of acetate overflow metabolism under nutrient-rich 
condition is clarified. In the second section, the global self-protection machinery in 
response to nutrient deficiency and depletion conditions is disclosed. In the third section 
the global metabolic response during recombinant protein overproduction is elaborated 
upon. 
1.3 Theoretical background 
1.3.1 Recombinant protein production by autoinduction method 
The idea of autoinduction in the lac operon based E. coli expression system was introduced 
by Studier [25]. It presents an easy and convenient way to perform recombinant protein 
production. Cultivation using the autoinduction method contains only two steps, 
inoculation and harvest, which makes the whole procedure easy, economical and 
reproducible. Autoinduction omits the procedure of adding inducer to start production at a 
particular growth stage. This places the switch from cell growth to recombinant protein 
production under metabolic control of the host cell [26] (as indicated in Fig. 1.2). 
Nowadays, there are several complex autoinduction media available: such as the medium 
described by Studier [25] or even commercial media, e.g. Overnight Express™ 
Autoinduction System from Novagen and MagicMedia™ from Invitrogen. All these media 
contain complex nutrients such as tryptone and yeast extract, which make the media 
expensive, and not compatible for protein labeling with heavy isotopes or 
selenomethionine, or similar labling methods. 
Introduction 
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Fig. 1.2 Control of carbon source consumption in autoinduction cultivation 
Based on Studier's protocol [25], several chemically defined autoinduction media were 
developed [26-30]. However, the composition of these media are complex; they contain 
several different amino acids, vitamins and trace elements, and so far only a limited 
number of reports are available on the universal applicability of these media [31-33]. 
Development of a defined autoinduction medium using a mixture of glucose, glycerol, and 
lactose as carbon substrates and NH4
+
 as the sole nitrogen source will significantly reduce 
the manual handling during recombinant protein production and will improve the heavy 
isotope labeling process. 
1.3.2 Specifically labelled recombinant proteins 
For heavy isotope labeling in E. coli, a chemically defined medium is the most important 
requirement; the recombinant protein production is performed in a defined medium 
supplied with stable heavy isotope labeled substrates. That is, 
13
C-carbon, 
15
N-nitrogen or 
deuterium oxide (D2O). For Se-Met labeling, when the protein synthesis is carried out in a 
defined medium supplied with Se-Met instead of methionine (Met), the Met in the target 
protein will be replaced or partially replaced by Se-Met. 
Stable heavy isotopes (
15
N, 
13
C and 
2
H) and selenomethionine (Se-Met) labeled proteins 
are commonly used for protein structure determination through NMR spectroscopy [4] and 
X-ray crystallography [5], respectively. The generation of isotope-enriched protein samples 
is a prerequisite for carrying out structural studies using NMR spectroscopy [34-36]; and 
incorporation of Se-Met into proteins considerably helps protein structure determination by 
X-ray crystallography [37, 38]. 
Glucose
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An efficient and simple procedure for the generation of labeled material is very important 
for protein structure determination. Protocols described in literature are mainly based on 
M9 minimal medium [5, 39-43] leading to very poor final biomass concentrations (OD600 
of 1~2), and consequently, low yields of labeled proteins. Some improvements have been 
obtained by establishing carbon limited fed-batch processes [44, 45], or by optimizing the 
minimal medium [25, 27, 28, 46].  
Despite the improvements, some of cultivation performances when using defined medium, 
e.g. final biomass, yield and productivity of proteins of interest, are still worse than the 
cultivation using traditional Luria-Bertani and Terrific Broth media. Clarification of the 
physiological and molecular differences between the recombinant protein production in 
defined and complex media may offer helpful advice and suggestions to improve the 
cultivation performance in defined media specifically for the labeling application. 
1.3.3 Defined and complex medium 
Two groups of media are mainly used in laboratory study and industrial production: the 
complex medium with unknown composition (e.g. Luria-Bertani broth or Terrific Broth 
which contains tryptone, a pancreatic digest of casein, and yeast extract, the water soluble 
portion of autolyzed yeast), or defined medium with chemically defined ingredients, e.g. 
M9 medium or Defined Non-inducing Broth (DNB) [13], in which glucose, NH4
+
, PO4
3-
 
and SO4
2-
are the sole carbon, nitrogen, phosphorus and sulfur sources, respectively. 
The use of chemically defined media is gaining more and more popularity [12], because 
the lot-to-lot variation of raw materials (e.g. yeast extract, peptone or tryptone) used in 
complex medium results in very poor reproducibility [25, 47]. When compared with 
cultivation in defined medium, it was found that when growing at maximum growth rate in 
complex medium E. coli produces more acetate [7, 16, 21], which inhibits cell growth and 
also protein production [17-20]. 
Despite many advantages, the culture performance in defined medium is normally “poorer” 
(e.g. more inclusion body formation, lower productivity and reduced product titer) than 
when using complex medium. When E. coli grows in defined or complex medium, the cell 
physiology shows big differences in growth kinetics [6-8] and the transcriptome [9-11]. So 
far there are only a few reports on the proteome differences. Clearing the physiological 
differences at the proteome level will help a lot towards choosing the appropriate 
conditions for the specific applications, and for improving recombinant protein production. 
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1.3.4 Acetate overflow metabolism  
Acetate is the major by-product when E. coli metabolizes substrates at high rates even 
under well-aerated conditions [14-16]. The acetate has resulted in many negative effects on 
recombinant protein production [17-21]. It is found that when the loads and fluxes surpass 
the level of NADH turnover rate or the capacity of the TCA cycle, switching to acetate 
overflow can be predicted [48]. 
 
Fig. 1.3 Central metabolic pathways of E. coli 
Acetate is located at the centre of the central metabolic pathways (CMPs) as shown in Fig. 
1.3 The monomers (e.g. amino acids) for the cellular macromolecules (e.g. proteins) are 
made from a relatively small group of precursors that are the products of the CMPs, 
indicating a direct relation between acetate overflow metabolism and biomass building 
block biosynthesis [49]. Another important factor is that reducing equivalents [NAD(P)H], 
generated by CMPs are also required for monomer synthesis, especially for the amino acid 
biosynthesis [50], which implies a direct association between biomass building block 
biosynthesis and the NADH turnover rate. Since NADH and NADPH can be converted 
into each other through reversible transfer of reducing equivalents between NAD and 
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NADP by the two native E. coli transhydrogenases (PntAB and UdhA) [51-53], they are 
regarded as equal in this thesis. 
The Arc two component system [Aerobic respiration control protein (ArcA) and its sensor 
protein (ArcB)] has been proved to be the mediator between the NADH turnover rate and 
the TCA cycle activity [54-58], which will in turn influence the acetate overflow 
metabolism. It was observed that the arcA deletion mutant showed a higher TCA cycle 
activity and a lower acetate formation rate [59, 60]. Due to the complexity of the 
intracellular metabolic network and also the extracellular environment, the understanding 
of the synergetic regulation of CMPs, oxidative phosphorylation, biomass building block 
biosynthesis and acetate overflow metabolism is still ambiguous. 
The experimental observation of acetate formation and re-assimilation [61] suggests that 
acetate is probably one of the last utilized carbon substrates; and that after the re-
assimilation of acetate, E. coli may face nutrient starvation and enter the stationary phase. 
1.3.5 Self-protection response of E. coli against starvation 
When essential nutrients are exhausted, the bacteria enter the stationary phase [62]. The 
organisms adapt to the starvation condition and survive in the absence of nutrients [63]. 
The cell’s metabolism must be redirected to maintenance; endogenous energy reserves 
must be mobilized; and the cell must survive in the absence of reproduction. These 
changes require noticeable physiological and structural changes in the cells [64]. 
Proteins produced early during starvation play very important roles in the cell’s survival 
[64-66]. For example, the synthesis of many proteins with specific roles in protecting the 
cell against external stresses is highly up-regulated during stasis survival [67-69]. It was 
found that many functions induced during stationary phase are also induced when the cells 
were grown at a low growth rate [63], so the inducible property of the stationary phase 
may also be important for growth under poor nutrient supply conditions. 
When the concentration of nutrients decreases, cell growth and metabolic processes 
gradually slow down. Analysis at the proteome level would be an appropriate procedure for 
the investigation of the molecular response to nutrient starvation. It is clear that E. coli can 
establish a self-protection mechanism in response to nutrient starvation. Among the 
proteomic reports [65, 68, 70-73] the number of identified proteins is limited, which does 
not give a comprehensive overview of the stationary phase physiology. 
So far, there is no report showing the relation between the self-protection response to 
nutrient deficiency and depletion, and the metabolic response during recombinant protein 
production in E. coli. In this thesis, it is found that clarification of the self-protection 
mechanism helps a lot in understanding the global metabolic response during recombinant 
protein overproduction. 
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1.3.6 The metabolic burden during recombinant protein production 
Under the control of strong promoters (e.g. T7 promoter), heterologous proteins are 
typically produced at high levels in E. coli, which causes a physiological stress known as 
metabolic burden. The investigation of the metabolic burden caused by the overproduction 
of recombinant protein has been extensively studied at the macroscopic view [22-24]. This 
is shown to lead to a decrease of specific growth rate [74-78] and biomass yield [76-78]; 
and results in an increase of maintenance energy coefficient [74], respiratory activity [77, 
79, 80], overflow metabolism of by-products [76] and inclusion bodies formation [81-86]. 
Apart from the production of the target protein, the simultaneously enhanced chaperones 
[77, 87, 88] and proteases [89, 90] also contribute to the metabolic burden. 
Owing to the complexity of metabolic networks and production conditions, the molecular 
mechanism of the metabolic burden is still ambiguous. Proteomic analyses could 
significantly help in the understanding of the underlying mechanism in E. coli, however, 
among the published proteomic reports [76-79, 88, 91-96], the identified proteins are often 
limited, which may increase the probability of misinterpretation. Therefore, there is still a 
huge demand for comprehensive proteomic analysis to understand the metabolic burden 
during recombinant protein overproduction. 
Ostensibly, there is no direct link between the cellular self-protection response to nutrient 
deficiency and depletion, and the metabolic burden during recombinant protein production 
in E. coli. In this thesis, the systemic proteomic analysis clearly revealed that the self-
protection mechanism is significantly disturbed when cells are forced to overproduce 
recombinant protein.  
1.3.7 E. coli proteome analysis 
E. coli is probably the best understood of all the simple model organisms, with a fully 
sequenced genome which makes it accessible for proteomic analysis using mass 
spectrometry [97]. For comprehensive proteomic studies, both the more recent liquid 
chromatography based- [98, 99] and the traditional two-dimensional gel electrophoresis 
based- [97, 100] approaches have their strengths and limitations; and the choice of one or 
the other approach depends on the questions to be answered. Liquid chromatography-mass 
spectrometry (LC-MS) combines physical separation using liquid chromatography with 
mass spectrometry. Proteolytic peptides are separated by chromatography. When eluted 
from the column, they enter the mass spectrometer where the final analysis is performed. 
In this thesis, the two-dimensional gel electrophoresis (2-DE) based proteomic platform 
was chosen to provide the relative abundance of each protein in the whole cell for the cross 
comparison between different growth conditions. 2-DE is a form of gel electrophoresis 
commonly used to analyze proteins [101]. It separates proteins in two steps, according to 
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two independent properties: the first dimension is isoelectric focusing (IEF), which 
separates proteins according to their isoelectric point (pI); the second dimension is sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), which separates proteins 
according to their molecular mass. With this method, complex mixtures consisting of 
thousands of different proteins can be resolved and the relative amount of each protein can 
be determined. 
 
Fig. 1.4 Flowchart of E. coli proteome analysis 
Matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF 
MS) [102] is a relatively novel technique in which a co-precipitate of an UV-light 
absorbing matrix and a biomolecule is irradiated by a nanosecond laser pulse. The ionized 
biomolecules are accelerated in an electric field and enter the flight tube. During the flight 
in this tube, different molecules are separated according to their mass to charge ratio. In 
this way each molecule yields a distinct signal. This method is used for detection and 
characterization of biomolecules, such as peptides, oligosaccharides and oligonucleotides.  
2-DE and MALDI-TOF-MS are the workhorses for proteomics as shown in Fig. 1.4. For 
organisms whose genome sequence is known, the identification of “interesting” protein 
spots from a 2-D gel is routine. Protein spots are excised and digested with a specific 
protease, e.g. trypsin, and the fragments measured by MALDI-TOF-MS. This peptide mass 
fingerprint then can be used to search databases to identify the protein [103]. 
Cultivation 2D gel electrophoresis MALDI MS
Peptide mass fingerprinting
Protein identification
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2 Novel defined modular media to produce recombinant proteins 
2.1 Introduction 
In this chapter, a simple defined autoinduction medium for recombinant protein 
production using T7-based E. coli expression systems with high product yields and 
good universal applicability is described. Based on the developed simple defined 
autoinduction medium, a protocol to generate heavy isotope and selenomethionine 
labeled proteins with high label incorporation and easy handling has been set up. 
The present chapter is based on two articles: 
Zhaopeng Li, Wolfgang Kessler, Joop van den Heuvel, Ursula Rinas. Simple 
defined autoinduction medium for high-level recombinant protein production for 
T7-based Escherichia coli expression systems, Appl Microbiol Biotechnol, 2011, 
91(4), 1203-1213 
Zhaopeng Li, Manfred Nimtz, Ursula Rinas. Optimized procedure to generate 
heavy isotope and selenomethionine-labeled proteins for structure determination 
using Escherichia coli-based expression systems, Appl Microbiol Biotechnol, 2011, 
92(4), 823-833 
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2.2 Simple defined autoinduction medium for high-level recombinant 
protein production using T7-based Escherichia coli expression 
systems 
Chapter 2.2 is an entire paper reprinted with the permission from Springer that was 
published in Applied Microbiology and Biotechnology in August 2011, Volume 91, 
Number 4, Page: 1203–1213 
License Number: 2951820701925 
License date: Jul 18, 2012 
Licensed content publisher: Springer 
Licensed content publication: Applied Microbiology and Biotechnology 
Licensed content title: Simple defined autoinduction medium for high-level 
recombinant protein production using T7-based Escherichia coli expression systems 
Licensed content author: Zhaopeng Li 
Licensed content date: Jan 1, 2011 
Volume number: 91 
Issue number: 4 
Type of Use: Thesis/Dissertation 
2.2.1 Abstract 
Protein production under the control of lac operon regulatory elements using autoinduction 
is based on diauxic growth of Escherichia coli on lactose after consumption of more 
preferred carbon substrates. A novel simple and cost-effective defined autoinduction 
medium using a mixture of glucose, glycerol, and lactose as carbon substrate and NH4
+
 as 
sole nitrogen source without any supplementation of amino acids and vitamins was 
developed for T7-based E. coli expression systems. This medium was successfully 
employed in 96-well microtiter plates, test tubes, shake flasks, and 15-L bioreactor 
cultivations for production of different types of proteins achieving an average yield of 500 
mg L
−1
 product. Cell-specific protein concentrations and solubility were similar as during 
conventional isopropyl β-D-1-thiogalactopyranoside induction using Luria-Bertani broth. 
However, the final yield of target proteins was about four times higher, as a higher final 
biomass was achieved using this novel defined autoinduction broth. 
Keywords Escherichia coli ∙ Recombinant protein production ∙ Autoinduction ∙ Defined 
medium  
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2.2.2 Introduction 
The Gram-negative bacterium Escherichia coli is the most popular organism for 
recombinant protein production because of its well-characterized genetic background, its 
ability to grow to high cell densities, and the large number of available cloning vectors and 
optimized host strains. Among numerous E. coli-based expression systems, the 
bacteriophage T7 RNA polymerase-controlled system is currently the most popular protein 
production system [1]. The T7 RNA polymerase is usually under control of the lac operon, 
thus protein production initiated by the addition of isopropyl β-D-1-thiogalactopyranoside 
(IPTG). 
The idea of autoinduction was introduced as a convenient way to perform recombinant 
protein production without inducer addition in small laboratory scale for lac operon-
controlled expression systems [25]. Carbon substrate mixtures of glucose, glycerol, and 
lactose are used, where glucose as the preferred carbon substrate is utilized first, followed 
by glycerol and lactose which also acts as the inducer of lac operon-controlled protein 
production [26]. Autoinduction omits biomass monitoring for the correct timing of inducer 
addition and places the shift from growth to recombinant protein production under 
metabolic control of the expression host [26]. 
There are several complex autoinduction media currently available: the original medium 
described by Studier [25] and others from commercial sources (Overnight Express™ 
Autoinduction System from Novagen and MagicMedia™ from Invitrogen with unknown 
ingredients). The presence of complex medium compounds such as tryptone, yeast extract, 
and others renders these media expensive and also not compatible with protein labeling 
(selenomethionine or heavy isotope labeling). Thus, several defined autoinduction media 
have been described later, but all contain various amino acid and vitamin supplements [26-
30]. For example, a defined autoinduction medium using an enhanced green fluorescent 
protein (GFP) as a reporter protein was announced which contains 18 different amino acids, 
8 different vitamins, and 10 different trace elements, altogether 46 different compounds [26, 
30]. This medium was successfully employed for screening studies in 96-well microtiter 
plates [104], but lower yields were achieved in larger-scale culture vessels [26]. Also, this 
medium has only been tested for a few proteins [31-33, 105] and, thus, has not been proven 
for universal applicability. 
Here, we present a novel, simple-to-prepare defined autoinduction medium consisting of 
glucose, glycerol, and lactose as carbon substrate and NH4
+
 as sole nitrogen source. 
Supplementation of this medium with amino acids and vitamins is not required. This 
medium was developed using three target proteins with different properties (GFP, 
glutathione-S-transferase-tagged GFP, and human basic fibroblast growth factor) and 
optimized in test tube and shake flask cultures. Finally, it was successfully tested for 
production of various proteins in the molecular mass range of 18 to 90 kDa. Moreover, the 
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optimized autoinduction medium revealed the same efficacy for protein production in 96-
well microtiter plates as well as in 15-L bioreactor cultivations leading to high final 
biomass concentrations (OD600>20) and average yields of 500 mg L
−1
 target protein.  
2.2.3 Materials and methods 
2.2.3.1 Strains and plasmids 
Table 2.2.1 Strains, plasmids, and target proteins 
Host strain Plasmid Target protein (MW) Reference 
E. coli BL21 (DE3) pET-29c-hFGF-2 hFGF-2 (18 kDa) [82] 
E. coli BL21 (DE3) pET-28c-His6-GFP GFP (27 kDa) This work 
E. coli BL21 (DE3) pET-15b-hPrP hPrP (29 kDa) [106] 
E. coli BL21 (DE3) pET-28a-PPARγ PPARγ (33 kDa) [107] 
E. coli Rosetta 2 
(DE3) 
PGEX-6P-1-Rab1A 
and pETM30-SidM 
Rab1A (50 kDa) 
and SidM (53 kDa) 
[108] 
E. coli BL21 
CodonPlus (DE3) RIL 
pETM30- Auto27-243-GST Auto27-243-GST (52 kDa) [109] 
E. coli BL21 (DE3) pETM30-His6-GST-GFP GST-GFP (54 kDa) [110] 
E. coli BL21 (DE3) PGEX-6P-1-YopO-GST YopO-GST (90 kDa) [111] 
 
Strains and plasmids are described in Table 2.2.1. The construction of the plasmids pET-
28c-His6-GFP and pETM30-His6-GST-GFP for production of different GFPs, His6-GFP 
(abbreviation: GFP), and His6-GST-GFP (abbreviation: GSTGFP) under the control of the 
T7 promoter was as follows. The plasmid pBAD-GFPuv (Clontech, Heidelberg, Germany) 
was used to generate pET-28c and pETM30 vector combinations for the C-terminal fusion 
of GFP to proteins of interest. Site-directed mutagenesis was used to remove the internal 
Nco1, Nde1, and BamH1 sites from the coding sequence of GFPuv. The reaction was done 
using the Quickchange Kit of Stratagene as recommended by the supplier. In subsequent 
rounds of mutagenesis using the primer pairs GFPmut1 and mut2 (GFPmut1: 5′-
GAAAACTACCTGTTCCCTGGCCAACACTTGTCA - 3′, GFPmut2: 5′ - TGA 
CAAGTGTTGGCCAGGGAACAGGTAGTTTTC-3′), GFPmut3 and mut4 (GFPmut3: 5′-
CCGTTATCCGGATCACATGAAACGGCATGAC -3′, GFPmut4: 5′ -GTCATGCCGTTT 
CATGTGATCCGGATAACGG-3′), and GFPmut5 and mut6 (GFPmut5: 5′-CACAACATT 
GAAGATGGAAGCGTTCAACTAGCAGA-3′, GFPmut6: 5′- TCTGCTAGTTGAACGCT 
TCCATCTTCAATGTTGTG-3′), respectively, the restriction sites were removed. An N-
terminal adapter sequence was introduced to be able to generate in-frame fusions to genes 
of interest. The primer pair GFPfus1 and GFPfus2 (GFPfus1: 5′-
CATGTGCCATGGGTCATAT G T G T TA A C T G A G TA G G AT C C G C TAGCGCT 
GGCTCCGCTGCTGGTTCTGGTA-3′, GFPfus2: 5′-CTAGTACCAGAACCAGCAGCG 
GAGCCAGCGCTAGCGGATCCTACTCAGTTAACACATATGACCCATGGCA-3′) was 
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annealed and ligated in pBADGFPmut digested with NheI. Correct linker integration 
concomitant to removal of the downstream Nhe1 site was verified by sequencing. After 
selection of the correct clone, the vector was named pBADGFPFUS. The GFPFUS 
sequence was then cloned into pETM30 vector (EMBL, Heidelberg, Germany) using the 
Nco1 site from the new linker and the downstream EcoR1 site. The GFPFUS fragment was 
cloned into linearized pETM30 digested with Nco1 and EcoR1. The positive clone was 
named pETM30GFPFUS. A similar clone pET-28c was generated by using the Nde1-
EcoR1 fragment of pBADGFPFUS cloned into the Nde1 and EcoR1 sites of pET-28c. This 
vector was named pET-28cGFPFUS. To create an in-frame fusion of GFP to His6- GST, 
the vector pETM30GFPFUS was digested with Nde1 and BamH1. The ends were filled 
using Klenow polymerase and dNTPs, and thereafter, the vector was religated. The 
resulting vector was called pETM30-His6-GST-GFP. The pET-28cGFPFUS vector was 
used to create a His-tagged GFP fusion by digestion with NheI and religation. This vector 
was called pET-28c-His6-GFP. The His6-GST-GFP (abbreviation: GST-GFP) and His6-
GFP (abbreviation: GFP) expression vectors were used as model systems to analyze the 
efficiency of recombinant gene expression. 
2.2.3.2 Medium preparation 
The composition of Luria-Bertani (LB) broth (low salts) was as follows: 10 gL
−1
 tryptone, 
5 gL
−1
 yeast extract, and 5 gL
−1
 NaCl. The pH was adjusted to 7 using 5 mol L
−1
 NaOH 
before autoclaving. For solidification, 15 gL
−1
 agar was added. The defined medium is 
based on methods described by Korz et al. [112]; details in composition are given in Table 
2.2.2. Special instructions for medium preparation are given in the Supplementary Tables 
5.2.1 and 5.2.2. Briefly, trace elements (CoCl2·6H2O, MnCl2·4H2O, CuCl2·2H2O, H3BO3, 
Zn (CH3COOH)2·2H2O, and Titriplex III) were prepared as 2,000 times concentrated stock 
solution mixture, sterilized by filtration (0.2 μm), and stored at 4 °C. Na2MoO4·2H2O was 
prepared as 5,000 times concentrated stock solution, sterilized by filtration (0.2 μm), and 
stored separately at 4 °C to prevent coprecipitation with the other trace elements during 
long-term storage. Carbon sources and MgSO4 (glucose, glycerol, lactose, and MgSO4) 
were prepared together as a combined stock solution and sterilized by filtration (0.2 μm). 
For larger amounts, the combined glucose, glycerol, lactose, and MgSO4 stock solution 
was heat-sterilized (121 °C, 20 min). After sterilization of the combined glucose, glycerol, 
lactose, and MgSO4 stock solution, the 5,000 times concentrated Na2MoO4·2H2O stock 
solution can be added, and the mixture can be kept at room temperature for long-term 
storage (carbon source stock). Ammonium and phosphate salts additionally including citric 
acid and ferric citrate [(NH4)2HPO4, KH2PO4, citric acid, and Fe(III) citrate] were prepared 
as combined stock solution. After adjusting the pH value to 6.8, the ammonium and 
phosphate salt stock solution can be heat-sterilized (121 °C, 20 min) or sterilized by 
filtration (0.2 μm). When the pH is adjusted by ammonium hydroxide (30%), filter 
sterilization is preferable. After sterilization, the ammonium and phosphate salts stock 
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solution can be mixed with the 2,000 times concentrated trace elements stock solution for 
long-term storage at room temperature (salt-trace stock). Directly before inoculation, the 
two major stock solutions (carbon source stock and salt-trace stock) were combined and 
supplemented with the appropriate antibiotics. Antibiotics working and stock solutions 
were prepared according to Molecular Cloning: A Laboratory Manual (Third Edition) 
[113]. For bioreactor cultures, the pH was adjusted to 6.8 with ammonium hydroxide after 
heat-sterilization. 
Table 2.2.2 Carbon source matrix for autoinduction medium development 
Experiment 
test tubes 
Experiment 
shake flasks 
Glucose 
(gL
−1
) 
Glycerol 
(gL
−1
) 
Lactose 
(gL
−1
) 
Carbon 
source (gL
−1
) 
T1  0 0 3.8 3.8 
T2  0 4.0 3.8 7.8 
T3 S1 0 7.4 3.8 11.2 
 S3 0 7.4 7.6 15.0 
 S3 0 11.1 3.8 14.9 
 S4 0 11.1 7.6 18.7 
T4  2.9 0 3.8 6.7 
T5  2.9 4.0 3.8 10.7 
T6 S5 2.9 7.4 3.8 14.1 
 S6 2.9 7.4 7.6 17.9 
 S7 2.9 11.1 3.8 17.8 
 S8 2.9 11.1 7.6 21.6 
T7  5.9 0 3.8 9.7 
T8  5.9 4.0 3.8 13.7 
T9 S9 5.9 7.4 3.8 17.1 
 S10 5.9 7.4 7.6 20.9 
 S11 5.9 11.1 3.8 20.8 
 S12 5.9 11.1 7.6 24.6 
IPTG control 10.9 0 0 10.9 
Except for the concentration of carbon substrate(s), the concentrations of the remaining components were 
identical and as follows: 4 gL
−1
 (NH4)2HPO4, 13.3 gL
−1
 KH2PO4, 1.55 gL
−1
 citric acid, 0.59 gL
−1
 MgSO4, 
100.8 mg L
−1
 Fe(III) citrate, 2.1 mg L
−1
 Na2MoO4·2H2O, 2.5 mg L
−1
 CoCl2·6H2O, 15 mg L
−1
 
MnCl2·4H2O, 1.5 mg L
−1
 CuCl2·2H2O, 3 mg L
−1
 H3BO3, 33.8 mg L
−1
 Zn(CH3COOH)2·2H2O, and 14.1 
mg L
−1
 Titriplex III. The pH was adjusted with ∼2.7 gL−1 NaOH to pH 6.8 
2.2.3.3 Analysis of cell growth 
Cell growth was monitored by measurement of the absorbance at 600 nm (OD600) and dry 
cell mass (DCM) as described [112]. One unit of OD600 corresponds to 0.37 g dry cell 
mass per liter for E. coli BL21(DE3) [determined during growth in Defined Non-inducing 
Broth (DNB) at 30 °C]. 
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2.2.3.4 Analysis of protein concentration 
Culture samples were centrifuged at 17,000×g and 4 °C for 3 min. After removal of the 
supernatant, cell pellets were stored at −80 °C until further analysis. For preparation of cell 
extracts and determination of soluble and insoluble product fractions, cell pellets were 
disrupted by BugBuster™ Protein Extraction Reagent (Novagen, USA) with rLysozyme 
and Benzonase according to manufacturer's instructions. Soluble and insoluble cell 
fractions were separated by centrifugation at 17,000×g and 4 °C for 25 min. Sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis of total cell 
protein and soluble and insoluble protein fractions was performed using Criterion™ Tris–
HCl Gel (8–16% polyacrylamide gel, 26-well) in Criterion™ Cell (Bio-Rad, USA) 
according to standard procedures [114] and manufacturer's instructions. Electrophoresis 
was carried out at constant voltage (160 V). After electrophoresis, SDS-PAGE gels were 
stained using colloidal Coomassie G-250 [115]. Destained wet gels were scanned using 
ScanMaker 9800XL (Microtek, Taiwan). Expression levels of target protein (in percentage 
of total cell protein) were determined by AIDA Image Analyzer (Raytest, Germany) from 
SDS-PAGE. Specific and volumetric product concentrations were calculated assuming a 
constant cell protein content of 550 mg protein per gram cell dry mass [116]. Fluorescence 
measurements were conducted in triplicate using Infinite™ M200 (Tecan, Switzerland) 96-
well plate reader with 395 nm excitation and 510 nm emission filters as described [117] 
and according to equipment manufacturer's instructions.  
2.2.3.5 Cultivation conditions 
2.2.3.5.1 Test tube and shake flask cultivations 
Test tubes with diameter of 10 mm, 100- or 250-ml Erlenmeyer flasks with three baffles, 
and 1.8-L Fernbach flask with three baffles were used with working volumes of 2, 10 or 25, 
and 200 ml, respectively. Glycerol stocks of recombinant E. coli strain were streaked on 
LB agar plates and incubated overnight at 37 °C. After overnight incubation, single 
colonies were picked and transferred to LB medium (2 ml in test tube or 10 ml in 100-ml 
shake flask). The cultures were shaken at 37 °C for 4∼6 h until the OD600 reached about 
1.0. Following, DNB medium in shake flasks were inoculated with LB medium pre-
cultures to give a starting OD600 of 0.02. Cultures were shaken at 37 °C for 6∼7 h until 
the OD600 reached 1.5∼2.0. DNB medium pre-cultures were used to inoculate the main 
cultures (DNB or S-DAB) giving a starting OD600 of 0.02. The shaking speed was 180 
and 140 rpm, respectively, for test tubes and shake flasks using a shaker with amplitude of 
5 cm. The cultivation time using autoinduction medium was as follows: 18 h at 37 °C, 26 h 
at 30 °C, and 48 h at 23 °C. For IPTG-induced cultivation (in LB or DNB medium), the 
inoculated cultures were shaken at 37 °C until the OD600 reached 1.0 (LB medium) or 1.5 
(DNB medium). Then, 0.25 mmol L
−1
 IPTG was added to the culture to start protein 
production, and the temperature was reduced to 30 °C or 23 °C, depending on the required 
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induction temperature. The time of induction at 37 °C, 30 °C, and 23 °C was 4 h, 6 h, and 
overnight (about 16 h), respectively. Special attention should be paid to E. coli Rosetta 2 
(DE3), which grows slower than E. coli BL21 (DE3). In this case, the starting OD600 
value should be raised to 0.04 or the cultivation time prolonged. Test tube and shake flask 
cultivations were carried out in triplicate and duplicate, respectively. Mean values are 
given. 
2.2.3.5.2 Bioreactor cultivations 
For a 10-L autoinduction cultivation carried out in a 15-L bioreactor (Fermenter B10, Fa. 
Biologische Verfahrenstechnik, Switzerland), the following settings were chosen: starting 
OD600 of 0.02, temperature of 23 °C, starting pH of 6.8 (controlled at pH 6.8 by addition 
of ammonium hydroxide or non-controlled), air-flow rate of 1 vvm, and stirrer speed of 
450 rpm. The conditions were kept constant during the entire cultivation. Off-gas analysis 
was performed using a BCproFerm system (BlueSens, Germany). The end of the 
cultivation was indicated by a sudden rise in the dissolved oxygen concentration indicating 
depletion of all carbon compounds. 
2.2.3.5.3 Microtiter plate cultivations 
For autoinduction cultivation carried out in 96 deep well plates (2 ml total volume per 
well), single colonies were transferred from LB agar plates to 0.5 ml LB broth (per well) 
and shaken at 1,000 rpm with an orbital amplitude of 2 mm at 37 °C for 7 h to reach 
stationary phase. Five microliters of these LB pre-cultures were inoculated to 0.5 ml DNB 
(per well) and cultivation carried out overnight (16 h) at 25 °C. After overnight cultivation, 
OD600 values of DNB pre-cultures were analyzed. Following, 0.5 ml of S-DAB (HNC) 
(per well) was inoculated with DNB grown pre-cultures to give a starting OD600 of 0.02. 
The cultures in 96 deep well plates were shaken at 25 °C for 40 h. All cultivations were 
carried out in triplicate. Mean values are given. 
2.2.4 Results 
2.2.4.1 Choice of reporter proteins 
For the development of a universal production medium with a broad application range, 
three reporter proteins were chosen for medium optimization covering different protein 
properties, e.g., propensity to form inclusion bodies, size, biological activity, and post-
translational oxidative fluorophore formation. 
Two fluorescent proteins were employed. The amount of properly folded GFP can be 
easily accessed by fluorescence measurements rendering GFPs as the most popular 
reporter proteins [118, 119]. In addition to conventional GFP carrying an N-terminal His6 
extension, a GFP fusion protein was chosen which additionally included the sequence of 
glutathione-S-transferase (GST) between the N-terminal His6 tag and GFP. The additional 
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presence of the GST tag increases the size of the protein from 27 to 54 kDa and also 
strongly increases the propensity to form inclusion bodies. The GST-GFP fusion protein 
only emits fluorescence when the entire fusion protein is correctly folded. As third reporter 
protein, human basic fibroblast growth factor (hFGF-2, 18 kDa) was employed. hFGF-2 
can be produced as soluble active protein but also aggregates into non-active inclusion 
bodies. The expression level and the fraction of soluble active protein is strongly 
influenced by the culture conditions [3, 82, 83]. 
2.2.4.2 The influence of temperature and carbon substrate composition on protein 
production using autoinduction 
Screenings were carried out in test tube and shake flask cultivations and not in microtiter 
plates to prevent potential inaccuracies during autoinduction medium development 
resulting from evaporation [26, 120]. 
The initial screening for temperature effects was carried out in test tube cultures using GFP 
and GST-GFP as reporter proteins. Both proteins were produced in test tube cultivations at 
37 °C, 30 °C, and 23 °C employing a carbon source matrix with nine independent 
combinations of glucose, glycerol, and lactose (indicated as T1–T9 in Table 2.2.2) and 
using IPTG induction in DNB as control. 
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Fig. 2.2.1 Influence of temperature on protein production using autoinduction 
Cells were grown in test tubes using autoinduction (T6, refer to Table 2.2.2), and production of GFP 
(white columns) and GST-GFP (black columns) followed using IPTG induction in defined medium (DNB) 
as control. Upper panel: relative fluorescence per nanomol of GFP (white columns) and GST-GFP (black 
columns). Final OD600 of GFP (white squares) and GST-GFP- (black squares) producing culture. Lower 
panel: volumetric concentration of GFP (white columns) or GST-GFP (black columns). Temperature and 
induction method are indicated below 
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A representative result showing the temperature effect on protein production using Defined 
Autoinduction Broth (DAB) is shown in Fig. 2.2.1. The volumetric product concentrations 
were not significantly affected by the temperature; however, the amount of correctly folded 
protein (indicated as fluorescence per nanomolar of GFP or GST-GFP) increased 
dramatically for both proteins with decreasing temperature. Thus, further experiments for 
optimizing the medium composition were carried out at 23 °C. 
To obtain a general optimized autoinduction medium, the carbon source matrix from test 
tube cultivations was complemented by a matrix including 12 different carbon source 
combinations employed in shake flask cultivations (S1–S12) resulting in 18 different 
combinations of glucose, glycerol, and lactose and containing three combinations which 
were tested both in test tube and shake flask cultures (Table 2.2.2). The carbon source 
combination screening was performed with the two fluorescent proteins and hFGF-2. 
The results revealed that each protein has its unique optimal carbon source combination 
(Fig. 2.2.2). For example, the highest volumetric fluorescence of GFP was obtained in 
autoinduction medium without glucose. Increasing glucose concentrations were 
accompanied with decreasing volumetric fluorescence of GFP in agreement with 
previously reported results [26]. However, the best production of the GST-GFP fusion 
protein was achieved in the presence of ∼3 gL−1 glucose, and the best hFGF-2 production 
was obtained in the range of ∼3 to 6 gL−1 glucose. Thus, the best medium composition for 
production of a new protein is determined as a compromise and might be used as a starting 
point for further optimization if repetitive or large-scale production is envisioned. For 
further studies, the combination of ∼3 gL−1 glucose, ∼11 gL−1 glycerol, and ∼7.5 gL−1 
lactose was chosen, and this medium was named “Smart”- DAB (S-DAB) (Table 2.2.3). It 
should be noticed that this autoinduction medium is superior to conventional IPTG 
induction in defined medium regarding the amount of properly folded protein (see GST-
GFP as an example in Figs. 2.2.1 and 2.2.2). The complete dataset showing the influence 
of carbon source combination on protein production using autoinduction is shown in 
Supplementary Figs. 5.2.1 and 5.2.2. 
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Fig. 2.2.2 Influence of carbon substrate composition on protein production using autoinduction 
Cells were grown in test tube (narrow column) and shake flask (broad column). Upper panel: 
fluorescence per 100 μl of GFP-producing culture (white columns). Middle panel: fluorescence per 100 μl 
of GST-GFP-producing culture (black columns). Lower panel: volumetric hFGF-2 concentration (gray 
columns). The light gray shadows indicate the maximum product yield area. Test tube and shake flask run 
numbers and glucose, glycerol, and lactose concentrations are indicated below (refer to Table 2.2.2) 
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Table 2.2.3 Optimized defined (autoinduction) medium 
Medium Application Carbon source(s) pH adjustment 
S-DAB (HNC): “smart”-
defined autoinduction broth 
(high nitrogen content) 
Cultivation with 
good 
oxygen supply 
2.9 gL
−1 
glucose  
11.17 gL
−1 
glycerol  
7.6 gL
−1 
lactose  
about 4.5 ~5 ml L
−1 
NH3·H2O (~30 %) to 
reach pH 6.8 
S-DAB: 
“smart”-defined 
autoinduction broth 
Cultivation with 
intermediate 
oxygen supply 
2.9 gL
−1 
glucose  
11.17 gL
−1 
glycerol 
7.6 gL
−1 
lactose  
about 2.7gL
−1 
NaOH 
to bring final pH to 
6.8 
DAB: defined autoinduction 
broth 
Cultivation with 
poor 
oxygen supply 
2.9 gL
−1 
glucose 
7.4 gL
−1 
glycerol 
3.8 gL
−1 
lactose  
DNB: defined non-inducing 
broth 
IPTG induction 
or pre-culture 
10.9 gL
−1 
glucose  
Except for the concentration of carbon substrate(s) and method of pH adjustment, the concentrations of 
remaining components were as in Table 2.2.2 
2.2.4.3 The influence of nitrogen content on protein production using 
autoinduction 
The pH of the medium can be adjusted either by sodium or ammonium hydroxide, which 
increases either the salt (sodium) or the nitrogen content of the medium, respectively. 
When pH adjustment of S-DAB was carried out with ammonium instead of sodium 
hydroxide, the ammonium content increased from 60 to 120 mmol L
−1
, decreasing the C/N 
ratio from 12 to 6 (C-mol/N-mol), respectively. 
Adjusting the pH with ammonium instead of sodium hydroxide resulted in higher final cell 
densities and higher final volumetric product concentrations (Fig. 2.2.3). Moreover, for 
GFP and GST-GFP, also a slight increase in the specific product concentration was 
observed, while no changes were found for hFGF-2 (Supplementary Fig. 5.2.3). The 
percentage of soluble target protein was unaffected for GFP and hFGF-2, but for GST-GFP, 
a substantial increase in inclusion body formation occurred when the medium pH was 
adjusted with ammonium hydroxide (Fig. 2.2.3). However, the volumetric concentration of 
correctly folded GST-GFP (also shown as GFP fluorescence per culture volume) was 
unaffected as the decreased solubility was compensated by the higher final volumetric 
GST-GFP concentration (Fig. 2.2.3). Thus, it is recommended to adjust the pH by using 
ammonium hydroxide. The corresponding medium has a higher nitrogen content (HNC) 
and, thus, is named S-DAB (HNC) (Table 2.2.3). 
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Fig. 2.2.3 The influence of nitrogen content on protein production using autoinduction 
The nitrogen content of S-DAB was increased by using ammonium hydroxide [S-DAB (HNC)] for pH 
adjustment instead of sodiumhydroxide (S-DAB). (A) Volumetric concentrations of GFP (white columns), 
GST-GFP (black columns), and hFGF-2 (gray columns) in S-DAB (left column) and S-DAB (HNC) 
(right column). (B) Fluorescence per 100 μl of GFP (white columns) and GST-GFP-producing culture 
(black columns) in S-DAB (left column) and S-DAB (HNC) (right column). (C) Percentage of soluble 
(left column) and insoluble (right column) product amounts and final cell densities, respectively, of GFP 
(white columns, white squares), GST-GFP (black columns, black squares), and hFGF-2- (gray columns, 
gray squares) producing cultures in S-DAB and S-DAB (HNC) 
2.2.4.4 The influence of oxygen supply on protein production using autoinduction 
The oxygen supply in simple culture vessels can be improved by increasing the shaking 
speed and/or the culture surface to volume ratio. The analysis of oxygen supply on the 
production of GFP and hFGF-2 in S-DAB (HNC) clearly showed an increase in final cell 
density and volumetric product concentration for both proteins with increasing oxygen 
supply (Fig. 2.2.4). Moreover, better oxygenation also strongly decreased the formation of 
inclusion bodies during hFGF-2 production (Supplementary Fig. 5.2.4). Thus, protein 
production using autoinduction should be carried out under conditions which provide the 
best oxygenation. However, if sufficient oxygen cannot be supplied (e.g., growth in test 
tubes at 37 °C), glycerol and lactose concentrations can be reduced (to ∼7.5 and 4 gL−1, 
respectively). The resulting DAB can be pH adjusted with sodium hydroxide (Table 2.2.3). 
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Fig. 2.2.4 The influence of oxygen supply on protein production using autoinduction 
Fluorescence per 100 μl of GFP-producing culture (white columns) and volumetric hFGF-2 concentration 
(gray columns) and final cell densities of the GFP (white squares) and hFGF-2- (gray squares) producing 
culture using S-DAB (HNC). The experimental conditions were as follows: (A) 10 ml in 100-ml shake 
flask at 140 rpm, (B) 25 ml in 100-ml shake flask at 140 rpm, (C) 10 ml in 100-ml shake flask at 80 rpm, 
(D) 50 ml in 100-ml shake flask at 140 rpm, (E) 25 ml in 100-ml shake flask at 80 rpm, and (F) 50 ml in 
100-ml shake flask at 80 rpm 
2.2.4.5 Test of general applicability of S-DAB (HNC) for T7-based production 
systems 
The general applicability of S-DAB (HNC) medium was tested for the production of eight 
different proteins involving three different T7-based host strains (Table 2.2.1). Production 
using autoinduction in S-DAB (HNC) was compared to production in conventional LB 
medium using IPTG for induction of protein synthesis. This comparison revealed in 
general similar specific product concentrations using either S-DAB (HNC) or LB, but final 
yields of target proteins were significantly higher in S-DAB (HNC) as about four times 
higher final biomass concentrations were reached (Fig. 2.2.5). However, it should be noted 
that the actual attainment is specific to the target protein. For example, in case of the 
protein Auto27-243-GST, the utilization of S-DAB (HNC) instead of LB not only resulted 
in six times higher cell densities but also significantly improved the specific product 
concentration and the solubility of the target protein. In most cases, the improvement was 
less spectacular, and in some cases, a slight decline in specific product concentration or 
solubility was observed. Thus, S-DAB (HNC) can be used for the production of different 
types of proteins with usual excellent results; moreover, it can also be used for T7-based 
host strains, which show poor growth characteristics such as E. coli Rosetta 2 (DE3). 
2.2.4.6 Test of applicability of S-DAB (HNC) for screening studies in 96-well 
microtiter plates 
The availability of a medium which omits inducer addition would greatly facilitate 
screening in 96-well microtiter plates for best production clones. Thus, the production of 
eight different proteins involving three different T7-based host strains (Table 2.2.1) was 
tested in 96 deep well plates using S-DAB (HNC) (Fig. 2.2.6). In all cases, the specific 
protein concentration was similar or even higher compared to production in shake flask 
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cultures (refer to Fig. 2.2.5). Moreover, in all cases, higher final cell densities were 
obtained presumably as a result of evaporation. In summary, it can be concluded that S-
DAB (HNC) is very well suited for screening studies employing 96-well microtiter plates. 
 
Fig. 2.2.5 Test of general applicability of S-DAB (HNC) for T7 based production systems 
Production of various proteins using different T7-based expression systems was carried out in Fernbach 
flasks using S-DAB (HNC) or IPTG-induction in Luria Bertani broth as control. Produced target proteins 
(refer to Table 2.2.1) and media are indicated above. Below are indicated the cell fraction analyzed by 
SDS-PAGE (W: whole cell protein. S: soluble part and I: insoluble part of whole cell protein) and the 
final cell densities (OD600) 
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Fig. 2.2.6 Test of applicability of S-DAB (HNC) for screening studies in 96-well microtiter 
plates 
The following proteins (refer to Table 2.2.1) were produced in deep-well plates and the total cell protein 
analyzed by SDS-PAGE: hFGF-2 (lane 3), hPrP (lane 4), GFP (lane 5), PPARγ (lane 6), co-production of 
Rab1A and SidM (lane 7), Auto27-243-GST (lane 8), GST-GFP (lane 9), and YopO-GST (lane 10). 
Protein standard (lanes 1 and 11) and plasmid free E. coli BL21 (DE3) are included as control (lane 2). 
The final cell densities are indicated below 
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Fig. 2.2.7 Test of applicability of S-DAB (HNC) for large-scale cultivation 
hFGF-2 was produced in 15-L bioreactors (A) with pH control (pH 6.8) and (B) without pH control. All 
other culture variables were identical in both cultures. The concentrations of oxygen (solid line) and 
carbon dioxide (dashed line) in the exhaust gas and the pH of the culture broth (dotted line) are shown. 
The inserts show SDS-PAGE analysis of whole cell protein from samples taken at indicated time points 
and final cell densities 
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2.2.4.7 Test of applicability of S-DAB (HNC) for large-scale cultivation 
The applicability of S-DAB (HNC) for large-scale cultivation was analyzed in 15-L 
bioreactors for the production of hFGF-2. Cultivations were carried out as pH-controlled 
batch process and also in the absence of pH control while keeping other culture variables 
identical. Both conditions were leading to nearly identical final cell densities and 
expression levels as were obtained in well-aerated shake flask cultures (Fig. 2.2.7 and refer 
to Fig. 2.2.5). The final pH in the non-pH controlled culture reached pH 5.9, indicating an 
excellent buffering capacity of S-DAB (HNC) and its applicability for large-scale 
cultivation without pH control. 
2.2.5 Discussion 
A simple defined autoinduction medium was developed with general applicability for 
production of proteins with diverse properties using T7-based host strains with different 
growth characteristics. It can be employed in micro- as well as in macro-scale culture 
vessels leading to high final biomass concentrations (OD600>20) and average yields of 
500 mg L
−1
 target protein. As there is no need for pH control and inducer addition, this 
defined medium represents a very convenient way for protein production. The final 
product levels are in average four times higher than can be reached in complex LB broth 
through IPTG-induced protein production. The well-balanced composition of SDAB (HNC) 
also becomes evident as the medium C/N ratio is close to the C/N ratio of the E. coli cell 
[121] and the biomass yield coefficient close to the one at best attainable, e.g., 0.5 and 0.43 
gg
−1
 for glucose and glycerol, respectively [112, 122]. Moreover, the defined composition 
only including basic compounds and no vitamin and amino acid supplements also renders 
it suitable for production of labeled proteins. However, special attention should be given to 
provide sufficient oxygen, e.g., growth at low temperature and high surface-to-volume 
ratio of culture broth. Under conditions of poor oxygen supply, glycerol and lactose 
concentrations can be reduced. 
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2.3 Optimized procedure to generate heavy isotope and 
selenomethionine-labeled proteins for structure determination 
using Escherichia coli-based expression systems 
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2.3.1 Abstract 
Generating sufficient quantities of labeled proteins represents a bottleneck in protein 
structure determination. A simple protocol for producing heavy isotope as well as 
selenomethionine (Se-Met)-labeled proteins was developed using T7-based Escherichia 
coli expression systems. The protocol is applicable for generation of single-, double-, and 
triple-labeled proteins (
15
N, 
13
C, and 
2
H) in shaker flask cultures. Label incorporation into 
the target protein reached 99% and 97% for 
15
N and 
13
C, respectively, and 75% of (non-
exchangeable) hydrogen for 
2
H labeling. The expression yields and final cell densities 
(OD600 ~16) were the same as for the production of non-labeled protein. This protocol is 
also applicable for Se-Met labeling, leading to Se-Met incorporation into the target protein 
of 70% or 90% using prototrophic or methionine auxotrophic E. coli strains, respectively. 
Keywords Escherichia coli ∙ Recombinant protein production ∙ Stable heavy isotope 
labeling ∙ Selenomethionine labeling ∙ Autoinduction ∙ Defined medium 
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2.3.2 Introduction 
Stable heavy isotope (
15
N, 
13
C, and 
2
H) and selenomethionine (Se-Met)-labeled proteins 
are commonly used for protein structure determination through NMR spectroscopy [4] and 
X-ray crystallography [5], respectively. The generation of isotope-enriched protein 
samples is a prerequisite for carrying out structural studies using NMR spectroscopy [34-
36]. Also, incorporation of Se-Met into proteins considerably improves protein structure 
studies by X-ray crystallography through phase determination by multi-wavelength 
anomalous diffraction [37, 38]. 
As labeling experiments are usually costly, an efficient and simple protocol for generating 
labeled proteins is of crucial importance to structural biologists. Current protocols for 
production of heavy isotope and Se-Met-labeled proteins using Escherichia coli expression 
systems are mainly based on M9 minimal medium [5, 39-43] leading to very poor final 
biomass concentrations (OD600 of 1~2) and, consequently, low yields of labeled proteins. 
Some improvements have been obtained by optimizing the minimal medium [46] or by 
using autoinduction medium for the generation of 
15
N and/or 
13
C or Se-Met-labeled 
proteins [25, 27, 28]. Moreover, carbon-limited fed-batch processes have been developed 
for production of 
15
N and 
13
C [44] or Se-Met labeled proteins [45] which lead to higher 
final biomass concentrations (OD600 of ~6 or ~11 for heavy isotope or Se-Met-labeled 
proteins, respectively) and, thus higher labeled target protein yields. However, the 
establishment of carbon-limited fed-batch processes usually requires the availability of 
more sophisticated technical equipment and, more importantly, the availability of 
dedicated staff. Thus, there is still a great need for protein labeling protocols which are 
easy to implement and lead to sufficient protein amounts with high-label incorporation at 
acceptable costs. 
The production of deuterated (
2
H-labeled) proteins is even more difficult and very costly 
with current protocols as multiple adaptation steps of E. coli to pure D2O are required to 
generate protein with high-label content [123]. Even after adaptation, cell densities reached 
in D2O did not increase above OD600 ~5 [123, 124]. As alternative, cells can be grown in 
the presence of 75% D2O to avoid the strong inhibitory effect of pure D2O on growth and 
protein production; however, the reduced D2O content also reduces the deuteration 
efficiency of the target protein [125]. Furthermore, for all labeling methods, different 
protocols are currently employed, all with their unique stock solutions and procedures, 
making the production of highly labeled proteins tedious, more costly than necessary and 
most often the bottleneck of protein structure determination. 
In this work, we present a unified protocol based on a modular system which can be used 
to efficiently produce heavy isotope (mono- or multiple-incorporations of 
2
H, 
13
C, and 
15
N) 
as well as Se-Met-labeled proteins with high-label content using the T7-based E. coli 
expression system. Special attention is given to the production of deuterated proteins.  
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2.3.3 Materials and methods 
2.3.3.1 Strains and plasmids 
E. coli BL21 (DE3) (Novagen, Germany) and the methionine auxotrophic strain T7 
Express Crystal (New England Biolabs, USA) were used. The plasmid pET-15b-hPrP 
encoding the human prion protein (hPrP, residues 23–231) under control of the T7 
promoter is described elsewhere [106]. Details concerning the plasmids pET-29c-hFGF-2 
and pET-28c-His6-GFP encoding human basic fibroblast growth factor (hFGF-2) and 
His6-tagged green fluorescent protein (GFP) are found elsewhere [82, 110]. 
2.3.3.2 Medium composition and preparation 
The composition of the Luria-Bertani (LB) medium was as follows: 10 g L
−1
 tryptone, 5 g 
L
−1
 yeast extract, 5 g L
−1
 NaCl and 15 g L
−1
 agar added for medium solidification, the final 
pH was adjusted to pH 7 before autoclaving. The composition and preparation of the 
defined labeling medium are based on the defined high cell-density cultivation medium 
[112] and the defined autoinduction medium [110]. A general scheme for the usage and 
composition of the defined labeling medium including medium abbreviations are given in 
Table 2.3.1. Detailed instructions for medium preparation are provided in the 
Supplementary Tables 5.2.1 and 5.2.2. Appropriate antibiotics were added to the medium 
for plasmid maintenance (pET-15b-hPrP, 100 mg L
−1
 ampicillin, pET-29c-hFGF-2 and 
pET-28c-His6-GFP, 50 mg L
−1
 kanamycin). D-glucose (U-
13
C6, 99%), ammonium 
chloride (
15
N, 99%), and deuterium oxide (D, 99.9%) used for labeling experiments were 
purchased from Cambridge Isotope Laboratories Inc. (Andover, MA, USA). L-
selenomethionine was purchased from Sigma-Aldrich (Munich, Germany). 
2.3.3.3 Cultivation conditions 
Two different cultivation strategies for different labeling purposes were employed (for 
details, refer to Fig. 2.3.1). In principle, autoinduction was performed for non-labeled 
protein production (control run), and for 
15
N and 
2
H labeling. For 
13
C labeling (or 
combined with 
2
H or 
15
N labeling) and for selenomethionine labeling, medium exchange 
was applied (spin down pre-cultures and resuspend cell pellets in labeling medium). 
Cultivations were carried out in duplicate using 250 mL shake flasks with three baffles 
containing 25 mL medium at 180 rpm (using a shaker with an amplitude of 5 cm). Mean 
values are given. 
2.3.3.4 Analysis of cell growth and protein production 
Cell growth was monitored by measurement of the absorbance at 600 nm (OD600). For 
protein production analysis, culture samples were centrifuged at 17,000×g and 4°C for 3 
min. After removal of supernatant, cell pellets were stored at −80°C until further analysis. 
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SDS-PAGE analysis was performed in PROTEAN II xi (Bio-Rad, USA) according to 
standard procedures [114] and instructions from the manufacturer. BugBuster
TM 
Protein 
Extraction Reagent (Novagen, USA) was used to generate cell extracts and to prepare 
soluble and insoluble fractions according to the instructions from the manufacturer. After 
electrophoresis, proteins on SDS-PAGE gels were visualized by colloidal Coomassie G-
250 staining [115]. Stained wet gels were scanned by ScanMaker 9800XL (Microtek, 
Taiwan). 
2.3.3.5 Heavy isotope and selenomethionine labeling efficiency determination 
The heavy isotope or Se-Met labeling efficiency was analyzed by matrix-assisted laser 
desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). Protein bands 
were excised manually from the SDS-PAGE gels. After washing, reduction, and alkylation, 
in-gel digestion was carried out by incubation with sequencing grade-modified trypsin 
(Promega, USA). Obtained peptides were extracted and purified with reversed-phase C18 
ZipTips (Millipore, USA). Desalted peptide solutions were mixed with a saturated matrix 
solution and spotted onto a 384 MTP target and dried at room temperature. A Bruker 
Ultraflex time-of-flight mass spectrometer (Bruker Daltonics GmbH, Germany) was 
employed to obtain peptide mass fingerprints. Details of the protocol have been described 
previously [126, 127]. 
The mass fingerprint spectra of proteins with different labeling methods were analyzed 
using the software flexAnalysis
TM
 (Bruker Daltonics GmbH, Germany). The theoretical 
mass fingerprint spectra of the proteins were generated by PeptideCutter in ExPASy 
Proteomics Server (http://www.expasy.org/tools/peptidecutter/). The formula of each 
peptide was calculated by ProtParam in ExPASy Proteomics Server 
(http://www.expasy.org/tools/protparam.html). The theoretical peptide isotopic 
distributions with the different isotope abundances were calculated using IsoPro 3.0 
MS/MS software and matched with the experimental mass spectra to determine the 
isotopic labeling efficiency. The numbers of non-exchangeable and exchangeable 
hydrogen atoms in the proteins were determined according to the amino acid sequence as 
described previously [128]. The theoretical isotopic distribution of the peptides with 
methionine replaced by Se-Met was calculated by IsoPro 3.0 MS/MS software and 
compared with the experimental mass spectra to help locate the position of peptides 
containing Se-Met in the experimental mass spectra. The area below the mass spectrum of 
a peptide containing methionine or Se-Met was integrated. The Se-Met labeling efficiency 
for each individual peptide was calculated according to the literature [129]. Average heavy 
isotope or Se-Met labeling efficiency of trypsin digested peptides in the experimental MS 
fingerprint was used to determine the approximate overall labeling efficiency of the protein.  
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2.3.4 Results 
2.3.4.1 General considerations for developing media for heavy isotope and 
selenomethionine labeling 
Two different types of defined media were developed for generating labeled proteins based 
on the two methods used for induction of protein production: autoinduction and isopropyl 
β-D-1-thiogalactopyranoside (IPTG) induction (for details refer to Table 2.3.1). 
Special attention was given to generate media recipes where labeled substrates of the 
lowest price can be used. For example, 
15
NH4Cl is much cheaper than (
15
NH4)2HPO4, thus 
NH4Cl was used as the sole nitrogen source in labeling medium instead of (NH4)2HPO4. 
Usually, ammonium phosphate is the better nitrogen source in defined media as it 
contributes to a better buffering capacity for pH maintenance and additionally provides the 
required phosphate for cell growth. When replacing (NH4)2HPO4 in the medium (e.g., in 
the defined non-inducing broth [DNB]) by NH4Cl (e.g., in the labeling defined non-
inducing broth [L-DNB]), the labeling medium contains in addition 60.5 mmol L
−1
 NaCl, 
which is introduced by pH adjustment using NaOH (instead of NH4OH). This higher salt 
content causes a decrease of the specific growth rate by 13% of E. coli BL21 (DE3) at 
37°C in L-DNB compared to DNB. 
If possible, autoinduction was used as a very convenient method for generating labeled 
proteins as it omits biomass monitoring for the correct timing of inducer addition and 
places the shift from growth to recombinant protein production under metabolic control of 
the expression host [110]. Using autoinduction, a mixture of glucose, glycerol, and lactose 
is used as carbon substrate. However, the prices of 
13
C-labeled glycerol and lactose are 
beyond the budget of most research groups and much higher compared to 
13
C-glucose. 
Thus, employing the autoinduction method for generating 
13
C-labeled proteins is not 
advised. In this case, the utilization of 
13
C-labeled glucose as sole carbon source in 
combination with IPTG induction is the better choice. To reduce labeling costs, cells are 
pregrown on non-labeled glucose prior to simultaneous addition of IPTG and 
13
C-glucose. 
For high-label incorporation, it is recommended to remove unlabelled carbon substrates 
and potentially toxic by-products such as acetic acid prior to adding IPTG and the labeled 
substrate. Thus, it is recommended to exchange the medium with fresh medium containing 
the IPTG and labeled glucose. 
Another point to consider is the toxicity of labeled substrates. For example, Se-Met is a 
very toxic compound and E. coli BL21 (DE3) is not able to grow in autoinduction medium 
with more than 50 mg L
−1
 Se-Met leading to low label incorporation into the target protein 
(data not shown). Thus, IPTG induction combined with medium exchange is the best 
approach for generating Se-Met-labeled proteins. A general summary of the specific 
medium properties for specific labeling purposes is given in Table 2.3.1.  
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Table 2.3.1 General scheme for the usage and composition of the defined labeling medium 
Name of 
medium 
Solvent General usage 
Induction 
method 
Carbon(s) (g L
−1
) 
Nitrogen 
(g L
−1
) 
KH2PO4 
(g L
−1
) 
S-DAB 
(HNC) 
H2O 
Non-labeled protein 
production 
Auto-
induction 
2.9 glucose,11.1 glycerol, 
7.6 lactose 
4.0 (NH4)2HPO4 13.3 
S-DAB H2O 
Non-labeled protein 
production 
Auto-
induction 
2.9 glucose,11.1 glycerol, 
7.6 lactose 
4.0 (NH4)2HPO4 13.3 
DNB H2O 
Pre-cultures 
and IPTG induction 
IPTG 10.9 glucose 4.0 (NH4)2HPO4 13.3 
SL-DAB H2O For 
15N labeling 
Auto-
induction 
2.9 glucose, 11.1 
glycerol, 7.6 lactose 
3.2 15N-NH4Cl 17.4 
SL-DAB 
(in D2O)
 D2O 
For 2H and 15N* 
labeling 
Auto-
induction 
2.9 glucose, 11.1 
glycerol, 7.6 lactose 
3.2 15N-NH4Cl 17.4 
rL-DNB H2O 
For 13C and 15N* 
labeling 
IPTG 6.5 13C-glucose 2.6 15N-NH4Cl 17.4 
rL-DNB 
(in D2O) 
D2O 
For 2H, 13C and 15N* 
labeling 
IPTG 6.5 13C-glucose 2.6 15N-NH4Cl 17.4 
L-DNB 
(in D2O) 
D2O 
Pre-culture of 15N*, 
13C and 2H labeling 
IPTG 10.9 glucose 3.2 15N-NH4Cl 17.4 
L-DNB H2O 
Pre-cultures and 
Se-Met labeling 
IPTG 10.9 glucose 3.2 NH4Cl 17.4 
For selenomethionine labeling, the pre-culture and main culture were supplemented with 250 mg L
−1
 
methionine and 200 mg L
−1
 selenomethionine, respectively. 
15
N
*
: the labeling of 
15
N
 
is optional. If 
15
N 
labeling is not required, 
15
N-NH4Cl can be replaced by normal NH4Cl 
Except for the concentrations of the carbon and nitrogen substrates, potassium phosphate and the method 
of pH adjustment, the concentrations of remaining components were identical and as follows: 1.55 g L
−1
 
Citric acid, 0.59 g L
−1
 MgSO4, 100.8 mg L
−1
 Fe(III) citrate, 2.1 mg L
−1
 Na2MoO4. 2H2O, 2.5 mg L
−1
 
CoCl2. 6H2O, 15 mg L
−1
 MnCl2. 4H2O, 1.5 mg L
−1
 CuCl2. 2H2O, 3 mg L
−1
 H3BO3, 33.8 mg L
−1
 
Zn(CH3COO)2. 2H2O, 14.10 mg L
−1
 Titriplex III. Except for S-DAB (HNC), the final pH of all other 
media was adjusted to 6.8 by NaOH. Details for medium preparation are given in the supplementary 
material  
S-DAB (HNC) smart-defined autoinduction broth (high nitrogen content) with pH adjustment by NH4OH, 
S-DAB smart-defined autoinduction broth, DNB defined non-inducing broth, SL-DAB smart labeling-
defined autoinduction broth, rL-DNB reduced labeling-defined non-inducing broth (with reduced 
concentrations of carbon and nitrogen substrates), L-DNB labeling-defined non-inducing broth 
2.3.4.2 Heavy isotope labeling 
A set of shake flask experiments was carried out at 37°C for the production of single, 
double, and triple-labeled (
15
N, 
13
C and 
2
H) hPrP using E. coli Bl21 (DE3) as expression 
host (details for production are given in Fig. 2.3.1). When labeling was performed in 
autoinduction medium (only 
15
N and/or 
2
H labeling) or by medium exchange and IPTG 
induction (
13
C labeling alone or in combination with 
15
N and/or 
2
H labeling), final OD 
values reached OD600 ~16 or ~12, respectively (Fig. 2.3.2). The expression level and the 
final biomass yields were not affected by the different labeling strategies and the target 
protein reached ~21% of the total cell protein (Fig. 2.3.2). Even deuterium labeling did not 
cause a decrease in the expression level and final biomass yield although cells grew 
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considerably slower in D2O compared to H2O. For example, the growth rate of E. coli 
BL21 (DE3) decreased by 60% at 37°C when the medium was prepared with D2O instead 
of H2O. 
 
Fig. 2.3.2 Heavy isotope labeling of hPrP protein 
Cells were grown at 37°C in labeling medium and protein production analyzed by SDS-PAGE. The 
labeling strategies and final cell densities (OD600) are indicated on top of the figure. The analyzed cell 
fractions are indicated below (W whole cell protein. S soluble part. I insoluble part of whole cell protein. 
M Marker) 
The overall labeling efficiency for the different isotopes and isotope combinations was 
determined from five peptides which cover 38% of the hPrP protein sequence (Table 2.3.2). 
Details of the isotopic distribution are shown in the mass spectrum of the most 
representative peptide (Fig. 2.3.3). For 
15
N labeling, 99% labeling was achieved using 
autoinduction. For 
13
C labeling, 97% labeling was achieved with medium exchange and 
IPTG induction. This slight reduction in 
13
C labeling efficiency was caused because cells 
were grown on non-labeled glucose before they were transferred into fresh labeling 
medium containing IPTG and 
13
C glucose. However, this overall high-label content also 
shows that the turnover of 
12
C-carbon from cells pre-grown on 
12
C glucose to the newly 
synthesized target protein was lower than 4%. 
For mono 
2
H or combined 
2
H and 
15
N labeling, cells were grown in the presence of more 
than 98% D2O using autoinduction medium. The overall labeling efficiency for deuterium 
was determined as 58% (Table 2.3.2). This seemingly low label incorporation was obtained 
because all analytical procedures after cell harvest were performed in H2O instead of D2O 
(e.g., SDS-PAGE, sample preparation for MALDI-TOF analysis). Deuterium at 
exchangeable hydrogen positions in deuterated proteins (peptides) will exchange to 
protium (
1
H) in the presence of excess H2O. Thus, the obtained overall labeling efficiency 
Control
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of deuterium of 58% needs to be corrected to obtain the true labeling efficiency at non-
exchangeable hydrogen positions (identical to the true labeling efficiency of all hydrogen 
positions directly after cell harvest before further sample processing). These corrections 
revealed a true labeling efficiency for deuterium of 75%. This lower labeling efficiency for 
deuterium compared to the other heavy isotopes was caused by the utilization of non-
deuterated substrates (e.g., carbon substrates) which are incorporated into the biomass and 
target protein. 
 
Fig. 2.3.3 Mass spectra of representative hPrP peptide after heavy isotope labeling 
a Experimental mass spectra of the YPNQVYYRPVDQYNNQNNFVHDC(CAM)VNITIK peptide 
resulting from different heavy isotope labeling strategies (indicated in the right upper corner of each 
panel). b Theoretical mass spectra of the YPNQVYYRPVDQYNNQNNFVHDC(CAM)VNITIK peptide 
(Formula: C161H236N45O49S1) at different isotope abundances (indicated in the left upper corner of each 
panel). The y-axis of each panel indicates the relative abundance of MS peaks and the x-axis indicates the 
mass/charge (m/z) ratio. C(CAM) carbamidomethyl cysteine  
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Table 2.3.2 Heavy isotope labeling efficiency of hPrP 
Peptide fragment in hPrP 
15
N 
Labeling 
13
C 
Labling 
2
H 
labeling 
2
H and 
15
N 
labeling 
  
2
H, 
15
N and 
13
C 
labeling 
Labeling efficiency (%) 
15
N 
13
C 
2
H 
2
H 
15
N 
2
H 
15
N 
13
C 
YPGQGSPGGNR 99 98 
54
a
 
(75
b
) 
54
a
 
(75
b
) 
99 
54
a
 
(75
b
) 
99 98 
YPNQVYYR 99 98 
54
a
 
(70
b
) 
54
a
 
(70
b
) 
99 
54
a
 
(70
b
) 
99 98 
VVEQMCTTQYQK 99 97 
59
a
 
(77
b
) 
59
a
 
(77
b
) 
99 
59
a
 
(77
b
) 
99 97 
HMAGAAAAGAVVG
GLGGYMLGSAMSR 
99 98 
63
a
 
(79
b
) 
63
a
 
(75
b
) 
99 
63
a
 
(75
b
) 
99 98 
YPNQVYYRPVDQYN
NQNNFVHDCVNITIK 
99 97 
57
a
 
(75
b
) 
57
a
 
(75
b
) 
99 
57
a
 
(75
b
) 
99 97 
Overall hPrP 
(approximate) 
99 97 
58
a
 
(75
b
) 
58
a
 
(75
b
) 
99 
58
a
 
(75
b
) 
99 97 
a
 Labeling efficiency for deuterium as determined by MALDI-TOF MS 
b
 Corrected as true labeling efficiency at non-exchangeable hydrogen positions 
For double- and triple-labeling, the labeling efficiency for each isotope was the same as for 
mono-labeling. However, for combined 
13
C and 
15
N labeling, cells should be pre-grown on 
15
NH4Cl before they are transferred to fresh labeling medium containing IPTG, 
15
NH4Cl 
and 
13
C glucose, otherwise the 
15
N labeling efficiency will decrease to 95%. The turnover 
of nitrogen from cells pre-grown on non-labeled nitrogen to the newly synthesized target 
protein is higher than the carbon turnover as nitrogen is always recycled and carbon 
partially lost as carbon dioxide. 
The general applicability of this labeling approach was tested for the production of two 
more proteins using T7-based expression systems. Moreover, proteins were chosen which 
can be produced as soluble protein but also in form of inclusion bodies to examine if label 
incorporation is different in soluble and aggregated proteins (Fig. 2.3.4). The results of 
these studies revealed that the labeling efficiency was independent of the protein being 
produced and, moreover, identical in both the soluble and aggregated fraction (Table 2.3.3 
and Fig. 2.3.5). 
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Fig. 2.3.4 Heavy isotope labeling of GFP and hFGF-2 
Cells were grown at 30°C in labeling medium and protein production analyzed by SDS-PAGE. The 
labeling strategies and final cell densities (OD600) are indicated on top of the figure. The analyzed cell 
fractions are indicated below (W whole cell protein, S soluble part, I insoluble part of whole cell protein, 
M marker, N non-induced negative control) 
Table 2.3.3 Heavy isotope labeling efficiency of hFGF-2 and GFP 
Peptide fragment 
in hFGF-2 
2
H and 
15
N labeling 
efficiency (%) 
 
Peptide fragment 
in GFP 
2
H and 
15
N labeling 
efficiency (%)
 
2
H 
15
N 
 2
H 
15
N 
YLAMKEDGR 
63
a
 
(82
b
) 
99 
 
FEGDTLVNR 
61
a
 
(80
b
) 
99 
IHPDGRVDGVR 
64
a
 
(81
b
) 
99 
 
SAMPEGYVQER 
60
a
 
(77
b
) 
99 
GVVSIKGVCANR 
61
a
 
(78
b
) 
99 
 
AEVKFEGDTLVNR 
61
a
 
(79
b
) 
99 
YTSWYVALKR
  
60
a
 
(74
b
) 
99 
 
GIDFKEDGNILGHK 
59
a
 
(76
b
) 
99 
CVTDECFFFER
  
59
a
 
(75
b
) 
99 
 
LEYNYNSHNVYITADKQK 
58
a
 
(75
b
) 
99 
Overall hFGF-2 
(approximate) 
61
a
 
(78
b
) 
99 
 Overall GFP 
(approximate) 
60
a
 
(77
b
) 
99 
a
 Labeling efficiency for deuterium as determined by MALDI-TOF MS. 
b
 Corrected as true labeling efficiency at non-exchangeable hydrogen positions. 
2.3.4.3 Selenomethionine labeling 
Se-Met is toxic for E. coli, thus a similar labeling strategy with medium exchange was 
chosen as used for generating 
13
C-labeled proteins. Cells were first grown on non-inducing 
medium which was supplemented with 250 mg L
−1
 methionine to suppress the methionine 
biosynthesis pathway. Thereafter, cells were collected by centrifugation and resuspended in 
fresh medium containing IPTG, glucose as carbon substrate and Se-Met (experimental 
details are given in Fig. 2.3.1). Production of hPrP was studied in media supplemented 
with different Se-Met concentrations using the methionine prototrophic strain E. coli Bl21 
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(DE3) and the auxotrophic strain T7 Express Crystal (Fig. 2.3.6). The final cell densities 
and expression yields (OD600 ~10 and 22% hPrP of total cell protein) was independent on 
the Se-Met concentration (25–200 mg L−1) for E. coli Bl21 (DE3). However, for the 
auxotrophic strain T7 Express Crystal a strong influence of the Se-Met concentration on 
the final biomass yield and expression level was observed (Fig. 2.3.6). For this strain, the 
final biomass and the target protein expression level increased with increasing Se-Met 
concentration (up to 150 mg L
−1
) reaching a maximum of OD600 ~20 and 17% hPrP of 
total cell protein, respectively. Compared to the methionine prototrophic stain E. coli BL21 
(DE3), the methionine auxotrophic strain (T7 Express Crystal) exhibited a higher tolerance 
towards the toxic Se-Met by reaching higher cell densities; however, the target protein 
expression level was lower. 
 
Fig. 2.3.5 Mass spectra of representative peptides of hFGF-2 and GFP after 
2
H and 
15
N double-
labeling 
a Experimental mass spectra of the C(CAM)VTDEC(CAM)FFFER peptide of hFGF-2: (A1) non-labeled 
hFGF-2, (A2) 
2
H-, and 
15
N-labeled in soluble and (A3) insoluble fraction of hFGF-2. b Theoretical mass 
spectra of the C(CAM)VTDEC(CAM)FFFER peptide (formula: C62H86N14O19O2+ C4H6N2O2) of hFGF-2: (B1) 
non-labeling control and (B2) 
2
H- and 
15
N-labeled peptide. c Experimental mass spectra of the 
LEYNYNSHNVYITADKQK peptide of GFP: (C1) non-labeled GFP, (C2) 
2
H- and 
15
N-labeled in soluble 
and (C3) insoluble fraction of GFP. d Theoretical mass spectra of the LEYNYNSHNVYITADKQK 
peptide (formula: C98H146N26O32) of GFP: (D1) non-labeling control and (D2) 
2
H- and 
15
N-labeled peptide. 
The y-axis of each panel indicates the relative abundance of MS peaks and the x-axis indicates the 
mass/charge (m/z) ratio. C(CAM) carbamidomethyl cysteine 
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Fig. 2.3.6 Selenomethionine labeling of hPrP protein 
Cells were grown at 37°C in labeling medium and the whole cell protein analyzed by SDS-PAGE. The 
host strain and the final cell densities (OD600) are indicated on top of the figure. Lane numbers are 
indicated below. M marker; lanes 1-7 hPrP produced in T7 Express Crystal (methionine auxotroph), lane 
1 positive control with 200 mg L
−1
 methionine, lane 2 negative control without methionine and Se-Met, 
lane 3 25 mg L
−1
 Se-Met, lane 4 50 mg L
−1
 Se-Met, lane 5 100 mg L
−1
 Se-Met, lane 6 150 mg L
−1
 Se-
Met, lane 7 200 mg L
−1
 Se-Met; lanes 8-13 hPrP produced in E. coli BL21 (DE3), lane 8 25 mg L
−1
 Se-
Met, lane 9 50 mg L
−1
 Se-Met, lane 10 100 mg L
−1
 Se-Met, lane 11 150 mg L
−1
 Se-Met, lane 12 200 mg 
L
−1
 Se-Met, lane 13 positive control with 200 mg L
−1
 methionine 
Table 2.3.4 Se-Met labeling efficiency of hPrP in E. coli BL21 (DE3) 
Peptide fragment in hPrP 
Se-Met labeling efficiency at different Se-Met concentration 
50 mg L
−1
 100 mg L
−1
 150 mg L
−1
 200 mg L
−1
 
VVEQMCTTQYQK 33% 50% 75% 70% 
PMMHFGNDWEDRYYR 56% 55% 77% 74% 
HMAGAAAAGAVVGGLGGYM
LGSAMSR 
43% 62% 67% 70% 
Overall hPrP (approximate) 45% 55% 70% 70% 
Table 2.3.5 Se-Met labeling efficiency of hPrP in T7 Express Crystal 
Peptide fragment in hPrP 
Se-Met labeling efficiency at different Se-Met concentration 
50 mg L
−1
 100 mg L
−1
 150 mg L
−1
 200 mg L
−1
 
YYERNMNR 74% 68% 88% 95% 
VVEQMCTTQYQK 74% 83% 81% 89% 
PMMHFGNDWEDR 72% 69% 83% 86% 
GENFTETDIKIMER 86% 91% 90% 92% 
Overall hPrP (approximate) 75% 75% 85% 90% 
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The overall Se-Met labeling efficiency of hPrP produced in E. coli BL21 (DE3) and T7 
Express Crystal was determined from three and four peptides, respectively, containing at 
least five of the nine methionines of hPrP (Tables 2.3.4 and 2.3.5, respectively). Details of 
the isotopic distribution are shown in the mass spectra of two representative peptides (Fig. 
2.3.7). For E. coli BL21 (DE3), the Se-Met labeling efficiency increased from 45% to 70% 
with increasing Se-Met concentration reaching the maximum efficiency of 70% at 150 or 
200 mg L
−1
 Se-Met (Table 2.3.4). For E. coli T7 Express Crystal, higher labeling 
efficiencies were achieved, increasing from 75% to 90% with increasing Se-Met 
concentration and reaching the highest efficiency of 90% at 200 mg L
−1
 Se-Met (Table 
2.3.5).  
 
Fig. 2.3.7 Mass spectra of two representative hPrP peptides after Se-Met labeling 
a Experimental mass spectra of T1: “VVEQMC(CAM)TTQYQK” and T2: “PMMHFGNDWEDR” peptides. 
b Theoretical mass spectra of the T1 peptide: (B1) VVEQMC(CAM)TTQYQK (m/z 1,515.7, T1[Met]) and 
(B2) VVEQM(Seleno)C(CAM)TTQYQK (m/z 1,562.7, T1[Se-Met]). Theoretical mass spectra of the T2 peptide: 
(B3) PMMHFGNDWEDR (m/z 1,535.7, T2[Met]2) and (B4) PM(Seleno)M(Seleno)HFGNDWEDR (m/z 
1,628.6, T2[Se-Met]2). The host strain and Se-Met concentrations in the labeling medium are indicated in 
the right upper corner of each panel. The y-axis of each panel indicates the relative abundance of MS 
peaks and the x-axis indicates the mass/charge (m/z) ratio. Met methionine, Metox oxidized methionine, 
Se-Met and M(Seleno) Selenomethionine, C(CAM) carbamidomethyl cysteine 
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2.3.5 Discussion 
A unified protocol based on a modular system for production of labeled proteins using E. 
coli-based expression systems was developed. This protocol can be used to efficiently 
produce heavy isotope (mono- or multiple-incorporations of 
2
H, 
13
C, and 
15
N) as well as 
Se-Met-labeled proteins with high-label content. The labeling efficiency reached 99% and 
97% for 
15
N and 
13
C-labeling, respectively. The 
13
C-labeling efficiency can be further 
increased when cells are pre-cultured on labeled glucose prior to induction of labeled 
protein production. The labeling efficiency for deuterated proteins was at least 75% with 
80% as the theoretical maximal 
2
H labeling efficiency when using non-deuterated carbon 
substrates. Incorporation of 99% deuterium can only be achieved when deuterated carbon 
substrates are used [40]. We also show that double- and triple-heavy isotope labeling did 
not change the labeling efficiency achieved by mono-labeling. Moreover, the labeling 
efficiency was independent of the target protein and identical for soluble and aggregated 
proteins. However, for the production of soluble proteins, it might be necessary to use 
lower culture temperatures during labeling. Labeling efficiency for Se-Met incorporation 
was 70% using the conventional E. coli strain BL21 (DE3) or increased to 90% using the 
methionine auxotrophic strain T7 Express Crystal. Incorporation of other labeled amino 
acids is possible by employing the appropriate labeled amino acid and the corresponding 
auxotrophic host strain. The target protein expression level as well as its solubility is 
characteristic for each protein; however, expression yields and solubility in labeling 
medium were not different from those obtained in non-labeling medium. Final cell 
densities and product titers for all labeling purposes were the most efficient so far reaching 
for deuterated proteins ~4 times higher levels as in previously published protocols. 
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2.4 Summary and conclusion  
A defined autoinduction medium was developed with very high final biomass 
concentrations (OD600 >20). The expression level is similar as in LB medium with 
conventional IPTG induction. The universal applicability of the medium has been proved 
with different T7-based E. coli expression systems. Moreover, the application scalability 
has been successfully tested at different temperatures from 23°C to 37°C using microtiter 
plates, test tubes, shake flasks and bioreactors. 
Following, a set of modular defined media for heavy isotopes as well as for Se-Met 
labeling was developed with easy experimental handling and high reproducibility. The 
methods have been tested for 
2
H, 
13
C, and 
15
N labeling leading to heavy isotope 
incorporation of ~75%, ~99%, and 99%, respectively, with three different target proteins. 
Se-Met labeling was proved to work both with methionine-auxotrophic and prototrophic E. 
coli leading to Se-Met incorporation of ~90% and ~70%, respectively. 
2.5 Outlook 
Two major bottlenecks for recombinant protein production in E. coli are the solubility of 
target protein and the final biomass, i.e. the final protein concentration. Current analyses 
indicate that the insoluble target protein (or inclusion body) formation during the 
cultivation using defined medium (S-DAB or DNB) is higher than using complex medium 
(LB medium). Conversely, the final biomass is much lower when using LB medium than 
using S-DAB or DNB medium. 
The shortage of molecular chaperones and overflow metabolism of acetate (the growth-
inhibiting by-product) are probably the reason for inclusion body formation and low final 
biomass yields, respectively. When the traditional process optimization reaches the 
bottleneck, there is a need for a deeper level of understanding of the molecular bottlenecks 
of recombinant protein production.  
To reveal the corresponding bottlenecks at the molecular level, two comprehensive 
proteomic analyses of E. coli under recombinant protein production and non-production 
conditions in defined and complex media have been carried out as shown in the following 
chapter. 
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3 A comprehensive proteomic study of Escherichia coli 
3.1 Introduction 
In this chapter, two comprehensive proteomic analyses were carried out for E. coli 
grown in defined and complex media at exponential and stationary phases under 
recombinant protein production and non-production conditions.  
Based on the first proteomic analysis under non-production condition, the 
regulatory basis of acetate overflow metabolism under nutrient-rich condition is 
shown first, and then the self-protection mechanism under insufficient nutrient 
condition is analyzed. The second proteomic analysis indicates that this self-
protection mechanism breaks down when the cell is forced to overproduce a 
recombinant protein. 
3.2 A comprehensive proteomic study I. Regulation of acetate overflow 
metabolism in Escherichia coli under nutrient-rich condition 
3.2.1 Abstract 
By the methods of two-dimensional gel electrophoresis and mass spectrometry, a 
comprehensive Escherichia coli proteomic analysis of the central metabolic pathways 
(CMPs), oxidative phosphorylation and synthesis of biomass building blocks, was 
performed for E. coli grown in defined and complex media, to understand the regulatory 
mechanism of acetate overflow metabolism under a nutrient-rich condition (i.e. growth in 
complex medium). During exponential growth in complex medium in the presence of 
excess nutrients (e.g., amino acids or peptides), precursors and reducing equivalents 
generated by the CMPs are sufficient for cell growth. E. coli spontaneously reduces the 
synthesis of enzymes of the tricarboxylic acid cycle (TCA cycle) to decrease the generation 
of reducing equivalents and precursors. Simultaneously, the lower glycolysis enzymes are 
up-regulated in the absence of catabolite repression by glucose. In this situation, the lower 
glycolytic pathway does not coincide with the TCA cycle capacity, which leads to the 
acetate overflow metabolism. At the transition into stationary phase facing nutrient 
depletion in the complex medium, the acetate can be completely re-assimilated through the 
up-regulated acetyl-coenzyme A synthetase (Acs) and TCA cycle enzymes. 
Keywords Escherichia coli proteome ∙ Central metabolic pathways ∙ Overflow metabolism 
∙ Acetic acid ∙ Two-dimensional gel electrophoresis ∙ Defined medium ∙ Complex medium  
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3.2.2 Introduction 
Acetate is the major by-product, when E. coli is grown at a high rate of substrates 
consumption even in the presence of abundant oxygen [14-16]. For many years, it has been 
regarded as a negative effect in many fields of modern microbiology and biotechnology 
[17-21]. It was found that when loads are imposed and flux constraints exist either at the 
level of NADH turnover rate or the activity of TCA cycle, switching to acetate overflow is 
predicted [48]. The Arc two component system, the aerobic respiration control protein 
(ArcA) and its sensor protein (ArcB), has been proved to be the mediator between the 
NADH turnover rate and the TCA cycle activity [54-58]. It was observed that the arcA 
deletion mutant shows a higher TCA cycle activity, lower acetate formation rate [59, 60] 
and even a lower substrate yield coefficient for glucose compared to the wild-type strain 
[59]. These findings suggest that acetate may play a key role in keeping the balance of fast 
and efficient growth. 
Acetate locates at the centre of central metabolic pathways (CMPs). The monomers, such 
as amino acids, for the synthesis of cellular macromolecules, such as proteins, are made 
from a relatively small group of precursors that are the products of the CMPs, indicating a 
direct relation between acetate overflow metabolism and synthesis of biomass building 
blocks [49]. Another important factor is that NAD(P)H generated by CMPs is also required 
for the monomers biosynthesis, especially for the amino acids [50], which implies an 
association between synthesis of biomass building blocks and NADH turnover rate. 
Owning to the complexity of intracellular metabolic networks and also the extracellular 
environment, the understanding of the synergetic regulation between CMPs, oxidative 
phosphorylation and biomass block biosynthesis is still ambiguous. As metabolic pathways 
are networks of enzymatic reactions, a comprehensive proteomic study will greatly help to 
disclose the corresponding regulatory mechanism of CMPs and the acetate overflow 
metabolism. 
E. coli is probably the best understood of the simple model organisms, with fully 
sequenced genome which makes it accessible for comprehensive proteomic analysis [97-
100]. Most of the modern proteomic studies were carried out with E. coli K-12 strains [97-
100, 130-133]. But it was found that less acetate is produced by E. coli B strains compared 
to K-12 strains [134, 135] which could be explained by more active glyoxylate shunt, TCA 
cycle, and higher acetate uptake [136, 137]. In addition to the existing literature [93, 138-
140], there is still a great need for a more detailed report on the global physiological 
analysis at the proteome level for the E. coli B strains. 
It was found that when growing at maximum growth rate in complex medium E. coli 
produces more acetate than in defined medium [7, 16, 21]. For clarification, a 
comprehensive proteomic analysis was carried out for E. coli BL21 (DE3) grown in 
defined and complex media using 2-D gelelectrophoresis in combination with mass 
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spectrometry for protein identification. The molecular regulatory basis of the CMPs, 
oxidative phosphorylation and synthesis of biomass building blocks is investigated. Two 
major proteomic comparisons are explored: first, the proteomic difference between E. coli 
grown in defined and complex media at exponential phase (also referred to as log phase) is 
investigated to illustrate why acetate is produced in complex medium during exponential 
growth; secondly, the proteomic difference between E. coli grown at stationary and 
exponential phases in complex medium is used to show how acetate is re-assimilated at the 
early stationary phase. 
3.2.3 Materials and methods 
3.2.3.1 Strain, media and cultivation conditions 
E. coli BL21 (DE3) (Novagen, Germany) was used. The composition of Luria-Bertani (LB) 
medium is as follows: 10 g L
−1
 tryptone, 5 g L
−1
 yeast extract, 5 g L
−1
 NaCl. The 
composition of Terrific-Broth (TB) medium is as follows: 12 g L
−1
 tryptone, 24 g L
−1
 yeast 
extract, 5 g L
−1
 glycerol, 2.31 g L
−1
 KH2PO4, 12.54 g L
−1
 K2HPO4. The composition of 
Defined Non-inducing Broth (DNB) is as follows: 10.91 g L
−1
 glucose, 4 g L
−1
 
(NH4)2HPO4, 13.3 g L
−1
 KH2PO4, 1.55 g L
−1
 Citric acid, 0.59 g L
−1
 MgSO4, 100.8 mg L
−1
 
Fe(III) citrate, 2.1 mg L
−1
 Na2MoO4.2H2O, 2.5 mg L
−1
 CoCl2.6H2O, 15 mg L
−1
 
MnCl2.4H2O, 1.5 mg L
−1
 CuCl2.2H2O, 3 mg L
−1
 H3BO3, 33.8 mg L
−1
 
Zn(CH3COOH)2.2H2O, 14.10 mg L
−1
 Titriplex III. The pH of all media was adjusted to 6.8 
by NaOH before sterilization. Cultivations were carried out in duplicate using 2 L 
Erlenmeyer flasks with three baffles containing 200 mL medium at 37 °C and 180 rpm 
(Multitron Cell, INFORS HT, Switzerland). Cell growth was monitored by measurement of 
the absorbance at 600 nm (OD600) (WPA CO8000 Cell Density Meter, Biochrom, UK). 
Acetate was analyzed by an acetic acid kit (Cat. No. K-ACETRM, Megazyme, Ireland). 
Culture samples at exponential phase and stationary phase were centrifuged at 17,000 g 
and 4 °C for 3 min. After removal of the supernatant, cell pellets were stored at −80 °C 
until further analysis. Details about medium preparation and culture conditions have been 
described previously [110, 141]. 
3.2.3.2 Two-dimensional gel electrophoresis 
Cell pellets were disrupted by BugBuster™ Protein Extraction Reagent (Novagen, USA) 
with rLysozyme and Benzonase according to manufacturer's instructions. Whole cell 
protein in the BugBuster suspension (without centrifugation) was precipitated as described 
previously [142]. The protein pellets were solubilized in rehydration solution with IPG 
buffer (GE Healthcare, UK). About 280 μg of each protein sample were loaded onto 
Immobiline DryStrip gels of pH 3-10 NL (GE Healthcare, UK). The first-dimension using 
isoelectric focusing (IEF) and second dimension using SDS-PAGE (10-15% gradient gel) 
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were run with the IPGphor™ Isoelectric Focusing System and Hoefer™ DALT System 
(GE Healthcare, UK), respectively. The detailed experimental conditions were according to 
manufacturer's instructions and as described before [126] (For details refer to section 5.1.1 
in the Appendix). Coomassie stained gels [115] were analyzed using Proteomweaver™ 4.0 
(Bio-Rad, USA) for protein spot detection, matching and quantification. For each sample, 
2D gels were made in triplicate. The best two gels were analyzed by Proteomweaver™ 4.0. 
Each spot’s intensity was normalized by the whole spots intensity on the same 2D gel. The 
corresponding average of the resulting percentage value from the duplicate gels was used 
for indication of the spot’s protein portion (%) of the whole cell protein mass (WCPM). 
The total “WCPM %” of all spots representing the same protein was used for indicating the 
abundance of the corresponding protein.  
3.2.3.3 Protein identification and classification 
Protein spots were identified by matrix-assisted laser desorption ionization time-of-flight 
mass spectrometry (MALDI-TOF MS). Protein spots were excised manually from 2D gels. 
After washing, reduction and alkylation, in-gel digestion was carried out by incubation 
with sequencing grade trypsin (Promega, USA). Obtained peptides were extracted and 
purified with reversed-phase C18 ZipTips (Millipore, USA). Desalted peptide solutions 
were mixed with the saturated matrix solution and spotted onto a 384 MTP target and dried 
at room temperature. Bruker Ultraflex time-of-flight mass spectrometer (Bruker Daltonics 
GmbH, Germany) was employed to obtain peptide mass fingerprints. The detailed protocol 
was as described previously [126, 127] (For details refer also to section 5.1.2 in the 
Appendix). The MASCOT search program (Matrix Science, UK) was used for protein 
identification based on the annotated E. coli genome [Uniprot (http://www.uniprot.org/) 
serving as database]. All proteins with a Mowse score greater than 54 were regarded as 
significant (p < 0.05). 
EcoCyc (http://ecocyc.org/) database [143] was mainly used for classification of identified 
proteins. The classification was confirmed by KEGG (http://www.genome.jp/kegg/) 
database [144]. The information on transcriptional regulation of identified proteins (genes) 
was mainly acquired from RegulonDB (http://regulondb.ccg.unam.mx/) database [145]. 
3.2.4 Results  
3.2.4.1 Growth kinetics in defined and complex media 
In complex medium (e.g. Luria-Bertani broth or Terrific-Broth which contains tryptone, a 
pancreatic digest of casein, and yeast extract, the water soluble portion of autolyzed yeast), 
different nutrients, e.g. sugars, alcohols, and organic acids, amino acids, peptides and 
nucleotides, will support a high growth rate of E. coli. Comparatively, defined medium (e.g. 
M9 or DNB medium, in which glucose, NH4
+
, PO4
3−
 and SO4
2− 
are the sole carbon, 
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nitrogen, phosphorus and sulfur sources, respectively) requires E. coli to synthesize all 
cellular components.  
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Fig. 3.2.1 Growth and acetate metabolism of E. coli BL21 (DE3) 
Cultivations were carried out in shake flasks using DNB (square) and LB medium (triangle) at 37 °C. 
Samples for 2D gel electrophoresis analysis were taken at the time points indicated by arrows.  
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The growth of E. coli BL21 (DE3) at 37 °C in DNB and LB media is shown in Fig. 3.2.1A 
with maximum specific growth rates of 0.8 h
−1
 and 1.5 h
−1
, respectively (The growth in TB 
medium is shown in the Appendix). During growth in defined medium cells exhibited a 
nearly constant specific growth rate during the exponential phase. During growth in 
complex medium, the specific growth rate gradually decreased as shown in Fig. 3.2.1B. 
This occurs because E. coli reveals a sequential mode of substrate utilization in complex 
medium [9-11]. 
Excreted acetate concentration is shown in Fig. 3.2.1C. In LB medium acetate is produced 
during exponential growth of E. coli. The maximum acetate concentration is about 440 mg 
L
−1
 when OD600 is 1.6. From the late exponential phase acetate starts to decrease to zero 
at early stationary phase. In LB medium no oxygen limitation was observed during the 
whole course of cultivation (i.e. dissolved oxygen did not drop below 30% of saturation; 
data not shown). In DNB medium at exponential phase, acetate remains at very low level 
(< 50 mg L
−1
). During the transition from late exponential phase to early stationary phase, 
acetate increases to about 300 mg L
−1 
when OD600 is 13. The excreted acetate decreases 
quickly to zero at stationary phase. In DNB medium, no oxygen limitation was observed at 
the exponential phase, but from late exponential phase to early stationary phase the 
dissolved oxygen dropped to zero for about 1 hour (data not shown). Fig. 3.2.1D shows 
that for E. coli growing in complex medium, the acetate excretion per biomass during 
exponential growth and the re-assimilation per biomass at the transition into stationary 
phase, are much higher than in defined medium. 
3.2.4.2 Systematic and comparative proteome analysis  
The whole cell proteome of E. coli BL21 (DE3) grown in defined (DNB) and complex (LB 
and TB) media at exponential and stationary phase was systematically analyzed. The 
proteomic data in LB and TB media are very similar, so an average from LB and TB media 
was used to represent a (unified) complex medium as shown in Suppl. Table 5.3.1. 516 
spots were identified by MALDI-TOF MS representing 369 different proteins. These 369 
proteins already cover approximately 80% of WCPM. All identified proteins were 
classified into 11 categories with 29 groups as shown in Suppl. Tables 5.3.1 and 5.3.2. 
Results of analysis were visualized and shown in Suppl. Figs 5.3.1-5.3.6. Annotated 2D 
gels are shown in the Suppl. Figs. 5.3.7-5.3.12. In this study, we focus on the proteomic 
differences in three functional categories at different growth stages and in defined and 
complex media: (I) carbohydrate metabolism (as shown in Fig. 3.2.2), (II) oxidative 
phosphorylation and (III) synthesis of biomass building blocks. Proteins involved in 
metabolite degradation, transportation, transcription, translation, protein folding and other 
processes are presented in chapter 3.3. 
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Fig. 3.2.2 Synthesis of central metabolic pathway related proteins at different conditions 
Growth conditions are shown on the top: Defined exp., sample from cultivation in defined medium (DNB) 
at exponential phase; Complex exp., sample from cultivation in complex medium (LB) at exponential 
phase; Complex stationary, sample from cultivation in complex medium (LB) at stationary phase. Names 
of protein are marked at the left side. Pathway names are marked at the bottom. For details refer to Suppl. 
Figure 5.3.7-5.3.12. 
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3.2.4.3 Central carbon metabolism 
At exponential phase, the synthesis of identified upper glycolysis proteins, PfkAB, FbaAB, 
and TpiA, is in general higher in defined medium than in complex medium, but for the 11 
identified lower glycolysis proteins, nearly all of them are down-regulated in defined 
medium (as compared to complex medium) (Fig. 3.2.2 and 3.2.3A). In this study, the 
identified pyruvate dehydrogenase (AceEF) and dihydrolipoyl dehydrogenase (LpdA) are 
regarded as lower glycolysis proteins. 
Gnd, TktAB, TalAB and Eda were identified from the pentose phosphate pathway (PPP). 
At exponential phase, except for TktB and TalA [which are isozymes of transketolase 
(TKT) and transaldolase (TAL), respectively], the rest of the identified proteins involved in 
PPP are all down-regulated in defined medium. In other words, proteins in PPP and lower 
glycolysis are higher in complex medium at exponential phase, which can lead to a higher 
level of carbon flux to the end of lower glycolysis (or before the TCA cycle, Fig. 3.2.4B) in 
complex medium. 
When the cell reaches stationary phase, the identified proteins involved in glycolysis and 
PPP are generally up-regulated in all media (as compared to exponential phase) (Fig. 3.2.2, 
3.2.3B and 3.2.3C). 
The observed regulation of glycolysis proteins can be explained by the antagonistic 
regulation of two transcriptional regulators (Suppl. Table 5.3.3): catabolite repressor 
activator (Cra) [146] and cAMP receptor protein (CRP) [147]. Fructose-1-phosphate (F1P) 
or fructose-1,6-bisphosphate (FBP) inactivate Cra for relieving the repression of the 
majority of genes in glycolysis [148]. Glucose causes catabolite repression on many lower 
glycolysis genes by lowering the intracellular levels of CRP-cAMP [149]. 
At exponential phase in defined medium, the glucose concentration is high, which will lead 
to a high level of FBP (through the upper glycolysis pathway). The general up-regulation 
of upper glycolysis proteins in defined medium might be caused by relieving the catabolite 
repression exerted by Cra (Fig. 3.2.4A and 3.2.4B). At the same time, the catabolite 
repression by glucose, acting as an antagonist to the relieve of the catabolite repression by 
Cra, would be the reason for the down-regulation of lower glycolysis proteins in defined 
medium (Fig. 3.2.4A and 3.2.4B). 
At stationary phase, the carbon sources are consumed. The catabolite repression by glucose 
is relieved. Simultaneously, Cra repression will be activated by the absence of inducers 
(F1P and FBP). But there is still another key factor controlling the regulation of glycolysis 
proteins at stationary phase: nearly all glycolysis genes are under the control of stationary 
phase sigma factor σS (Fig. 3.2.4C), as summarized in Suppl. Table 5.3.3. A general up-
regulation of glycolysis proteins was clearly observed in stationary phase. 
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Fig. 3.2.3 Proteome comparison of E. coli grown in different conditions 
A: Comparison between E. coli grown in defined/complex medium at exponential phase. B: Comparison 
between E. coli grown at stationary/exponential phase in complex medium. C: Comparison between E. 
coli grown at stationary/exponential phase in defined medium. Corresponding values of 
Log2(defined/complex medium) at exponential phase (A), Log2(stationary/exponential phase) in complex 
medium (B) and Log2(stationary/exponential phase) in defined medium (C) as indicated by arrows are 
shown in Suppl. Table 5.3.1. DNB medium was employed to indicate the defined medium. An average of 
LB and TB media is calculated to represent complex medium. Figs. 3.2.3A, 3.2.3B and 3.2.3C are parts 
of Suppl. Figs. 5.3.1, 5.3.2 and 5.3.3, respectively. Abbreviations used in Fig. 3.2.3 are listed in Suppl. 
Abbreviation before Suppl. Figs. 5.3.1.  
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3.2.4.4 By-product metabolism 
During growth of E. coli, acetate is produced as the the main by-product by PoxB or Pta-
AckA pathway (Fig 1.3) [150]. The acetate can be converted back to Acetyl-CoA by Acs or 
by reversing the Pta-AckA pathway. 
At exponential phase, Pta and AckA are down-regulated in defined medium (as compared 
to complex medium). At the same time, the PoxB is at very low level (less that 0.02% of 
WCPM), which is only about 5% of the amount of Pta and AckA. And the abundance of 
Acs is higher in defined medium than in complex medium at exponential phase (Fig. 
3.2.3A). 
When entering the stationary phase, the synthesis of Pta and AckA decreases in complex 
medium (Fig. 3.2.2, 3.2.3B and 3.2.3C). Simultaneously, Acs increases in all media. The 
proteomic results are compatible with the data shown in Fig. 3.2.2C: the Pta-AckA 
pathway (which is highly up-regulated in complex medium at exponential phase) functions 
primarily in a catabolic role, excreting acetate and generating ATP during aerobic growth 
on excess carbohydrates [137, 151]; in contrast, Acs (which is highly up-regulated at 
stationary phase) having a higher binding affinity towards acetate than AckA [152] mainly 
functions to metabolize extracellular acetate.  
Ethanol can be produced by AdhE during anaerobic growth of E. coli [153]. AdhE is 
highly up-regulated in LB medium at exponential phase (no oxygen limitation was 
observed in the cultivation in LB medium; data not shown), which also indicates that the 
carbon flux exceeds the capacity of the CMPs in complex medium during exponential 
growth. Formate can be produced by PflB [154]. The regulatory pattern of PflB is similar 
to Pta and AckA. At exponential phase PflB is higher in complex medium. And it decreases 
in all media during entry into stationary phase. Fermentative lactate dehydrogenase can 
directly convert pyruvate to lactic acid [155]. At exponential phase the total amount of 
three identified lactate dehydrogenases (LldD, Dld and LdhA) is similar in all media, 
suggesting that in complex medium the excess of pyruvate is converted to acetate, formate 
and ethanol through acetyl-CoA by the higher level of AceEF, LpdA, Pta, AckA, AdhE and 
PflB. When E. coli reaches stationary phase, LldD, Dld and LdhA remain constant in 
defined medium but are up-regulated in complex medium, which could be caused by the 
reutilization of acetate in complex medium (discussed in the section 3.2.4.6). 
3.2.4.5 TCA cycle 
At exponential phase, the abundance level of 14 identified TCA cycle proteins is much 
higher in defined medium than in complex medium (Figs. 3.2.2 and 3.2.3A), which may be 
another important reason for the low- and high-level of acetate secretion in defined and 
complex media, respectively.  
When bacteria reach stationary phase, nearly all of the TCA cycle proteins are highly up-
  A comprehensive proteomic study of Escherichia coli 
53 
regulated in complex medium (Figs. 3.2.2, 3.2.3B and 3.2.3C). The reuse of formerly 
excreted acetate may play here an important role. But for E. coli grown in defined medium, 
TCA cycle proteins show a slight decrease at stationary phase. 
The observed regulation of TCA cycle proteins can also be explained by the antagonistic 
regulation of two transcriptional regulators (Suppl. Table 5.3.3): phosphorylated-ArcA (P-
ArcA) and CRP-cAMP. Oxidized forms of quinone electron carriers in the electron 
transport chain (oxidative phosphorylation) inhibit autophosphorylation of ArcB and 
therefore inhibit the transphosphorylation of ArcA. If quinones are present in the reduced 
form, ArcB undergoes autophosphorylation and then catalyzes the transphosphorylation of 
ArcA [54], which represses nearly all operons encoding TCA cycle proteins [156-159]. 
Glucose causes catabolite repression of most TCA cycle genes [158, 160-164] by 
decreasing the intracellular level of CRP-cAMP [149].  
At exponential phase in complex medium (in which no glucose is supplied), the glucose-
mediated catabolite repression does not occur, but synthesis of TCA cycle proteins is lower 
than in defined medium (with glucose as sole carbon source). This proteomic observation 
suggests that the repression by P-ArcA is stronger than the activation of CRP-cAMP (Fig. 
3.2.4A and 3.2.4B). 
The observed regulatory pattern of GatDZ, which are responsible for the degradation of 
galactitol into glyceraldehyde-3-phosphate (G3P) and dihydroxyacetone phosphate (DHAP) 
[165], and are also under the competitive control of P-ArcA [166] and CRP-cAMP [167], 
gives further evidence that it is the P-ArcA repression, not the CRP-cAMP activation, 
which determines synthesis of TCA cycle proteins. The synthesis of GatDZ is the same as 
TCA cycle proteins: they are up-regulated in defined medium compared to complex 
medium at exponential phase, and in complex medium at stationary phase compared to 
exponential phase. 
3.2.4.6 Connection between glycolysis and TCA cycle 
At exponential phase, the synthesis of 4 identified proteins (e.g. MaeB and PckA), which 
create bridges between glycolysis and TCA cycle, is up-regulated in defined medium 
compared to complex medium (Fig. 3.2.2 and 3.2.3A), which corresponds to the higher 
level of TCA cycle proteins and lower level of acetate excretion in defined medium. 
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At stationary phase (Fig. 3.2.2 and 3.2.3B), the up-regulation of MaeB and PckA in 
complex medium suggests an increase of carbon flux in TCA cycle. During re-assimilation 
of acetate, acetyl-CoA will enter the TCA cycle. The carbon flux can be converted back to 
pyruvate through MaeB (or SfcA) or to PEP through PckA. Meanwhile the up-regulation 
of PpsA catalyzing the conversion of pyruvate to PEP, and lactate dehydrogenases (LldD, 
Dld and LdhA), which can temporally direct the excess pyruvate to lactic acid, also 
corresponds to the reuse of acetate in complex medium to generate PEP and pyruvate that 
can be further used by E. coli for growth and maintenance. 
3.2.4.7 Oxidative phosphorylation 
Four subunits of NADH dehydrogenase I (NuoBCFG) and three subunits of ATP synthase 
F1 complex (AtpADH) were identified, which catalyze the transfer of electrons from 
NADH to the oxidized quinone pool and produce ATP for cell growth, respectively. The 
regulation of NADH dehydrogenase and ATP synthase is not prominent. Only the synthesis 
of NuoBCFG decreases a little from exponential to stationary phase in defined medium, 
which matches the slight down-regulation of TCA cycle proteins at the same condition. 
The non-significant regulation of the oxidative phosphorylation proteins is consistent with 
literature reports [168-170], suggesting that the electron transfer chain may be the 
bottleneck of energy production. But inside of the electron transport chain, quinone acts as 
a redox signal for the P-ArcA system [54], which may create a feedback control loop on 
the major reducing equivalents [NAD(P)H] generation pathway, the TCA cycle (Fig. 3.2.4). 
Due to the fact that NADH and NADPH can be converted into each other through 
reversible transfer of reducing equivalents between NAD and NADP by transhydrogenase 
[51-53], they are regarded as equal in this study. 
3.2.4.8 Amino acid and nucleotide metabolism 
During exponential growth in defined medium all amino acids must be synthesized from 
glucose, NH4
+
 and SO4
2-
. In defined medium the total abundance of 68 identified amino 
acid metabolism proteins (appr. 18% of WCPM), is three times higher than the 
corresponding abundance in complex medium (appr. 6% of WCPM) with the rich supply 
of amino acids and peptides (Suppl. Figs 5.3.1 and Table 5.3.1). This can be explained by 
the fact that most of the amino acid biosynthesis pathways are regulated by feedback 
inhibitions (as summarized in Suppl. Table 5.3.4). At the same time in complex medium, 
several proteins (e.g. AstD, Tdh, Kbl and PutA) identified in arginine, threonine and 
tryptophan degradation pathways are up-regulated. This also suggests that the amino acid 
biosynthesis is strongly repressed during the exponential phase in complex medium. Since 
the strongly down-regulated amino acids synthesis pathways require low amounts of 
precursors and reducing equivalents (generated by the CMPs), their down-regulation may 
also contribute to the acetate overflow metabolism in complex medium at exponential 
phase (as indicated by the dashed arrows in Fig. 3.2.4B). 
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When E. coli reaches the stationary phase, the feedback inhibition is relieved in complex 
medium. Some enzymes involved in amino acid biosynthesis are up-regulated (Suppl. Fig 
5.3.2 and Table 5.3.1), but the up-regulation of proteins, which are responsible for amino 
acids degradation (e.g. AstABD, Tdh, Kbl and PutA), becomes more prominent. Whereas 
in defined medium during the entry into stationary phase, the abundance of amino acid 
biosynthesis and degradation proteins does not change significantly. 
Inosine monophosphate (IMP) is the most important intermediate in purine biosynthesis. 
At exponential phase, the total abundance of identified IMP biosynthesis proteins in 
defined medium is two times higher than in complex medium (Suppl. Fig 5.3.1 and Suppl. 
Table 5.3.1). The down regulation of IMP biosynthesis proteins in complex medium at 
exponential phase is due to feedback inhibitions (mediated by PurR repressor) by purine 
nucleotides in complex medium [171-173]. At exponential phase in defined medium IMP 
must be synthesized de novo, but in complex medium IMP can be synthesized through 
salvage pathways [174]. 
Other proteins identified belonging to purine and pyrimidine biosynthesis or nucleotides 
salvage pathways show a similar regulatory pattern: at exponential phase nearly all the 
proteins are up-regulated in complex medium as compared to defined medium. In complex 
medium, E. coli can produce nucleotides faster through salvage pathways with less 
consumption of carbon and nitrogen sources, which may also contribute to the acetate 
overflow metabolism. 
When the culture reaches stationary phase, the feedback inhibition is relieved. In complex 
medium, the amount of some IMP biosynthesis proteins (e.g. PurCDT) increases, but other 
proteins for nucleotide biosynthesis decrease with the cessation of cell growth (Suppl. Fig 
5.3.2). 
3.2.4.9 Lipid, lipopolysaccharide and other cellular component biosynthesis 
In addition to enzymes involved in amino acid and nucleotide metabolism, 7 proteins for 
lipid synthesis, 10 proteins for lipopolysaccharide biosynthesis and 16 proteins belonging 
to different biomass block biosynthesis pathways were identified. The total abundance of 
these proteins is not high. Their abundance is mainly related to the growth rate, but 
individual regulations still exist. The proteomic data suggest that the lipid, 
lipopolysaccharide and other cellular component biosynthesis may not be related to the 
acetate overflow metabolism (for details, refer to Suppl. Table 5.3.1 and Suppl. Figs. 5.3.1, 
5.3.2 and 5.3.3).  
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3.2.5 Discussion 
Based on the information of E. coli transcription regulation from RegulonDB [145] as 
summarized in Suppl. Table 5.3.3 and current proteomic data as shown in Suppl. Table 
5.3.1, a general regulatory model of the CMPs, oxidative phosphorylation and synthesis of 
biomass building blocks (e.g. amino acids) is proposed to explain the acetate overflow 
metabolism under nutrient-rich conditions (Fig. 3.2.4). During aerobic exponential growth, 
the high levels of enzymes in the PPP and lower glycolysis, and the low levels of TCA 
cycle and amino acid biosynthesis enzymes in complex medium are the main reasons 
leading to the corresponding acetate overproduction. 
Many transcriptional factors are involved in the regulation of CMPs, but the most 
predominant three are Cra, CRP-cAMP, and P-ArcA. The observed regulation of proteins 
in glycolysis and TCA cylce can be explained by the antagonistic regulation through these 
three transcriptional regulators. In general, active Cra inhibits the expression of glycolysis 
genes [146, 148], CRP-cAMP activates the expression of genes in the lower glycolysis 
[149] and TCA cycle [158, 160-164], and P-ArcA only inhibits the TCA cycle genes [156-
159]. It is found that there are competitions between Cra vs. CRP-cAMP and P-ArcA vs. 
CRP-cAMP, controlling the synthesis of lower glycolysis and TCA cycle proteins, 
respectively.  
The mechanism of competition between Cra and CRP-cAMP is easy to understand: under a 
condition without additional fructose, glucose will cause catabolite repression by lowering 
the intracellular level of CRP-cAMP, but fructose-1,6-bisphosphate (FBP), which is 
produced during the utilization of glucose in upper glycolysis, will inactivate Cra for 
relieving the catabolite repression. When glucose is not present, the situation is the other 
way round. The proteomic data in this study indicate that Cra is the weaker one: during 
exponential growth, most of the upper glycolysis proteins in complex medium (no glucose 
added) are lower than in defined medium (~10 g L
−1
 glucose), but the majority of proteins 
in lower glycolysis are higher in complex medium. 
To explain the mechanism of competition between CRP-cAMP and P-ArcA, the amino 
acid biosynthesis and NADH turnover in oxidative phosphorylation must be taken into 
consideration, because they can affect the transphosphorylation of ArcA. With the presence 
of yeast extract and tryptone, the amino acid biosynthesis pathways in complex medium 
are deeply down-regulated at exponential phase. The corresponding demand for the 
precursors and energy (ATP and reducing equivalents) are lower in complex medium. It is 
difficult to judge the production level of reducing equivalents during exponential growth in 
defined and complex media, but through calculation as described in Suppl. Methods 
(determination of NADPH turn-over involved in amino acid biosynthesis), about 80% of 
total NADPH is spent on the amino acid biosynthesis in defined medium. Then a 
hypothesis is made that during exponential growth the reducing equivalents entering 
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oxidative phosphorylation to produce ATP in complex medium is higher than in defined 
medium. The high level of NADH turnover rate will lead to a low level of oxidized 
quinones. Then the inhibition of transphosphorylation of ArcA imposed by oxidized 
quinones is week. The P-ArcA will address strong inhibition on the expression of TCA 
cycle genes [59]. It was observed that the synthesis of TCA cycle proteins in complex 
medium is much lower than in defined medium. Furthermore, in defined medium and also 
in complex medium at stationary phase, low level of NADH entering oxidative 
phosphorylation, results in a large size of oxidized quinone pool, which will inhibit the 
phosphorylation of ArcA to relieve the repression of P-ArcA on TCA cycle genes. The up-
regulation of TCA cycle proteins in these two conditions was clearly observed. The 
proteomic data suggest that P-ArcA is stronger than CRP-cAMP. 
It is proposed that P-ArcA creates a feedback control loop on the major reducing 
equivalent generation pathway, the TCA cycle; when reducing equivalents are enough for 
high speed of growth, E. coli tends to reduce TCA cycle activity. Simutanuously, enzymes 
in lower glycolysis can not be down-regulated as a result of the competition between Cra- 
and CRP-cAMP-dependent regulations. At this situation, the carbon flux in glycolysis is 
not compatible with TCA cycle capacity, which results in a high level of by-product 
production. The enhanced by-product production may make the carbon sources utilization 
more efficient, because acetate can be re-assimilated after other nutrients are consumed. 
Moreover, the excreted acetate can also inhibit the growth of other competitors in the same 
milieu, which helps E. coli to win the competition against other microorganisms. 
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3.3 A comprehensive proteomic study II. Global response of 
Escherichia coli to nutrient deficiency and depletion 
3.3.1 Abstract 
Through the techniques of two-dimensional gel electrophoresis and mass spectrometry, a 
systematic quantitative proteome analysis was carried out for Escherichia coli grown in 
defined and complex media. The global self-protection response of E. coli towards nutrient 
deficiency and depletion was analyzed. When cells enter stationary phase but also when 
cells are grown on nutrient-poor medium, the sugar, amino acid and peptide transport 
systems, by-products assimilation pathways (e.g. acetate) as well as the upper glycolysis 
pathway are up-regulated to absorb the limited nutrients in the environment; amino acid 
and certain metabolite degradation processes are also up-regulated to recycle the 
intracellular resources that are no longer required. Concurrently, the synthesis of proteins 
involved in the elimination of the reactive oxygen species and DNA protection is also 
highly increased. Conversely, proteins associated with transcription and translation 
processes, which represent a large amount of total cellular protein during fast exponential 
growth, are down-regulated with the decrease of the growth rate. 
Keywords Escherichia coli proteome ∙ Stationary phase ∙ Starvation ∙ Stress response ∙ 
Two-dimensional gel electrophoresis ∙ Defined medium ∙ Complex medium 
3.3.2 Introduction 
In the natural environment bacteria seldom encounter conditions that permit continuous 
balanced growth. The biosphere in a given area always undergoes a cycle of “feast” and 
“famine”. When nutrients are insufficient for steady growth, bacteria face such demanding 
conditions by entering a state named stationary phase [62]. The organisms should adapt to 
nutrient starvation and survive for long periods in the absence of nutrients [63]. The 
cellular metabolism must be reoriented to maintenance. Endogenous energy reserves must 
be mobilized, and the cell must survive in the absence of reproduction. These changes 
require noticeable physiological and structural changes in the cells [64]. Proteins 
synthesized early during starvation are the likely candidates required for starvation survival 
[64-66]. For example, the synthesis of many proteins with specific roles in protecting the 
cell against external stresses, e.g. heat, oxidants, osmotic challenge, and exposure to toxic 
chemicals, is highly up-regulated in stationary phase for cell survival [67-69]. 
It was found that many functions induced during stationary phase are also induced when 
the cells are grown with a long doubling time [63]. So properties identified as stationary 
phase induced may be also important for growth under conditions of nutrient deficiency or 
poor nutrient availability, such as the growth in defined (minimal) medium. 
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The investigation of starving bacterial cells is not only of crucial importance in medicine, 
but also in many fields of modern biotechnology [175]. Owing to the arrested cell growth 
and reduced metabolic activity, a study on whole cell proteome, which performs the direct 
biological functions, will be the most suitable procedure to study how cells deal with “poor” 
nutrient availability. The fully sequenced E. coli genome makes it accessible for proteomic 
analysis using mass spectrometry [97]. But only a few proteomic analyses of stationary 
phase physiology [65, 68, 70-73] with very limited number of identified proteins have been 
reported.  
The growth rates of microorganism are not constant when facing different environmental 
conditions. The influence of temperature, pH, dissolved oxygen and other environmental 
conditions, has been widely investigated for many years. But how different nutrients, 
especially different carbon and nitrogen sources, determine the specific growth rate is still 
ambiguous [14]. Generating comprehensive proteomic data will greatly facilitate to reveal 
the global regulation of cell growth. 
Together with chapter 3.2, a systematic proteomic study using a 2D gel-based proteome 
analysis was carried out for E. coli BL21 (DE3) cells from exponential and stationary 
phase cultures grown in defined and complex media to reveal the cellular physiology when 
nutrients are insufficient. When comparing to the growth in complex medium, the 
nutritional condition in defined medium is described as nutrient deficiency. When 
comparing to the growth at exponential phase (also known as log phase), the nutritional 
condition at the stationary phase is defined as nutrient depletion. In the present study, two 
major proteomic comparisons are investigated: first the proteomic difference between 
defined and complex media at exponential phase is used to reveal the cellular response to 
nutrient deficiency; secondly the proteomic difference between stationary and exponential 
phases in complex medium is studied to show the cellular response to nutrient depletion. 
3.3.3 Materials and methods 
3.3.3.1 Strain, media and cultivation conditions 
E. coli BL21 (DE3) (Novagen, Germany) was used in this study. The composition of 
Luria-Bertani (LB) medium, Terrific-Broth (TB) medium and Defined Non-inducing Broth 
(DNB) [110, 141], and cultivation conditions were described in chapter 3.2.3.  
3.3.3.2 Two-dimensional gel electrophoresis and protein spot identification 
Immobiline DryStrip gels of pH 3-10 NL (GE Healthcare, UK) and SDS-PAGE (10-15% 
gradient gel) were used for the first and second dimension of 2D gel electrophoresis. 
Coomassie stained gels were analyzed by using Proteomweaver™ 4.0 (Bio-Rad, USA) for 
protein spot detection, matching and quantification. Each spot’s intensity was normalized 
by the whole spot intensity on the same 2D gel. The corresponding average value from the 
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duplicated gels was used indicating the spot’s protein portion (%) of whole cell protein 
mass (WCPM). The sum “WCPM %” of spots representing the same protein was used for 
indicating the expression of the corresponding protein. Protein spots were identified by 
matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF 
MS). The MASCOT search program (Matrix Science, UK) was used for protein 
identification with the annotated E. coli genome [Uniprot (http://www.uniprot.org/) serving 
as database]. All proteins with a Mowse score greater than 54 were regarded as significant 
(p < 0.05). Detailed methods have been described previously [126, 127] and in section 5.1 
in the Appendix. 
EcoCyc (http://ecocyc.org/) [143] and KEGG (http://www.genome.jp/kegg/) databases 
[144] were used for classification of identified proteins. The transcriptional regulation of 
identified proteins was mainly acquired from the RegulonDB 
(http://regulondb.ccg.unam.mx/) database [145]. 
3.3.4 Results 
3.3.4.1 Growth kinetics in defined and complex media 
With the presence of tryptone and yeast extract, E. coli has a maximum specific growth 
rate of about 1.5 h
−1 
in complex medium (37 °C). But in defined medium, the maximum 
specific growth rate decreases to 0.8 h
−1 
(37 °C). It has also been observed that the acetate 
excretion during exponential growth and assimilation during entry into stationary phase, 
are much higher for E. coli grown in complex medium than in defined medium. Detailed 
growth and acetate production kinetics of E. coli in defined (DNB) and complex (LB) 
media were shown in the Fig. 3.2.1 in chapter 3.2. In this chapter, the defined medium was 
used to mimic the nutrient deficiency as compared to complex medium, and the stationary 
phase was used to simulate nutrient depletion compared with the exponential phase.  
3.3.4.2 Systematic and comparative proteome analysis  
The whole cell proteome of E. coli grown in defined and complex media at exponential 
and stationary phase was analyzed. 516 spots were identified by MALDI-TOF MS 
representing 369 different proteins. Results of analysis and annotated 2D gels are 
summarized in Suppl. Figs 5.3.1-5.3.12. The most representative 2D gels are shown in Fig. 
3.3.1. All identified proteins are classified into 11 categories with 29 groups as shown in 
Suppl. Table 5.3.1 and 5.3.2. The first three categories: carbohydrate metabolism, oxidative 
phosphorylation and synthesis of biomass building blocks are thoroughly discussed in 
chapter 3.2. In the current chapter, we focus on the proteomic differences of the remaining 
categories: (IV) (Metabolite) degradation, (V) transportation, (VI) transcription and 
translation, (VII) protein folding and degradation, (VIII) cell redox balance, (IX) DNA 
protection and repair, (X) unclassified and (XI) uncharacterized proteins.  
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3.3.4.3 (Metabolite) degradation  
During exponential growth, the total abundance of 19 identified proteins belonging to 
different metabolite degradation processes is at similar level in defined and complex media. 
But regulations of individual proteins are very different. Four proteins, MalPQ [176], TreC 
[177] and FadH [178] are highly up-regulated in complex medium at exponential phase 
indicating that different carbon sources, e.g. maltose, trehalose and even fatty acids, can be 
used during exponential growth of E. coli. Especially for maltose, the corresponding 
maltose transport systems are also up-regulated in complex medium (discussed in the next 
section). 
During the transition from exponential to stationary phase, the proteins belonging to 
different metabolite degradation processes remain constant in defined medium, but greatly 
increase in complex medium. 11 proteins, which are involved in degradation pathways of 
galactitol(GatZD) [165], trehalose(TreA) [177], melibiose(MelA) [179], 4-aminobutyrate(GabDT) 
[180], putrescine(Prr)
 
[181], nucleotides(CpdB) [182], fatty acids(FadB)
 
[183], methylglyoxal(DkgA) 
[184] and sialic acid(NanA) [185], are highly up-regulated in complex medium at stationary 
phase as compared to exponential phase (Suppl. Table 5.3.1). 
3.3.4.4 Sugar transport 
At exponential phase, four identified proteins (PtsIH, Crr and ManX) belonging to the 
phosphotransferase system (PTS) are higher in defined medium (with glucose as sole 
carbon source) than in complex medium (in which no glucose is supplied) (Suppl. Fig 
5.3.1). Meanwhile, the three identified maltose transport proteins (MalEK and LamB) are 
lower in defined medium than in complex medium. When E. coli reaches stationary phase, 
PtsH, Crr, ManX and MalE are highly up-regulated in all media (Suppl. Fig 5.3.2 and 
5.3.3). 
The proteomic data show that the sugar transport systems (especially PTS) are up-
regulated in response to nutrient deficiency and depletion (Fig. 3.2.3 in chapter 3.2). The 
observed synthesis of PTS proteins can be explained by the antagonistic regulation of four 
transcription regulators (CRP-cAMP, Cra, NagC and Mlc). The mechanisms of regulation 
through CRP-cAMP and Cra were discussed in chapter 3.2. The repressing activity of 
NagC is induced by GlcNAc-6-P, the product of GlcNAc transport by the PTS [186]. And 
the repressing activity of Mlc is inactivated by binding to the dephosphorylated form of 
EIICB
Glc
 (PtsG), which is formed during the transport of glucose [187]. 
At exponential phase in defined medium, glucose is the sole carbon source. The repression 
of PTS genes by low level of CRP-cAMP (caused by the high glucose concentration) is 
strong. However, the inhibitions by Cra, Mlc and NagC are week, which are caused by the 
high level of fructose-1,6-bisphosphate (FBP, produced during the utilization of glucose), 
the dephosphorylated form of PtsG (formed during the transport of glucose) and the 
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absence GlcNAc in defined medium, respectively. The observed up-regulation of PTS 
proteins suggests that the derepression of Cra, Mlc and NagC is stronger than the catabolite 
repression by glucose in defined medium at exponential phase. 
At the transition into stationary phase with the depletion of carbon sources, the repression 
by glucose and NagC is relieved. But the repression by Mlc (caused by the cessation of 
glucose uptake through PTS) and Cra (caused by the absence of F1P and FBP) is activated. 
The derepression of CRP and NagC seem to win the competition: up-regulation of PTS 
proteins is observed in all media at stationary phase. 
The observed synthesis of proteins of the maltose transport system can be explained by the 
co-regulation of CRP-cAMP [188] and MalT [189]. At exponential phase in complex 
medium, catabolite repression by glucose does not occur, and maltose or maltodextrin in 
the medium can induce MalT to activate the expression of the malK-lamB-malM and 
malEFG operons [189]. At exponential phase, up-regulation of maltose transport proteins 
is observed in complex medium. When cells enter stationary phase with the depletion of 
carbon sources, the MalT activation vanishes (which will suppress the expression of 
maltose transport genes), but the catabolite repression by glucose is relieved (which will 
activate the expression of maltose transport genes). The up-regulation of MalE and the 
down- and/or non-regulation of MalK and LamB, respectively, are observed. 
3.3.4.5 Amino acid and peptide transport 
The general regulation of the amino acid and peptide transport proteins is very similar to 
PTS proteins. At exponential phase, the synthesis of 7 identified proteins (GlnH, ArtJ, ArgT, 
LivJ, DppA and OppAD) is much higher in defined medium (Suppl. Fig 5.3.1), in which 
no amino acids are added. At the transition into stationary phase with the exhaustion of 
nutrients, except GlnH, strong up-regulation of the remaining 6 proteins was observed in 
both defined and complex media (Suppl. Fig 5.3.2 and 5.3.3). 
3.3.4.6 Other transport proteins 
14 identified proteins are assigned to the group of other transport proteins (for details refer 
to Suppl. Table 5.3.1), which altogether account for about 5% of WCPM. At exponential 
phase, the synthesis of the majority of them is slightly higher in complex medium as 
compared to defined medium, suggesting that the nonspecific diffusion channels, e.g. 
OmpA and OmpF, may be sufficient for rapid nutrient absorption to support the fast growth, 
when the concentration of nutrients is high in complex medium. During the transition into 
stationary phase, the nonspecific diffusion channels (OmpAF) in complex medium remain 
constant, but have an increase in defined medium. The synthesis of OmpAF can be 
explained by the control of CRP-cAMP [162, 190]. In defined medium, at exponential 
phase the high concentration of glucose represses the synthesis of OmpAF; whereas at 
stationary phase catabolite repression by glucose is relieved which allows the up-regulation 
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of OmpAF. 
3.3.4.7 RNA polymerases and binding proteins 
The regulation of the identified three subunits (RpoABC) of the core RNA polymerase 
(RNAP) is directly correlated with the growth rate. At exponential phase, the synthesis of 
RpoABC in defined medium is lower than in complex medium. When reaching stationary 
phase, RpoABC decreases in both defined and complex media. 
RNAP-associated proteins bind to RNAP affecting various steps in the transcription cycle 
or RNAP assembly. At exponential phase, 7 identified RNAP binding proteins (RapA, 
NusAG, Rho, RpoD, SspA and DksA) are also generally down-regulated in defined 
medium as compared to complex medium. When E. coli reaches stationary phase, the total 
abundance of identified RNAP-associated proteins decreases in complex medium, but the 
corresponding total abundance remains constant in defined medium (Suppl. Table 5.3.2). 
There are only two identified RNAP binding proteins (SspA and DksA), which are up-
regulated when E. coli enters stationary phase in all media. SspA is induced by starvation 
and increases with the decrease of growth rate [191] and is essential for cell survival 
during acid-induced stress [192]. DksA binds directly to RNA polymerase, affecting 
transcript elongation and augmenting the effect of the alarmone ppGpp [193], which 
causes a redirection of transcription so that genes important for starvation survival are 
favored at the expense of those required for growth and proliferation [194]. 
3.3.4.8 Ribosomal proteins and associated proteins 
Ribosomes are responsible for synthesizing the proteins in the cell. In the current study, 5 
ribosomal proteins (RplLI and RpsABF) were identified. Their synthesis is strictly 
correlated with the growth rate (growth rate dependent). At exponential phase, the 
synthesis of identified ribosomal proteins in defined medium is much lower than in 
complex medium (Fig. 3.3.2A). When E. coli enters stationary phase, the synthesis of 5 
ribosomal proteins remains nearly constant (or decreases slightly) in defined medium, but 
in complex medium, significant down-regulations are observed (Fig. 3.3.2B and 3.3.2C).  
8 ribosome-associated proteins were identified. At exponential phase, most of them are 
also lower in defined medium than in complex medium (Fig. 3.3.2A). When the culture 
reaches stationary phase, regulations are divided into two groups: EngAD, YcaO, TypA, 
HflX and Tig are generally down-regulated; Frr and RaiA are up-regulated (Fig. 3.3.2B and 
3.3.2C). In the first group, four proteins (EngAD, TypA and HflX) have GTPase activity 
[195] providing energy for translation by the hydrolysis of GTP. The trigger factor (Tig) is 
a ribosome-associated chaperone guiding the initial steps of emerging nascent peptide 
chain folding [196, 197]. In the second group, Frr is important for the ribosome recycling 
and is also involved in preventing translation errors [198]. And RaiA was found likely to be 
involved in the stabilization and preservation of ribosomes in the stationary phase [199]. 
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Fig. 3.3.2 Proteome comparison of transcription and translation processes of E. coli grown in 
different conditions 
A: Proteome comparison of E. coli grown in defined/complex medium at exponential phase. B: 
Comparison of E. coli grown at stationary/exponential phase in complex medium. C: Comparison of E. 
coli grown at stationary/exponential phase in defined medium. Corresponding values of 
Log2(defined/complex medium) at exponential phase (A), Log2(stationary/exponential phase) in complex 
medium (B) and Log2(stationary/exponential phase) in defined medium (C) as indicated by arrows are 
shown in Suppl. Table 5.3.1. DNB medium was employed as defined medium. An average of protein 
abundancies from cells grown in LB and TB media is calculated to represent the proteome of cells grown 
in complex medium. Figs 3.3.2A, 3.3.2B and 3.3.2C are parts of Suppl. Figs 5.3.1, 5.3.2 and 5.3.3, 
respectively. Abbreviations used in Fig 3.3.2 are listed in Suppl. abbreviation before Suppl. Fig 5.3.1.  
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3.3.4.9 Aminoacyl-tRNA synthetases 
Aminoacyl-tRNA synthetases link amino acids to their specific tRNA molecules to 
generate aminoacyl-tRNAs which are substrates for translation [200]. 20 aminoacyl-tRNA 
synthetases, plus three proteins (Fmt, YgfZ and MnmA) which are responsible for the 
modification of aminoacyl-tRNAs, were identified. In generally, the synthesis of all the 
aminoacyl-tRNA synthetases is directly related to the growth rate. At exponential phase, 
identified aminoacyl-tRNA synthetases are lower in defined medium than in complex 
medium (Fig. 3.3.2A). When entering stationary phase, general down-regulation of 
aminoacyl-tRNA synthetases in both defined and complex media is observed (Fig. 3.3.2B 
and 3.3.2C).  
At exponential phase, Fmt is highly up-regulated during slow growth in defined medium. 
During the transition to stationary phase in complex media, its synthesis increases with the 
cessation of cell growth. The regulation of Fmt is consistent with its proposed biological 
function: Fmt attaches a formyl group only to the initiator Met-tRNA; the formyl group 
provides a positive determinant for the initiation factor IF2, which blocks the binding of 
the elongation factor [201]. YgfZ, involved directly in tRNA modification, may present a 
novel global regulatory system [202]. Its synthesis is up-regulated during stationary phase 
in all media. 
3.3.4.10 Elongation factors 
One protein chain initiation factor (InfB), four elongation factors (FusA, TufA, Tsf and 
LepA) and one peptide chain release factor (PrfC) were identified. At exponential phase, 
these six proteins are all down-regulated in the defined medium (with a slower growth rate) 
as compared to complex medium (Fig. 3.3.2A). When E. coli enters stationary phase, the 
abundance of the identified initiation, elongation and release factors remains constant in 
defined medium, but in complex medium they decrease greatly to a similar level as in 
defined medium (Figs. 3.3.2B and 3.3.2C).  
The regulation pattern, which is very similar to the ribosomal proteins, is directly related to 
the growth rate with an exception during the transition into stationary phase in the defined 
medium. This indicates that the synthesis of ribosomal proteins and elongation factors may 
have reached the minimum level in defined medium at exponential phase. 
3.3.4.11 RNA degradation 
Three proteins (Rnb, Pnp and RhlB) responsible for RNA degradation were identified. The 
synthesis of Rnb, Pnp and RhlB, is strictly correlated with the growth rate: they are down-
regulated at lower growth rate (in defined medium as compared to complex medium) and 
in stationary phase in all media (Fig. 3.3.2). 
When cells grow at a faster rate, the total RNA synthesis rate increases with the increase of 
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growth rate [203], but mRNA half-lives do not decrease with the increase of growth rate 
[204]. A larger amount of “waste” tRNA and mRNA will be produced after translation at 
higher growth rate (e.g. during exponential growth in complex medium). The regulation of 
Rnb, Pnp and RhlB perfectly fits their biological responsibility for RNA degradation. 
3.3.4.12 Isomerases 
Peptidyl prolyl cis-trans isomerases (PPIases) catalyze the cis-trans isomerization of 
proline peptide bonds during protein folding [205, 206]. Five PPIases (PpiB, SurA, FklB, 
FkpA and SlyD) were identified. The total abundance of them is very low (only about 0.6% 
of WCPM). The regulation of nearly all proteins involved in transcription and translation is 
directly proportional to the growth rate. But the identified PPIases remain constant in 
different media and growth stages indicating that the PPIase may be a potential bottleneck 
for the protein folding after translation. 
3.3.4.13 Chaperones 
Within the current experimental setup, the majority of E. coli chaperones were identified as 
shown in Suppl. Table 5.3.1. The DnaK chaperone system and GroL-GroS chaperonin 
complex play the central role in the folding of nascent polypeptide chains and stress 
response [207, 208]. 
At exponential phase, most of the identified chaperones (e.g. DnaK, GrpE, GroL, HtpG, 
HscA and ClpA) are down-regulated in defined medium as compared to complex medium. 
Only two identified chaperones, IbpA and ClpB, which are able to bind to or resolubilize 
aggregated proteins [87, 209, 210], are up-regulated in nutrient deficient conditions (in 
defined medium as compared to complex medium) (Fig. 3.3.2A). 
During the transition to stationary phase, the total abundance of chaperones remains 
constant in all media (Suppl. Table 5.3.1). But the regulations of individual proteins are 
very prominent. IbpA and ClpB are up-regulated during nutrient depletion in complex 
medium (Fig. 3.3.2B and 3.3.2C). The identified DnaK system (DnaK and GrpE) and 
GroL-GroS complex are slightly increased at the stationary phase. On the contrary, the 
synthesis of HtpG [211], ClpA [212], and HscA [213] is down-regulated in stationary 
phase in all media. 
3.3.4.14 Proteases 
Proteolysis in E. coli serves to rid the cell of abnormal and misfolded proteins and to limit 
the time and amounts of availability of critical regulatory proteins [214]. At exponential 
phase in complex medium, the higher synthesis of 13 identified proteases (e.g. HslU, PepP 
and PrlC as shown in Suppl. Table 5.3.1) corresponds to the hypothesis that in addition to 
the chaperones, proteases also play a very important role in the cellular system for the de 
novo folding and quality control of proteins [215]. In defined medium at exponential phase, 
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only DepP, which can degrade abnormal and aggregated proteins in the periplasm [216], is 
up-regulated. 
Proteases are also very important for E. coli to survive during stationary phase [217-219]. 
The enhanced proteolysis can provide the starving cell with a source of amino acids for the 
synthesis of stationary phase proteins [64, 219]. As observed in this study, not all identified 
proteases are up-regulated during the transition to stationary phase. In complex medium, 
five identified proteases (DegP, PepQDN and Dcp) are highly up-regulated. And five (Prc, 
HslVU, PepBP) are down-regulated. In general, the total abundance of identified proteases 
increases during entry of E. coli into stationary phase in complex medium. But in defined 
medium under nutrient deficient conditions, no prominent up-regulation occurs. 
Correspondingly, proteome differences between exponential and stationary phase cells are 
much less prominent in defined medium than in complex medium (as indicated in Fig. 
3.3.3). 
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Fig. 3.3.3 Proteome comparison of E. coli during exponential and stationary phase 
The log2 ratios of all identified proteins were plotted for E. coli grown at stationary phase versus 
exponential phase in complex medium (A) and in defined medium (B). Corresponding values of 
Log2(stationary/exponential phase) in complex medium (A) and Log2(stationary/exponential phase) in 
defined medium (B) are shown in Suppl. Table 5.3.1. DNB medium was employed as the defined 
medium. An average of protein abundancies from cells grown in LB and TB media is calculated to 
represent the proteome of cells grown in complex medium. Bar charts were generated with individual 
proteins plotted on the x axis and the log2 expression ratios plotted on the y axis. 
3.3.4.15 Cell redox balance 
The intracellular redox balance is tightly regulated in E. coli. At exponential phase, the 
synthesis of 9 identified proteins having dehydrogenase activity, 8 identified proteins with 
oxidoreductase activity, 5 hydroperoxide reductases and one superoxide dismutase are at 
same level (about 2.6% of WCPM) in different media (for details refer to Suppl. Table 
5.3.1).  
When E. coli reaches stationary phase, the proteins involved in maintaining cell redox 
balance show a general increase in both defined and complex media. But the regulation in 
defined medium is less prominent as compared to complex medium (Suppl. Table 5.3.1). 
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In the past decades, the oxidative damage caused by superoxide (O2
−
) and hydrogen 
peroxide (H2O2) was studied in E. coli [220, 221]. Hydroperoxidase I and II, lipid 
hydroperoxide peroxidase, superoxide dismutase and alkyl hydroperoxide reductase have 
been proven to play an important role in eliminating reactive oxygen species (ROS) [222, 
223]. But the formation of ROS in E. coli is still obscure so far. 
At exponential phase, the synthesis of identified hydroperoxide reductases (AhpFC, Tpx 
and KatG) and SodB is similar in defined and complex media (Suppl. Fig 5.3.1). When E. 
coli reaches stationary phase, except AhpF, the synthesis of AhpC, Tpx, KatG and SodB, is 
generally up-regulated in all media (Suppl. Fig 5.3.2 and 5.3.3), clearly indicating that the 
capacity of ROS degradation is higher at stationary phase. At the same time, the observed 
up-regulation of CueO, which can oxidize Fe(II) to Fe(III) [224], and Bfr, which greatly 
attenuates the production of hydroxyl radicals during Fe(II) oxidation by H2O2 [225], also 
corresponds to the increased capacity of scavenging ROS at stationay phase. 
Based on the current observation, it could be speculated that the production of H2O2 and 
O2
–
 is higher at stationary phase than during exponential growth, at least in complex 
medium. The reuse of formerly excreted acetate (as observed in chapter 3.2) may play an 
important role. It was found that a hydroperoxidase-deficient E. coli strain, that can grow 
with glucose or glycerol, cannot grow using acetate as sole carbon source [222], indicating 
that when E. coli metabolizes acetate, the ROS generation rate is higher. 
The ratio between NADH and NADPH may be the potential “switcher” for the generation 
of intracellular ROS. During aerobic batch growth on glucose, only 55–70% of the 
NADPH is produced through the pentose phosphate pathway and tricarboxylic acid cycle 
(TCA cycle). The remainig part of NADPH is mostly generated from NADH by 
transhydrogenases [53]. But during acetate utilization, the situation is the other way round. 
Acetate will be firstly metabolized to acetyl-CoA. Acetyl-CoA will enter the TCA cycle, in 
where isocitrate dehydrogenase (Icd) is the major source for generation of NADPH. At 
stationary phase the enhanced synthesis of SthA; which is a transhydrogenase catalyzing 
the conversion of NADPH to NADH [53]; and WrbA which has NADPH-dependent redox 
activity and reduces quinones [226], corresponds to the potentially increased level of 
NADPH in complex medium. The high level of NADPH (produced by the utilization of 
acetate) may lead to the generation of ROS. 
3.3.4.16 DNA protection and repair 
The protection of DNA is crucial for E. coli. 7 proteins related to DNA protection and 
repair were identified (Suppl. Table 5.3.1). Three of them (Ssb, Dps, and CbpA) are non-
sequence-specific DNA binding proteins. Ssb is involved in all aspects of DNA 
metabolism: replication, repair, and recombination [227]. Dps forming extremely stable 
complexes with DNA, plays an important role both in gene expression and DNA protection 
during stationary phase [228]. CbpA binds to curved DNA without sequence-specificity 
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[229]. The universal stress protein, UspA, is a member of all starvation and stress 
stimulons [230, 231]. It also plays a critical role for resistance to DNA damaging agents 
[232]. 
At exponential phase, the synthesis of Ssb, Dps, and CbpA is at very low level in all media 
(Suppl. Table 5.3.1). UspAG are up-regulated in defined medium as compared to complex 
medium. When E. coli reaches stationary phase, all three identified non-sequence-specific 
DNA binding proteins and the universal stress protein UspA are highly up-regulated in all 
media (Suppl. Fig 5.3.2 and 5.3.3), clearly indicating that DNA protection mechanisms are 
activated when E. coli responds to nutrient depletion. 
PolA is required for several types of DNA repair. At exponential phase, the synthesis of 
PolA is higher in complex media indicating that higher level of proofreading capacity is 
required for the faster growth of E. coli. During the transition into stationary phase, the 
synthesis of PolA and SodA, which is more effective than SodB in preventing damage to 
DNA [233], does not increase. This may indicate that the oxidative damage to DNA at 
stationary phase is not significant in our experimental setup. The up-regulated 
hydroperoxide reductases and SodB can manage the oxidative stress before it causes real 
damage to DNA at stationary phase. 
3.3.4.17 Transcription factors, unclassified and uncharacterized proteins 
In this study 12 identified proteins are transcription factors, which bind to specific DNA 
sequences controlling the transcription of genetic information. The synthesis of them is 
nearly constant under different conditions (For details refer to Suppl. Table 5.3.1). 
However, their biological activities are generally regulated by post translation modification 
(e.g. phosphorylation of ArcA), which need more detailed study in the future.  
7 proteins with different biological functions are assigned to the unclassified protein group. 
The corresponding regulations are generally correlated with growth rate. 13 proteins 
identified in this research are uncharacterized proteins or proteins with putative function. 
Many of them (e.g. YjgR, YdcJ, YcgB, YgaU, YfbU, LfiI and YhdH) show very strong up-
regulation towards nutrient deficiency (exponential phase in defined medium) and/or 
nutrient depletion (stationary phase in complex medium). So there is a great requirement 
for further characterizations to reveal their underlying biological functions. For details of 
synthesis and regulation of unclassified and uncharacterized proteins, please refer to Suppl. 
Table 5.3.1. 
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Fig. 3.3.4 Summary of proteome data of E. coli grown at different conditions 
The number in the bracket after each category is the number of proteins that were identified belonging to 
the corresponding category. A: in complex medium at exponential phase (white bar) and at stationary 
phase (black bar). B: in defined medium at exponential phase (gray bar) and at stationary phase (dark 
gray bar). DNB medium was employed as the defined medium. An average of protein abundancies from 
cells grown in LB and TB media is calculated to represent the proteome of cells grown in complex 
medium. The entire data sets are shown in Suppl. Table 5.3.2. 
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3.3.5 Discussion 
In complex medium supplied with yeast extract and tryptone, E. coli grows in a nutrient 
rich environment. Comparatively, when cultivated in defined medium with glucose and 
NH4
+
 as the sole carbon and nitrogen sources, respectively, the nutritional condition is 
defined as nutrient deficiency. The most apparent difference is the cell growth: the 
maximum growth rate at 37 °C in defined medium (~0.8 h
−1
) is much lower than in 
complex medium (~1.5 h
−1
). Simultaneously, during exponential growth in complex 
medium much more by-product, acetate, is produced and re-assimilated when cells reach 
stationary phase (Fig. 3.2.1). 
Together with results revealed in chapter 3.2, the cellular responses towards nutrient 
deficiency and depletion are shown here in detail (Fig. 3.3.4 and Suppl. Figs. 5.3.1-5.3.6). 
When nutrient supplementation is poor, the PTS system for sugar transport and amino acid 
and peptide transport systems are highly up-regulated for a better assimilation of nutrients 
at low concentration or for scavenging remains from dying neighbors. But the maltose 
transport system and other transport proteins, e.g. OmpAFX and TolBC, do not show a 
strong regulation towards nutrient limitation. Corresponding to the enhanced level of 
proteins from the PTS system, proteins from carbohydrate metabolism, e.g. glycolysis, 
pentose phosphate pathway and TCA cycle, also show a general up-regulation. 
Interestingly, the proteins belonging to oxidative phosphorylation remain nearly constant. 
Concerning the synthesis of biomass building blocks, only proteins from pathways for 
amino acid and IMP biosynthesis are up-regulated when nutrient supplementation is poor. 
The amounts of proteins from other pathways for biomass building block synthesis are 
generally proportional to the growth rate. 
Proteins from amino acid biosynthesis pathways occupy more than 17% of the whole 
proteome during growth in defined medium, compared with only about 6% in complex 
medium. During the transition to stationary phase in complex medium, instead of greatly 
increasing the whole amino acid biosynthesis pathway, E. coli chooses a more efficient 
strategy: enzymes involved in amino acids degradation are highly up-regulated. Many 
identified proteins in the (metabolite) degradation category are also strongly up-regulated 
during the transition to stationary phase in complex medium. But for the growth in defined 
medium, the corresponding up-regulation is not significant.  
Most of the proteins involved in transcription and translation, e.g. ribosomal proteins, 
aminoacyl-tRNA synthetases and elongation factors, are of high abundance and correlate in 
abundance with the growth rate. It is clear that when facing a “famine” environment, E. 
coli will greatly reduce the abundance of these proteins. For example, when cells reach 
stationary phase in complex medium, the total abundance of identified proteins involved in 
transcription and translation decreases from ~27% to ~17% of WCPM. In contrast, 
proteases and enzymes from amino acid degradation and (metabolite) degradation 
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pathways are highly up-regulated (Fig. 3.3.4). 
Reducing the damage of cellular components, especially of DNA, is of crucial importance 
for E. coli to surve during starvation. Some oxidoreductases, nearly all hydrogen peroxide 
reductases and SodB for eliminating reactive oxygen species, are strongly up-regulated at 
stationary phase to prevent the cellular damage caused by superoxide or hydrogen peroxide. 
Non-sequence-specific DNA binding proteins for DNA protection are also highly up-
regulated at stationary phase. 
In complex medium, the difference in the composition of the proteome of cells in 
exponential and stationary phases is much more significant than in defined medium (as 
indicated by Fig. 3.3.3). This is a result of the re-assimilation of formerly excreted acetate 
and the possible scavenging of remains from proteins involved in transcription and 
translation which are not longer required and can be used to provide energy and resources 
for fine-tuning the proteome for the survival during starvation. 
In this chapter, a comprehensive quantitative proteomic profile of a self-protection 
mechanism employed by E. coli to cope with nutrient deficiency or depletion is presented: 
proteins from transport systems, glycolysis and by-products (e.g. acetate) assimilation 
pathways are up-regulated to absorb limited nutrients; the abundance of transcription and 
translation related proteins is greatly reduced; correspondingly, proteins involved in 
different degradation processes (e.g. amino acid degradation) are increased to salvage 
reusable materials; proteins for different stress responses (e.g. eliminating reactive oxygen 
species) and for the protection of DNA are also greatly enhanced. Furthermore, in the next 
chapter, it will be shown that this kind of self-protection mechanism collapses when E. coli 
is forced to overproduce recombinant protein. 
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3.4 A comprehensive proteome study III. Global metabolic response in 
Escherichia coli during recombinant protein overproduction  
3.4.1 Abstract 
The global metabolic response during recombinant protein overproduction in Escherichia 
coli grown in defined and complex media has been analyzed using two-dimensional gel 
electrophoresis and mass spectrometry. During recombinant protein production, the 
proteome of E. coli shows a completely different regulation pattern as when facing nutrient 
deficiency and depletion. When E. coli is forced to overproduce a recombinant protein, 
chaperones are simultaneously highly up-regulated. Proteins from the transcription and 
translation processes remain at the same level as before induction. But proteins from the 
transport systems (e.g. the PTS, maltose, amino acid and peptide transport systems), the 
central metabolic pathways [e.g. glycolysis and tricarboxylic acid cycle (TCA cycle)], by-
product (e.g. acetate) metabolism, and proteins for degradations, reactive oxygen species 
elimination and DNA protection are down-regulated, which causes an overall metabolic 
breakdown: in complex medium, the formerly excreted acetate cannot be efficiently re-
assimilated; in defined medium, extracellular glucose cannot be utilized completely.  
Keywords Escherichia coli proteome ∙ Recombinant protein production ∙ Stress response ∙ 
Metabolic burden ∙ Two-dimensional gel electrophoresis ∙ Defined medium ∙ Complex 
medium 
3.4.2 Introduction 
Recombinant DNA techniques with the combination of bioprocess engineering allowed 
many therapeutic and diagnostic proteins to be produced in large quantities in genetically 
modified microorganisms, such as Escherichia coli. Under the control of strong promoters, 
e.g. T7 promoter, heterologous proteins are typically produced at high levels in E. coli, 
which will address a physiological stress named metabolic burden. Then the proteins of 
interest tend to aggregate into inclusion bodies [81-86]. 
The metabolic burden caused by overexpression of heterologous genes has been 
extensively studied [22-24], it will lead to a decrease of specific growth rate [74-78] and 
biomass yield [76-78], and will result in an increase of maintenance energy coefficient [74], 
respiratory activity [77, 79, 80], and acetate overflow metabolism [76]. Besides the 
production of target protein, the simultaneously enhanced formation of chaperones [77, 87, 
88] and proteases [89, 90] will also contribute to the metabolic burden. 
Owing to the complexity of metabolic networks and different production conditions, e.g. 
temperature, growth rate and the dose of inducer, the molecular mechanism of the 
metabolic burden is still ambiguous. 2D gel electrophoresis seems to be the most suitable 
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techniques to disclose the underling machinery. Among the proteomic studies [76-79, 88, 
91-96] about recombinant protein production in E. coli, the numbers of identified proteins 
are often low, which may increase the probability of misinterpretation, so there is a great 
demand for a comprehensive proteomic analysis for helping to reveal the global metabolic 
response during recombinant protein overproduction. 
Two groups of media are used in laboratory study and industrial production: complex and 
defined media [6-11]. The lot-to-lot variations of raw materials (e.g. yeast extract, peptone 
or tryptone) used in complex medium lead to poor production reproducibility [25, 47]. So 
the use of chemically defined medium is gaining more and more popularity [12, 110, 141]. 
Clearing the physiological differences of recombinant protein production in complex and 
defined media will help a lot towards choosing the appropriate conditions for the specific 
applications. 
Previous proteomic analysis (as described in chapters 3.2 and 3.3) revealed that during 
nutrient deficiency and depletion, E. coli will activate a self-protection mechanism to 
enhance the amount of proteins from transport systems, central metabolic pathways 
(CMPs), by-product metabolism, and proteins involved in different degradation processes, 
for eliminating reactive oxygen species (ROS) and for DNA protection. Conversely, the 
transcription and translation related proteins will be greatly reduced.  
In the present study, compared with non-induced controls, E. coli is forced to overproduce 
a recombinant protein (human basic fibroblast growth factor, hFGF-2, which serves as a 
model protein) in defined and complex media by the addition of isopropyl β-D-1-
thiogalactopyranoside (IPTG). The major proteomic comparisons between production and 
non-production conditions are investigated to show that the self-protection mechanism, 
which is observed when E. coli faces nutrient deficiency and depletion (as shown in 
chapter 3.3), breaks down completely: proteins involved in transcription and translation 
remain constant; and the proteins from transport systems, CMPs, by-product metabolism, 
and proteins for degradations, eliminating ROS and DNA protection are down-regulated. 
This causes an overall metabolic breakdown. 
3.4.3 Materials and methods 
3.4.3.1 Strain, media and cultivation conditions 
E. coli BL21 (DE3) with the plasmid pET-29c-hFGF-2 was used in this study [82]. The 
composition of Luria-Bertani (LB) medium is as follows: 10 g L
−1
 tryptone, 5 g L
−1
 yeast 
extract and 5 g L
−1
 NaCl. The composition of Defined Non-inducing Broth (DNB) is as 
follows: 10.91 g L
−1
 glucose, 4 g L
−1
 (NH4)2HPO4, 13.3 g L
−1
 KH2PO4, 1.55 g L
−1
 Citric 
acid, 0.59 g L
−1
 MgSO4, 100.8 mg L
−1
 Fe(III) citrate, 2.1 mg L
−1
 Na2MoO4.2H2O, 2.5 mg 
L
−1
 CoCl2.6H2O, 15 mg L
−1
 MnCl2.4H2O, 1.5 mg L
−1
 CuCl2.2H2O, 3 mg L
−1
 H3BO3, 33.8 
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mg L
−1
 Zn(CH3COOH)2.2H2O, 14.10 mg L
−1
 Titriplex III. The pH of all media was 
adjusted to 6.8 by NaOH before sterilization. After sterilization, 50 mg L
−1
 kanamycin was 
added to the media. Details of the media preparation were described in previous reports 
[110, 141]. 
Cultivations were carried out in duplicate using 1.8 L Fernbach flasks with three baffles 
containing 200 mL medium at 30°C and 180 rpm. When the culture reaches the mid-
exponential phase, isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to a final 
concentration of 0.25 mmol L
−1
 for starting hFGF-2 production. The cells were harvested 
after 3.5h and 5h of IPTG induction in LB and DNB media, respectively. Culture samples 
were centrifuged at 17,000×g and 4°C for 3 min. After removal of the supernatant, cell 
pellets were stored at −80°C until further analysis. 
3.4.3.2 Analysis of cell growth, acetate and glucose concentration, and protein 
production 
The cell growth was monitored by measuring the absorbance at 600 nm (OD600). Acetate 
was analyzed by an acetic acid kit (Cat. No. K-ACETRM, Megazyme, Ireland). Glucose 
was determined by YSI 2300 STAT Plus (YSI Life Sciences, USA). For protein production 
SDS-PAGE analysis was performed in Mini-PROTEAN 3 Cell (Bio-Rad, USA) according 
to standard procedures [114] and instructions from the manufacturer. BugBuster
TM
 protein 
extraction reagent with rLysozyme and Benzonase (Novagen, USA) was used to generate 
cell extracts and to prepare soluble and insoluble fractions according to the instructions 
from the manufacturer. After electrophoresis, SDS-PAGE proteins were visualized by 
Coomassie staining [115]. 
3.4.3.3 Two-dimensional gel electrophoresis 
Cell pellets were disrupted by BugBuster™ protein extraction reagent. The whole cell 
protein in the BugBuster suspension was precipitated as described previously [142]. The 
protein pellets were re-solubilized in rehydration solution with IPG buffer (GE Healthcare, 
UK). About 280 μg protein for each sample was loaded onto Immobiline DryStrip gel (pH 
gradient 3-10NL, GE Healthcare, UK). The first-dimension using isoelectric focusing (IEF) 
and second dimension using SDS-PAGE (10-15% gradient acrylamide gel) were run with 
the IPGphor™ Isoelectric Focusing System and Hoefer ™ DALT System (GE Healthcare, 
UK), respectively. The detailed protocol has been described previously [126] with 
reference to manufacturer's instructions (For details refer to section 5.1.1 in the Appendix). 
For each sample, 2D gels were made in triplicate. And the best two Coomassie stained gels 
[115] were analyzed by Proteomweaver™ 4.0 (Bio-Rad, USA) for protein spot detection, 
matching and quantification. Each spot’s intensity was normalized by the whole spots 
intensity of the same 2D gel. An average of the resulting percentage values from the 
corresponding duplicated gels was taken indicating each spot’s protein portion (%) of 
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whole cell protein mass (WCPM). The total “WCPM %” of all spots representing the same 
protein was used for indicating the abundance of the corresponding protein.  
3.4.3.4 Protein identification and classification 
Protein spots were identified by matrix-assisted laser desorption ionization time-of-flight 
mass spectrometry (MALDI-TOF MS). Protein spots were excised from the 2D gels. After 
washing, reduction and alkylation, in-gel digestion was carried out by incubation with 
sequencing grade trypsin (Promega, USA). Obtained peptides were extracted and purified 
with reversed-phase ZipTips C18 (Millipore, USA). The resulting peptide solutions were 
mixed with a saturated matrix solution (acetonitrile 40%, α-Cyano-4-hydroxycinnamic 
acid 1% and trifluoroacetic acid 0.06%) and spotted onto a 384 MTP target and dried at 
room temperature. A Bruker Ultraflex time-of-flight mass spectrometer (Bruker Daltonics 
GmbH, Germany) was used to obtain peptide mass fingerprints. Detailed experimental 
procedures have been described previously [126, 127] (For details refer to section 5.1.2 in 
the Appendix). The MASCOT search program (Matrix Science, UK) was used for protein 
identification with the annotated E. coli genome [Uniprot (http://www.uniprot.org/) serving 
as database]. All proteins with a Mowse score greater than 54 were regarded as significant 
(p < 0.05). 
For classification of identified proteins the EcoCyc (http://ecocyc.org/) [143] and KEGG 
(http://www.genome.jp/kegg/) databases [144] were used as described chapter 3.2. The 
transcriptional regulation information was mainly obtained from the RegulonDB 
(http://regulondb.ccg.unam.mx/) database [145]. 
3.4.4 Results 
3.4.4.1 hFGF-2 overexpression in E. coli using defined and complex media 
hFGF-2 production was carried out in shake flasks at 30°C with DNB and LB media. In 
the defined medium (DNB), all cellular components are exclusively synthesized from 
glucose, NH4
+
, PO4
3−
, and SO4
2−
. But in complex medium (LB) with the presence of sugars, 
amino acids, peptides, nucleotides and other nutrients from yeast extract and tryptone, the 
growth rate is much higher, because less energy and resources are loaded into the 
corresponding biosynthetic processes (as shown in chapter 3.2). The maximum growth rate 
in complex medium during exponential growth before induction is much higher than in 
defined medium (Fig. 3.4.1.B1 and 3.4.1B2). But after induction, there is a significant 
decrease of growth rate in complex medium, especially during the first two hours after 
induction. SDS-PAGE analysis indicates (Fig. 3.4.2) that hFGF-2 production in complex 
medium is much faster than in defined medium, which triggers a higher level of inclusion 
body formation (Suppl. Figs 5.3.29 and 5.3.30). 
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In complex medium (LB) as indicated in Figs. 3.4.1C1 and 3.4.1D1, the excreted acetate 
(during exponential growth) can be re-assimilated in the control run, but in the hFGF-2 
overproduction cultivation, the acetate is not completely re-assimilated. No oxygen 
limitation (i.e. dissolved oxygen did not drop below 30% of saturation; data not shown) 
was observed during the whole cultivation process in LB medium. 
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Fig. 3.4.1 Kinetics of growth, glucose utilization and acetate formation during hFGF-2 
production 
hFGF-2 production was carried out in shake flasks with LB medium as indicated in A1-D1, and DNB 
medium as indicated in A2-D2. 0.25 mM IPTG was added to the culture at 3.5 h for LB medium and 8 h 
for DNB medium. Control run without IPTG induction is marked using white symbols. hFGF-2 
producing culture is marked with black symbols. Samples for 2D gel electrophoresis analysis were taken 
at the time points indicated by arrows.  
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In defined medium (DNB), acetate excretion was observed at early stationary phase in the 
control run, but was not found in the cultivation with hFGF-2 overproduction (Fig. 
3.4.1C2). Correspondingly, in the control run an increased glucose utilization was observed 
also at early stationary phase, but during hFGF-2 production, glucose cannot be completely 
metabolized (Fig. 3.4.1A2). In the cultivation using DNB medium, oxygen limitations 
were observed at the early stationary phase for about 1.5 hours (data not shown). 
 
Fig. 3.4.2 Recombinant protein overproduction in defined and complex media 
hFGF-2 production as analyzed by SDS-PAGE was carried out in DNB medium (A) and LB medium (B). 
The time after IPTG induction is indicated below the gel images. The analyzed cell fractions are indicated 
above (S: soluble part of whole cell protein, I: insoluble part of whole cell protein, M: marker) 
3.4.4.2 Proteome analysis during recombinant protein production 
Culture samples (as indicated in Fig. 3.4.1A1 and 3.4.1A2) from LB and DNB media at 
exponential phase before IPTG induction, 1h after IPTG induction, 3.5h (for LB medium) 
or 5h (for DNB medium) after IPTG induction, and stationary phase without IPTG 
induction were analyzed by 2D gel electrophoresis. More than 500 spots representing 
about 370 different proteins were identified by mass spectrometry. Spots on 2D gels were 
identified, matched, normalized and categorized (the most representative 2D gels are 
shown in Fig. 3.4.3). All identified proteins were classified into 11 categories with 29 
groups as described in chapter 3.2 and 3.3. Results of analysis have been summarized in 
Suppl. Tables 5.3.5-5.3.6 and visualized in Suppl. Figs 5.3.13-5.3.20. Annotated 2D gels 
are shown in the Suppl. Figs 5.3.21-5.3.28.  
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Fig. 3.4.3 E. coli proteome changes in response to hFGF-2 overproduction 
The E. coli proteome of cells grown at stationary phase without IPTG induction in defined medium (A) 
and complex medium (B) is compared with the proteome of cells grown after 5h IPTG induction in 
defined medium (C) and 3.5 h IPTG induction in complex medium (D), respectively. 56 proteins with 
significant regulations are shown on the 2D gels: FbaA 1, GpmA 2, PpsA 3, TalB 4, GltA 5, SucD 6, Mdh 
7, PckA 8, MaeB 9, Acs 10, Pta 11, AckA 12, PoxB 13, AdhE 14, IlvE 15, IlvC 16, CysK 17, TnaA 18, 
AstA 19, PurC 20, GatZ 21, GatD, 22, FadB 23, Crr 24, ManX 25, MalE 26, OppA 27, TolB 28, RpoB 29, 
RpoD 30, Rho 31, RpsA 32, RpsB 33, RpsF 34, TypA 35, GlyS 36, InfB 37, Pnp 38, Dnak 39, GrpE 40, 
GroL 41, GroS 42, HtpG 43, ClpB 44, IbpA 45, PepQ 46, PepN 47, Bfr 48, AhpC 49, Tpx 50, SodB 51, 
Dps 52, UspA 53, YgaU 54, LfiI 55, hFGF-2 56. Different geometric shapes (e.g. circle, triangle, 
rectangle and square) are used for helping to locate and cross-compare identified proteins. For other 
conditions and the rest of identified proteins, please refer to Suppl. Figs 5.3.21-5.3.28. 
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3.4.4.3 Transportation system 
At the end of IPTG induction in both defined and complex media, proteins in transport 
systems are generally down-regulated as compared to the non-induced cultivation at 
stationary phase. The down-regulation of proteins in transport systems, such as 
phosphotransferase system (PTS) (PtsHI and Crr), maltose transport system (ManX, 
MalEK and LamB), amino acid (ArgT and LivJ) and peptide (DppA and OppAD) transport 
systems, which require energy during operation [e.g. adenosine triphosphate (ATP) or 
phosphoenolpyruvate (PEP)], is more significant than for transport proteins (e.g. CusB, 
FadL, OmpAF and TolC), which do not require energy during operation (Suppl. Table 
5.3.5). The glucose in defined medium can not be completely utilized in the IPTG induced 
culture as shown in Fig. 3.4.1A2, which coresponds the proteomic observation (Fig. 3.4.4). 
In defined medium at stationary phase, proteins in PTS and maltose transport systems are 
up-regulated as compared to the exponential phase (also known as log phase) (Fig. 3.4.4A), 
leading to an accelerated glucose uptake as shown in Fig. 3.4.1A2. Proteins in amino acid 
and peptide transport systems are also slightly up-regulated. In complex medium, the up-
regulation of proteins from sugar, amino acid and peptide transport systems is even more 
significant during entry into stationary phase in the non-induced cultivation (Fig. 3.4.5A). 
Other transport proteins, such as FadL, OmpAFX and TolBC, remain relatively constant at 
exponential and stationary phases in both media (Suppl. Table 5.3.5). 
It is found that when nutrients are not sufficient in the environment, the sugar, amino acid 
and peptide transport systems are up-regulated for a better absorption of the limited supply 
of nutrients in the environment. However, the increased nutrient uptake capacity at low 
nutrient concentrations is impaired by the overproduction of recombinant protein.  
3.4.4.4 Central carbon metabolism 
After 1h IPTG induction, the amount of glycolysis proteins catalyzing the reactions from 
glucose-6-phosphate (G6P) to PEP and proteins in the pentose phosphate pathway (PPP) is 
still the same as before induction. But the decrease of proteins (PykAF, AceEF and LpdA) 
for the conversion of PEP to Acetyl-CoA already starts (Suppl. Figs. 5.3.13 and 5.3.17), 
which potentially impairs the production of precursors (e.g. pyruvate, Acetyl-CoA and 2-
oxoglutarate) or reducing equivalents, and the assimilation of non-fermentable carbon 
sources, e.g. acetate. At the end of the hFGF-2 production phase, most of proteins of the 
glycolysis and PPP are down-regulated as compared to the exponential phase (before 
induction) or the stationary phase (without IPTG induction).  
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Fig. 3.4.4 Proteome changes during hFGF-2 production in defined medium (DNB) 
A: Proteome comparison of E. coli growing at stationary/exponential phase without production. B: 
Proteome comparison 5 h after IPTG induction/exponential phase (before IPTG induction). C: Proteome 
comparison 5 h after IPTG induction/stationary phase without production. Corresponding values of 
Log2(stationary/exponential phase) (A), Log2(5 h after IPTG induction/exponential phase) (B) and Log2(5 
h after IPTG induction/stationary phase) (C) as indicated by arrows are shown in Suppl. Table 5.3.5. Fig 
3.4.4A, 3.4.4B and 3.4.4C are parts of Suppl. Fig 5.3.16, 5.3.14 and 5.3.15, respectively. A comparison 
between 1 h after IPTG induction/exponential phase in defined medium is provided in Suppl. Fig 5.3.13. 
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Fig. 3.4.5 Proteome changes during hFGF-2 production in complex medium (LB) 
A: Proteome comparison of E. coli growing at stationary/exponential phase without production. B: 
Proteome comparison 3.5 h after IPTG induction/exponential phase (before IPTG induction). C: 
Proteome comparison 3.5 h after IPTG induction/stationary phase without production. Corresponding 
values of Log2(stationary/exponential phase) (A), Log2(3.5 h after IPTG induction/exponential phase) (B) 
and Log2(3.5 h after IPTG induction/stationary phase) (C) as indicated by arrows are shown in Suppl. 
Table 5.3.5. Fig 3.4.5A, 3.4.5B and 3.4.5C are parts of Suppl. Fig 5.3.20, 5.3.18 and 5.3.19, respectively. 
A comparison between 1 h after IPTG induction/exponential phase in complex medium is provided in 
Suppl. Fig 5.3.17. 
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When E. coli enters stationary phase without induced protein production, enzymes in the 
glycolytic pathway catalyzing the reactions from G6P to PEP and the PPP are generally up-
regulated, especially in complex medium (as shown in Figs. 3.4.4A and 3.4.5A) helping 
cells to respond better to nutrient depletion. Proteins in the lower glycolytic pathway 
catalyzing the conversion of PEP via pyruvate to Acetyl-CoA (PykAF, AceEF and LpdA) 
are slightly down-regulated in both media as compared to the exponential phase. The 
ability to increase the amount of enzymes in the glycolytic pathway during entry into 
stationary phase for a better assimilation of nutrients at low concentration is compromised 
when E. coli is forced to produce a recombinant protein (as shown in Fig. 3.4.4C and 
3.4.5C). 
The observed changes of enzymes from the glycolytic pathway can be explained by the 
regulation through two transcriptional regulators: the catabolite repressor activator (Cra) 
[146] and the cAMP receptor protein (CRP) [147]. Intracellular fructose-1,6-bisphosphate 
(FBP, which can be produced during glucose catabolism) and fructose-1-phosphate (F1P) 
will deactivate Cra for relieving the repression of the majority of glycolysis genes [146, 
148]. High level of glucose causes catabolite repression on many lower glycolysis genes by 
lowering the intracellular levels of CRP-cAMP [147, 149]. 
In defined medium at the end of the production phase, the glucose concentration is higher 
than under non-production conditions (as shown in Fig. 3.4.1A2, caused by the down-
regulated PTS system), thus, the catabolite repression on lower glycolysis genes by glucose 
will be stronger. At the same time under production conditions, the intracellular FBP will 
also be lower than at non-production conditions due to the down-regulated PTS system. 
The low level of FBP under production conditions will activate the catabolite repression by 
Cra on glycolysis genes. Thus, a decrease of glycolysis proteins is observed during 
recombinant protein production. 
In complex medium (no glucose is added), the difference of catabolite repression by 
glucose between production and non-production conditions can be neglected. However, 
under production conditions, intracellular FBP and F1P can be lower than in the non-
induced cells because of the down-regulated transport system, which may exert a stronger 
catabolite repression by Cra on glycolysis genes.  
Another reason that causes the down-regulation of glycolysis proteins (under production 
condition) may be the stationary phase sigma factor σS. Nearly all glycolysis genes are 
under the control of sigma factor σS (as summarized in Suppl. Table 5.3.3), which can 
cause an increase of the synthesis of glycolysis proteins at stationary phase. The 
recombinant protein overproduction may influence its activity, leading to the down-
regulation of glycolysis proteins after IPTG induction. 
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3.4.4.5 By-product metabolism 
The mechanism of acetate overflow was analyzed for E. coli BL21 (DE3) growing at 37°C 
(as described in chapter 3.2). When the temperature is decreased to 30°C, no significant 
difference between 37°C and 30°C is observed without protein production: the 
extracellular acetate concentration (Fig. 3.4.1C) and synthesis of proteins involved in by-
product metabolism (Fig. 3.4.4A and 3.4.5A) follow the same pattern. 
After IPTG induction in complex medium, the synthesis of Acs (which mainly functions to 
metabolize extracellular acetate as discussed in chapter 3.2) is much lower than in the 
control cultivation without IPTG induction (Fig. 3.4.5C), and the synthesis of Pta-AckA 
(which function primarily in a catabolic role for excreting acetate and generating ATP) is 
higher than the corresponding value at stationary phase without induction. The regulatory 
pattern of Acs and Pta-AckA in complex medium after IPTG induction indicates that the 
acetate re-assimilation is compromised by the stress of recombinant proteins 
overproduction. Under non-production conditions in complex medium during the transition 
to stationary phase, the excreted acetate can be re-assimilated (Fig. 3.4.1C1) by the up-
regulated Acs (Fig. 3.4.5A). Simultaneously, the Pta and AckA are down-regulated to 
decrease (or stop) the excretion of acetate. However, the acetate is not efficiently re-
assimilated after IPTG induction (Fig. 3.4.1C1 and 3.4.1D1) due to the down-regulated 
Acs and up-regulated Pta-AckA. 
PoxB, which is under control of the stationary phase sigma factor σS [234], catalyzes the 
oxidative decarboxylation of pyruvate to acetate and carbon dioxide [235]. In complex 
medium before and after IPTG induction, PoxB is not detectable in 2D gels. But it is found 
in cells growing in defined medium. 
In defined medium 5h after IPTG induction, the synthesis of PoxB (together with proteins 
of the PTS system and glycolysis catalyzing the reactions from G6P to PEP) is down-
regulated as compared to stationary phase without IPTG induction (Fig. 3.4.4C). In the 
absence of protein production at stationary phase (Fig. 3.4.4A), the up-regulation of PoxB 
(together with proteins of the PTS system and glycolysis catalyzing the reactions from G6P 
to PEP) and the slightly down-regulated TCA cycle proteins, may cause acetate excretion 
at early stationary phase (about 200 mg L
−1 
as shown in Fig. 3.4.1C2). This kind of acetate 
excretion is not observed during protein production due to the down-regulated PoxB, PTS 
system and glycolysis proteins. 
After IPTG induction, proteins involvd in lactate (LldD, Dld and LdhA), formate (PflB) 
and ethanol (AdhE) metabolism are generally down-regulated as compared to the non-
induced conditions (Fig. 3.4.4C and 3.4.5C). To achieve a better assimilation of lactate, 
formate or ethanol, the synthesis of them increases when other nutrients in growth media 
are insufficient. However, the increased assimilation capacities are hampered by the 
recombinant protein overproduction. 
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3.4.4.6 TCA cycle and oxidative phosphorylation 
A major function of the TCA cycle is the generation of precursors for amino acid synthesis 
and reducing equivalents. In defined medium 5h after IPTG induction, the TCA cycle 
proteins together with the proteins connecting TCA cycle and glycolysis (e.g. Ppc and 
MaeB) are down-regulated as compared to the exponential phase before induction (Fig. 
3.4.4B). In complex medium 3.5h after IPTG induction, the TCA cycle proteins together 
with the proteins connecting TCA cycle and glycolysis (e.g. PckA and MaeB) are up-
regulated in relation to the exponential phase (Fig. 3.4.5B). However, when comparing 
with the stationary phases without production, several hours after IPTG induction, the 
synthesis of proteins in the TCA cycle and connecting pathways to glycolysis is much 
lower for both defined and complex media (Fig. 3.4.4C and 3.4.5C), clearly indicating that 
when E. coli is forced to overproduce a recombinant protein, the TCA cycle cannot 
properly perform its biological functions to generate precursors and reducing equivalents. 
Under non-production condition when entering the stationary phase in complex medium, 
the proteins of the TCA cycle and connecting pathways to glycolysis are highly up-
regulated leading to acetate re-assimilation (Fig. 3.4.1C1). However, during recombinant 
protein production in complex medium, the acetate is not completely re-assimilated 
because the proteins of the TCA cycle are down-regulated. 
Oxidative phosphorylation is responsible for the transfer of electrons from NADH to the 
oxidized quinone pool to produce ATP for cell growth. When E. coli is induced to 
overproduce recombinant proteins, identified subunits of NADH dehydrogenase I 
(NuoBCFG) and ATP synthase F1 complex (AtpADH) are slightly down-regulated as 
compared to the control runs, especially in the cultivation using defined medium. But in 
the absence of protein production, the synthesis of proteins involved in oxidative 
phosphorylation remains nearly constant at different conditions, indicating that the energy-
generating pathway (oxidative phosphorylation) is also compromised by the 
overproduction of the recombinant protein. 
3.4.4.7 Biomass block biosynthesis 
Amino acid biosynthesis pathways are important pathways in E. coli and are mainly 
controlled by the feedback inhibition (as described in chapter 3.2). The synthesis of amino 
acid biosynthesis proteins contributes to the biggest proteomic difference of E. coli grown 
in complex and defined media (as shown in Suppl. Table 5.3.5 and 5.3.6): when E. coli was 
grown at exponential phase, the total abundance of 57 identified amino acid biosynthesis 
proteins is much higher in defined medium (about 12% of WCPM) than in complex 
medium (about 4% of WCPM).  
After 3.5h or 5h IPTG induction in complex or defined media, general down-regulations of 
amino acid biosynthesis proteins was observed compared to the stationary phase without 
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IPTG induction; the observed down-regulation in complex medium is more significant 
than in defined medium (Suppl. Figs 5.3.15 and 5.3.19). Specifically, during hFGF-2 
production in complex medium extracellular amino acids and peptides decrease, which 
relieves the feedback inhibition, but the amino acid biosynthesis proteins are not up-
regulated compared to the non-production control. The down-regulation of amino acid 
biosynthesis proteins could contribute to the down-regulation of other important proteins 
(e.g. proteins in glycolysis and TCA cycle).  
The regulations of the majority of proteins of the nucleotide, lipopolysaccharide and other 
cellular component biosynthesis pathways [especially of the inosine monophosphate (IMP) 
biosynthesis pathway, which is an important intermediate of purine synthesis] are similar 
but less pronounced than the amino acid biosynthesis pathways (for details refer to Suppl. 
Table 5.3.5 and 5.3.6). At the end of hFGF-2 production, moderate down-regulations were 
observed when comparing to the stationary phase of the non-induced culture. The synthesis 
of biomass building blocks is impaired by the overproduction of recombinant protein, 
especially in the culture using complex medium. 
The regulation of proteins which are responsible for the fatty acid biosynthesis is directly 
proportional to the growth rate at the non-induced condition, and the recombinant protein 
overproduction does not affect the regulatory pattern (Suppl. Table 5.3.5). 
3.4.4.8 Intracellular degradation processes 
When FGF-2 production is induced by IPTG in complex medium, the general regulation of 
identified proteins belonging to amino acid and different metabolite degradation processes 
(e.g. TnaA, AstABD and GatDZ) (groups 6.2 and 11 in Suppl. Table 5.3.6) is very similar 
to the corresponding pattern of TCA cycle proteins: the up-regulations of proteins at the 
end of the production (as compared to the exponential phase before induction) are less 
significant compared to stationary phase without production. At the end of production, the 
synthesis of proteins of degradation processes is down-regulated as compared to stationary 
phase without IPTG induction. Moreover, during production the down-regulation of 
proteins involved in different degradation processes is more significant in complex 
medium than in defined medium. 
When entering stationary phase without protein production, proteins from different 
degradation processes are generally up-regulated to salvage the intracellular resources 
especially amino acids, which are no longer required. The up-regulation is less significant 
in defined medium (as shown in Suppl. Table 5.3.5). In complex medium, the salvage 
capacity is greatly impaired by the overproduction of recombinant protein due to the down-
regulation of proteins from intracellular degradation pathways. In defined medium, this 
impairment still exists but to a lesser extent (Suppl. Figs 5.3.15 and 5.3.19). 
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3.4.4.9 Cell redox balance and DNA protection 
Eliminating ROS and protecting DNA are crucial for E. coli to survive during starvation. 
At the end of production, the synthesis of critical proteins (groups 26 and 27 in Suppl. 
Table 5.3.6) for eliminating ROS (e.g. WrbA, SthA, CueO, Bfr, AhpFC, Tpx, KatG and 
SodB) and for protecting DNA (e.g. Ssb, Dps, UspA) are at the same or slightly lower level 
than before IPTG induction. But when comparing with the non-induced cultivation at 
stationary phase, the synthesis of the critical proteins is significantly lower (Suppl. Figs 
5.3.15 and 5.3.19).  
When entering stationary phase without protein production, this self-protection mechanism 
is activated (as described in chapter 3.3): proteins for eliminating ROS and protecting DNA 
are highly up-regulated (Suppl. Figs 5.3.16 and 5.3.20). But recombinant protein 
overproduction diminishes nearly all the up-regulations of these critical proteins. Moreover, 
when recombinant protein production is faster (as in complex medium), the down-
regulation of these critical proteins (as compared to the stationary phase in the control run) 
is more significant as when the recombinant protein production is slower (as in defined 
medium)(Suppl. Table 5.3.5). 
3.4.4.10 Transcription and translation 
Identified proteins involved in transcription and translation (groups 15-22 in Suppl. Table 
5.3.6), e.g. RNA polymerase, RNA polymerase binding proteins, ribosomal proteins, 
ribosome-associated proteins, aminoacyl-tRNA synthetases, elongation factors and RNA 
degrading enzymes, are mostly high abundance proteins in E. coli. Their synthessis is 
directly proportional to the growth rate under non-production conditions (as described in 
chapter 3.3). 
After IPTG induction, the synthesis of transcription and translation related proteins does 
not change (or slightly decreases) as compared to the situation before induction in both 
defined and complex media. When comparing samples from the end of the cultivation with 
and without protein production, the amounts of RNA polymerases, ribosomal proteins, 
aminoacyl-tRNA synthetases and proteins for RNA degradation are higher in the producing 
culture in both defined and complex media. 
In the absence of production in complex medium during the transition into stationary phase, 
a general down-regulation of these proteins is observed (Suppl. Fig 5.3.20). The decrease 
in transcription and translation related proteins can make allowance (or make proteome 
space) for the increase of stationary phase- or starvation induced-proteins, which helps E. 
coli to survive in the absence of sufficient nutrients. However, the general down-regulation 
is hindered by recombinant protein production in complex medium. The proteome data (as 
shown in Suppl. Table 5.3.5) clearly indicate that in complex medium during production, 
proteins required for translation and protein synthesis are high; E. coli cannot reduce the 
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transcription and translation related proteins for extra resources as it does when responding 
to nutrient depletion under non-producing conditions. 
In defined medium when entering stationary phase, transcription and translation related 
proteins remain at nearly the same level as during exponential growth, which may be 
because the synthesis of these proteins have reached already the minimal level during 
exponential growth in defined medium (Suppl. Fig 5.3.16). Thus, during production in 
defined medium the unchanged (or slightly increased) amounts of RNA polymerases, 
ribosomal proteins, aminoacyl-tRNA synthetases, will not significantly disturb cellular 
metabolism. 
3.4.4.11 Protein folding and degradation 
After IPTG induction in both defined and complex media, the identified peptidyl prolyl 
cis-trans isomerases (PPIases) (PpiB, SurA, FklB, FkpA and SlyD, in group 23 in Suppl. 
Table 5.3.6) which could help protein folding [205, 206], are down-regulated as compared 
to the stationary phase without induction or exponential phase before induction. Moreover, 
the down-regulation is more pronounced in complex medium (with faster recombinant 
protein production). In non-induced cultures, the identified PPIases are generally up-
regulated at stationary phase in both media. The proteomic data (as indicated in Suppl. Figs 
5.3.15 and 5.3.19) suggest that the lack of isomerases may be a bottleneck for recombinant 
protein folding processes. 
Chaperones are critical for protein folding. After several hours of IPTG induction, except 
HscA and ClpA, the identified chaperones, DnaK, GrpE, GroLS, HtpG, ClpB and IbpA, 
are highly up-regulated, and the up-regulation is much stronger and faster in complex 
medium. The total abundances of 9 identified chaperones increased from about 2% and 3% 
of WCPM at the exponential phase (before induction), to about 5% and 7% of WCPM at 
the end of production phase in defined and complex media, respectively. Under non-
induced conditions, when E. coli grows to stationary phase, the identified chaperones 
remain at roughly the same level as during exponential growth. The proteomic analysis 
shows that in addition to the overproduction of recombinant protein, the up-regulated 
chaperones will also contribute to the metabolic burden. 
Proteases are very important for the quality control of synthesized proteins [215] and also 
for surviving in stationary phase [217-219] (as described in chapter 3.3). At the end of 
production in both complex and defined media, the amounts of DegP, PepDQNP and PrlC 
are much lower than the corresponding amounts at stationary phase without protein 
production, which could explain the constant levels of proteins involved in amino acid 
degradation, transcription and translation during the production phase. Oppositely, under 
non-induced conditions when entering the stationary phase in defined and complex media, 
the proteases, e.g. DegP and PepDQP, are up-regulated, especially in complex medium, 
which correspons to the general up-regulation of amino acid degrading proteins and also 
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the general down-regulation of proteins involved in transcription and translation at these 
condions. The resource recycling systems have been compromised through recombinant 
protein overproduction. 
At the end of the production phase, three proteases (Dcp and HslUV) are highly up-
regulated in both media, and the up-regulation is not observed in the control cultivation, 
indicating that these three proteases may play important roles in folding and quality control 
of recombinant proteins. 
3.4.5 Discussion 
When nutrients are not sufficient, E. coli will construct a self-protection mashinery (as 
described chapter 3.2 and 3.3) to elevate the transport and by-product assimilation 
pathways to absorb nutrients at low concentrations from the environment. Many 
degradation processes are up-regulated to salvage the intracellular components that are no 
longer required. The proteins involved in ROS elimination and DNA protection are also 
highly up-regulated. Conversely, proteins involved in transcription and translation are 
down-regulated, which can provide extra resources towards fine-tuning the whole 
proteome for long periods of starvation.  
However, when E. coli is forced to overproduce a recombinant protein, this self-protection 
machinery is severly compromised. The present proteomic analysis (as shown in Fig. 3.4.6) 
also suggests that during faster recombinant protein production (i.e. production using 
complex medium), the damage to the self-protection machinery is more significant than 
during production at lower speed (i.e. production using defined medium). 
The target protein normally amounts to about 10%-20% of WCPM. In response to the 
overproduction of the recombinant protein, the abundance of chaperones also increases to 
about 6% of WCPM. Simultaneously, proteins involved in transcription and translation, e.g. 
ribosomal proteins, aminoacyl-tRNA synthetases and elongation factors, do not change 
their abundance during the production phase. Thus, E. coli cannot relocate the resources 
from proteins involved in transcription and translation processes as it usually does in the 
absence of protein production in the stationary phase. Following, the resource recycling 
systems, such as certain proteases, proteins for amino acid or metabolite degradation, are 
not up-regulated at the end of recombinant protein production. The critical proteins for 
ROS elimination and protection of DNA also do not increase after IPTG induction, 
indicating that the cell is more vulnerable to oxidative damages and damage to genomic or 
plasmid DNA during recombinant protein production. 
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Fig. 3.4.6 Summary of proteome data of E. coli from stationary phase with and without 
protein production 
Number in the bracket after each category is the number of proteins that were identified belonging to the 
corresponding category. A: in complex medium (LB) after 3.5h IPTG induction (white bar) and at 
stationary phase without induction (black bar). B: in defined medium (DNB) after 5h IPTG induction 
(gray bar) and at stationary phase without induction (dark gray bar). The entire data sets are shown in 
Suppl. Table 5.3.6. 
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Most importantly, nutrients decrease in the medium during the cultivation. This requires an 
up-regulation of proteins of different nutrient uptake pathways to increase substrate uptake 
efficiency. This up-regulation is hindered by the overproduction of recombinant proteins: 
at the end of the production phase, proteins of the glycolytic pathway and nutrient uptake 
systems, such as the PTS, maltose, amino acid, and peptide transport systems and proteins 
of the by-product assimilation pathways, show lower amounts than at stationary phase in 
the absence of protein production. 
Acetate is the major growth-inhibiting by-product of E. coli and is produced during 
exponential growth in complex medium. During the transition into stationary phase, it is 
re-assimilated through the up-regulated Acs, TCA cycle proteins and proteins connecting 
TCA cycle and glycolysis. But when E. coli is forced to produce a recombinant protein, the 
up-regulation of Acs and proteins of the TCA cycle and pathways connecting TCA cycle 
and glycolysis is less prominent, which decreases the capability to metabolize acetate. The 
acetate is not completely re-assimilated during recombinant protein production. 
In defined medium at the early stationary phase, acetate is produced because of the up-
regulated PTS system (which leads to an accelerated glucose uptake), proteins from the 
glycolytic pathway (from G6P to pyruvate), PoxB and the slightly down-regulated TCA 
cycle proteins. But after 5h IPTG induction, proteins of the PTS and glycolytic pathway 
are down-regulated; glucose is consumed at lower rates. Thus, during protein production in 
defined medium, acetate excretion at the early stationary phase is lower than in the control 
cultivation without IPTG induction. 
Although chaperones are strongly up-regulated, formation of inclusion bodies is still at a 
high level indicating that the capacity of the cellular protein folding support is not 
sufficient for the high speed of transcription and translation. Moreover, the reduced levels 
of isomerases may represent a bottleneck for protein folding. Trying to maintain the 
chaperones up-regulated and simultaneously reducing the amount of enzymes involved in 
translation and transcription seems to be the ultimate way to improve recombinant 
production in E. coli. A reduced capacity for translation and transcription would reduce the 
speed of protein synthesis before the folding process, and may also help to maintain a 
general metabolic balance or capacity for the synthesis of proteins required for e.g. 
glycolysis, TCA cycle, nutrient absorption and cell protection. 
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3.5 Summary and conclusion 
Two proteomic analyses were performed by the methods of 2D gel electrophoresis and 
mass spectrometry to reveal the physiological responses of E. coli to different conditions. 
First, the regulation of the central metabolic pathways (CMPs), respiratory chain and 
biomass block biosynthesis was clarified: when precursors and reducing equivalents 
generated by the CMPs are sufficient for cell growth. E. coli simultaneously reduces the 
synthesis of proteins in the TCA cycle to decrease the generation of reducing equivalents 
and precursors for saving resources and energy. Simultaneously, enzymes of the lower 
glycolytic pathway are not down-regulated due to the absence of catabolite repression. 
This leads to an increased formation of the growth-inhibiting by-product acetate. 
Second, a self-protection mechanism in response to insufficient nutrient supply was 
disclosed: proteins from transport and by-product assimilation pathways are elevated for 
absorbing the reduced amounts of nutrients in the environment. Degradation processes are 
enhanced to salvage the intracellular components that are no longer required. The proteins 
involved in eliminating the reactive oxygen species (ROS) and DNA protection are greatly 
enhanced. Conversely, proteins required for transcription and translation are down-
regulated, which can provide extra resources towards fine-tuning the whole proteome for 
long term starvation. 
Third, this self-protection mechanism cannot be activated when E. coli is forced to 
overproduce a recombinant protein: the relative amounts of transcription and translation 
related proteins remain constant. The proteins of transport systems, CMPs, by-product 
metabolism, and proteins for degradations, eliminating ROS and DNA protection, decrease 
in abundance. This causes a severe damage to the metabolic mashinery (e.g. nutrients 
cannot be efficiently utilized). 
3.6 Outlook 
The proteomic profiles of E. coli grown in shaker flask cultures under different conditions 
were thoroughly studied. However, fed-batch cultivations are more practical for improving 
industrial production processes. Time-course proteomic data from fed-batch cultivations 
will help to understand cell physiology under industrially relevant conditions. 
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5 Appendix 
5.1 Detailed experimental procedures of E. coli proteome analysis 
5.1.1 Protocol of 2D gel electrophoresis 
The following protocol of 2D gel electrophoresis is based on the manufacturer's instruction 
(GE Healthcare, UK) with some modifications for this study. 
5.1.1.1 Harvest E. coli culture 
For each 2D gel, add 1 mL of culture broth corresponding to an OD600 (optical density at 
600 nm) of 12 (or 0.1 mL of culture broth with OD600 of 120) to a 1.5 mL or 2 mL 
microcentrifuge tube (Eppendorf, Germany). Centrifuge at 13300 rpm for 1 min and 
discard supernatant completely. When the original OD600 value is low (i.e. less than 6), a 
step of concentration is necessary. After collecting the sample, do not wash the sample. 
Freeze cell pellet in liquid nitrogen and store at −80°C as quickly as possible. All the 
manipulations are preformed on ice at 4°C. 
5.1.1.2 Cell pellet washing 
Take out microcentrifuge tube containing cell pellet stored at −80°C. Add 1.4 mL ice cold 
sonication buffer [Tris 40 mM (pH=7.5), EDTA 0.5 mM] to resuspend the cell pellet. 
Centrifuge the suspension at 4°C, 13300 rpm for 1 min and discard the supernatant. The 
pellet should be washed twice. After the third centrifugation, adjust OD600 of the 
suspension to 18 with ice cold sonication buffer before performing the BugBuster 
treatment. Transfer 350 µL of suspension with OD600 of 18 to a new 1.5 mL 
microcentrifuge tube and centrifuge at 4°C, 13300 rpm for 1 min. After centrifugation, 
discard supernatant.  
5.1.1.3 BugBuster treatment 
Prepare BugBuster (Novagen, USA) working solution [0.8 µL Benzonase (250 U/µL, 
Merck, Germany) and 0.5 µL rLysozyme stock solution (2 KU/µL, Novagen, USA) are 
added to 2 mL BugBuster stock solution)]. Add 350 µL BugBuster working solution to the 
cell pellet after washing. Vortex a few seconds to completely resuspend cell pellet and put 
the sample to a bench top Eppendorf Thermomixer shaking at 27°C, 350 rpm for 20 min. 
At the same time, thaw the resolubilization buffer (urea 9 M, thiourea 2 M, CHAPS 4%, 
Tris 2 mg/mL, SDS 0.2%, bromophenol blue 0.002%) using the Thermomixer.  
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5.1.1.4 Chloroform/Methanol precipitation 
Take out 100 µL BugBuster treated whole cell suspension to perform the 
Chloroform/Methanol precipitation according to Suppl. Table 5.1.1. Also generate a water 
control sample using 100 µL water instead of 100 µL BugBuster treated whole cell 
suspension: From this control use the upper layer after Chloroform/Methanol precipitation 
and final centrifugation to gently wash the surface of the real sample protein pellet. 
Suppl. Table 5.1.1 Simple protocol of Chloroform/Methanol precipitation 
Step  Procedure 
1 Place 100 µL BugBuster treated whole cell suspension into a 1.5 mL microcentrifuge 
tube.  
Prepare water control, using 100 µL Milli-Q (Millipore, USA) water to substitute 100 
µL cell suspension to perform steps 2 to 5. 
2 Add 600 µL methanol and vortex for 10 seconds. 
3 Add 150 µL chloroform and vortex for 10 seconds. 
4 Add 450 µL Milli-Q water and vortex for 10 seconds. 
5 Centrifugation at 17000 g and 25°C for 7 min (13300 rpm). 
6 After centrifugation, a white layer of protein can be seen in the lower part of the 
solution. Use pipette to remove the upper part of solution. Use the upper layer of water 
control after the final centrifugation to wash the surface of protein pellet of the real 
sample. Only gently shake the tube and do not vortex. After that, use pipette to remove 
the upper part of solution and carefully turn around the microcentrifuge tube to let the 
white layer of protein stick to the inner wall of microcentrifuge tube, then carefully 
remove the rest of the solution with pipette. Let the residual methanol and chloroform 
evaporate till there is not smell of methanol. This drying procedure should not take 
more than 10 min and one should not over-dry the protein pellet. 
 
5.1.1.5 Resolubilization of protein pellet 
After the Chloroform/Methanol precipitation, add 500 µL resolubilization buffer (urea 9 M, 
thiourea 2 M, CHAPS 4%, Tris 2 mg/mL, SDS 0.2%, bromophenol blue 0.002%), 7.5 µL 
IPG buffer and 7.5 µL 1 M DTT stock solution to resolubilize the protein pellets. To 
facilitate the resolubilization, put the sample to a bench top Eppendorf Thermomixer 
shaking at 26°C, 1000 rpm for 4 h. During this time, use ultrasonic bath to sonicate the 
sample for 10 min twice. At this point, make sure the water temperature of ultrasonic bath 
does not surpass 35°C. After 4 h, freeze the sample in liquid nitrogen and store at −80°C.  
5.1.1.6 Beginning of isoelectric focusing (IEF) 
For IEF loading, take out the sample at −80°C to a bench top Eppendorf Thermomixer 
shaking at 28°C, 1000 rpm for 1.5 h. Ensure that urea and thiourea are completely 
dissolved. Add another 7.5 µL 1 M DTT stock solution to the sample to make the final 
DTT concentration 30 mM. After 1.5 h, centrifuge the sample at 25°C, 13300 rpm for 25 
min. Chose the centrifuge with temperature control. After the centrifugation, transfer 420 
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µL supernatant to a new microcentrifuge tube. 
Carefully clean the Ettan IPGphor strip holder (GE Healthcare, UK) using 10% SDS 
solution with a toothbrush. Then, use Milli-Q (Millipore, USA) water to thoroughly rinse 
the strip holder to remove the SDS and other contaminants. After drying, two of IEF 
sample application pieces (GE Healthcare, UK) are placed in the lateral wells at both ends 
of the strip holder. Add 20 µL rehydration solution (urea 9 M, thiourea 2 M, CHAPS 4%, 
Tris 2 mg/mL) onto each of the IEF sample application pieces.  
Take care of the number on the IPG strip and which sample will be loaded to this IPG strip. 
Do not write on the IPG strip. Load 360 µL sample into the center of a cleaned strip holder. 
Use forceps to open the IPG strip from the “+” end. Let the gel slide down and put the IPG 
strip in the IPG holder with loaded sample. Do not geneate bubbles. Add 2.5 mL silicone 
oil on plastic backing of the IPG strip and cover the strip holder. Start the IEF according to 
the following procedure (Suppl. Table 5.1.2):  
Suppl. Table 5.1.2 IEF program 
Procedure Program Step Voltage (V) Step duration (hr) Voltage gradient type 
Rehydration   0 36 Step-n-hold 
Isoelectric 
Focusing 
1 50 4 Step-n-hold 
2 50-100 4 Gradient 
3 100-300 3 Gradient 
4 300-1000 3 Gradient 
5 1000-3500 3 Gradient 
6 3500-5000 3 Gradient 
7 5000 3 Step-n-hold 
8 5000-8000 3 Gradient 
End 9 8000 10 Step-n-hold 
Temperature: 20°C, Current limit for each strip: 30 µA(3-10 NL strip) or 35 µA(3-10 strip) 
 
5.1.1.7 Preparation of SDS equilibration buffer 
Add DTT and iodoacetamide to two conical tubes, respectively. Add appropriate volume of 
SDS equilibration buffer (50mM Tris-HCl pH 8.8, 6 M urea, 30% glycerol, 2% SDS) to 
each conical tube to obtain final concentrations of 1% (w/v) DTT and 5% (w/v) 
iodoacetamide, respectively. Gently shake to dissolve the DTT and iodoacetamide. At this 
step, avoid generating bubbles in the SDS equilibration buffer. 
5.1.1.8 IPG strip equilibration 
After IEF, carefully remove silicone oil with pipette and take out the IPG strips using 
forceps to a blotting paper to absorb the excess oil. Make sure that the plastic backing 
touches the blotting paper and the gel side is up in the air. After removing excess silicone 
oil, use forceps to transfer the IPG strip to a self made plexiglass tray. Each tray can 
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accommodate two IPG strips (make sure the gel sides are up in the air). Add 4.5 mL SDS 
equilibration buffer with 1% DTT to each tray. Carefully place the self made plexiglass 
tray containing IPG strips and SDS equilibration buffer to a rocking shaker for 15 min with 
gentle shaking. After 15 min, pour out the SDS equilibration buffer with DTT. Add 4.5 mL 
SDS equilibration buffer with 5 % iodoacetamide to each line. Place the plexiglass tray to 
the rocking shaker for 18 min with gentle shaking. After 18 min, pour out the SDS 
equilibration buffer with iodoacetamide to a waste container. 
5.1.1.9 Transfer the IPG strips to the SDS-PAGE electrophoresis 
During the IPG strip equilibration step, melt the agarose sealing solution (agarose 1 %, Tris 
24 mM, glycine 0.2 M, bromophenol blue 0.002 % and SDS 0.1 %) in a microwave (Do 
not allow the solution to boil!!!). 
Take out gradient SDS-PAGE slab gel cassette from 4°C storage place and wash with 
purified water. Apply some SDS electrophoresis buffer to the loading space for the IPG 
strip to facilitate the transition procedure. After the IPG strip equilibration step, carefully 
transfer the IPG strip on the surface of the SDS-PAGE gel, using forceps to make sure that 
the plastic backing is against one of the glass plates, and the IPG gel do not touch the glass 
plates. Pour out the SDS electrophoresis buffer and put IPG strip in the center of 
acrylamide gel. Lift one side of the cassette. Carefully deliver agarose sealing solution at 
the higher side of the cassette. Let the agarose sealing solution flow to the lower side, and 
slowly move the pipette from the higher side to the lower side across the gel, deliver 
agarose sealing solution onto the IPG strip to seal it in place (carefully avoid bubbles). 
Wait 10~15 minutes to allow the agarose to solidify.  
5.1.1.10 Placement of cassettes into the DALT tank 
Use purified water to wash the surface of the cassette to remove excess (un)polymerized 
acrylamide. Dip the hinge side of the cassette into the tank buffer to lubricate it before 
inserting it into the flap seals. Use both hands to slide cassette firmly to the bottom. The 
cassette is correctly loaded in running orientation in the DALT tank (GE Healthcare, UK) 
with the IPG strip vertical along the left side (the cathode).  
Adjust the buffer level after all cassettes are loaded in position. Close the lid and connect 
the power supply. Turn on the cooling circulating bath (10°C) and connect it to the DALT 
tank. Set the power supply to 40 V constant voltage for the first 45 min and increase to 80 
V constant voltage for another 45 min. After 45 min electrophoresis at 80 V, increase the 
voltage to 105 V for overnight run. Migration proceeds toward the anode (or right end of 
the chamber). 
5.1.1.11 Ending second-dimension SDS-PAGE electrophoresis  
After the bromophenol blue tracking dye runs to the right edge of the polymerized 
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acrylamide gel, carefully take out and open the cassette. Carefully transfer the gel to a 
plastic box. Add fixing solution to submerge the gels and put the box on a horizontal 
rocking shaker. After 45 min, remove the fixing solution, and add new fixing solution for 
another 45 min shaking. After 1.5 h, remove the fixing solution and add Colloidal Silver 
Coomassie G-250 staining solution and shake overnight. Use Milli-Q water to destain the 
Coomassie stained gels. 
5.1.2 Protocol of MALDI identification 
5.1.2.1 Trypsin digestion protocol for MALDI 
1.  Preparation 
1.1.  Wash SDS-PAGE gel with Milli-Q water (shaking on horizontal shaker 
overnight is recommended). 
1.2. Cut gel spots and put them into 1.5 mL microcentrifuge tubes. 
1.3. Wash the gel spots 5 times with 1 mL Milli-Q water. For each washing step, 
shake for 5 min. At the last step of washing, use a small pipette tip to cut gel 
spot into small pieces (one gel spot one tip!!!). 
1.4. After washing, samples can be stored in water at 4°C for 1 day (or use 
Eppendorf vacufuge concentrator to dry and store at 4°C for several days). 
1.5. After storage at 4°C, wash samples with 1 mL Milli-Q water. 
1.6. Withdraw water (be careful to not suck out any pieces of the gel). 
1.7. Dehydration 
 - Add 200 µL acetonitrile (ACN)  
 - withdraw ACN completely 
2. Carbamidomethylation  
2.1.  Add 50 µL DTT solution [20 mM DTT (3.1 mg/mL) in 0.1 M NH4HCO3] in 
each sample. 
2.2.  Incubate samples for 30 min at 56°C in an Eppendorf thermomixer (not 
shaking). 
2.3.  Withdraw DTT solution completely from each sample (be careful to not suck 
out any pieces of the gel). 
2.4.  Dehydrate (as step 1.7 above).  
2.5.  Add 50 µL iodoacetamide solution [55 mM iodoacetamide (10.2 mg/mL) in 
0.1 M NH4HCO3] to each sample. 
2.6.  Incubate 30 min at room temperature in the dark. 
2.7.  Withdraw iodoacetamide solution completely. 
2.8.  Dehydrate (as step 1.7 above)  
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3. Buffering 
3.1. Wash each sample with 200 µL 0.1 M NH4HCO3. Incubate samples for 15 
min at room temperature. After 15 min, withdraw NH4HCO3 solution. 
3.2. Dehydrate (as step 1.7 above)  
3.3. Use Eppendorf vacufuge concentrator to dry samples (about 20 min). 
4. Digestion 
4.1. Preparation of trypsin working solution 
 Add 100 µL suspension buffer (Promega, USA) to one vial of trypsin 
(Promega, USA). Incubate 30 min at room temperature. Then add 900 µL 0.1 
M NH4HCO3. After mixing, aliquot 50 µL into 0.5 mL microcentrifuge tube 
and store at −20°C. Before use, thaw and add 450 µL H2O to make 500 µL 
trypsin working solution. 
4.2.  Add about 30 µL trypsin working solution to each gel spot. 
4.3. Incubate all the samples overnight at 37°C. 
4.4. Extract peptide using Prespotted AnchorChip (PAC) target (refer to 5.1.2.2) or 
ZipTips (Millipore, USA) (refer to 5.1.2.3) 
5.1.2.2 Sample preparation for MALDI using Prespotted AnchorChip target 
5.  Peptide-Extraction 
5.1. Add 30 µL acetonitrile (ACN) to the gel spots. Shake on an Eppendorf 
thermomixer for 15 min at 37°C and 800 rpm. 
5.2.  After shaking for 15 min, transfer the supernatant of each sample into another 
1.5 mL microcentrifuge tube*. 
5.3.  Add 30 µL 5% formic acid solution to each gel spot. Shake on an Eppendorf 
thermomixer for 15 min at 37°C and 800 rpm. 
5.4. Add 30 µL ACN to each gel spot. Shake for 15 min at 37°C and 800 rpm. 
5.5. After 15 min combine the supernatant with supernatant in the tube* from step 
5.2. 
5.6. Use Eppendorf vacufuge concentrator to dry samples (the sample combined 
with the supernatant from step 5.2 and 5.5) for about 1~2 hour. 
5.7. After drying, add 7~8 µL 32% methanol and 0.5% formic acid solution and 
put samples into ultrasonic bath for 10 min. 
6. Loading to PAC target for MALDI mass spectrometry analysis 
6.1.  Deposit 1 µL sample solution onto matrix spot. 
6.2.  Allow three minutes incubation. 
6.3.  Add 7 µL PAC target washing buffer (10mM NH4H2PO4, 0.1% TFA), and 
remove the whole droplet after 3~5 second. 
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5.1.2.3 Sample preparation for MALDI using ZipTips (C18) 
5.  Peptide-Extraction 
5.1. Add 30 µL acetonitrile (ACN) to the gel spots. Shake on an Eppendorf 
thermomixer for 15 min at 37°C and 800 rpm. 
5.2.  After shaking for 15 min, transfer the supernatant of each sample into another 
1.5 mL microcentrifuge tube*. 
5.3.  Add 30 µL 5% formic acid solution to each gel spot. Shake on an Eppendorf 
thermomixer for 15 min at 37°C and 800 rpm. 
5.4. Add 30 µL ACN to each gel spot. Shake for 15 min at 37°C and 800 rpm. 
5.5. After 15 min combine the supernatant with supernatant in the tube* from step 
5.2. 
5.6. Use Eppendorf vacufuge concentrator to dry samples (the sample combined 
with the supernatant from step 5.2 and 5.5) about 1~2 hour. 
5.7. After drying, add 20 µL ZipTips washing solution (2% methanol, 0.5% 
formic acid) and put samples into ultrasonic bath for 10 min. 
6. Desalting with ZipTips (C18) 
 - No air into ZipTips! 
 - ZipTips washing solution: 2% methanol, 0.5% formic acid 
 - ZipTips elution solution: 65% methanol, 0.5% formic acid 
6.1. Clean ZipTip 3 times with 10 µL ZipTips elution solution. 
6.2. Equilibrate ZipTip 3 times with 10 µL ZipTips washing solution. 
6.3. Pipette sample up and down for 10 to 15 times very slowly. 
6.4. Wash ZipTip 3 times with 10 µL ZipTips washing solution. 
6.5. Elution for MALDI 
Add 5 µL ZipTips elution solution into a 0.5 mL microcentrifuge tube. Using 
the ZipTip containing sample from step 6.4, pipette 5 µL ZipTips elution 
solution up and down 3 times to elute sample from ZipTip. 
7. Loading for MALDI mass spectrometry analysis 
Mix 1 µL of sample from ZipTips elution solution (from step 6.5) with 1 µL 
saturated matrix solution (10 mg α-Cyano-4-hydroxycinnamic acid, 400 µL 
acetonitril and 600 µL 0.1% TFA). Transfer 2 µL of this mixture onto a 
MALDI sample target. The mass spectrometry analysis is performed after the 
sample target is complete dry.  
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5.1.3 Buffers and solutions for 2D gel electrophoresis and MALDI MS 
identification 
Suppl. Table 5.1.3 Buffers and solutions for 2D gel electrophoresis and MALDI 
identification 
Name Chemical Concentration  Preparation method 
1 M DTT stock 
solution 
DTT 1 M 
Add 0.925 g DTT (MW: 154.25) into a 
15 mL conical tube and add about 5 
mL Milli-Q water to bring the final 
volume to 6 mL. After complete 
dissolution aliquot 75 µL of this 
solution to several PCR tubes and 
store at −80°C. 
1 M Tris stock 
solution 
Tris 1 M 
Add 0.242 g Tris (MW: 121.14) into a 
2 mL microcentrifuge tube and add 
about 1.7 mL Milli-Q water to bring 
the final volume to 2 mL. After 
complete dissolution, store in 4°C
 
refrigerator. This solution is only Tris 
base solution, the pH does not need to 
be adjusted. 
1 % bromophenol blue 
stock solution 
Bromophenol 
blue 
1 % 
Add 100 mg bromophenol blue and 60 
mg Tris (MW: 121.14) to a 15 mL 
conical tube and add Milli-Q water to 
bring the final volume to 10 mL. After 
complete dissolution, aliquot 1.2 mL 
of this solution to several 
microcentrifuge tubes and store at 
4 °C. 
Tris 50 mM 
1.5 M Tris-HCl, pH 
8.8 stock solution  
(4× resolving gel 
buffer solution) 
Tris 1.5 M 
Add 181.71 g Tris (MW: 121.14), 600 
mL Milli-Q water to a graduated 
cylinder and dissolve the Tris base. 
Adjust the pH to 8.8 using HCl. Add 
Milli-Q water to bring the final 
volume to 1000 mL and check the pH 
of the final solution. Filter this solution 
through a 0.2 µm membrane to an 
autoclaved glass bottle.  
Sonication buffer 
Tris 40 mM Add 4.85 g Tris (MW: 121.14), 0.19 g 
Titriplex III and 970 mL Milli-Q into a 
1 L graduated cylinder. Dissolve the 
solution completely. Adjust the pH to 
7.5 using HCl. Store at 4 °C. 
Titriplex III 0.5 mM 
10 % SDS stock 
solution 
SDS 10 %  
Add 100 g SDS powder (Bio-Rad, 
MW:  288.38) into a 1 L graduated 
cylinder, and add Milli-Q water to 
bring the final volume to 1 L. Dissolve 
the solution completely. Filter this 
solution through a 0.2 µm membrane 
to an autoclaved 1 L glass bottle.  
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Name Chemical Concentration  Preparation method 
Rehydration solution 
for 2D electrophoresis 
(This rehydration 
solution is only for 
wetting IEF sample 
application pieces in 
IPGphor strip holder) 
Urea 9 M 
Add 10.81 g urea (MW: 60.06), 3.05 g 
thiourea (MW: 76.12), 0.8 g CHAPS 
(MW: 614.89), 37 µL 1 M Tris stock 
solution (only Tris base solution, pH 
not adjusted) into a 20 mL glass 
beaker and add about 10 mL Milli-Q 
water to bring the final volume to 20 
mL. After complete dissolution, 
aliquot 0.4 mL of this solution to 
several 1.5 mL microcentrifuge tubes 
and store at −20°C. 
Thiourea 2 M 
CHAPS 4 % 
Tris 0.2 mg/mL 
Resolubilization 
buffer for 2D 
electrophoresis 
Urea 9 M 
Add 32.43 g urea (MW: 60.06), 9.14 g 
thiourea (MW: 76.12), 2.4 g CHAPS 
(MW: 614.89), 111 µL 1 M Tris stock 
solution (only Tris base solution, pH 
not adjusted), 1.2 mL 10 % SDS stock 
solution and 120 µL 1 % bromophenol 
blue stock solution into a 100 mL 
graduated cylinder and add about 30 
mL Milli-Q water to bring the final 
volume to 60 mL. After complete 
dissolution, aliquot 1.7 mL of this 
solution to several 2 mL 
microcentrifuge tubes and store at 
−20°C. 
Thiourea 2 M 
CHAPS 4 % 
Tris 0.2 mg/mL 
SDS 0.2 % 
Bromophenol 
Blue 
0.002 % 
SDS equilibration 
buffer for 2-D 
electrophoresis 
Tris-HCl, pH 
8.8 
50 mM 
Add 108.15 g urea (MW: 60.06), 60 
mL 10 % SDS stock solution, 103.5 
mL (126.3 g) glycerol (86% w/w, MW: 
92.1), and 10 mL 1.5 M Tris-HCl, pH 
8.8 stock solution (4× resolving gel 
buffer solution) into a 500 mL 
graduated cylinder. Bring the final 
volume to 300 mL with Milli-Q water. 
After complete dissolution, aliquot 13 
mL of this solution to several 15 mL 
conical tubes and store at −20°C. This 
is a stock solution without DTT or 
iodoacetamide. 
Urea 6 M 
Glycerol 30 % 
SDS  2 % 
SDS electrophoresis 
buffer for agarose 
sealing solution 
(Without SDS) 
Tris 24 mM 
Add 2.9 g Tris (MW: 121.1), 15.01 g 
glycine (MW: 75.07), into a 1 L 
graduated cylinder. Add Milli-Q water 
to bring the final volume to 1 L. Filter 
this solution through a 0.2 µm 
membrane to an autoclaved 1 L glass 
bottle and store at 4 °C. 
Glycine 0.2 M 
Agarose sealing 
solution for 2-D 
electrophoresis 
Agarose  1 % Add 0.5 g agarose (Biozym LE GP 
agarose) to a 100 mL glass bottle. And 
add 50 mL SDS electrophoresis buffer 
of agarose sealing solution (without 
SDS) into this bottle. Add 100 µL 1 % 
bromophenol blue stock solution and 
500 µL 10 % SDS stock solution. Heat 
in microwave oven on low power until 
the agarose is completely dissolved. 
Tris 24 mM 
Glycine 0.2 M 
Bromophenol 
blue 
0.002 % 
SDS 0.1 % 
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Name Chemical Concentration  Preparation method 
Tank electrophoresis 
buffer for 2-D 
electrophoresis 
Tris 24 mM 
Add 58 g Tris (MW: 121.1), 300 g 
glycine (MW: 75..07), 200 mL 10 % 
SDS stock solution in the 
electrophoresis tank and add Milli-Q 
water to bring the final volume to 20 
L. Use the circulating pump to 
dissolve the compounds. After 
complete dissolution, put the two 
barrier-combs back to their original 
position. This buffer can be used for 3 
runs of SDS-PAGE electrophoresis. 
Glycine 0.2 M 
SDS 0.1 % 
Fixing solution 
Acetic acid 10 % 
And 600 mL ethanol (or 857 mL 70 % 
ethanol) to a 2 L graduated cylinder. 
Add Milli-Q water to bring the volume 
to 1.8 L. Finally add 200 mL acetic 
acid (MW: 60.05) and mix the 
solution. 
Ethanol 30 % 
Colloidal Silver 
Coomassie G-250 
staining solution 
H3PO4 8.5 % 
First add 250 mL Milli-Q water to a 
glass bottle and add 250 mL 85 % 
H3PO4 (MW: 98.0) and mix. Secondly, 
add 250 g (NH4)2SO4 (MW: 132.0) to a 
500 mL graduated cylinder and add 
Milli-Q water to bring the final 
volume to 500 mL. Add a magnetic 
stirrer for mixing. Thirdly, add 2.5 g 
Coomassie Blue G250 to a 500 mL 
glass graduated cylinder and add Milli-
Q water to bring the final volume ot 
500 mL. Add a magnetic stirrer for 
mixing. After the (NH4)2SO4 and 
Coomassie Blue G-250 are dissolved, 
mix them with the H3PO4 solution and 
add 500 mL Milli-Q water to bring the 
volume to 2 L. Mix at high stirrer 
speed overnight. Then, very slowly 
(important) add 500 mL methanol 
(MW: 32.04) to this solution. It is 
better to store this solution in a brown 
bottle. 
(NH4)2SO4 10 % 
Coomassie 
Blue G250 
0.1 % 
Methanol 20 % 
Displacing solution 
for casting gradient 
gels 
Tris  0.375 M Add 100 mL glycerol (MW: 92.1), 50 
mL Milli-Q water, 50 mL 1.5 M Tris-
HCl, pH 8.8 stock solution (4× 
resolving gel buffer solution) and 200 
µL 1 % bromophenol blue stock 
solution to a glass bottle and mix 
them. 
Glycerol 43 % 
Bromophenol 
Blue 
0.001 % 
10% TEMED for 
casting gradient gels 
TEMED 10% 
Add 300 µL TEMED (MW: 116.21) 
and 2700 µL Milli-Q water to a 15 mL 
conical tube. Vortex for mixing. Store 
at −20°C. 
10% APS for casting 
gradient gels 
Ammonium 
persulfate 
10 % 
Add 2 g ammonium persulfate (MW: 
228.2) to a 50 mL conical tube. Add 
Milli-Q water to bring the final 
volume to 20 mL and vortex for 
mixing. Store at −80°C. 
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Name Chemical Concentration  Preparation method 
0.1% SDS solution for 
2-D electrophoresis 
SDS 0.1 % 
Add 5 mL 10 % SDS stock solution to 
500 mL graduate cylinder. Add Milli-
Q water to bring the final volume to 
500 mL.  
Gel storage solution 
Tris 0.375 M 
Add 20 mL 10 % SDS stock solution 
and 500 mL 1.5 M Tris-HCl, pH 8.8 
stock solution (4× resolving gel buffer 
solution) to a 2 L glass bottle. Add 
Milli-Q water to bring the final 
volume to 2 L. Store at 4 °C. 
SDS 0.1 % 
Gel drying solution 
Glycerol 13 % 
And 400 mL ethanol (or 570 mL 70 % 
ethanol) and 150 mL glycerol (86% 
w/w, MW: 92.1) to a 1 L graduated 
cylinder. Add Milli-Q water to bring 
the volume to 1 L. 
Ethanol 40 % 
0.1 M NH4HCO3 
solution  
NH4HCO3 0.1 M 
Add 3.95 g NH4HCO3 (MW: 79.06) to 
500 mL graduate cylinder, and add 
Milli-Q water to bring the final 
volume to 500 mL. Filter this solution 
through a 0.2 µm membrane to an 
autoclaved glass bottle. Store at 4 °C. 
0.1 M NH4HCO3 with 
DTT  
DTT 3.1 mg/mL Add 31 mg DTT (MW: 154.25) into a 
15 mL conical tube and add 10 mL 1 
M NH4HCO3 solution to bring the 
final volume to 10 mL. NH4HCO3 0.1 M 
0.1 M NH4HCO3 
with iodoacetamide  
Iodoacetamide 10.2 mg/mL Add 102 mg iodoacetamide (MW: 
184.96) into a 15 mL conical tube and 
add 10 mL 1 M NH4HCO3 solution to 
bring the final volume to 10 mL. NH4HCO3 0.1 M 
Trypsin working 
solution  
Trypsin 2 µg/mL 
One vial of trypsin (sequencing grade 
modified trypsin, Promega) is 
combined with 100 µL trypsin 
resuspension buffer (Promega) and 
incubated 30 min at room temperature. 
Then add 900 µL 1 M NH4HCO3 
solution. After mixing, aliquot 50 µL 
into 0.5 mL microcentrifuge tubes and 
store at −80°C. Before using, thaw and 
add 450 µL Milli-Q to make 500 mL 
trypsin working solution.  
5 % formic acid  Formic acid 5 % 
Add 25 mL formic acid (MW: 46.03) 
to a  500 mL graduate cylinder, and 
add Milli-Q water to bring the final 
volume to 500 mL. Store at 4 °C. 
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Name Chemical Concentration  Preparation method 
32 % methanol and 
0.5 % formic acid 
solution  
Formic acid 0.5 % 
Add 160 mL methanol (MW: 32.04) 
and 2.5 mL formic acid (MW: 46.03) 
to 500 mL graduate cylinder, and add 
Milli-Q water to bring the final 
volume to 500 mL. Store at 4 °C. Methanol 32 % 
PAC target washing 
buffer 
TFA 0.1 % 
Add 1 mL trifluoroacetic acid (TFA, 
MW: 114.02) to 1 L graduate cylinder, 
and add Milli-Q water to bring the 
final volume to 1 L.  
Add 23 mg NH4H2PO4 and 20 mL 
0.1 % TFA solution to a glass bottle 
Store at 4 °C. 
NH4H2PO4 10 mM 
ZipTips washing 
solution 
Formic acid 0.5 % 
Add 2 mL methanol (MW: 32.04) and 
0.5 mL formic acid (MW: 46.03) to 
100 mL graduate cylinder, and add 
Milli-Q water to bring the final 
volume to 100 mL. Store at 4 °C. 
Methanol 2 % 
ZipTips elution 
solution 
Formic acid 0.5 % 
Add 65 mL methanol (MW: 32.04) 
and 0.5 mL formic acid (MW: 46.03) 
to 100 mL graduate cylinder, and add 
Milli-Q water to bring the final 
volume to 100 mL. Store at 4 °C. 
Methanol 65 % 
Saturated matrix 
solution  
TFA 0.06 % 
Add 1 mL trifluoroacetic acid (TFA, 
MW: 114.02) to 1 L graduate cylinder, 
and add Milli-Q water to bring the 
final volume to 1 L to make 0.1 % TFA 
solution.  
Add 10 mg α-Cyano-4-
hydroxycinnamic acid (MW: 189.17), 
400 µL acetonitrile (MW: 41.05) and 
600 µL 0.1 % TFA solution into a 1.5 
mL microcentrifuge tube. Vortex for 
mixing. Store at 4 °C. 
Acetonitrile 40 % 
α-Cyano-4-
hydroxycinna
mic acid 
10 mg/mL 
Suppl. Table 5.1.4 Heavy solution and light solution for casting gradient gels 
Stock solution 
Light Solution Heavy Solution 
260 mL 
10 small gels 
1100 mL 
23 big gels 
260 mL 
10 small gels 
1100 mL 
23 big gels 
Acrylamide stock solution 
Rotiphorese Gel 30 (37,5:1) 
84 mL 357 mL 127 mL 536 mL 
1.5 M Tris-HCl, pH 8.8 stock 
solution 
65 mL 275 mL 65.00 mL 275 mL 
Milli-Q water 105 mL 444 mL 44 mL 184 mL 
10 % SDS stock solution 2.6 mL 11 mL 2.6 mL 11 mL 
86 % Glycerol  0 0 21 mL(16.91 g) 88 mL 
Before addition of APS and TEMED to begin polymerization, bring above mixture to 4°C
 
for 3 h. 
10 % APS 2.60 mL 11 mL 1.30 mL 5.5 mL 
10 % TEMED 0.44 mL 1.88 mL 100 µL 0.42 mL 
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5.2 Supplementary material for Chapter 2 - Novel defined modular 
media to produce recombinant proteins 
5.2.1 Supplementary figures  
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Suppl. Fig 5.2.1 Influence of carbon substrate composition on GFP production at 23°C using 
autoinduction 
Cells were grown in test tube (narrow column, small symbols) and shake flask cultures (broad column, 
big symbols). Upper panel: Expression level ( ) and GFP fluorescence per 100 μl of GFP producing 
culture ( ). Lower panel: Volumetric GFP concentration ( ) and final cell density ( ). The light 
gray shadow indicates the maximum product yield area. Test tube and shake flask run numbers and 
glucose, glycerol and lactose concentrations are indicated below (refer to Table 2.2.2). 
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Suppl. Fig 5.2.2 Influence of carbon substrate composition on GST-GFP production at 23°C 
using autoinduction.  
Cells were grown in test tube (narrow column, small symbols) and shake flask (broad column, big 
symbols). Upper panel: Expression level ( ) and GST-GFP fluorescence per 100 μl of GST-GFP 
producing culture ( ). Lower panel: Volumetric GST-GFP concentration ( ) and final cell 
density ( ). The light gray shadow indicates the maximum product yield area. Test tube and shake flask 
run numbers and glucose, glycerol and lactose concentrations are indicated below (refer to Table 2.2.2). 
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Suppl. Fig 5.2.3 The influence of nitrogen content on protein production and partitioning of the 
recombinant protein into soluble and insoluble cell fractions at 23°C using autoinduction.  
Increasing the nitrogen content of S-DAB was accomplished by using ammonium hydroxide for pH 
adjustment instead of sodium hydroxide resulting in S-DAB (HNC). SDS-PAGE analysis of samples 
from duplicate experiments corresponding to whole cell protein, and soluble and insoluble fractions of 
cells producing (A) hFGF-2, (B) GFP and (C) GST-GFP, and. Arrows indicate the positions of the 
recombinant proteins. Below are indicated the cell fractions analyzed (W: whole cell protein. S: soluble 
part and I: insoluble part of whole cell protein) and above the medium employed. 
 
 
Suppl. Fig 5.2.4 The influence of oxygen supply on hFGF-2 production and partitioning of the 
recombinant protein into soluble and insoluble cell fractions at 23°C using S-DAB (HNC). 
SDS-PAGE analysis of samples from duplicate experiments (X1 and X2) corresponding to whole cell 
protein, and soluble and insoluble cell fractions. Arrows indicate the position of hFGF-2. Below are 
indicated the cell fractions analyzed (W: whole cell protein. S: soluble part and I: insoluble part of whole 
cell protein) and above the experimental conditions employed (A): 10 ml in 100 ml shake flask at 140 
rpm, (B): 25 ml in 100 ml shake flask at 140 rpm, (C): 10 ml in 100 ml shake flask at 80 rpm, (D): 50 ml 
in 100 ml shake flask at 140 rpm, and (E): 25 ml in 100 ml shake flask at 80 rpm.  
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5.2.2 Supplementary tables 
Suppl. Table 5.2.1 (Part A) Media preparation (For 1 Liter) 
G
ro
u
p
s 
N
o
. 
Name of media S-DAB (HNC)# S-DAB# DNB# 
General usage or of the medium 
No labeled 
production with 
good 
oxygen supply 
No labeled 
production with 
intermediate 
oxygen supply 
Pre-
cultures 
and IPTG 
induction 
Inducer Lactose Lactose IPTG 
Volume of stock solution mL mL mL 
A
 g
ro
u
p
 
Magnesium 
F1 50 X MgSO4 stock solution (H2O) 20 20 20 
F2 50 X MgSO4 stock solution (D2O)    
Carbon 
source 
A1 
4 X 2.94-11.07-7.6 carbon source 
stock solution (H2O) 
250 250  
A2 
4 X 2.94-11.07-7.6 carbon source 
stock solution (D2O) 
   
A3 20 X Glucose stock solution (H2O)   50 
A4 20 X Glucose stock solution (D2O)    
A5 
13C labeled Glucose stock solution 
(H2O) 
   
A6 
13C labeled Glucose stock solution 
(D2O) 
   
Trace G1 
5000 X Na2MoO4.H2O stock solution 
(H2O) 
0.2 0.2 0.2 
B
 g
ro
u
p
 
elements H1 
2000 X trace element stock solution 
(H2O) 
0.5 0.5 0.5 
Nitrogen 
B1 
50 X (NH4)2HPO4 stock solution 
(H2O) 
20 20 20 
B2 50 X NH4Cl stock solution (H2O)    
B3 
50 X 15N labeled NH4Cl stock 
solution (H2O) 
   
B4 
50 X 15N labeled NH4Cl stock 
solution (D2O) 
   
B5 50 X NH4Cl stock solution (D2O)    
Phosphate 
and 
other salts 
C1 
10 X KH2PO4 (High concentration) 
stock solution (H2O) 
   
C2 
10 X KH2PO4 (High concentration) 
stock solution (D2O) 
   
C3 
10 X KH2PO4 (Low concentration) 
stock solution (H2O) 
100 100 100 
D1 50 X Citric acid stock solution (H2O) 20 20 20 
D2 50 X Citric acid stock solution (D2O)    
E1 
50 X Fe(III) citrate stock solution 
(H2O) 
20 20 20 
E2 
50 X Fe(III) citrate stock solution 
(D2O) 
   
pH 
adjusting 
I1 25 X NH4OH stock solution (H2O)  45~50   
J1 50 X NaOH stock solution (H2O)  13.5 13.5 
J2 50 X NaOH stock solution (D2O)    
Solvent 
H1 Milli-Q water (H2O) 520 556 756 
H2 Deuterium oxide (D2O)    
A group: Mix magnesium and carbon source solution, sterilize. After adding 5000 X Na2MoO4.H2O stock 
solution, the solution (A group) can be kept for long term storage at room temperature. B group: Mix 
ammonium, phosphate and other salts and add solvent, adjust to pH 6.8, sterilize. After adding 2000 X trace 
element stock solution, the solution (B group) can be kept for long term storage at room temperature. 
#:autoclave (or sterilize by filtration); ##: sterilize by filtration.*: the labeling of 15N is optional. If 15N 
incorporation is not required, 15N-NH4Cl in the medium can be replaced by normal NH4Cl. 
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Suppl. Table 5.2.1 (Part B) Media preparation (For 1 Liter) 
G
ro
u
p
s 
N
o
. 
Name of media SL-DAB## 
SL-DAB 
(in D2O)
## 
rL-DNB## 
General usage or of the medium 15N labeling 
2H and 15N* 
labeling 
13C and 15N* 
labeling 
Inducer Lactose Lactose IPTG 
Volume of stock solution mL mL mL 
A
 g
ro
u
p
 
Magnesium 
F1 50 X MgSO4 stock solution (H2O) 20  20 
F2 50 X MgSO4 stock solution (D2O)  20  
Carbon 
source 
A1 
4 X 2.94-11.07-7.6 carbon source 
stock solution (H2O) 
250   
A2 
4 X 2.94-11.07-7.6 carbon source 
stock solution (D2O) 
 250  
A3 20 X Glucose stock solution (H2O)    
A4 20 X Glucose stock solution (D2O)    
A5 
13C labeled Glucose stock solution 
(H2O) 
  50 
A6 
13C labeled Glucose stock solution 
(D2O) 
   
Trace G1 
5000 X Na2MoO4.H2O stock 
solution (H2O) 
0.2 0.2 0.2 
B
 g
ro
u
p
 
elements H1 
2000 X trace element stock solution 
(H2O) 
0.5 0.5 0.5 
Nitrogen 
B1 
50 X (NH4)2HPO4 stock solution 
(H2O) 
   
B2 50 X NH4Cl stock solution (H2O)   
16* 
B3 
50 X 15N labeled NH4Cl stock 
solution (H2O) 
20  
B4 
50 X 15N labeled NH4Cl stock 
solution (D2O) 
 
20* 
 
B5 50 X NH4Cl stock solution (D2O)   
Phosphate 
and 
other salts 
C1 
10 X KH2PO4 (High concentration) 
stock solution (H2O) 
100  100 
C2 
10 X KH2PO4 (High concentration) 
stock solution (D2O) 
 100  
C3 
10 X KH2PO4 (Low concentration) 
stock solution (H2O) 
   
D1 
50 X Citric acid stock solution 
(H2O) 
20  20 
D2 
50 X Citric acid stock solution 
(D2O) 
 20  
E1 
50 X Fe(III) citrate stock solution 
(H2O) 
20  20 
E2 
50 X Fe(III) citrate stock solution 
(D2O) 
 20  
pH 
adjusting 
I1 25 X NH4OH stock solution (H2O)     
J1 50 X NaOH stock solution (H2O) 20  20 
J2 50 X NaOH stock solution (D2O)  20  
Solvent 
H1 Milli-Q water (H2O) 550  754 
H2 Deuterium oxide (D2O)  550  
A group: Mix magnesium and carbon source solution, sterilize. After adding 5000 X Na2MoO4.H2O stock 
solution, the solution (A group) can be kept for long term storage at room temperature. B group: Mix 
ammonium, phosphate and other salts and add solvent, adjust to pH 6.8, sterilize. After adding 2000 X trace 
element stock solution, the solution (B group) can be kept for long term storage at room temperature. 
#:autoclave (or sterilize by filtration); ##: sterilize by filtration.*: the labeling of 15N is optional. If 15N 
incorporation is not required, 15N-NH4Cl in the medium can be replaced by normal NH4Cl. 
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Suppl. Table 5.2.1 (Part C) Media preparation (For 1 Liter) 
G
ro
u
p
s 
N
o
. 
Name of media 
rL-DNB 
(in D2O)
## 
L-DNB 
(in D2O)
## 
L-DNB# 
General usage or of the medium 
2H, 13C and 
15N* labeling 
Pre-culture 
for 15N*, 13C 
and 2H 
labeling 
Pre-cultures 
and Se-Met 
labeling 
Inducer IPTG IPTG IPTG 
Volume of stock solution mL mL mL 
A
 g
ro
u
p
 
Magnesium 
F1 50 X MgSO4 stock solution (H2O)   20 
F2 50 X MgSO4 stock solution (D2O) 20 20  
Carbon 
source 
A1 
4 X 2.94-11.07-7.6 carbon source 
stock solution (H2O) 
   
A2 
4 X 2.94-11.07-7.6 carbon source 
stock solution (D2O) 
   
A3 20 X Glucose stock solution (H2O)   50 
A4 20 X Glucose stock solution (D2O)  50  
A5 
13C labeled Glucose stock solution 
(H2O) 
   
A6 
13C labeled Glucose stock solution 
(D2O) 
50   
Trace G1 
5000 X Na2MoO4.H2O stock 
solution (H2O) 
0.2 0.2 0.2 
B
 g
ro
u
p
 
elements H1 
2000 X trace element stock solution 
(H2O) 
0.5 0.5 0.5 
Nitrogen 
B1 
50 X (NH4)2HPO4 stock solution 
(H2O) 
   
B2 50 X NH4Cl stock solution (H2O)   20 
B3 
50 X 15N labeled NH4Cl stock 
solution (H2O) 
   
B4 
50 X 15N labeled NH4Cl stock 
solution (D2O) 16
* 20* 
 
B5 50 X NH4Cl stock solution (D2O)  
Phosphate 
and 
other salts 
C1 
10 X KH2PO4 (High concentration) 
stock solution (H2O) 
  100 
C2 
10 X KH2PO4 (High concentration) 
stock solution (D2O) 
100 100  
C3 
10 X KH2PO4 (Low concentration) 
stock solution (H2O) 
   
D1 50 X Citric acid stock solution (H2O)   20 
D2 50 X Citric acid stock solution (D2O) 20 20  
E1 
50 X Fe(III) citrate stock solution 
(H2O) 
  20 
E2 
50 X Fe(III) citrate stock solution 
(D2O) 
20 20  
pH 
adjusting 
I1 25 X NH4OH stock solution (H2O)     
J1 50 X NaOH stock solution (H2O)   20 
J2 50 X NaOH stock solution (D2O) 20 20  
Solvent 
H1 Milli-Q water (H2O)   750 
H2 Deuterium oxide (D2O) 754 750  
A group: Mix magnesium and carbon source solution, sterilize. After adding 5000 X Na2MoO4.H2O stock 
solution, the solution (A group) can be kept for long term storage at room temperature. B group: Mix 
ammonium, phosphate and other salts and add solvent, adjust to pH 6.8, sterilize. After adding 2000 X trace 
element stock solution, the solution (B group) can be kept for long term storage at room temperature. 
#:autoclave (or sterilize by filtration); ##: sterilize by filtration.*: the labeling of 15N is optional. If 15N 
incorporation is not required, 15N-NH4Cl in the medium can be replaced by normal NH4Cl. 
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Suppl. Table 5.2.2 Stock solution preparation 
No. Name Working concentration Stock solution preparation 
Sterilization 
method 
F1 
50 X MgSO4 stock 
solution (H2O) 
0.586 g L−1 MgSO4 
Add 30 g MgSO4.7H2O (MW: 246.47) to 
a 0.5 L graduated cylinder. Bring final 
volume to 0.5 L with water (Milli-Q or 
similar quality). 
121°C 
autoclave or 
filtration  
(0.2 µm) 
F2 
50 X MgSO4 stock 
solution (D2O) 
Add 3 g MgSO4.7H2O (MW: 246.47) [or 
1.47 g MgSO4 (MW: 120.37)] to a 50 mL 
graduated cylinder. Bring final volume to 
50 mL with deuterium monoxide (D2O). 
Filtration  
(0.2 µm) 
A1 
4 X 2.94-11.07-7.6 
carbon source stock 
solution (H2O) 
2.94 g L−1 glucose 
11.07 g L−1 glycerol 
7.6 g L−1 lactose 
Add 12.92 g glucose.H2O (MW: 198.17), 
44.28 g glycerol (MW: 92.09) and 32 g 
lactose.H2O (MW: 360.31) to a 1 L 
graduated cylinder. Bring final volume to 
1 L with water (Milli-Q or similar 
quality). 
121°C 
autoclave or 
filtration 
 (0.2 µm) 
A2 
4 X 2.94-11.07-7.6 
carbon source stock 
solution (D2O) 
Add 1.292 g glucose.H2O (MW: 198.17), 
4.428 g glycerol (MW: 92.09) and 3.2 g 
lactose.H2O (MW: 360.31) [or 1.176 g 
glucose (MW: 180.16), 4.428 g glycerol 
(MW: 92.09) and 3.04 g lactose (MW: 
342.30)] to a 100 mL graduated cylinder. 
Bring final volume to 100 mL with 
deuterium monoxide (D2O). 
Filtration  
(0.2 µm) 
A3 
20 X Glucose stock 
solution (H2O) 
10.91 g L−1 glucose  
Add 240 g glucose.H2O (MW: 198.17) to 
a 1 L graduated cylinder. Bring final 
volume to 1 L with water (Milli-Q or 
similar quality). 
121°C 
autoclave or 
filtration  
(0.2 µm) 
A4 
20 X Glucose stock 
solution (D2O) 
Add 24 g glucose.H2O (MW: 198.17) [or 
21.82 glucose (MW: 180.16)] to a 100 mL 
graduated cylinder. Bring final volume to 
100 mL with deuterium monoxide (D2O). 
121°C 
autoclave or 
filtration  
(0.2 µm) 
A5 
13C labeled Glucose 
stock solution (H2O) 
6.55 g L−1 13C-glucose 
Add 6.546 g 13C-glucose to a 50 mL 
graduated cylinder. Bring final volume to 
50 mL with water (Milli-Q or similar 
quality). 
Filtration  
(0.2 µm) 
A6 
13C labeled Glucose 
stock solution (D2O) 
Add 6.546 g 13C-glucose to a 50 mL 
graduated cylinder. Bring final volume to 
50 mL with deuterium monoxide (D2O). 
Filtration  
(0.2 µm) 
G1 
5000 X 
Na2MoO4.H2O stock 
solution (H2O) 
2.1 mg L−1 
Na2MoO4.2H2O 
Add 525 mg of Na2MoO4.2H2O (MW: 
241.95) to a 50 mL graduated cylinder. 
Bring final volume to 50 mL with water 
(Milli-Q or similar quality). 
Filtration  
(0.2 µm) 
H1 
2000 X trace element 
stock solution (H2O) 
2.5 mg L
−1 
CoCl2.6H2O 
15 mg L
−1 
MnCl2.4H2O 
1.5 mg L
−1 
CuCl2.2H2O 
3 mg L
−1 
H3BO3 
33.8 mg L
−1 
Zn(CH3COO)2.2H2O 
14.10 mg L
−1 
Titriplex III 
Add 0.5 g of CoCl2.6H2O (MW: 237.93), 
3 g of MnCl2.4H2O (MW: 197.9), 0.3 g of 
CuCl2.2H2O (MW: 170.48), 0.6 g of 
H3BO3 (MW: 61.83), 6.76 g of 
Zn(CH3COO)2.2H2O (MW: 219.49), 2.82 
g of Titriplex III (MW: 372.24) to a 100 
mL graduated cylinder. Bring final 
volume to 100 mL with Milli-Q water (or 
similar quality). 
Filtration  
(0.2 µm) 
B1 
50 X (NH4)2HPO4 
stock solution (H2O) 
4 g L−1 (NH4)2HPO4 
Add 100 g (NH4)2HPO4 (MW: 132.06) to 
a 0.5 L graduated cylinder. Bring final 
volume to 0.5 L with water (Milli-Q or 
similar quality). 
121°C 
autoclave or 
filtration  
(0.2 µm) 
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No. Name Working concentration Stock solution preparation 
Sterilization 
method 
B2 
50 X NH4Cl stock 
solution (H2O) 
3.24 g L−1 NH4Cl  
Add 81 g NH4Cl (MW: 53.49) to a 0.5 L 
graduated cylinder. Bring final volume to 
0.5 L with water (Milli-Q or similar 
quality). 
121°C 
autoclave or 
filtration  
(0.2 µm) 
B3 
50 X 15N labeled 
NH4Cl stock solution 
(H2O) 
3.24 g L−1 15N-NH4Cl 
Add 8.1 g 15N-NH4Cl to a 50 mL 
graduated cylinder. Bring final volume to 
50 mL with water (Milli-Q or similar 
quality). 
Filtration  
(0.2 µm) 
B4 
50 X 15N labeled 
NH4Cl stock solution 
(D2O) 
Add 8.1 g 15N-NH4Cl to a 50 mL 
graduated cylinder. Bring final volume to 
50 mL with deuterium monoxide (D2O). 
Filtration  
(0.2 µm) 
B5 
50 X NH4Cl stock 
solution (D2O) 
3.24 g L−1 NH4Cl 
Add 8.1 g NH4Cl (MW: 53.49) to a 50 mL 
graduated cylinder. Bring final volume to 
50 mL with deuterium monoxide (D2O). 
Filtration  
(0.2 µm) 
C1 
10 X KH2PO4 (High 
concentration) stock 
solution (H2O) 
17.42 g L−1 KH2PO4 
Add 174.2 g KH2PO4 (MW: 136.09) to a 
1 L graduated cylinder. Bring final 
volume to 1 L with water (Milli-Q or 
similar quality). 
121°C 
autoclave or 
filtration  
(0.2 µm) 
C2 
10 X KH2PO4 (High 
concentration) stock 
solution (D2O) 
Add 17.42 g KH2PO4 (MW: 136.09) to a 
100 mL graduated cylinder. Bring final 
volume to 100 mL with deuterium 
monoxide (D2O). 
Filtration  
(0.2 µm) 
C3 
10 X KH2PO4 (Low 
concentration) stock 
solution (H2O) 
13.3 g L−1 KH2PO4 
Add 133 g KH2PO4 (MW: 136.09) to a 1 
L graduated cylinder. Bring final volume 
to 1 L with water (Milli-Q or similar 
quality). 
121°C 
autoclave or 
filtration  
(0.2 µm) 
D1 
50 X Citric acid 
stock solution (H2O) 
1.55 g L−1 Citric acid 
Add 42.5 g Citric acid.H2O (MW: 210.14) 
to a 0.5 L graduated cylinder. Bring final 
volume to 0.5 L with water (Milli-Q or 
similar quality) 
121°C 
autoclave or 
filtration  
(0.2 µm) 
D2 
50 X Citric acid 
stock solution (D2O) 
Add 4.25 g Citric acid.H2O (MW: 210.14) 
[or 3.886 g Citric acid (MW: 192.12)] to a 
50 mL graduated cylinder. Bring final 
volume to 50 mL with deuterium 
monoxide (D2O). 
Filtration  
(0.2 µm) 
E1 
50 X Fe(III) citrate 
stock solution (H2O) 
100.8 mg L−1 Fe(III) 
citrate 
Add 2.52 g Fe(III) citrate (MW: 244.94) 
to a 0.5 L graduated cylinder. Bring final 
volume to 0.5 L with water (Milli-Q or 
similar quality). 
121°C 
autoclave or 
filtration  
(0.2 µm) 
E2 
50 X Fe(III) citrate 
stock solution (D2O) 
Add 0.252 g Fe(III) citrate (MW: 244.94) 
to a 50 mL graduated cylinder. Bring final 
volume to 50 mL with deuterium 
monoxide (D2O). 
Filtration  
(0.2 µm) 
I1 
25 X NH4OH stock 
solution (H2O)  
To bring final pH to 6.8 
Add 50 mL 30~33 % Ammonium 
hydroxide to a 0.5 L graduated cylinder. 
Bring final volume to 0.5 L with water 
(Milli-Q or similar quality). 
 
J1 
50 X NaOH stock 
solution (H2O) 
Add 100 g NaOH (MW: 40) to a 0.5 L 
graduated cylinder. Bring final volume to 
0.5 L with water (Milli-Q or similar 
quality). 
 
J2 
50 X NaOH stock 
solution (D2O) 
Add 10 g NaOH (MW: 40) to a 50 mL 
graduated cylinder. Bring final volume to 
50 mL with deuterium monoxide (D2O). 
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5.3 Supplementary material for Chapter 3 - A comprehensive 
proteomic study of Escherichia coli 
5.3.1 Supplementary figures  
Abbreviation in Suppl. Figs 5.3.1 - 5.3.3 and 5.3.13 - 5.3.20 
13-BPG 1,3-bisphospho-D-glycerate 
2345THD (S)-2,3,4,5-tetrahydrodipicolinate 
23DDP (S)-2,3-dihydrodipicolinate 
23DH3MB 2,3-dihydroxy-3-methylbutanoate 
23DH3MV 2,3-dihydroxy-3-methylvalerate 
2A2HBu 2-aceto-2-hydroxy-butanoate 
2A3OBu 2-amino-3-oxobutanoate 
2AM-SeA 2-aminomalonate-semialdehyde 
2H2M3OB (S)-2-hydroxy-2-methyl-3-oxobutanoate 
2isoPMe 2-isopropylmaleate 
2K3MV 2-keto-3-methyl-valerate 
2OBu 2-oxobutanoate 
2PG 2-phospho-D-glycerate 
2S2isoPM (2S)-2-isopropylmalate 
3-HP 3-hydroxypropionate 
3-HPA 3-hydroxypropionaldehyde 
3isoPM (2R,3S)-3-isopropylmalate 
3PG 3-phospho-D-glycerate 
3P-HP 3-phospho-hydroxypyruvate 
3P-serine 3-phospho-L-serine 
4HPP 4-hydroxyphenylpyruvate 
4M2OPT 4-methyl-2-oxopentanoate 
5,10-CH2-THF 5,10-methylenetetrahydrofolate 
5PRA 5-phospho-β-D-ribosyl-amine 
6PG 6-phospho-D-gluconate 
A5PS adenosine 5'-phosphosulfate 
Acetyl-P acetylphosphate 
Acetyl-Ser O-acetyl-L-serine 
Ade-Suc adenylo-succinate 
ADP-GMH ADP-D-glycero-β-D-manno-heptose 
AICAR aminoimidazole carboxamide ribonucleotide 
AOrn N-acetyl-L-ornithine 
Arg-Suc L-arginino-succinate 
Asp4P L-aspartyl-4-phosphate 
Appendix 
A-22 
Asp-SA L-aspartate-semialdehyde 
CAIR 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylate 
Carbamoyl-P carbamoyl-phosphate 
DAHP 3-deoxy-D-arabino-heptulosonate-7-phosphate 
DH7O5Cholanate 3α,12α-dihydroxy-7-oxo-5β-cholanate 
DHA dihydroxyacetone 
DHAP dihydroxyacetone phosphate 
E4P D-erythrose-4-phosphate 
F6P D-fructose-6-phosphate 
FAICAR phosphoribosyl-formamido-carboxamide 
FBP fructose-1,6-bisphosphate 
FGAM 5-phosphoribosyl-N-formylglycineamidine 
FGAR 5'-phosphoribosyl-N-formylglycineamide 
G1P α-D-glucose 1-phosphate 
G3P D-glyceraldehyde-3-phosphate 
G6P β-D-glucose-6-phosphate 
GA14L D-galactono-1,4-lactone 
GAR 5-phospho-ribosyl-glycineamide 
GlcN1P D-glucosamine-1-phosphate 
GlcN6P D-glucosamine-6-phosphate 
Glu5P L-glutamate-5-phosphate 
GMH17P D-glycero-β-D-manno-heptose 1,7-bisphosphate 
GMH1P D-glycero-β-D-manno-heptose 1-phosphate 
GMH7P D-glycero-D-manno-heptose-7-phosphate 
GSH Glutathione 
GSSG Glutathione disulfide 
HisP L-histidinol-phosphate 
I3GP (1S,2R)-1-C-(indol-3-yl)glycerol 3-phosphate 
IAP imidazole acetol-phosphate 
IGP D-erythro-imidazole-glycerol-phosphate 
IMP inosine-5'-phosphate 
KPP keto-phenylpyruvate 
L-G3P sn-glycerol-3-phosphate 
L-G3P sn-glycerol-3-phosphate 
Ma-SeA malonate semialdehyde 
M-DAP meso-diaminopimelate 
Methyl-THF 5-methyl-tetrahydrofolate 
N
2
-SuccArg N
2
-succinylarginine  
N
2
-SuccGlu-SA N
2
-succinylglutamic-semialdehyde 
N
2
-SuccGlut N2-succinylglutamate 
N
2
-SuccOrn N
2
-succinylornithine 
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N5PRA N-(5'-phosphoribosyl)-anthranilate 
NAG5SA N-acetyl-L-glutamate 5-semialdehyde 
NAGP N-acetylglutamyl-phosphate 
Nitroaromatics  nitroaromatic compound 
OC1D5P 1-(o-carboxyphenylamino)-1'-deoxyribulose-5'-phosphate 
P-ATP phosphoribosyl-ATP  
PEP phosphoenolpyruvate 
P-Homoserine  O-phospho-L-homoserine 
preQ0 7-cyano-7-deazaguanine 
preQ1 7-aminomethyl-7-deazaguanine 
PRFAR phosphoribulosylformimino-AICAR-P 
PRPP 5-phospho-α-D-ribose 1-diphosphate 
Pyr5Car (S)-1-pyrroline-5-carboxylate 
R5P D-ribose-5-phosphate 
Ribose-1P α-D-ribose-1-phosphate 
RL5P D-ribulose-5-phosphate 
S7P D-sedoheptulose-7-phosphate 
SAICAR 5'-phosphoribosyl-4-(N-succinocarboxamide)-5-
aminoimidazole SAMe S-adenosyl-L-methionine 
S-Homoserine  O-succinyl-L-homoserine 
SL26DAP N-succinyl-L,L-2,6-diaminopimelate 
SL2A6KP N-succinyl-2-amino-6-ketopimelate 
TDP-G dTDP-α-D-glucose 
TDP-od-G dTDP-4-dehydro-6-deoxy-D-glucose 
THF tetrahydrofolate 
TMG 1,3-propanediol 
UDP-GlcNAc UDP-α-N-acetyl-D-glucosamine 
X5P D-xylulose-5-phosphate 
αG6P α-D-glucose 6-phosphate 
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Suppl. Fig 5.3.1 Comparative proteome analysis of E. coli 
(exponential phase in defined medium versus exponential phase in complex medium) 
Arrow indicates relative change of each protein (log2 ratio). Color code is shown in the figure. Number is 
given in Suppl. Table 5.3.1. Pathways are drawn according to EcoCyc database (http://ecocyc.org/) 
[confirmed by KEGG database (http://www.genome.jp/kegg/)]. 
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Suppl. Fig 5.3.2 Comparative proteome analysis of E. coli 
(stationary phase versus exponential phase in complex media) 
Arrow indicates relative change of each protein (log2 ratio). Color code is shown in the figure. Number is 
given in Suppl. Table 5.3.1. Pathways are drawn according to EcoCyc database (http://ecocyc.org/) 
[confirmed by KEGG database (http://www.genome.jp/kegg/)]. 
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Suppl. Fig 5.3.3 Comparative proteome analysis of E. coli  
(stationary phase versus exponential phase in defined medium) 
Arrow indicates relative change of each protein (log2 ratio). Color code is shown in the figure. Number is 
given in Suppl. Table 5.3.1. Pathways are drawn according to EcoCyc database (http://ecocyc.org/) 
[confirmed by KEGG database (http://www.genome.jp/kegg/)]. 
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Suppl. Fig 5.3.4 Pathway comparison of E. coli  
(exponential phase in defined medium versus exponential phase in complex medium) 
Color indicates relative change of each pathway (log2 ratio). Color scale is shown in the figure. Number 
is given in Suppl. Table 5.3.2. Identified proteins are classified into each pathewy according to EcoCyc 
database (http://ecocyc.org/) [confirmed by KEGG database (http://www.genome.jp/kegg/)].  
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Suppl. Fig 5.3.5 Pathway comparison of E. coli  
(stationary phase versus exponential phase in complex media) 
Color indicates relative change of each pathway (log2 ratio). Color scale is shown in the figure. Number 
is given in Suppl. Table 5.3.2. Identified proteins are classified according to EcoCyc database 
(http://ecocyc.org/) database [confirmed by KEGG database (http://www.genome.jp/kegg/)]. 
  
DNA
mRNA
AA(s)-tRNA(s)
RNA
Frr
RaiA
tRNA
A
R
N
C
D
E
Q
G H
I
L
K
Amino acids
AA(s)
Ribosome-
associated 
proteins
Log2 ratio:
-2 0 21 1.50.5-0.5-1-1.5
Glycerol 
metabolism 
TCA cycle
Fatty acid biosynthesis
Lipopolysaccharide  
biosynthesis
Nucleotide biosynthesis 
(start from IMP)
Amino acid biosynthesis
Amino acid degradation
Ribosomal 
proteins
Aminoacyl-
tRNA 
synthetases
(Metabolite) 
degradation
Elongation 
factors
Isomerases
Chaperones
RNA 
degradation
RNA polymerases
RNA polymerase
binding proteins Transcription 
factors
DNA 
protection
and repair
Unclassified 
proteins
Proteases
Other transport proteins
Synthesis of other cellular components Oxidative 
phosphorylation
Oxidoreductases
Hydroperoxide reductases 
and superoxide dismutase
Other dehydrogenases
By-product metabolism 
Acetyl-CoA synthetase 
(ACS      )
Cell redox homeostasis
Amino acid biosynthesis
Uncharacterized 
proteins
Translation 
termination
Rho
 Appendix 
A-29 
 
 
Suppl. Fig 5.3.6 Pathway comparison of E. coli  
(stationary phase versus exponential phase in defined medium) 
Color indicates relative change of each pathway (log2 ratio). Color scale is shown in the figure. Number 
is given in Suppl. Table 5.3.2. Identified proteins are classified according to EcoCyc database 
(http://ecocyc.org/) [confirmed by KEGG database (http://www.genome.jp/kegg/)].  
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Suppl. Fig 5.3.7 2D gel of E. coli BL21 (DE3) growing in DNB medium at exponential phase 
Identified proteins are marked as dots (red). Cultivation was carried out in shaker flask with baffles at 
37 °C and 200 rpm.  
 
Suppl. Fig 5.3.8 2D gel of E. coli BL21 (DE3) growing in DNB medium at stationary phase 
Identified proteins are marked as dots (red). Cultivation was carried out in shaker flask with baffles at 
37 °C and 200 rpm.  
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Suppl. Fig 5.3.9 2D gel of E. coli BL21 (DE3) growing in TB medium at exponential phase 
Identified proteins are marked as dots (red). Cultivation was carried out in shaker flask with baffles at 
37 °C
 
and 200 rpm. 
 
Suppl. Fig 5.3.10 2D gel of E. coli BL21 (DE3) growing in TB medium at stationary phase 
Identified proteins are marked as dots (red). Cultivation was carried out in shaker flask with baffles at 
37 °C
 
and 200 rpm. 
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Suppl. Fig 5.3.11 2D gel of E. coli BL21 (DE3) growing in LB medium at exponential phase 
Identified proteins are marked as dots (red). Cultivation was carried out in shaker flask with baffles at 
37 °C
 
and 200 rpm. 
 
Suppl. Fig 5.3.12 2D gel of E. coli BL21 (DE3) growing in LB medium at stationary phase 
Identified proteins are marked as dots (red). Cultivation was carried out in shaker flask with baffles at 
37 °C
 
and 200 rpm.  
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Suppl. Fig 5.3.13 Comparative proteome analysis of E. coli during hFGF-2 production 
(1h after IPTG induction versus exponential phase (before induction) in defined medium) 
Arrow indicates relative change of each protein (log2 ratio). Color code is shown in the figure. Number is 
given in Suppl. Table 5.3.5. Pathways are drawn according to EcoCyc database (http://ecocyc.org/) 
[confirmed by KEGG database (http://www.genome.jp/kegg/)]. 
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Suppl. Fig 5.3.14 Comparative proteome analysis of E. coli during hFGF-2 production 
(5h after IPTG induction versus exponential phase (before induction) in defined medium) 
Arrow indicates relative change of each protein (log2 ratio). Color code is shown in the figure. Number is 
given in Suppl. Table 5.3.5. Pathways are drawn according to EcoCyc database (http://ecocyc.org/) 
[confirmed by KEGG database (http://www.genome.jp/kegg/)]. 
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Suppl. Fig 5.3.15 Comparative proteome analysis of E. coli during hFGF-2 production 
(5h after IPTG induction versus stationary phase (without induction) in defined medium) 
Arrow indicates relative change of each protein (log2 ratio). Color code is shown in the figure. Number is 
given in Suppl. Table 5.3.5. Pathways are drawn according to EcoCyc database (http://ecocyc.org/) 
[confirmed by KEGG database (http://www.genome.jp/kegg/)]. 
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Suppl. Fig 5.3.16 Comparative proteome analysis of E. coli during hFGF-2 production 
(stationary phase versus exponential phase in defined medium without protein production) 
Arrow indicates relative change of each protein (log2 ratio). Color code is shown in the figure. Number is 
given in Suppl. Table 5.3.5. Pathways are drawn according to EcoCyc database (http://ecocyc.org/) 
[confirmed by KEGG database (http://www.genome.jp/kegg/)]. 
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Suppl. Fig 5.3.17 Comparative proteome analysis of E. coli during hFGF-2 production 
(1h after IPTG induction versus exponential phase (before induction) in complex medium) 
Arrow indicates relative change of each protein (log2 ratio). Color code is shown in the figure. Number is 
given in Suppl. Table 5.3.5. Pathways are drawn according to EcoCyc database (http://ecocyc.org/) 
[confirmed by KEGG database (http://www.genome.jp/kegg/)]. 
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Suppl. Fig 5.3.18 Comparative proteome analysis of E. coli during hFGF-2 production 
(3.5h after IPTG induction versus exponential phase (before induction) in complex medium) 
Arrow indicates relative change of each protein (log2 ratio). Color code is shown in the figure. Number is 
given in Suppl. Table 5.3.5. Pathways are drawn according to EcoCyc database (http://ecocyc.org/) 
[confirmed by KEGG database (http://www.genome.jp/kegg/)]. 
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Suppl. Fig 5.3.19 Comparative proteome analysis of E. coli during hFGF-2 production 
(3.5h after IPTG induction versus stationary phase (without induction) in complex medium) 
Arrow indicates relative change of each protein (log2 ratio). Color code is shown in the figure. Number is 
given in Suppl. Table 5.3.5. Pathways are drawn according to EcoCyc database (http://ecocyc.org/) 
[confirmed by KEGG database (http://www.genome.jp/kegg/)]. 
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Suppl. Fig 5.3.20 Comparative proteome analysis of E. coli during hFGF-2 production 
(stationary phase versus exponential phase in complex medium without protein production) 
Arrow indicates relative change of each protein (log2 ratio). Color code is shown in the figure. Number is 
given in Suppl. Table 5.3.5. Pathways are drawn according to EcoCyc database (http://ecocyc.org/) 
[confirmed by KEGG database (http://www.genome.jp/kegg/)]. 
  
>1 0.7~1 0.5~0.7 0.2~0.5 0.1~0.2 <-1-0.7~-1-0.5~-0.7-0.2~-0.5-0.1~-0.20.1~-0.1 <-2>2
Log2 ratio:
3-HP
L-Serine H
+NADPH
Ma-SeA
2AM-SeANADP
+
3-HPA 
An acid
An aldehyde
NADP+
TMG
An aldehyde
An alcohol
H+NADPH
AcetateNADP+ Acetaldehyde H+NADPH
Glycolaldehyde
L-Lactaldehyde
H+NADH
Glycolate
(S)-Lactate
NAD+H2O
Galactose H+NADHGA14LNAD+
UDP-glucose H+NADHUDP-glucoronateNAD+H2O
Cholate H+NADHDH7O5CholanateNAD+
Menaquinone H+MenaquinolH+H2O
Oxidized thioredoxinNADP+ Reduced thioredoxin H+NADPH
GSSG NADPH H+ NADP+GSH
Reduced
nitroaromatics
Oxidized 
nitroaromatics
NADPH NADP+
preQ0 NADPH H+ NADP+preQ1
N-Ethylmaleimide H+ N-Ethylsuccinimide
Fe2+ or Cu+ O2 H+ Fe3+ or Cu2+ H2O
NAD+ NADPH NADP+NADH
Quione NAD(P)H H+ NAD(P)+Quinol
Fe2+ H2O2 H+FeOOH(core)H2O
H2O2 H2O O2
NADHAn organic 
H2O2
An 
alcohol
NAD+H+
An organic 
H2O2
An oxidized 
thioredoxin
An 
alcohol
A reduced 
thioredoxin
O2- H2O2 O2H+
(Metabolite) degradation
Glycogen degradation
β-Glucoside sugar degradation
Galactitol degradation
Xylose degradation 
Trehalose degradation
Melibiose degradation
4-Aminobutyrate degradation
Ornithine degradation
Hexuronide and hexuronate 
degradation
Ribonucleic acid degradation
Methylglyoxal degradation
Sialic acid degradation
Lipid degradation
Isomerases
Protein folding
Aminoacyl-tRNA synthetases
tRNA modification
Protein phosphorylation
YeaG
RNA polymerases
mRNA
Ribosomal
proteins
Protein chain initiation factor
Elongation factors
Peptide chain release factor
AA(s)-tRNA(s)
RNA degradation
Transcription 
termination
Rho
DNA topoisomerase
Chromosomal 
segregation 
Proteases
Protein degradation 
Chaperones 
Stress response / Folding
Essential cell 
division protein 
FtsZ
DNA protection
and repair
Transcription factors
DNA binding
RNA polymerase binding proteins
Transcription regulation
tRNA Amino acids
AA(s)
Methylation
of 16S rRNA
RsmC
A
R
N
C
D
E
Q
G H
I
L
K
Transcription and translation
Other transport proteins
Copper or silver 
transport
Glutathione 
transport
Lipopolysaccharide 
transport
Fatty acids
transport OmpF TolB
OmpA
OmpA(2)
OmpX YjjKTolC YbiT Unfolded protein 
transport (to membrane)
OMP biogenesis
NADH
NAD+
ATP
H+
H+
H+
AtpA
AtpD
AtpH
NuoB
NuoC
NuoF
NuoG
Pi+ADP
H+
Fatty acid 
biosynthesis
“Core” -
oligosaccharide 
biosynthesis
O antigen 
biosynthesis
Purine 
metabolism
Lipid A
biosynthesis
Glutamine
Glutamate  
Glyoxylate
SL26DAP 
M-DAP 
L-Methionine
SAMe
E4P X5P
IAP
HisP
Hydrogen sulfide  
Sulfate  A5PS  
Glycerol
L-G3P DHA
Acetate
Formate Acetyl-P
Acetaldehyde
Ethanol
Lactate
Malonyl-CoA
Acetyl-[acp]
Citrate
Oxaloacetate
(S)-Malate
Fumarate
Succinate Succinyl-CoA
2-Oxoglutarate
Oxalosuccinate
Isocitrate
Cis-aconitate
G6P
6PG
RL5P
S7P
G3P
F6P G3P
GMH7P
GMH17P
GlcN6P
GlcN1P
FBP
DHAP
13-BPG
3PG
2PG
PEP
DAHP
Chorismate
Anthranilate
N5PRA 
I3GP  
L-Tryptophan  
G3P
L-Serine  
3P-Serine  
3P-HP  
Glutamate  
2-Oxoglutarate
Prephenate
4HPPKPP
Glutamate  
2-Oxoglutarate
L-Tyrosine  
Pyruvate Acetyl-CoA
L-Glutamine
X5PR5P
P-ATP
Glutamate  
2-Oxoglutarate
Histidinol
L-Histidine
L-Cysteine  
HCO3-
Carbamoyl-P
NAGP
NAG5SA
AOrn
Ornithine
Citrulline
Arg-Suc
L-Arginine  
NH4+
Glu5P 
Pyr5Car 
L-Proline 
Pyruvate
NH4+
Indole  L-Alanine  
IMP 
XMP 
GMP 
Ade-Suc
AMP 
Guanosine  
Adenosine  
Guanine  
Adenine  
Glutamate  
2-Oxoglutarate
L-Glutamate
3-Dehydroquinate
3-Dehydroshikimate
IGP
PRFAR
D-Alanine  
N2-SuccArgN2-SuccOrn
N2-SuccGlu-SA
Inosine  
GMH1P
ADP-GMH
αG6P
G1P
TDP-G
TDP-od-G
L-Aspartate
Glutamate  
2-Oxoglutarate
NH4+
L-Asparagine
Asp4P Asp-SA
23DDP 2345THD
L-Lysine 
Homoserine S-Homoserine
P-Homoserine L-Threonine 
2A3OBu
Glycine  
2OBu
2A2HBu
23DH3MV 
2K3MV 
L-Isoleucine
Acetate
NH4+
CO2
Homocysteine
SL2A6KP 
THF  Glycine  
Methyl-THF  
Acetyl-Ser
Sulfite  
N2-SuccGlut
Succinate
5,10-CH2-THF  
5PRA 
GAR
FGAR
CAIR
SAICAR
AICAR
Pyrimidine 
metabolism
Uridine
Uracil
L-Phenylalanine 
UDP-GlcNAc
PRPP
FGAM 
FAICAR 
Ribose-1P   
Sugar 
transport
Maltose 
transport 
system
PTS system
Fermentation/respiration 
switch protein
FrsA
Amino acid 
and peptide 
transport
Oligopeptide 
transport
Amino acid 
transport
Synthesis 
of other 
cellular 
components
Porphyrin biosynthesis
HemB HemL
Polyisoprenoid biosynthesis
IspG IspE
Peptidoglycan biosynthesis
Mpl
Glutathione biosynthesis
GshB
Glucan biosynthesis
MdoG
Polyamine biosynthesis
SpeA SpeE
Autoinducer AI-2 biosynthesis
LuxS
NAD biosynthesis
NadE
Pantothenate & Coenzyme A biosynthesis
PanB           PanC
Thiamin biosynthesis
ThiC
Trehalose biosynthesis
OstA 
Glycogen biosynthesis
GlgB
Uncharacterized proteins
Pentose
Phosphate
Pathway
R5P
2H2M3OB
23DH3MB
Oxoisovalerate
L-Valine
2S2isoPM 2isoPMe 3isoPM
4M2OPT
L-Leucine
Ribosome-associated proteins
Ribosome modification
GuaB
GuaA
PurB
PurA
Hpt DeoD
DeoD
DeoB
Add
LysC
ThrB
PurB
PurH
PurL
3 Steps
PurC
PurH
IlvB
IlvI   
IlvC
IlvD
IlvE
LeuA
Apt
Amn
GltB
PfkA
PfkB
FbaA
FbaBGlmS
GlmU
GlmMPgm
RmlA
RfbB
FabH
AccA
AccC
FabB
FabF
FabH
FabZ
FabI
Multi
steps
Mdh
FumA
FumC
SdhA
SdhB 
SucC
SucD
LpdA
SucA
SucB
Icd
Icd
AcnA    
AcnBAcnA    
AcnB
GlcB
AsnA
AsnB
Asd
DapA DapD
2 Steps
MetA
MetE
MetH
MetK
Tdh
IlvA
IlvE
IlvC
IlvD
IlvB
IlvI
GltA
LeuC
LeuD
LeuC
LeuD
LeuB
IlvE
AspC
AspA
PpsA
Acs
AckA
Pta
AdhE
AdhE
CysJ
CysI
CarA
CarB
GlnA
2 Steps 
ArgG
ProA
TpiA
GapA
Pgk
GpmA
Eno PykA
PykF
AceE
AceF
LpdA
YdbK
AroF
AroG
SerC
GdhA
ArgC
ArgD
TktA
TktB
Ppc
PckAMaeB
SfcA
AroB
AroD
ArgE
PutA
PoxB
LldD
Dld
LdhA
LysA
ArgD
2 Steps
CysN
Can
ArgI
TyrAPheA
3 Steps 
GlyA
4 Steps
ArgH
TnaA
TnaA
CysK
YfhO
Gnd
TktA
TktB
TalB
TalA
GmhA
HldE
TrpC
TrpD
TrpE
TrpA
TyrA
PheA
SerA
HisD
HisC
AspC
HisC(KEGG)
CysK
HisF
DadX
AstAAstB
AstD
HldD
MetF
GcvT
PurF
PurD
PurT
AspC
HisC(KEGG)
IlvE(EcoCyc)
GlpK
DhaK
Kbl
Udp
YdfG
YqhD
AldB
YhhX
HybC
TrxB
Gor
NsfA
QueF
NemA
CueO
SthA
WrbA
Bfr
KatG
AhpC
AhpF
Tpx
SodB
AldA
Ugd
HdhA
PflB
MalP
BglX
GatZ
XylA 
TreA
MelA
GabT
Prr
UidA
CpdB
DkgA
NanA
FabB
MalQ
GatD
TreC
GabD
FabH
PpiB
SurA
FklB
IleS
LeuS
LysS
MetG
PheT
ProS
SerS
ThrS
TyrS
LysU
YgfZ
Fmt
FkpA
SlyD
AlaS
ArgS
AsnS
AspS
CysS
GlnS
GltX
GlyQ
GlyS
HisS
MnmA
RpoA
RpoB
RpoC
RplL
RplI
RpsA
RpsB
RpsF
InfB
FusA
TufA
Tsf
LepA
PrfC
Pnp
Rnb
RhlB
GyrB
MerB
DegP
PepQ
PepD
PepN
Dcp
Prc
PmbA
ClpP
HslV
HslU
PepB
PepP
PrlC
DnaK
GrpE
GroL
GroS
HtpG
Ssb
Dps
CbpA
UspA
UspG
SodA
PolA
RpoD
SspA
DksA
RapA
NusA
NusG
HscA
ClpA
ClpB
IbpA
EngA
YcaO
EngD
TypA
HflX
Tig
Frr
RaiA
DNA
RNA
LacI
Hns
ArcA
KdgR
PspA
OmpR
CpxR
PhoP
OxyR
BasR
CspC
StpA
CusB GsiB LptD FadL
SecA 
YaeT 
YhbW
GalF
YbeZ
YjgR
YdcJ
YcgB
YgaU
YfbU
LfiI
YhdH
YicC
YajQ
YbgI
MalE
MalK
LamB
PtsI
PtsH
Crr
ManX
DppA
OppA
OppD
GlnH
ArtJ
ArgT
LivJ
Cell redox homeostasis
Oxidoreductases
+ +
+ +
+
+
+ +
+ + +
Hydroperoxide reductases & Superoxide dismutase
+ + +
+ +
+ + +
+ +
+ +
+ +
+ + +
+
+ + +
+ +
+
+
+ +
+ ++ +
+ +
+
+
+
+
++
+
+
++ +
Other dehydrogenases
+
+
Cytosol Inner
membrane
Periplasmic
space
Oxidative phosphorylation
LpxA
ArnA
PyrG
Ndk
Tmk
TrpD
HisG
 Appendix 
A-41 
 
Suppl. Fig 5.3.21 2D gel of E. coli BL21 (DE3) harbouring plasmid pET-29c-hFGF-2 growing 
in DNB medium at exponential phase (before IPTG induction)  
Identified proteins are marked as dots (red). Cultivation was carried out in shaker flask with baffles at 
30 °C
 
and 180 rpm 
 
Suppl. Fig 5.3.22 2D gel of E. coli BL21 (DE3) harbouring plasmid pET-29c-hFGF-2 growing 
in DNB medium 1 h after induction with 0.25 mM IPTG  
Identified proteins are marked as dots (red). Cultivation was carried out in shaker flask with baffles at 
30 °C
 
and 180 rpm  
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Suppl. Fig 5.3.23 2D gel of E. coli BL21 (DE3) harbouring plasmid pET-29c-hFGF-2 growing 
in DNB medium 5 h after induction with 0.25 mM IPTG  
Identified proteins are marked as dots (red). Cultivation was carried out in shaker flask with baffles at 
30 °C
 
and 180 rpm 
 
Suppl. Fig 5.3.24 2D gel of E. coli BL21 (DE3) harbouring plasmid pET-29c-hFGF-2 growing 
in DNB medium at stationary phase (without IPTG induction) 
Identified proteins are marked as dots (red). Cultivation was carried out in shaker flask with baffles at 
30 °C
 
and 180 rpm 
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Suppl. Fig 5.3.25 2D gel of E. coli BL21 (DE3) harbouring plasmid pET-29c-hFGF-2 growing 
in LB medium at exponential phase (before IPTG induction) 
Identified proteins are marked as dots (red). Cultivation was carried out in shaker flask with baffles at 
30 °C
 
and 180 rpm 
 
Suppl. Fig 5.3.26 2D gel of E. coli BL21 (DE3) harbouring plasmid pET-29c-hFGF-2 growing 
in LB medium 1 h after induction with 0.25 mM IPTG  
Identified proteins are marked as dots (red). Cultivation was carried out in shaker flask with baffles at 
30 °C
 
and 180 rpm 
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Suppl. Fig 5.3.27 2D gel of E. coli BL21 (DE3) harbouring plasmid pET-29c-hFGF-2 growing 
in LB medium 3.5 h after induction with 0.25 mM IPTG  
Identified proteins are marked as dots (red). Cultivation was carried out in shaker flask with baffles at 
30 °C
 
and 180 rpm 
 
Suppl. Fig 5.3.28 2D gel of E. coli BL21 (DE3) harbouring plasmid pET-29c-hFGF-2 growing 
in LB medium at stationary phase (without IPTG induction) 
Identified proteins are marked as dots (red). Cultivation was carried out in shaker flask with baffles at 
30 °C
 
and 180 rpm 
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Suppl. Fig 5.3.29 SDS-PAGE of soluble hFGF-2 production in LB and DNB medium 
The time after induction is indicated below of the figure. The media are indicated above (L: LB medium, 
D: DNB medium, M: marker) 
 
Suppl. Fig 5.3.30 SDS-PAGE of insoluble hFGF-2 production in LB and DNB medium 
The time after induction is indicated below of the figure. The media are indicated above (L: LB medium, 
D: DNB medium, M: marker) 
 
  
0
h
5
h
3
h
2
h
1.5
h
1
h
0.5
h
0
h
0.5
h
3.5
h
2.5
h
2
h
1.5
h
1
h
L LLLLLLD DDDDDD M
— 170
—
— 72
— 55
— 43
— 34
— 26
— 17
— 10
( kDa )
0
h
5
h
3
h
2
h
1.5
h
1
h
0.5
h
0
h
0.5
h
3.5
h
2.5
h
2
h
1.5
h
1
h
L LLLLLLD DDDDDD M
— 170
—
— 72
— 55
— 43
— 34
— 26
— 17
— 10
( kDa )
Appendix 
A-46 
5.3.2 Supplementary tables 
Suppl. Table 5.3.1 Proteome data of E. coli BL21 (DE3) growing in different media 
Whole Cell Protein Mass (WCPM) - %: Each spot’s intensity was normalized by the 
whole spots intensity on each 2D gel. The corresponding average from two duplicated 
gels was used indicating each spot’s protein portion (%) of whole cell protein mass 
(WCPM). The total “WCPM %” of all spots representing the same protein was used for 
indicating the abundance of the corresponding protein.  
For each protein's WCPM (%), number with two digits after the decimal point is given. 
But for a better comparison of low abundance proteins (WCPM <0.05 %), three digits 
after the decimal point are given. 
Log2(defined/complex) at exp. phase: Average of Log2[DNB (medium)/TB (medium)] 
and Log2[DNB (medium)/LB (medium)] at exponential phase 
Log2(stationary phase/exp. phase) in complex medium: Average of Log2(stationary 
phase/exponential phase) in TB and LB media 
Log2(stationary phase/exp. phase) in defined medium: Average of Log2(stationary 
phase/exponential phase) in DNB medium 
If WCPM (%) of a protein is zero, an artificial Log2 ratio: ">5" or "<-5" was given, 
indicating the corresponding Log2 ratio is larger than 5 or smaller than -5. 
DNB medium: 10.91 g L
−1
 glucose, 4 g L
−1
 (NH4)2HPO4, 13.3 g L
−1
 KH2PO4, 1.554 g 
L
−1
 Citric acid, 0.586 g L
−1
 MgSO4, 0.1008 g L
−1
 Fe(III) citrate, 2.1 mg L
−1
 
Na2MoO4.2H2O, 2.5 mg L
−1
 CoCl2.6H2O, 15 mg L
−1
 MnCl2.4H2O, 1.5 mg L
−1
 
CuCl2.2H2O, 3 mg L
−1
 H3BO3, 33.8 mg L
−1
 Zn(CH3COOH)2.2H2O, 14.10 mg L
−1
 
Titriplex III. µmax= 0.8 h
−1
 
TB medium: 12 g L
−1
 tryptone, 24 g L
−1
 yeast extract, 5 g L
−1
 glycerol, 2.31 g L
−1
 
KH2PO4, 12.54 g L
−1
 K2HPO4. µmax= 1.4 h
−1
 
LB medium: 10 g L
−1
 tryptone, 5 g L
−1
 yeast extract, 5 g L
−1
 NaCl. µmax= 1.6 h
−1
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Suppl. Table 5.3.1 Proteome data of E. coli BL21 (DE3) growing in different media 
Name1 Protein name1 Uniprot ID1 
Molecular 
mass2 
(Da) 
Calculated 
pI value2 
Mascot 
score2 
Expect2 
Mascot 
seq. 
cover.2 
Defind medium Complex medium 
Log2 
(DNB 
/TB) 
Log2 
(DNB 
/LB) 
Log2 
(defined/ 
complex) 
Log2(stationary phase 
/exp. phase) DNB medium TB medium LB medium 
exp. stationary exp. stationary exp. stationary 
in 
TB 
medium 
in 
LB 
medium 
in 
complex 
media 
in 
defined 
medium 
phase phase phase phase phase phase 
Whole Cell Protein Mass (WCPM) - % At exp. phase 
Central carbon metabolism (24 proteins): Upper and lower glycolysis, glycerol metabolism and 
pentose phosphate pathway. Total WCPM: 6.64 9.15 9.73 14.22 9.67 9.24 
-0.6 -0.5 -0.5 0.5 -0.1 0.2 0.5 
                     
Sub-group: Upper glycolysis (5 proteins) Total WCPM: 1.35 1.76 1.21 2.16 1.18 1.51 0.2 0.2 0.2 0.8 0.4 0.6 0.4 
                     
PfkA 6-Phosphofructokinase P0A797 35162 5.47 105 2.7E-06 41% 0.13 0.15 0.11 0.11 0.12 0.11 0.2 0.1 0.2 0.0 -0.1 -0.1 0.2 
PfkB 6-Phosphofructokinase isozyme 2 P06999 32664 5.25 145 7.2E-11 83% 0.038 0.037 0.025 0.05 0.025 0.06 0.6 0.6 0.6 1.0 1.3 1.1 0.0 
FbaA Fructose-bisphosphate aldolase class 2 P0AB71 39351 5.52 80 2.3E-04 25% 0.90 1.22 0.88 1.52 0.80 0.86 0.0 0.2 0.1 0.8 0.1 0.4 0.4 
FbaB Fructose-bisphosphate aldolase class 1 P0A991 38313 6.25 59 2.8E-02 29% 0.031 0.030 0.00 0.06 0.00 0.12 >5 >5 >5 >5 >5 >5 0.0 
TpiA Triosephosphate isomerase C2DNX7 26392 5.41 95 2.5E-05 44% 0.25 0.32 0.19 0.42 0.23 0.36 0.4 0.1 0.3 1.1 0.6 0.9 0.4 
                     
Sub-group: Lower glycolysis (to Acetyl-CoA) (11 proteins) Total WCPM: 4.20 6.06 7.08 9.44 7.01 5.73 -0.8 -0.7 -0.7 0.4 -0.3 0.1 0.5 
                     
GapA 
Glyceraldehyde-3-phosphate dehydrogenase 
A 
P0A9B2 35681 6.61 58 3.8E-02 22% 0.66 0.91 0.89 1.30 0.98 1.26 -0.4 -0.6 -0.5 0.5 0.4 0.5 0.5 
Pgk Phosphoglycerate kinase P0A799 41264 5.08 231 6.6E-19 66% 0.71 0.98 0.75 1.08 0.77 0.75 -0.1 -0.1 -0.1 0.5 0.0 0.2 0.5 
GpmA Phosphoglyceromutase P62709 28539 5.85 64 3.6E-02 37% 0.25 0.34 0.42 0.73 0.31 0.52 -0.7 -0.3 -0.5 0.8 0.7 0.8 0.4 
Eno Enolase C6EJ93 45683 5.32 166 2.1E-12 47% 0.35 0.70 0.52 0.91 0.67 0.51 -0.6 -0.9 -0.8 0.8 -0.4 0.2 1.0 
PykA Pyruvate kinase Q1RAT0 57338 6.78 135 2.7E-09 32% 0.11 0.08 0.09 0.14 0.08 0.10 0.3 0.5 0.4 0.6 0.3 0.5 -0.5 
PykF Pyruvate kinase I P0AD61 50675 5.77 89 1.1E-04 32% 0.19 0.24 0.35 0.29 0.31 0.22 -0.9 -0.7 -0.8 -0.3 -0.5 -0.4 0.3 
PpsA Phosphoenolpyruvate synthase Q8FH33 87798 4.93 126 2.1E-08 19% 0.06 0.08 0.07 0.15 0.14 0.22 -0.2 -1.2 -0.7 1.1 0.7 0.9 0.4 
YdbK 
Pyruvate flavodoxin/ferredoxin 
oxidoreductase domain protein 
A7ZZU0 129871 5.51 76 2.0E-03 14% 0.042 0.041 0.044 0.043 0.05 0.06 -0.1 -0.3 -0.2 0.0 0.3 0.1 0.0 
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Suppl. Table 5.3.1 Proteome data of E. coli BL21 (DE3) growing in different media 
Name1 Protein name1 Uniprot ID1 
Molecular 
mass2 
(Da) 
Calculated 
pI value2 
Mascot 
score2 
Expect2 
Mascot 
seq. 
cover.2 
Defind medium Complex medium 
Log2 
(DNB 
/TB) 
Log2 
(DNB 
/LB) 
Log2 
(defined/ 
complex) 
Log2(stationary phase 
/exp. phase) DNB medium TB medium LB medium 
exp. stationary exp. stationary exp. stationary 
in 
TB 
medium 
in 
LB 
medium 
in 
complex 
media 
in 
defined 
medium 
phase phase phase phase phase phase 
Whole Cell Protein Mass (WCPM) - % At exp. phase 
AceE 
Pyruvate dehydrogenase (acetyl-transferring), 
homodimeric type 
B3XKK6 99978 5.46 179 1.1E-13 28% 0.77 1.32 2.01 2.25 2.13 0.81 -1.4 -1.5 -1.4 0.2 -1.4 -0.6 0.8 
AceF 
Pyruvate dehydrogenase, 
dihydrolipoyltransacetylase component E2 
P06959 66112 5.09 156 2.1E-11 32% 0.32 0.52 0.94 0.86 0.63 0.31 -1.6 -1.0 -1.3 -0.1 -1.0 -0.6 0.7 
LpdA Dihydrolipoamide dehydrogenase P0A9P2 50942 5.79 85 2.9E-04 25% 0.74 0.86 1.01 1.68 0.93 0.97 -0.4 -0.3 -0.4 0.7 0.1 0.4 0.2 
                     
Sub-group: Glycerol metabolism (2 proteins) Total WCPM: 0.09 0.20 0.16 1.06 0.17 0.37 -0.8 -0.9 -0.9 2.7 1.1 1.9 1.1 
                     
GlpK Glycerol kinase C5A093 56480 5.36 129 2.9E-09 28% 0.07 0.17 0.14 1.00 0.17 0.33 -1.0 -1.3 -1.1 2.8 1.0 1.9 1.3 
Dhak Dihydroxyacetone kinase subunit DhaK A7ZZD5 38620 4.82 104 3.4E-06 44% 0.019 0.026 0.015 0.06 0.00 0.044 0.3 >5 >2.7 2.0 >5 >3.6 0.5 
                     
Sub-group: Pentose phosphate pathway (PPP) (6 proteins) Total WCPM: 1.00 1.14 1.29 1.56 1.31 1.63 -0.4 -0.4 -0.4 0.3 0.3 0.3 0.2 
                     
Gnd 6-Phosphogluconate dehydrogenase Q8FG44 51547 5.06 208 1.3E-16 56% 0.25 0.25 0.29 0.24 0.35 0.20 -0.2 -0.5 -0.3 -0.3 -0.8 -0.5 0.0 
TktA Transketolase P27302 72465 5.43 104 3.3E-06 22% 0.46 0.46 0.62 0.65 0.57 0.74 -0.4 -0.3 -0.4 0.1 0.4 0.2 0.0 
TktB Transketolase 2 P33570 73225 5.86 190 2.3E-15 27% 0.033 0.015 0.017 0.043 0.010 0.12 1.0 1.7 1.3 1.3 3.6 2.5 -1.1 
TalB Chain A, Structure Of Transaldolase B P0A870 35237 5.1 147 1.7E-10 59% 0.18 0.30 0.27 0.48 0.32 0.40 -0.6 -0.8 -0.7 0.8 0.3 0.6 0.7 
TalA Transaldolase A P0A867 35865 5.89 211 1.8E-17 62% 0.017 0.030 0.00 0.049 0.00 0.10 >5 >5 >5 >5 >5 >5 0.8 
Eda KHG/KDPG aldolase P0A955 22441 5.57 108 3.6E-07 49% 0.06 0.08 0.09 0.10 0.06 0.07 -0.6 0.0 -0.3 0.2 0.2 0.2 0.4 
                     
By-product metabolism (9 proteins) Total WCPM: 1.48 1.40 1.77 1.59 2.69 2.27 -0.3 -0.9 -0.6 -0.2 -0.2 -0.2 -0.1 
                     
Acs Acetyl-coenzyme A synthetase Q8FAY8 72321 5.5 100 9.5E-06 23% 0.09 0.11 0.07 0.13 0.06 0.59 0.4 0.6 0.5 0.9 3.3 2.1 0.3 
PoxB Pyruvate dehydrogenase [ubiquinone] Q47520 62542 5.86 160 2.3E-12 44% 0.018 0.047 0.018 0.06 0.013 0.11 0.0 0.5 0.2 1.7 3.1 2.4 1.4 
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Suppl. Table 5.3.1 Proteome data of E. coli BL21 (DE3) growing in different media 
Name1 Protein name1 Uniprot ID1 
Molecular 
mass2 
(Da) 
Calculated 
pI value2 
Mascot 
score2 
Expect2 
Mascot 
seq. 
cover.2 
Defind medium Complex medium 
Log2 
(DNB 
/TB) 
Log2 
(DNB 
/LB) 
Log2 
(defined/ 
complex) 
Log2(stationary phase 
/exp. phase) DNB medium TB medium LB medium 
exp. stationary exp. stationary exp. stationary 
in 
TB 
medium 
in 
LB 
medium 
in 
complex 
media 
in 
defined 
medium 
phase phase phase phase phase phase 
Whole Cell Protein Mass (WCPM) - % At exp. phase 
Pta Phosphate acetyltransferase P0A9M8 77466 5.28 159 1.1E-11 37% 0.13 0.15 0.35 0.21 0.31 0.14 -1.4 -1.3 -1.3 -0.7 -1.1 -0.9 0.2 
AckA Acetate kinase P0A6A3 43605 5.85 64 1.0E-02 18% 0.11 0.11 0.37 0.13 0.32 0.18 -1.8 -1.5 -1.6 -1.5 -0.8 -1.2 0.0 
AdhE 
Bifunctional acetaldehyde-CoA/alcohol 
dehydrogenase 
P0A9Q8 96580 6.32 192 5.3E-15 26% 0.48 0.36 0.29 0.33 1.15 0.36 0.7 -1.3 -0.3 0.2 -1.7 -0.7 -0.4 
PflB Formate acetyltransferase 1 P09373 85588 5.69 91 1.7E-05 20% 0.52 0.48 0.56 0.46 0.70 0.66 -0.1 -0.4 -0.3 -0.3 -0.1 -0.2 -0.1 
LldD L-Lactate dehydrogenase A7ZTF9 42902 6.33 107 1.1E-05 22% 0.06 0.06 0.06 0.06 0.06 0.09 0.0 0.0 0.0 0.0 0.6 0.3 0.0 
Dld D-Lactate dehydrogenase Q8FFW1 66546 6.39 106 2.1E-06 15% 0.043 0.031 0.024 0.06 0.035 0.042 0.8 0.3 0.6 1.3 0.3 0.8 -0.5 
LdhA D-Lactate dehydrogenase P52643 36854 5.29 115 7.2E-08 33% 0.029 0.05 0.031 0.15 0.043 0.10 -0.1 -0.6 -0.3 2.3 1.2 1.7 0.8 
                     
TCA cycle (14 proteins) Total WCPM: 6.94 5.89 3.45 8.55 4.16 9.49 1.0 0.7 0.9 1.3 1.2 1.2 -0.2 
                     
GltA Citrate synthase P0ABH7 48383 6.21 142 5.3E-10 36% 1.20 0.99 0.32 1.12 0.32 1.53 1.9 1.9 1.9 1.8 2.3 2.0 -0.3 
AcnA Aconitate hydratase 1 P25516 97985 5.59 219 1.1E-17 35% 0.17 0.33 0.17 0.52 0.19 0.62 0.0 -0.2 -0.1 1.6 1.7 1.7 1.0 
AcnB Aconitate hydratase 2 B1LGR9 91078 5.22 213 4.2E-17 46% 0.82 0.65 0.49 1.09 0.67 1.15 0.7 0.3 0.5 1.2 0.8 1.0 -0.3 
Icd Isocitrate dehydrogenase Q7WV51 43029 5.18 197 1.7E-15 55% 1.00 0.94 0.69 1.14 0.64 1.43 0.5 0.6 0.6 0.7 1.2 0.9 -0.1 
SucA 2-Oxoglutarate dehydrogenase E1 component P0AFG5 105566 6.04 99 1.0E-05 14% 0.57 0.30 0.31 0.73 0.59 0.62 0.9 0.0 0.4 1.2 0.1 0.7 -0.9 
SucB Dihydrolipoamide succinyltransferase A7ZXY7 44014 5.58 127 1.7E-08 38% 0.64 0.40 0.42 0.90 0.60 0.71 0.6 0.1 0.4 1.1 0.2 0.7 -0.7 
SucC Succinyl-CoA synthetase subunit beta P0A838 41652 5.37 256 2.1E-21 55% 0.56 0.52 0.28 0.79 0.29 0.70 1.0 0.9 1.0 1.5 1.3 1.4 -0.1 
SucD 
Succinyl-CoA ligase [ADP-forming] subunit 
alpha 
P0AGE9 29913 6.31 152 5.3E-11 60% 0.47 0.42 0.17 0.61 0.25 0.61 1.5 0.9 1.2 1.8 1.3 1.6 -0.2 
SdhA Succinate dehydrogenase flavoprotein subunit P0AC43 65008 5.85 108 1.3E-06 27% 0.60 0.37 0.24 0.62 0.26 0.63 1.3 1.2 1.3 1.4 1.3 1.3 -0.7 
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Suppl. Table 5.3.1 Proteome data of E. coli BL21 (DE3) growing in different media 
Name1 Protein name1 Uniprot ID1 
Molecular 
mass2 
(Da) 
Calculated 
pI value2 
Mascot 
score2 
Expect2 
Mascot 
seq. 
cover.2 
Defind medium Complex medium 
Log2 
(DNB 
/TB) 
Log2 
(DNB 
/LB) 
Log2 
(defined/ 
complex) 
Log2(stationary phase 
/exp. phase) DNB medium TB medium LB medium 
exp. stationary exp. stationary exp. stationary 
in 
TB 
medium 
in 
LB 
medium 
in 
complex 
media 
in 
defined 
medium 
phase phase phase phase phase phase 
Whole Cell Protein Mass (WCPM) - % At exp. phase 
SdhB 
Succinate dehydrogenase and fumarate 
reductase iron-sulfur protein 
Q8X9A8 27335 6.81 102 5.3E-06 34% 0.15 0.13 0.07 0.16 0.10 0.18 1.1 0.6 0.8 1.2 0.8 1.0 -0.2 
FumA 
Fumarate hydratase (fumarase A), aerobic 
Class I 
P0AC33 60774 6.11 116 2.1E-07 26% 0.06 0.038 0.028 0.08 0.021 0.12 1.1 1.5 1.3 1.5 2.5 2.0 -0.7 
FumC 
Fumarate hydratase (fumarase C), aerobic 
Class II 
P05042 50856 6.12 127 1.7E-08 29% 0.14 0.10 0.05 0.13 0.06 0.26 1.5 1.2 1.4 1.4 2.1 1.7 -0.5 
Mdh Malate dehydrogenase P61891 32488 5.61 79 1.0E-03 50% 0.51 0.63 0.13 0.62 0.10 0.76 2.0 2.4 2.2 2.3 2.9 2.6 0.3 
GlcB Malate synthase G P37330 80780 5.79 222 1.4E-18 37% 0.05 0.07 0.08 0.043 0.07 0.17 -0.7 -0.5 -0.6 -0.9 1.3 0.2 0.5 
                     
Connection between glycolysis and TCA cycle (4 proteins) Total WCPM: 0.74 0.86 0.56 0.89 0.43 0.82 0.4 0.8 0.6 0.7 0.9 0.8 0.2 
                     
Ppc Phosphoenolpyruvate carboxylase Q8FB98 99470 5.52 93 3.9E-05 21% 0.43 0.50 0.29 0.22 0.28 0.21 0.6 0.6 0.6 -0.4 -0.4 -0.4 0.2 
PckA Phosphoenolpyruvate carboxykinase P22259 59891 5.46 133 4.2E-09 33% 0.15 0.25 0.14 0.54 0.07 0.45 0.1 1.1 0.6 1.9 2.7 2.3 0.7 
MaeB 
Malate dehydrogenase (Oxaloacetate-
decarboxylating) (NADP(+)) 
A8A2V3 82908 5.34 185 2.7E-14 46% 0.12 0.07 0.08 0.09 0.045 0.13 0.6 1.4 1.0 0.2 1.5 0.9 -0.8 
SfcA NAD-dependent malic enzyme A7ZLS1 63481 5.19 88 3.2E-05 24% 0.042 0.041 0.05 0.040 0.030 0.029 -0.3 0.5 0.1 -0.3 0.0 -0.2 0.0 
                     
Oxidative phosphorylation (7 proteins) Total WCPM: 2.54 2.50 2.25 2.72 2.74 2.41 0.2 -0.1 0.0 0.3 -0.2 0.0 0.0 
                     
AtpA F0F1 ATP synthase subunit alpha P0ABB2 55416 5.8 128 1.3E-08 33% 1.19 1.23 1.02 1.33 1.21 1.09 0.2 0.0 0.1 0.4 -0.2 0.1 0.0 
AtpD F0F1 ATP synthase subunit beta P0ABB6 50351 4.9 113 4.2E-07 48% 0.47 0.62 0.61 0.67 0.66 0.57 -0.4 -0.5 -0.4 0.1 -0.2 0.0 0.4 
AtpH F0F1 ATP synthase subunit delta P0ABA5 19434 4.94 81 6.8E-04 41% 0.06 0.10 0.07 0.06 0.08 0.06 -0.2 -0.4 -0.3 -0.2 -0.4 -0.3 0.7 
NuoF NADH dehydrogenase I subunit F Q8XCX1 49802 6.44 117 1.7E-07 33% 0.18 0.11 0.12 0.14 0.18 0.16 0.6 0.0 0.3 0.2 -0.2 0.0 -0.7 
NuoG NADH dehydrogenase subunit G A8A2F2 101129 5.83 200 8.4E-16 35% 0.33 0.23 0.20 0.27 0.32 0.26 0.7 0.0 0.4 0.4 -0.3 0.1 -0.5 
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Suppl. Table 5.3.1 Proteome data of E. coli BL21 (DE3) growing in different media 
Name1 Protein name1 Uniprot ID1 
Molecular 
mass2 
(Da) 
Calculated 
pI value2 
Mascot 
score2 
Expect2 
Mascot 
seq. 
cover.2 
Defind medium Complex medium 
Log2 
(DNB 
/TB) 
Log2 
(DNB 
/LB) 
Log2 
(defined/ 
complex) 
Log2(stationary phase 
/exp. phase) DNB medium TB medium LB medium 
exp. stationary exp. stationary exp. stationary 
in 
TB 
medium 
in 
LB 
medium 
in 
complex 
media 
in 
defined 
medium 
phase phase phase phase phase phase 
Whole Cell Protein Mass (WCPM) - % At exp. phase 
NuoC 
Bifunctional NADH:ubiquinone 
oxidoreductase subunit C/D 
Q0TFG0 68451 5.98 64 3.1E-02 16% 0.21 0.13 0.15 0.16 0.18 0.18 0.5 0.2 0.4 0.1 0.0 0.0 -0.7 
NuoB NADH-quinone oxidoreductase subunit B C4ZUD0 25325 5.58 74 8.7E-04 36% 0.10 0.08 0.08 0.09 0.11 0.09 0.3 -0.1 0.1 0.2 -0.3 -0.1 -0.3 
                     
Amino acid biosynthesis and metabolism (68 proteins): Amino acid biosynthesis and amino acid 
degradation 
Total WCPM: 18.08 18.27 5.95 8.60 6.09 10.03 1.6 1.6 1.6 0.5 0.7 0.6 0.0 
                     
Sub-group: Amino acid biosynthesis (57 proteins) Total WCPM: 17.80 17.29 5.25 6.39 5.17 6.82 1.7 1.7 1.7 0.3 0.4 0.3 0.0 
                     
AroD 3-Dehydroquinate dehydratase A8A0N9 27459 5.3 68 3.8E-03 44% 0.08 0.12 0.043 0.05 0.047 0.044 0.9 0.8 0.8 0.2 -0.1 0.1 0.6 
AroB 3-Dehydroquinate synthase C4ZUP4 39141 5.72 91 1.7E-05 37% 0.024 0.028 0.021 0.027 0.00 0.028 0.2 >5 >2.56 0.4 >5 >2.7 0.2 
AroF 
Phospho-2-dehydro-3-deoxyheptonate 
aldolase 
Q3YYP3 39079 5.42 131 6.7E-09 35% 0.13 0.14 0.08 0.18 0.09 0.25 0.7 0.5 0.6 1.2 1.5 1.3 0.1 
AroG 
Phospho-2-dehydro-3-deoxyheptonate 
aldolase, Phe-sensitive 
P0AB91 38385 6.14 131 1.8E-09 53% 0.26 0.17 0.08 0.11 0.09 0.14 1.7 1.5 1.6 0.5 0.6 0.5 -0.6 
TrpD Anthranilate synthase, component II B3HP12 57176 6.26 157 1.7E-11 37% 0.13 0.10 0.002 0.002 0.002 0.038 6.0 6.0 6.0 0.0 4.2 2.1 -0.4 
TrpE Component I of anthranilate synthase P00895 58142 5.32 138 1.3E-09 30% 0.22 0.13 0.045 0.00 0.06 0.022 2.3 1.9 2.1 <-5 -1.4 <-3.2 -0.8 
TrpC Anthranilate isomerase C5W377 49774 5.43 191 6.7E-15 56% 0.11 0.10 0.11 0.11 0.11 0.07 0.0 0.0 0.0 0.0 -0.7 -0.3 -0.1 
TrpA Tryptophan synthase alpha chain B7L492 28905 5.31 107 4.6E-07 38% 0.12 0.16 0.026 0.026 0.027 0.031 2.2 2.2 2.2 0.0 0.2 0.1 0.4 
PheA P-protein P0A9J8 43312 6.21 154 9.1E-12 40% 0.08 0.05 0.037 0.028 0.046 0.028 1.1 0.8 1.0 -0.4 -0.7 -0.6 -0.7 
TyrA T-protein P07023 42187 5.68 165 7.2E-13 47% 0.11 0.10 0.028 0.046 0.028 0.06 2.0 2.0 2.0 0.7 1.1 0.9 -0.1 
AspC Aspartate aminotransferase, PLP-dependent P00509 43831 5.54 151 6.7E-11 46% 0.23 0.24 0.12 0.24 0.11 0.19 0.9 1.1 1.0 1.0 0.8 0.9 0.1 
SerA D-3-Phosphoglycerate dehydrogenase P0A9T2 44376 5.92 100 8.3E-06 32% 0.81 0.75 0.16 0.20 0.19 0.59 2.3 2.1 2.2 0.3 1.6 1.0 -0.1 
SerC Phosphoserine aminotransferase Q8FJB7 39974 5.36 169 1.1E-10 41% 0.46 0.43 0.18 0.16 0.17 0.22 1.4 1.4 1.4 -0.2 0.4 0.1 -0.1 
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Suppl. Table 5.3.1 Proteome data of E. coli BL21 (DE3) growing in different media 
Name1 Protein name1 Uniprot ID1 
Molecular 
mass2 
(Da) 
Calculated 
pI value2 
Mascot 
score2 
Expect2 
Mascot 
seq. 
cover.2 
Defind medium Complex medium 
Log2 
(DNB 
/TB) 
Log2 
(DNB 
/LB) 
Log2 
(defined/ 
complex) 
Log2(stationary phase 
/exp. phase) DNB medium TB medium LB medium 
exp. stationary exp. stationary exp. stationary 
in 
TB 
medium 
in 
LB 
medium 
in 
complex 
media 
in 
defined 
medium 
phase phase phase phase phase phase 
Whole Cell Protein Mass (WCPM) - % At exp. phase 
GdhA Glutamate dehydrogenase, NADP-specific P00370 48778 5.98 179 1.1E-13 52% 0.13 0.17 0.020 0.041 0.029 0.048 2.7 2.2 2.4 1.0 0.7 0.9 0.4 
GlnA Glutamine synthetase P0A9C7 52099 5.26 70 2.1E-03 15% 0.57 0.86 0.25 0.24 0.20 0.23 1.2 1.5 1.3 -0.1 0.2 0.1 0.6 
GltB Glutamate synthase subunit alpha A8A527 164335 6.15 111 6.7E-07 15% 0.09 0.10 0.002 0.002 0.002 0.002 5.5 5.5 5.5 0.0 0.0 0.0 0.2 
HisG ATP phosphoribosyltransferase Q8X8T4 33615 5.59 104 9.1E-07 38% 0.14 0.11 0.11 0.08 0.08 0.09 0.3 0.8 0.6 -0.5 0.2 -0.1 -0.3 
HisF 
Imidazole glycerol phosphate synthase 
subunit hisF 
C4ZSB4 28722 5.03 80 2.5E-04 38% 0.09 0.13 0.14 0.12 0.09 0.10 -0.6 0.0 -0.3 -0.2 0.2 0.0 0.5 
HisC Histidinol-phosphate aminotransferase B7NQG9 39907 5 144 9.1E-11 51% 0.08 0.09 0.036 0.047 0.00 0.033 1.2 >5 >3.1 0.4 >5 >2.7 0.2 
HisD Histidinol dehydrogenase A1ACN2 46939 5.13 125 2.7E-08 34% 0.038 0.040 0.029 0.026 0.00 0.014 0.4 >5 >2.7 -0.2 >5 >2.4 0.1 
GlyA Serine hydroxymethyltransferase P0A825 45459 6.03 138 1.3E-09 42% 0.74 0.80 0.32 0.53 0.36 0.55 1.2 1.0 1.1 0.7 0.6 0.7 0.1 
CysK Cysteine synthase A P0ABK5 34525 5.83 176 5.7E-14 60% 0.63 0.84 0.24 0.56 0.12 0.37 1.4 2.4 1.9 1.2 1.6 1.4 0.4 
CysN Sulfate adenylyltransferase, subunit 1 P23845 52640 4.98 120 8.4E-08 22% 0.10 0.042 0.022 0.00 0.019 0.00 2.2 2.4 2.3 <-5 <-5 <-5 -1.3 
CysJ Sulfite reductase subunit alpha A8A3P5 66415 4.92 161 6.6E-12 33% 0.07 0.07 0.014 0.017 0.032 0.012 2.3 1.1 1.7 0.3 -1.4 -0.6 0.0 
CysI Sulfite reductase subunit beta Q8X7U2 64262 7.27 79 9.9E-04 21% 0.07 0.030 0.00 0.00 0.00 0.00 >5 >5 >5 0.0 0.0 0.0 -1.2 
LysC Aspartokinase III P08660 48787 5.03 237 1.7E-19 62% 0.05 0.08 0.015 0.022 0.00 0.00 1.7 >5 >3.4 0.6 0.0 0.3 0.7 
Asd Maltose-binding periplasmic protein P0A9R0 43360 5.53 155 5.9E-12 42% 0.36 0.57 0.33 0.45 0.16 0.36 0.1 1.2 0.6 0.4 1.2 0.8 0.7 
DapA Dihydrodipicolinate synthase A7ZPS4 31549 5.98 119 2.9E-08 42% 0.14 0.10 0.08 0.10 0.10 0.14 0.8 0.5 0.6 0.3 0.5 0.4 -0.5 
DapD 
2,3,4,5-Tetrahydropyridine-2-carboxylate N-
succinyltransferase 
P0A9D8 30045 5.56 169 1.0E-12 63% 0.30 0.34 0.20 0.16 0.16 0.15 0.6 0.9 0.7 -0.3 -0.1 -0.2 0.2 
LysA Diaminopimelate decarboxylase P00861 46377 5.63 106 1.3E-05 45% 0.11 0.11 0.12 0.29 0.12 0.16 -0.1 -0.1 -0.1 1.3 0.4 0.8 0.0 
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Suppl. Table 5.3.1 Proteome data of E. coli BL21 (DE3) growing in different media 
Name1 Protein name1 Uniprot ID1 
Molecular 
mass2 
(Da) 
Calculated 
pI value2 
Mascot 
score2 
Expect2 
Mascot 
seq. 
cover.2 
Defind medium Complex medium 
Log2 
(DNB 
/TB) 
Log2 
(DNB 
/LB) 
Log2 
(defined/ 
complex) 
Log2(stationary phase 
/exp. phase) DNB medium TB medium LB medium 
exp. stationary exp. stationary exp. stationary 
in 
TB 
medium 
in 
LB 
medium 
in 
complex 
media 
in 
defined 
medium 
phase phase phase phase phase phase 
Whole Cell Protein Mass (WCPM) - % At exp. phase 
ThrB Homoserine kinase A7ZH92 34101 5.44 90 2.3E-05 34% 0.07 0.07 0.032 0.07 0.016 0.05 1.1 2.1 1.6 1.1 1.6 1.4 0.0 
MetA Homoserine O-succinyltransferase C5A0V0 35819 5.06 106 5.7E-07 35% 0.05 0.07 0.024 0.00 0.00 0.048 1.1 >5 >3.1 <-5 >5 - 0.5 
MetH Methionine synthase B3XC96 136639 4.97 291 6.7E-25 38% 0.07 0.06 0.027 0.030 0.028 0.014 1.4 1.3 1.3 0.2 -1.0 -0.4 -0.2 
MetE 
5-Methyltetrahydropteroyltriglutamate-
homocysteine S-methyltransferase 
B3XGD6 85074 5.61 107 1.7E-06 31% 3.38 3.65 0.08 0.22 0.12 0.10 5.4 4.8 5.1 1.5 -0.3 0.6 0.1 
IlvA Threonine dehydratase biosynthetic P04968 56559 5.57 213 2.7E-16 48% 0.26 0.19 0.08 0.13 0.05 0.16 1.7 2.4 2.0 0.7 1.7 1.2 -0.5 
IlvB Acetolactate synthase I, large subunit P08142 60915 5.3 85 2.4E-04 24% 0.10 0.049 0.00 0.044 0.010 0.05 >5 3.3 >4.1 >5 2.3 >3.7 -1.0 
IlvC 
Ketol-acid reductoisomerase, NAD(P)-
binding 
P05793 54376 5.2 233 4.2E-19 54% 2.69 2.79 0.17 0.19 0.14 0.08 4.0 4.3 4.1 0.2 -0.8 -0.3 0.1 
IlvD Dihydroxyacid dehydratase P05791 66174 5.59 235 2.6E-19 41% 0.55 0.35 0.09 0.07 0.06 0.06 2.6 3.2 2.9 -0.4 0.0 -0.2 -0.7 
IlvE 
Chain A, Branched-Chain Amino Acid 
Aminotransferase 
P0AB80 34112 5.54 108 1.3E-06 44% 0.51 0.40 0.06 0.14 0.044 0.20 3.1 3.5 3.3 1.2 2.2 1.7 -0.4 
IlvI Acetolactate synthase isozyme 3 large subunit P00893 63286 5.88 81 4.3E-03 25% 0.06 0.042 0.043 0.027 0.044 0.06 0.5 0.4 0.5 -0.7 0.4 -0.1 -0.5 
LeuA 2-Isopropylmalate synthase P09151 57604 5.47 98 1.4E-05 22% 0.08 0.09 0.00 0.00 0.00 0.00 >5 >5 >5 0.0 0.0 0.0 0.2 
LeuB 3-Isopropylmalate dehydrogenase P30125 39834 5.14 72 5.6E-03 27% 0.14 0.16 0.16 0.13 0.09 0.11 -0.2 0.6 0.2 -0.3 0.3 0.0 0.2 
LeuC Isopropylmalate isomerase large subunit A7ZW23 50377 5.9 162 5.3E-12 42% 0.19 0.13 0.00 0.00 0.00 0.020 >5 >5 >5 0.0 >5 >2.5 -0.5 
LeuD 3-Isopropylmalate isomerase subunit P30126 22587 5.16 128 1.3E-08 56% 0.08 0.05 0.00 0.00 0.00 0.00 >5 >5 >5 0.0 0.0 0.0 -0.7 
AsnA Aspartate--ammonia ligase B1LL71 36770 5.55 89 1.1E-04 33% 0.06 0.11 0.023 0.07 0.041 0.14 1.4 0.5 1.0 1.6 1.8 1.7 0.9 
AsnB Asparagine synthase B3ISY7 63075 5.55 84 3.4E-04 27% 0.09 0.12 0.036 0.05 0.042 0.08 1.3 1.1 1.2 0.5 0.9 0.7 0.4 
CarA Carbamoyl phosphate synthase small subunit B7NHD6 41677 5.91 107 1.7E-06 39% 0.21 0.15 0.08 0.041 0.16 0.10 1.4 0.4 0.9 -1.0 -0.7 -0.8 -0.5 
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Suppl. Table 5.3.1 Proteome data of E. coli BL21 (DE3) growing in different media 
Name1 Protein name1 Uniprot ID1 
Molecular 
mass2 
(Da) 
Calculated 
pI value2 
Mascot 
score2 
Expect2 
Mascot 
seq. 
cover.2 
Defind medium Complex medium 
Log2 
(DNB 
/TB) 
Log2 
(DNB 
/LB) 
Log2 
(defined/ 
complex) 
Log2(stationary phase 
/exp. phase) DNB medium TB medium LB medium 
exp. stationary exp. stationary exp. stationary 
in 
TB 
medium 
in 
LB 
medium 
in 
complex 
media 
in 
defined 
medium 
phase phase phase phase phase phase 
Whole Cell Protein Mass (WCPM) - % At exp. phase 
CarB Carbamoyl phosphate synthase large subunit B7MNN9 118633 5.22 103 4.2E-06 14% 0.47 0.35 0.15 0.12 0.32 0.18 1.6 0.6 1.1 -0.3 -0.8 -0.6 -0.4 
ArgC 
N-Acetyl-gamma-glutamyl-phosphate 
reductase 
B1LNR8 36328 5.58 105 2.7E-06 33% 0.08 0.08 0.040 0.035 0.05 0.046 1.0 0.7 0.8 -0.2 -0.1 -0.2 0.0 
ArgD 
Acetylornithine/succinyldiaminopimelate 
aminotransferase 
P18335 44081 5.79 141 6.6E-10 60% 0.29 0.32 0.18 0.19 0.18 0.17 0.7 0.7 0.7 0.1 -0.1 0.0 0.1 
ArgE Acetylornithine deacetylase C5A0C3 42777 5.54 99 3.0E-06 37% 0.06 0.041 0.07 0.05 0.047 0.08 -0.2 0.4 0.1 -0.5 0.8 0.1 -0.5 
ArgI Ornithine carbamoyltransferase chain I P04391 37112 5.46 93 1.2E-05 35% 0.05 0.07 0.033 0.022 0.039 0.040 0.6 0.4 0.5 -0.6 0.0 -0.3 0.5 
ArgG Argininosuccinate synthase B1XGY3 50038 5.23 143 2.6E-09 35% 0.26 0.29 0.12 0.09 0.17 0.13 1.1 0.6 0.9 -0.4 -0.4 -0.4 0.2 
ArgH Argininosuccinate lyase P11447 50686 5.11 128 1.3E-08 38% 0.13 0.17 0.15 0.11 0.20 0.10 -0.2 -0.6 -0.4 -0.4 -1.0 -0.7 0.4 
AspA Aspartate ammonia-lyase P0AC38 52950 5.19 135 7.2E-10 29% 0.35 0.33 0.24 0.52 0.28 0.54 0.5 0.3 0.4 1.1 0.9 1.0 -0.1 
ProA Gamma-glutamyl phosphate reductase B3XF57 45031 5.42 205 2.7E-16 52% 0.049 0.037 0.06 0.040 0.05 0.046 -0.3 0.0 -0.2 -0.6 -0.1 -0.4 -0.4 
IscS 
(Yfho) 
Cysteine desulfurase C4ZXA5 45232 5.94 127 4.6E-09 57% 0.38 0.12 0.44 0.14 0.55 0.25 -0.2 -0.5 -0.4 -1.7 -1.1 -1.4 -1.7 
                     
Sub-group: Amino acid degradation (11 proteins) Total WCPM: 0.90 0.98 0.70 2.21 0.92 3.20 0.4 0.0 0.2 1.7 1.8 1.7 0.1 
                     
DadX Alanine racemase, catabolic P29012 39048 6.56 60 2.6E-02 31% 0.042 0.044 0.029 0.038 0.031 0.05 0.5 0.4 0.5 0.4 0.7 0.5 0.1 
TnaA Tryptophanase B1LL35 53107 5.88 97 4.8E-06 20% 0.11 0.11 0.10 1.11 0.15 1.92 0.1 -0.4 -0.2 3.5 3.7 3.6 0.0 
MetF 5,10-Methylenetetrahydrofolate reductase P0AEZ1 33253 6 169 1.0E-12 69% 0.11 0.11 0.00 0.041 0.00 0.031 >5 >5 >5 >5 >5 >5 0.0 
MetK Chain A, S-Adenosylmethionine Synthetase P0A817 42022 5.1 155 2.6E-11 61% 0.35 0.37 0.24 0.23 0.25 0.17 0.5 0.5 0.5 -0.1 -0.6 -0.3 0.1 
GcvT Glycine cleavage system T protein B2ND95 40251 5.36 88 1.3E-04 34% 0.10 0.08 0.00 0.00 0.00 0.00 >5 >5 >5 0.0 0.0 0.0 -0.3 
AstA Arginine N-succinyltransferase C4ZZA3 38831 6.02 172 1.4E-13 58% 0.024 0.038 0.00 0.00 0.00 0.10 >5 >5 >5 0.0 >5 >2.5 0.7 
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Suppl. Table 5.3.1 Proteome data of E. coli BL21 (DE3) growing in different media 
Name1 Protein name1 Uniprot ID1 
Molecular 
mass2 
(Da) 
Calculated 
pI value2 
Mascot 
score2 
Expect2 
Mascot 
seq. 
cover.2 
Defind medium Complex medium 
Log2 
(DNB 
/TB) 
Log2 
(DNB 
/LB) 
Log2 
(defined/ 
complex) 
Log2(stationary phase 
/exp. phase) DNB medium TB medium LB medium 
exp. stationary exp. stationary exp. stationary 
in 
TB 
medium 
in 
LB 
medium 
in 
complex 
media 
in 
defined 
medium 
phase phase phase phase phase phase 
Whole Cell Protein Mass (WCPM) - % At exp. phase 
AstB N-Succinylarginine dihydrolase C4ZZA1 49439 5.74 116 5.7E-08 41% 0.027 0.040 0.026 0.037 0.026 0.09 0.1 0.1 0.1 0.5 1.8 1.2 0.6 
AstD 
N-Succinylglutamate 5-semialdehyde 
dehydrogenase 
C4ZZA2 53278 5.69 85 6.8E-05 29% 0.010 0.017 0.038 0.040 0.044 0.12 -1.9 -2.1 -2.0 0.1 1.4 0.8 0.8 
Tdh L-threonine 3-dehydrogenase C4ZXK8 37557 5.94 126 5.7E-09 56% 0.00 0.033 0.00 0.18 0.11 0.16 0.0 <-5 <-2.5 >5 0.5 >2.8 >5 
Kbl 2-Amino-3-ketobutyrate coenzyme A ligase A8A682 43360 5.74 132 5.3E-09 45% 0.11 0.13 0.20 0.42 0.25 0.46 -0.9 -1.2 -1.0 1.1 0.9 1.0 0.2 
PutA Bifunctional protein putA P09546 144467 5.69 148 3.6E-11 13% 0.020 0.011 0.07 0.11 0.06 0.10 -1.8 -1.6 -1.7 0.7 0.7 0.7 -0.9 
                     
IMP biosynthesis (for nucleotide) (7 proteins) Total WCPM: 1.19 1.36 0.41 0.51 0.39 0.61 1.5 1.6 1.6 0.3 0.6 0.5 0.2 
                     
PurF Amidophosphoribosyltransferase P0AG16 56852 5.33 82 4.7E-04 22% 0.06 0.031 0.025 0.024 0.014 0.016 1.3 2.1 1.7 -0.1 0.2 0.1 -1.0 
PurD Phosphoribosylamine--glycine ligase A7ZUM2 46326 4.89 80 8.9E-04 36% 0.15 0.24 0.07 0.11 0.06 0.07 1.1 1.3 1.2 0.7 0.2 0.4 0.7 
PurT 
Phosphoribosylglycinamide formyltransferase 
2 
C4ZZK6 42692 5.48 178 3.6E-14 46% 0.09 0.11 0.05 0.22 0.00 0.20 0.8 >5 >3 2.1 >5 >3.6 0.3 
PurL 
Phosphoribosylformyl-glycineamide 
synthetase 
B3Y153 142036 5.23 149 1.0E-10 24% 0.34 0.36 0.022 0.015 0.06 0.11 3.9 2.5 3.2 -0.6 0.9 0.2 0.1 
PurC 
Phosphoribosylaminoimidazole-
succinocarboxamide synthase 
A7ZPS1 27149 5.07 136 5.7E-10 51% 0.09 0.20 0.023 0.034 0.034 0.07 2.0 1.4 1.7 0.6 1.0 0.8 1.2 
PurB Adenylosuccinate lyase Q8X737 51652 5.68 173 4.2E-13 45% 0.16 0.12 0.11 0.08 0.14 0.08 0.5 0.2 0.4 -0.5 -0.8 -0.6 -0.4 
PurH Bifunctional purine biosynthesis protein PurH Q1R5X1 57747 5.53 81 6.4E-04 19% 0.30 0.30 0.11 0.026 0.08 0.06 1.4 1.9 1.7 -2.1 -0.4 -1.2 0.0 
                     
Nucleotide biosynthesis (start from IMP) (13 proteins) Total WCPM: 1.66 1.74 2.83 2.05 2.46 1.91 -0.8 -0.6 -0.7 -0.5 -0.4 -0.4 0.1 
                     
PurA Adenylosuccinate synthetase A7ZV47 47543 5.31 227 3.7E-19 65% 0.33 0.39 0.43 0.38 0.46 0.29 -0.4 -0.5 -0.4 -0.2 -0.7 -0.4 0.2 
GuaA 
GMP synthetase (glutamine 
aminotransferase) 
P04079 59041 5.24 178 1.3E-13 41% 0.15 0.19 0.19 0.10 0.16 0.08 -0.3 -0.1 -0.2 -0.9 -1.0 -1.0 0.3 
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Name1 Protein name1 Uniprot ID1 
Molecular 
mass2 
(Da) 
Calculated 
pI value2 
Mascot 
score2 
Expect2 
Mascot 
seq. 
cover.2 
Defind medium Complex medium 
Log2 
(DNB 
/TB) 
Log2 
(DNB 
/LB) 
Log2 
(defined/ 
complex) 
Log2(stationary phase 
/exp. phase) DNB medium TB medium LB medium 
exp. stationary exp. stationary exp. stationary 
in 
TB 
medium 
in 
LB 
medium 
in 
complex 
media 
in 
defined 
medium 
phase phase phase phase phase phase 
Whole Cell Protein Mass (WCPM) - % At exp. phase 
GuaB Inositol-5-monophosphate dehydrogenase P0ADG8 52275 6.02 94 3.7E-05 35% 0.17 0.13 0.25 0.12 0.25 0.08 -0.6 -0.6 -0.6 -1.1 -1.6 -1.4 -0.4 
Add Adenosine deaminase C4ZY85 36603 5.36 72 1.6E-03 40% 0.038 0.039 0.045 0.030 0.031 0.035 -0.2 0.3 0.0 -0.6 0.2 -0.2 0.0 
DeoB Phosphopentomutase C4ZT65 44684 5.11 158 3.6E-12 44% 0.05 0.08 0.13 0.10 0.07 0.06 -1.4 -0.5 -0.9 -0.4 -0.2 -0.3 0.7 
DeoD Chain A, Purine Nucleoside Phosphorylase P0ABP8 26030 5.42 130 8.3E-09 62% 0.06 0.07 0.36 0.19 0.31 0.15 -2.6 -2.4 -2.5 -0.9 -1.0 -1.0 0.2 
Hpt Hypoxanthine phosphoribosyltransferase B1LGS6 20315 5.09 76 2.0E-03 56% 0.14 0.20 0.23 0.23 0.21 0.24 -0.7 -0.6 -0.7 0.0 0.2 0.1 0.5 
Apt Adenine phosphoribosyltransferase P69503 19847 5.26 71 6.5E-03 52% 0.09 0.09 0.12 0.07 0.14 0.08 -0.4 -0.6 -0.5 -0.8 -0.8 -0.8 0.0 
                     
Udp Uridine phosphorylase Q8X8L3 27304 5.71 81 6.8E-04 54% 0.10 0.11 0.32 0.32 0.21 0.21 -1.7 -1.1 -1.4 0.0 0.0 0.0 0.1 
PyrG CTP synthase A7ZQM3 60792 5.63 74 1.0E-03 15% 0.24 0.21 0.50 0.33 0.43 0.32 -1.1 -0.8 -1.0 -0.6 -0.4 -0.5 -0.2 
Tmk Thymidylate kinase A7ZKK1 23768 5.33 65 7.6E-03 48% 0.05 0.05 0.11 0.047 0.06 0.07 -1.1 -0.3 -0.7 -1.2 0.2 -0.5 0.0 
Ndk Nucleoside diphosphate kinase C4ZX93 15511 5.54 120 2.3E-08 62% 0.14 0.14 0.11 0.08 0.08 0.24 0.3 0.8 0.6 -0.5 1.6 0.6 0.0 
Amn AMP nucleosidase P0AE13 54246 5.9 104 3.4E-06 35% 0.10 0.043 0.034 0.05 0.049 0.05 1.6 1.0 1.3 0.6 0.0 0.3 -1.2 
                     
Fatty acid biosynthesis (7 proteins) Total WCPM: 1.21 0.96 1.72 1.14 2.05 1.12 -0.5 -0.8 -0.6 -0.6 -0.9 -0.7 -0.3 
                     
AccA 
Acetyl-coenzyme A carboxylase carboxyl 
transferase subunit alpha 
A7ZHS5 35333 5.76 212 1.4E-17 57% 0.08 0.07 0.12 0.08 0.17 0.09 -0.6 -1.1 -0.8 -0.6 -0.9 -0.8 -0.2 
AccC 
Acetyl-CoA carboxylase, biotin carboxylase 
subunit 
P24182 49745 6.65 210 8.5E-17 43% 0.14 0.09 0.23 0.09 0.22 0.10 -0.7 -0.7 -0.7 -1.4 -1.1 -1.2 -0.6 
FabH 3-Oxoacyl-[acyl-carrier-protein] synthase 3 P0A6R0 33779 5.08 63 1.0E-02 19% 0.039 0.031 0.08 0.035 0.07 0.036 -1.0 -0.8 -0.9 -1.2 -1.0 -1.1 -0.3 
FabB 3-Oxoacyl-[acyl-carrier-protein] synthase I P0A953 42928 5.35 259 1.1E-21 64% 0.21 0.14 0.32 0.25 0.45 0.25 -0.6 -1.1 -0.9 -0.4 -0.8 -0.6 -0.6 
FabF 3-Oxoacyl-(acyl carrier protein) synthase II P0AAI7 43247 5.71 222 5.3E-18 71% 0.29 0.25 0.47 0.35 0.46 0.31 -0.7 -0.7 -0.7 -0.4 -0.6 -0.5 -0.2 
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Name1 Protein name1 Uniprot ID1 
Molecular 
mass2 
(Da) 
Calculated 
pI value2 
Mascot 
score2 
Expect2 
Mascot 
seq. 
cover.2 
Defind medium Complex medium 
Log2 
(DNB 
/TB) 
Log2 
(DNB 
/LB) 
Log2 
(defined/ 
complex) 
Log2(stationary phase 
/exp. phase) DNB medium TB medium LB medium 
exp. stationary exp. stationary exp. stationary 
in 
TB 
medium 
in 
LB 
medium 
in 
complex 
media 
in 
defined 
medium 
phase phase phase phase phase phase 
Whole Cell Protein Mass (WCPM) - % At exp. phase 
FabI 
Enoyl-[acyl-carrier-protein] reductase 
[NADH] FabI 
P0AEK4 28074 5.58 117 4.6E-08 51% 0.30 0.27 0.35 0.25 0.34 0.26 -0.2 -0.2 -0.2 -0.5 -0.4 -0.4 -0.2 
FabZ 
(3R)-Hydroxymyristoyl-[acyl-carrier-protein] 
dehydratase 
A7ZHS0 17136 6.84 71 4.5E-02 25% 0.15 0.11 0.15 0.08 0.34 0.07 0.0 -1.2 -0.6 -0.9 -2.3 -1.6 -0.4 
                     
Lipopolysaccharide  biosynthesis (10 proteins) Total WCPM: 0.81 0.88 1.22 1.24 0.93 0.91 -0.6 -0.2 -0.4 0.0 0.0 0.0 0.1 
                     
GmhA Phosphoheptose isomerase C2DM95 21686 5.97 142 5.3E-10 63% 0.048 0.05 0.045 0.09 0.042 0.08 0.1 0.2 0.1 1.0 0.9 1.0 0.1 
HldE Bifunctional protein hldE Q8FDH5 51232 5.29 122 5.3E-08 31% 0.045 0.048 0.06 0.06 0.06 0.06 -0.4 -0.4 -0.4 0.0 0.0 0.0 0.1 
HldD 
ADP-L-glycero-D-manno-heptose-6-
epimerase 
C4ZXL1 34985 4.8 83 1.2E-04 41% 0.15 0.25 0.17 0.21 0.09 0.16 -0.2 0.7 0.3 0.3 0.8 0.6 0.7 
                     
LpxA 
Acyl-[acyl-carrier-protein]--UDP-N-
acetylglucosamine O-acyltransferase 
C4ZRS3 28348 6.63 58 3.8E-02 32% 0.07 0.06 0.05 0.047 0.06 0.034 0.5 0.2 0.4 -0.1 -0.8 -0.5 -0.2 
ArnA 
Bifunctional polymyxin resistance protein 
ArnA 
P77398 74869 6.39 185 2.7E-14 39% 0.06 0.028 0.05 0.05 0.08 0.030 0.3 -0.4 -0.1 0.0 -1.4 -0.7 -1.1 
                     
GlmS 
Glucosamine--fructose-6-phosphate 
aminotransferase [isomerizing] 
P17169 67081 5.56 220 2.3E-18 38% 0.20 0.18 0.50 0.44 0.34 0.26 -1.3 -0.8 -1.0 -0.2 -0.4 -0.3 -0.2 
GlmM Phosphoglucosamine mutase P31120 47799 5.71 140 8.5E-10 36% 0.046 0.037 0.07 0.11 0.06 0.09 -0.6 -0.4 -0.5 0.7 0.6 0.6 -0.3 
GlmU Bifunctional protein GlmU P0ACC8 49384 6.2 116 2.1E-07 30% 0.05 0.040 0.07 0.048 0.07 0.031 -0.5 -0.5 -0.5 -0.5 -1.2 -0.9 -0.3 
RmlA Glucose-1-phosphate thymidylyltransferase P55253 32703 5.27 114 9.1E-08 48% 0.049 0.06 0.08 0.05 0.046 0.06 -0.7 0.1 -0.3 -0.7 0.4 -0.1 0.3 
RfbB dTDP-glucose 4,6-dehydratase P55293 40787 5.09 122 1.4E-08 44% 0.09 0.13 0.12 0.13 0.08 0.10 -0.4 0.2 -0.1 0.1 0.3 0.2 0.5 
                     
Synthesis of other cellular components (16 proteins) Total WCPM: 0.98 0.96 1.06 0.99 0.87 0.93 -0.1 0.2 0.0 -0.1 0.1 0.0 0.0 
                     
HemB Delta-aminolevulinic acid dehydratase B2NAC8 35962 5.25 95 2.4E-05 31% 0.07 0.13 0.12 0.13 0.13 0.07 -0.8 -0.9 -0.8 0.1 -0.9 -0.4 0.9 
HemL Glutamate-1-semialdehyde 2,1-aminomutase C4ZRP7 45907 4.73 127 4.6E-09 36% 0.05 0.05 0.07 0.06 0.05 0.041 -0.5 0.0 -0.2 -0.2 -0.3 -0.3 0.0 
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Suppl. Table 5.3.1 Proteome data of E. coli BL21 (DE3) growing in different media 
Name1 Protein name1 Uniprot ID1 
Molecular 
mass2 
(Da) 
Calculated 
pI value2 
Mascot 
score2 
Expect2 
Mascot 
seq. 
cover.2 
Defind medium Complex medium 
Log2 
(DNB 
/TB) 
Log2 
(DNB 
/LB) 
Log2 
(defined/ 
complex) 
Log2(stationary phase 
/exp. phase) DNB medium TB medium LB medium 
exp. stationary exp. stationary exp. stationary 
in 
TB 
medium 
in 
LB 
medium 
in 
complex 
media 
in 
defined 
medium 
phase phase phase phase phase phase 
Whole Cell Protein Mass (WCPM) - % At exp. phase 
IspG 
4-Hydroxy-3-methylbut-2-en-1-yl 
diphosphate synthase 
A7ZPV8 40943 5.87 146 5.7E-11 44% 0.08 0.06 0.11 0.09 0.11 0.06 -0.5 -0.5 -0.5 -0.3 -0.9 -0.6 -0.4 
IspE 
4-Diphosphocytidyl-2-C-methyl-D-erythritol 
kinase 
Q8FI04 31182 5.13 69 2.9E-03 33% 0.05 0.09 0.09 0.08 0.05 0.08 -0.8 0.0 -0.4 -0.2 0.7 0.3 0.8 
Mpl 
UDP-N-acetylmuramate:L-alanyl-gamma-D-
glutamyl-meso-diaminopimelate ligase 
P37773 50298 5.53 64 8.3E-03 28% 0.034 0.030 0.047 0.05 0.039 0.041 -0.5 -0.2 -0.3 0.1 0.1 0.1 -0.2 
GshB Glutathione synthetase P04425 35766 5.11 154 9.1E-12 47% 0.05 0.06 0.09 0.11 0.07 0.07 -0.8 -0.5 -0.7 0.3 0.0 0.1 0.3 
MdoG Glucan biosynthesis protein, periplasmic P33136 57876 6.7 89 1.0E-04 22% 0.09 0.07 0.09 0.07 0.09 0.07 0.0 0.0 0.0 -0.4 -0.4 -0.4 -0.4 
SpeA Biosynthetic arginine decarboxylase P21170 74308 4.83 76 5.5E-04 16% 0.08 0.06 0.11 0.08 0.07 0.09 -0.5 0.2 -0.1 -0.5 0.4 0.0 -0.4 
SpeE Spermidine synthase B1XC96 32643 5.33 87 4.3E-05 38% 0.06 0.07 0.043 0.040 0.034 0.06 0.5 0.8 0.7 -0.1 0.8 0.4 0.2 
LuxS S-ribosylhomocysteine lyase C4ZYT7 19575 5.18 77 4.4E-04 54% 0.046 0.08 0.05 0.06 0.041 0.09 -0.1 0.2 0.0 0.3 1.1 0.7 0.8 
NadE NH(3)-dependent NAD(+) synthetase B1XGK1 30789 5.41 63 1.0E-02 39% 0.06 0.06 0.06 0.06 0.036 0.048 0.0 0.7 0.4 0.0 0.4 0.2 0.0 
PanB 
3-Methyl-2-oxobutanoate 
hydroxymethyltransferase 
A7ZHM4 28389 5.16 63 1.1E-02 26% 0.034 0.037 0.034 0.037 0.030 0.06 0.0 0.2 0.1 0.1 1.0 0.6 0.1 
PanC Pantothenate synthetase C4ZRM6 31692 5.91 109 2.9E-07 42% 0.06 0.06 0.048 0.07 0.049 0.06 0.3 0.3 0.3 0.5 0.3 0.4 0.0 
ThiC Phosphomethylpyrimidine synthase B7NRS7 71320 5.66 66 6.3E-03 11% 0.14 0.06 0.07 0.014 0.049 0.014 1.0 1.5 1.3 -2.3 -1.8 -2.1 -1.2 
GlgB 1,4-Alpha-glucan branching enzyme P07762 84398 5.91 71 7.0E-03 19% 0.041 0.029 0.012 0.017 0.019 0.044 1.8 1.1 1.4 0.5 1.2 0.9 -0.5 
OtsA 
Alpha,alpha-trehalose-phosphate synthase 
[UDP-forming] 
B1X658 53749 6.37 91 1.7E-05 35% 0.039 0.015 0.016 0.020 0.00 0.034 1.3 >5 >3.1 0.3 >5 >2.6 -1.4 
                     
(Metabolite) degradation (19 proteins) Total WCPM: 1.48 1.44 1.32 3.97 1.27 2.61 0.2 0.2 0.2 1.6 1.0 1.3 0.0 
                     
MalP Maltodextrin phosphorylase P00490 90865 6.94 118 3.6E-08 20% 0.06 0.030 0.17 0.08 0.14 0.046 -1.5 -1.2 -1.4 -1.1 -1.6 -1.3 -1.0 
MalQ 4-Alpha-glucanotransferase P15977 79080 6.14 123 1.1E-08 28% 0.019 0.025 0.17 0.07 0.15 0.020 -3.2 -3.0 -3.1 -1.3 -2.9 -2.1 0.4 
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Suppl. Table 5.3.1 Proteome data of E. coli BL21 (DE3) growing in different media 
Name1 Protein name1 Uniprot ID1 
Molecular 
mass2 
(Da) 
Calculated 
pI value2 
Mascot 
score2 
Expect2 
Mascot 
seq. 
cover.2 
Defind medium Complex medium 
Log2 
(DNB 
/TB) 
Log2 
(DNB 
/LB) 
Log2 
(defined/ 
complex) 
Log2(stationary phase 
/exp. phase) DNB medium TB medium LB medium 
exp. stationary exp. stationary exp. stationary 
in 
TB 
medium 
in 
LB 
medium 
in 
complex 
media 
in 
defined 
medium 
phase phase phase phase phase phase 
Whole Cell Protein Mass (WCPM) - % At exp. phase 
Pgm Phosphoglucomutase P36938 58610 5.43 75 7.8E-04 19% 0.20 0.11 0.11 0.14 0.10 0.10 0.9 1.0 0.9 0.3 0.0 0.2 -0.9 
BglX Periplasmic beta-glucosidase precursor Q8CVX0 83562 5.85 113 4.2E-07 27% 0.08 0.035 0.07 0.08 0.06 0.049 0.2 0.4 0.3 0.2 -0.3 0.0 -1.2 
GatZ 
D-Tagatose-1,6-bisphosphate aldolase subunit 
gatZ 
B3X944 47440 5.52 74 3.8E-03 33% 0.39 0.52 0.16 1.80 0.21 0.76 1.3 0.9 1.1 3.5 1.9 2.7 0.4 
GatD Galactitol-1-phosphate 5-dehydrogenase P0A9S3 37822 5.94 61 2.0E-02 17% 0.21 0.17 0.08 0.65 0.08 0.40 1.4 1.4 1.4 3.0 2.3 2.7 -0.3 
XylA Xylose isomerase C4ZXF6 49939 5.75 63 1.2E-02 24% 0.025 0.030 0.038 0.00 0.00 0.024 -0.6 >5 - <-5 >5 - 0.3 
TreA Periplasmic trehalase C4ZTN8 63825 5.6 213 1.1E-17 46% 0.06 0.046 0.035 0.038 0.025 0.08 0.8 1.3 1.0 0.1 1.7 0.9 -0.4 
TreC Trehalose-6-phosphate hydrolase P28904 64082 5.51 122 1.4E-08 25% 0.06 0.036 0.15 0.09 0.17 0.08 -1.3 -1.5 -1.4 -0.7 -1.1 -0.9 -0.7 
MelA Alpha-galactosidase P06720 51309 5.52 109 2.9E-07 23% 0.07 0.07 0.05 0.62 0.06 0.16 0.5 0.2 0.4 3.6 1.4 2.5 0.0 
GabT 4-Aminobutyrate aminotransferase GabT P22256 46202 5.78 227 4.6E-19 67% 0.00 0.06 0.013 0.028 0.00 0.15 <-5 0.0 <-2.5 1.1 >5 >3.1 >5 
GabD 
Succinate-semialdehyde dehydrogenase 
[NADP+] GabD 
P25526 52030 5.44 125 7.2E-09 28% 0.10 0.06 0.09 0.11 0.09 0.17 0.2 0.2 0.2 0.3 0.9 0.6 -0.7 
Prr Gamma-aminobutyraldehyde dehydrogenase C4ZVI3 51197 5.65 80 2.1E-04 41% 0.06 0.07 0.036 0.041 0.025 0.18 0.7 1.3 1.0 0.2 2.8 1.5 0.2 
UidA Beta-glucuronidase P05804 68917 5.24 80 2.3E-04 21% 0.05 0.035 0.046 0.040 0.043 0.036 0.1 0.2 0.2 -0.2 -0.3 -0.2 -0.5 
CpdB 
2',3'-Cyclic-nucleotide 2'-
phosphodiesterase/3'-nucleotidase 
P08331 70902 5.45 114 9.1E-08 34% 0.024 0.026 0.028 0.05 0.024 0.044 -0.2 0.0 -0.1 0.8 0.9 0.9 0.1 
DkgA 2,5-Diketo-D-gluconic acid reductase A Q46857 31147 6 151 1.8E-11 53% 0.043 0.07 0.042 0.07 0.027 0.11 0.0 0.7 0.4 0.7 2.0 1.4 0.7 
NanA N-Acetylneuraminate lyase C4ZSW3 32801 5.61 119 2.9E-08 36% 0.00 0.00 0.00 0.025 0.043 0.045 0.0 <-5 <-2.5 >5 0.1 >2.5 0.0 
FadB 
Multifunctional fatty acid oxidation complex 
subunit alpha 
Q0TAL0 79829 6.01 136 2.1E-09 26% 0.016 0.034 0.011 0.022 0.00 0.13 0.5 >5 >2.8 1.0 >5 >3 1.1 
FadH 2,4-Dienoyl-CoA reductase [NADPH] P42593 73203 6.11 89 3.2E-05 9% 0.010 0.014 0.020 0.018 0.026 0.028 -1.0 -1.4 -1.2 -0.2 0.1 0.0 0.5 
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Suppl. Table 5.3.1 Proteome data of E. coli BL21 (DE3) growing in different media 
Name1 Protein name1 Uniprot ID1 
Molecular 
mass2 
(Da) 
Calculated 
pI value2 
Mascot 
score2 
Expect2 
Mascot 
seq. 
cover.2 
Defind medium Complex medium 
Log2 
(DNB 
/TB) 
Log2 
(DNB 
/LB) 
Log2 
(defined/ 
complex) 
Log2(stationary phase 
/exp. phase) DNB medium TB medium LB medium 
exp. stationary exp. stationary exp. stationary 
in 
TB 
medium 
in 
LB 
medium 
in 
complex 
media 
in 
defined 
medium 
phase phase phase phase phase phase 
Whole Cell Protein Mass (WCPM) - % At exp. phase 
Sugar transport (7 proteins) Total WCPM: 1.02 1.60 0.92 1.30 0.81 1.38 0.1 0.3 0.2 0.5 0.8 0.6 0.6 
                     
PtsI 
Phosphoenolpyruvate-protein 
phosphotransferase 
Q8XBL3 63722 4.78 109 1.0E-06 28% 0.40 0.44 0.30 0.17 0.25 0.17 0.4 0.7 0.5 -0.8 -0.6 -0.7 0.1 
PtsH Phosphocarrier protein HPr P0AA06 9114 5.65 123 4.2E-08 90% 0.19 0.29 0.07 0.23 0.15 0.19 1.4 0.3 0.9 1.7 0.3 1.0 0.6 
Crr 
Glucose-specific enzyme IIA component of 
PTS 
P69783 18240 4.73 104 3.6E-04 74% 0.11 0.32 0.09 0.16 0.10 0.29 0.3 0.1 0.2 0.8 1.5 1.2 1.5 
ManX 
PTS system mannose-specific EIIAB 
component 
P69797 35026 5.74 143 1.1E-10 42% 0.21 0.30 0.10 0.15 0.09 0.16 1.1 1.2 1.1 0.6 0.8 0.7 0.5 
MalE Maltose-binding periplasmic protein P0AEX9 43360 5.53 65 6.9E-03 16% 0.032 0.18 0.08 0.43 0.022 0.25 -1.3 0.5 -0.4 2.4 3.5 3.0 2.5 
MalK 
Maltose/maltodextrin import ATP-binding 
protein MalK 
P68188 41136 6.23 88 8.0E-04 33% 0.036 0.022 0.08 0.031 0.045 0.037 -1.2 -0.3 -0.7 -1.4 -0.3 -0.8 -0.7 
LamB Chain A, Maltoporin Maltose Complex P02943 47469 4.72 97 1.7E-05 35% 0.043 0.05 0.20 0.13 0.15 0.28 -2.2 -1.8 -2.0 -0.6 0.9 0.1 0.2 
                     
Amino acid and peptide transport (7 proteins) Total WCPM: 0.72 1.26 0.43 0.58 0.28 1.12 0.7 1.4 1.1 0.4 2.0 1.2 0.8 
                     
GlnH 
Glutamine ABC transporter periplasmic 
protein 
P0AEQ5 27173 8.44 75 2.8E-03 48% 0.20 0.12 0.09 0.08 0.12 0.07 1.2 0.7 0.9 -0.2 -0.8 -0.5 -0.7 
ArtJ Arginine transporter subunit P30860 26927 6.84 90 8.1E-05 38% 0.030 0.05 0.11 0.027 0.00 0.044 -1.9 >5 - -2.0 >5 - 0.7 
ArgT 
Lysine-arginine-ornithine-binding periplasmic 
protein 
P09551 28088 5.62 94 8.5E-06 51% 0.045 0.13 0.047 0.07 0.031 0.10 -0.1 0.5 0.2 0.6 1.7 1.1 1.5 
LivJ Leucine/isoleucine/valine transporter subunit P0AD96 39223 5.54 131 6.6E-09 55% 0.11 0.34 0.028 0.09 0.027 0.11 2.0 2.0 2.0 1.7 2.0 1.9 1.6 
DppA 
Chain A, Dipeptide Binding Protein Complex 
With Glycyl-L-Leucine 
P23847 57599 5.75 116 2.1E-07 42% 0.13 0.28 0.00 0.00 0.00 0.29 >5 >5 >5 0.0 >5 >2.5 1.1 
OppA Periplasmic oligopeptide-binding protein P23843 60975 6.05 138 3.0E-10 51% 0.16 0.29 0.15 0.31 0.10 0.47 0.1 0.7 0.4 1.0 2.2 1.6 0.9 
OppD 
Oligopeptide transport ATP-binding protein 
OppD 
P76027 37506 5.78 67 4.2E-03 41% 0.048 0.048 0.00 0.00 0.00 0.032 >5 >5 >5 0.0 >5 >2.5 0.0 
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Suppl. Table 5.3.1 Proteome data of E. coli BL21 (DE3) growing in different media 
Name1 Protein name1 Uniprot ID1 
Molecular 
mass2 
(Da) 
Calculated 
pI value2 
Mascot 
score2 
Expect2 
Mascot 
seq. 
cover.2 
Defind medium Complex medium 
Log2 
(DNB 
/TB) 
Log2 
(DNB 
/LB) 
Log2 
(defined/ 
complex) 
Log2(stationary phase 
/exp. phase) DNB medium TB medium LB medium 
exp. stationary exp. stationary exp. stationary 
in 
TB 
medium 
in 
LB 
medium 
in 
complex 
media 
in 
defined 
medium 
phase phase phase phase phase phase 
Whole Cell Protein Mass (WCPM) - % At exp. phase 
Other transport proteins (14 proteins) Total WCPM: 4.51 7.10 4.81 4.54 5.42 5.19 -0.1 -0.3 -0.2 -0.1 -0.1 -0.1 0.7 
                     
CusB 
Copper/silver efflux system, membrane 
fusion protein 
P77239 44277 5.93 253 4.2E-21 62% 0.032 0.10 0.00 0.00 0.00 0.00 >5 >5 >5 0.0 0.0 0.0 1.6 
GsiB 
Glutathione ABC transporter, periplasmic 
glutathione-binding protein GsiB 
B3IL13 56479 8.23 80 7.7E-04 22% 0.038 0.027 0.046 0.036 0.037 0.045 -0.3 0.0 -0.1 -0.4 0.3 0.0 -0.5 
LptD 
Exported protein required for envelope 
biosynthesis and integrity 
P31554 89843 4.94 158 1.3E-11 27% 0.06 0.07 0.06 0.047 0.07 0.05 0.0 -0.2 -0.1 -0.4 -0.5 -0.4 0.2 
FadL Long-chain fatty acid transport protein Q8XCN6 48509 5.19 84 7.1E-05 34% 0.019 0.032 0.042 0.021 0.033 0.11 -1.1 -0.8 -1.0 -1.0 1.7 0.4 0.8 
OmpF Outer membrane porin 1a (Ia;b;F) P02931 39309 4.76 197 1.7E-15 69% 2.17 2.68 1.30 1.66 2.49 2.35 0.7 -0.2 0.3 0.4 -0.1 0.1 0.3 
OmpA Outer membrane protein A P0A911 37292 5.99 133 9.4E-10 45% 1.00 2.37 1.13 1.02 0.85 1.05 -0.2 0.2 0.0 -0.1 0.3 0.1 1.2 
OmpA 
(2) 
Outer membrane protein A 
ZP_03085
789(NCBI, 3) 
28830 5.98 114 9.2E-07 49% 0.51 1.01 0.77 0.89 0.67 0.76 -0.6 -0.4 -0.5 0.2 0.2 0.2 1.0 
TolB Translocation protein TolB A7ZJC2 41502 6.22 100 8.5E-06 31% 0.05 0.14 0.07 0.07 0.06 0.19 -0.5 -0.3 -0.4 0.0 1.7 0.8 1.5 
TolC Outer membrane protein TolC B3I0L1 53784 5.46 72 5.3E-03 20% 0.10 0.10 0.15 0.09 0.13 0.07 -0.6 -0.4 -0.5 -0.7 -0.9 -0.8 0.0 
OmpX Outer membrane protein X P0A919 18648 6.56 110 8.3E-07 68% 0.25 0.26 0.69 0.29 0.57 0.19 -1.5 -1.2 -1.3 -1.3 -1.6 -1.4 0.1 
YbiT 
Putative ATP-binding component of a 
transport system 
P0A9U5 59877 4.99 123 4.2E-08 31% 0.05 0.033 0.09 0.030 0.044 0.026 -0.8 0.2 -0.3 -1.6 -0.8 -1.2 -0.6 
YjjK 
Uncharacterized ABC transporter ATP-
binding protein YjjK 
P0A9W3 62518 5.43 118 3.6E-08 34% 0.07 0.07 0.14 0.14 0.12 0.17 -1.0 -0.8 -0.9 0.0 0.5 0.3 0.0 
SecA Preprotein translocase subunit, ATPase P10408 102187 5.43 196 2.1E-15 36% 0.06 0.09 0.21 0.17 0.23 0.08 -1.8 -1.9 -1.9 -0.3 -1.5 -0.9 0.6 
YaeT 
Outer membrane protein assembly factor 
yaeT 
A7ZHR7 90611 4.93 161 1.5E-12 26% 0.10 0.12 0.11 0.08 0.12 0.10 -0.1 -0.3 -0.2 -0.5 -0.3 -0.4 0.3 
                     
RNA polymerases (3 proteins) Total WCPM: 1.16 1.02 1.47 0.76 1.65 0.73 -0.3 -0.5 -0.4 -1.0 -1.2 -1.1 -0.2 
                     
RpoA DNA-directed RNA polymerase subunit alpha P0A7Z6 36717 4.98 247 1.7E-20 69% 0.48 0.52 0.72 0.39 0.74 0.34 -0.6 -0.6 -0.6 -0.9 -1.1 -1.0 0.1 
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Suppl. Table 5.3.1 Proteome data of E. coli BL21 (DE3) growing in different media 
Name1 Protein name1 Uniprot ID1 
Molecular 
mass2 
(Da) 
Calculated 
pI value2 
Mascot 
score2 
Expect2 
Mascot 
seq. 
cover.2 
Defind medium Complex medium 
Log2 
(DNB 
/TB) 
Log2 
(DNB 
/LB) 
Log2 
(defined/ 
complex) 
Log2(stationary phase 
/exp. phase) DNB medium TB medium LB medium 
exp. stationary exp. stationary exp. stationary 
in 
TB 
medium 
in 
LB 
medium 
in 
complex 
media 
in 
defined 
medium 
phase phase phase phase phase phase 
Whole Cell Protein Mass (WCPM) - % At exp. phase 
RpoB DNA-directed RNA polymerase subunit beta P0A8V4 150935 5.15 117 1.7E-07 18% 0.58 0.44 0.68 0.31 0.82 0.33 -0.2 -0.5 -0.4 -1.1 -1.3 -1.2 -0.4 
RpoC DNA-directed RNA polymerase subunit beta' P0A8T8 155918 6.67 74 3.4E-03 15% 0.10 0.06 0.07 0.06 0.09 0.06 0.5 0.2 0.3 -0.2 -0.6 -0.4 -0.7 
                     
RNA polymerase binding proteins (7 proteins) Total WCPM: 0.90 0.84 1.35 0.97 1.49 0.91 -0.6 -0.7 -0.7 -0.5 -0.7 -0.6 -0.1 
                     
RapA RNA polymerase-associated protein rapA A7ZHF0 110057 5.04 65 6.9E-03 12% 0.018 0.012 0.08 0.021 0.07 0.017 -2.2 -2.0 -2.1 -1.9 -2.0 -2.0 -0.6 
NusA Transcription elongation protein nusA P0AFF8 55008 4.53 77 4.8E-04 20% 0.12 0.10 0.18 0.08 0.20 0.09 -0.6 -0.7 -0.7 -1.2 -1.2 -1.2 -0.3 
NusG Transcription antitermination protein NusG P0AFG1 20518 6.34 92 5.4E-05 64% 0.07 0.07 0.09 0.045 0.13 0.06 -0.4 -0.9 -0.6 -1.0 -1.1 -1.1 0.0 
Rho Transcription termination factor Rho P0AG32 47032 6.75 166 5.7E-13 33% 0.45 0.34 0.70 0.48 0.84 0.42 -0.6 -0.9 -0.8 -0.5 -1.0 -0.8 -0.4 
RpoD RNA polymerase sigma-subunit Q59371 69157 4.87 97 1.6E-05 31% 0.06 0.07 0.10 0.06 0.07 0.07 -0.7 -0.2 -0.5 -0.7 0.0 -0.4 0.2 
SspA Stringent starvation protein A P0ACA3 24346 5.22 128 3.6E-09 58% 0.10 0.13 0.14 0.21 0.12 0.17 -0.5 -0.3 -0.4 0.6 0.5 0.5 0.4 
DksA DnaK transcriptional regulator DksA P0ABS3 17745 5.06 72 6.0E-03 64% 0.08 0.12 0.06 0.07 0.06 0.08 0.4 0.4 0.4 0.2 0.4 0.3 0.6 
                     
Transcription factors (12 proteins) Total WCPM: 1.73 1.66 1.75 1.51 2.01 2.12 0.0 -0.2 -0.1 -0.2 0.1 -0.1 -0.1 
                     
LacI Lactose operon repressor P03023 38737 6.39 58 4.1E-02 28% 0.043 0.035 0.16 0.07 0.18 0.037 -1.9 -2.1 -2.0 -1.2 -2.3 -1.7 -0.3 
Hns 
Global DNA-binding transcriptional dual 
regulator H-NS 
P0ACG0 15587 5.43 92 5.9E-05 62% 0.67 0.79 0.76 0.76 1.07 1.06 -0.2 -0.7 -0.4 0.0 0.0 0.0 0.2 
ArcA Aerobic respiration control protein ArcA P0A9Q1 27389 5.21 156 5.7E-12 46% 0.07 0.10 0.08 0.07 0.09 0.21 -0.2 -0.4 -0.3 -0.2 1.2 0.5 0.5 
KdgR Transcriptional regulator kdgR P76268 30067 5.43 164 9.1E-13 74% 0.033 0.035 0.035 0.027 0.038 0.040 -0.1 -0.2 -0.1 -0.4 0.1 -0.2 0.1 
OxyR Hydrogen peroxide-inducible genes activator P0ACQ4 34596 5.96 95 7.1E-06 34% 0.08 0.06 0.06 0.08 0.08 0.07 0.4 0.0 0.2 0.4 -0.2 0.1 -0.4 
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Suppl. Table 5.3.1 Proteome data of E. coli BL21 (DE3) growing in different media 
Name1 Protein name1 Uniprot ID1 
Molecular 
mass2 
(Da) 
Calculated 
pI value2 
Mascot 
score2 
Expect2 
Mascot 
seq. 
cover.2 
Defind medium Complex medium 
Log2 
(DNB 
/TB) 
Log2 
(DNB 
/LB) 
Log2 
(defined/ 
complex) 
Log2(stationary phase 
/exp. phase) DNB medium TB medium LB medium 
exp. stationary exp. stationary exp. stationary 
in 
TB 
medium 
in 
LB 
medium 
in 
complex 
media 
in 
defined 
medium 
phase phase phase phase phase phase 
Whole Cell Protein Mass (WCPM) - % At exp. phase 
BasR Transcriptional regulatory protein BasR P30843 25072 5.66 70 2.1E-03 31% 0.07 0.06 0.06 0.049 0.046 0.07 0.2 0.6 0.4 -0.3 0.6 0.2 -0.2 
CspC CspC Q1PG46 7497 8.09 56 2.2E-01 60% 0.36 0.22 0.30 0.19 0.27 0.36 0.3 0.4 0.3 -0.7 0.4 -0.1 -0.7 
StpA DNA binding protein, nucleoid-associated P0ACG2 15338 7.93 50 8.1E-01 33% 0.19 0.15 0.13 0.07 0.12 0.07 0.5 0.7 0.6 -0.9 -0.8 -0.8 -0.3 
PspA Phage shock protein A P0AFM6 25477 5.39 76 6.3E-04 57% 0.033 0.021 0.026 0.029 0.025 0.022 0.3 0.4 0.4 0.2 -0.2 0.0 -0.7 
OmpR Transcriptional regulatory protein ompR P0AA16 27393 6.04 132 1.4E-09 52% 0.08 0.08 0.07 0.06 0.05 0.11 0.2 0.7 0.4 -0.2 1.1 0.5 0.0 
CpxR Transcriptional regulatory protein CpxR P0AE88 26296 5.39 71 1.9E-03 38% 0.06 0.06 0.046 0.06 0.039 0.047 0.4 0.6 0.5 0.4 0.3 0.3 0.0 
PhoP Transcriptional regulatory protein phoP P23836 25519 5.1 123 1.1E-08 51% 0.041 0.047 0.026 0.049 0.00 0.028 0.7 >5 >2.8 0.9 >5 >2.9 0.2 
                     
Ribosomal proteins (5 proteins) Total WCPM: 2.82 2.67 5.10 2.45 5.73 2.25 -0.9 -1.0 -0.9 -1.1 -1.3 -1.2 -0.1 
                     
RplL 50S ribosomal protein L7/L12 P0A7K2 12069 4.6 70 7.8E-03 44% 0.67 0.77 0.74 0.46 1.09 0.55 -0.1 -0.7 -0.4 -0.7 -1.0 -0.8 0.2 
RplI 50S ribosomal protein L9 P0A7R3 15759 6.17 197 1.7E-15 81% 0.47 0.38 0.78 0.34 0.77 0.36 -0.7 -0.7 -0.7 -1.2 -1.1 -1.1 -0.3 
RpsA 30S ribosomal protein S1 P0AG69 61235 4.89 189 1.0E-14 35% 0.81 0.93 1.98 0.94 2.10 0.78 -1.3 -1.4 -1.3 -1.1 -1.4 -1.3 0.2 
RpsB 30S ribosomal protein S2 A7ZHQ9 26798 6.62 137 3.7E-10 74% 0.59 0.43 1.06 0.48 1.24 0.44 -0.8 -1.1 -1.0 -1.1 -1.5 -1.3 -0.5 
RpsF 30S ribosomal protein S6 A7ZV71 15177 5.26 61 1.7E-02 39% 0.28 0.16 0.54 0.23 0.53 0.12 -0.9 -0.9 -0.9 -1.2 -2.1 -1.7 -0.8 
                     
Ribosome-associated proteins (8 proteins) Total WCPM: 0.85 0.95 1.58 1.02 1.60 0.98 -0.9 -0.9 -0.9 -0.6 -0.7 -0.7 0.2 
                     
EngA Predicted GTP-binding protein P0A6P5 55058 5.6 150 8.4E-11 32% 0.042 0.010 0.039 0.028 0.028 0.031 0.1 0.6 0.3 -0.5 0.1 -0.2 -2.1 
YcaO UPF0142 protein ycaO P75838 66009 4.38 75 7.8E-04 13% 0.019 0.009 0.032 0.023 0.049 0.015 -0.8 -1.4 -1.1 -0.5 -1.7 -1.1 -1.1 
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Suppl. Table 5.3.1 Proteome data of E. coli BL21 (DE3) growing in different media 
Name1 Protein name1 Uniprot ID1 
Molecular 
mass2 
(Da) 
Calculated 
pI value2 
Mascot 
score2 
Expect2 
Mascot 
seq. 
cover.2 
Defind medium Complex medium 
Log2 
(DNB 
/TB) 
Log2 
(DNB 
/LB) 
Log2 
(defined/ 
complex) 
Log2(stationary phase 
/exp. phase) DNB medium TB medium LB medium 
exp. stationary exp. stationary exp. stationary 
in 
TB 
medium 
in 
LB 
medium 
in 
complex 
media 
in 
defined 
medium 
phase phase phase phase phase phase 
Whole Cell Protein Mass (WCPM) - % At exp. phase 
EngD 
(YchF) 
GTP-dependent nucleic acid-binding protein 
EngD 
P0ABU3 39984 4.87 211 6.7E-17 60% 0.029 0.042 0.06 0.037 0.07 0.06 -1.0 -1.3 -1.2 -0.7 -0.2 -0.5 0.5 
TypA GTP-binding protein typA/BipA P32132 67542 5.16 71 4.1E-02 22% 0.19 0.12 0.25 0.11 0.26 0.13 -0.4 -0.5 -0.4 -1.2 -1.0 -1.1 -0.7 
HflX GTP-binding protein hflX P25519 48468 5.68 88 8.6E-04 21% 0.030 0.021 0.11 0.024 0.08 0.036 -1.9 -1.4 -1.6 -2.2 -1.2 -1.7 -0.5 
Tig Trigger factor Q1RFA0 47836 4.83 205 2.6E-16 46% 0.42 0.45 0.93 0.45 0.81 0.47 -1.1 -0.9 -1.0 -1.0 -0.8 -0.9 0.1 
Frr Ribosome recycling factor A1A7L6 19269 6.43 66 2.3E-02 40% 0.038 0.09 0.06 0.15 0.12 0.10 -0.7 -1.7 -1.2 1.3 -0.3 0.5 1.2 
RaiA Ribosome-associated inhibitor A P0AD51 12777 6.2 62 1.4E-02 46% 0.08 0.21 0.10 0.20 0.18 0.14 -0.3 -1.2 -0.7 1.0 -0.4 0.3 1.4 
                     
Aminoacyl-tRNA synthetases (23 proteins) Total WCPM: 3.40 2.79 5.14 4.63 4.89 3.27 -0.6 -0.5 -0.6 -0.2 -0.6 -0.4 -0.3 
                     
AlaS Alanyl-tRNA synthetase B1XCM5 96315 5.53 99 2.8E-06 16% 0.30 0.28 0.46 0.49 0.56 0.41 -0.6 -0.9 -0.8 0.1 -0.4 -0.2 -0.1 
ArgS Arginyl-tRNA synthetase Q8XCH2 64851 5.31 131 6.7E-09 26% 0.07 0.05 0.13 0.06 0.13 0.05 -0.9 -0.9 -0.9 -1.1 -1.4 -1.2 -0.5 
AsnS Asparaginyl tRNA synthetase P0A8M0 52766 5.17 182 5.3E-14 40% 0.25 0.18 0.29 0.19 0.30 0.17 -0.2 -0.3 -0.2 -0.6 -0.8 -0.7 -0.5 
AspS Aspartyl-tRNA synthetase P21889 66157 5.47 141 6.7E-10 29% 0.19 0.16 0.25 0.18 0.22 0.16 -0.4 -0.2 -0.3 -0.5 -0.5 -0.5 -0.2 
CysS Cysteinyl-tRNA synthetase Q8FK44 52436 5.33 76 2.0E-03 28% 0.22 0.10 0.13 0.22 0.11 0.16 0.8 1.0 0.9 0.8 0.5 0.6 -1.1 
GlnS Glutaminyl-tRNA synthetase Q8X9H8 64040 5.88 109 1.1E-06 31% 0.14 0.08 0.17 0.12 0.17 0.15 -0.3 -0.3 -0.3 -0.5 -0.2 -0.3 -0.8 
GltX Glutamyl-tRNA synthetase P04805 54181 5.59 151 6.7E-11 29% 0.14 0.10 0.26 0.17 0.23 0.16 -0.9 -0.7 -0.8 -0.6 -0.5 -0.6 -0.5 
GlyQ Glycyl-tRNA synthetase alpha subunit A7ZTA6 34979 4.94 106 5.7E-07 45% 0.09 0.06 0.13 0.07 0.10 0.06 -0.5 -0.2 -0.3 -0.9 -0.7 -0.8 -0.6 
GlyS Glycyl-tRNA synthetase beta subunit P00961 76936 5.29 181 1.8E-14 28% 0.20 0.10 0.36 0.16 0.34 0.16 -0.8 -0.8 -0.8 -1.2 -1.1 -1.1 -1.0 
HisS Histidyl-tRNA synthetase P60908 47285 5.65 148 1.3E-10 44% 0.08 0.06 0.11 0.06 0.11 0.05 -0.5 -0.5 -0.5 -0.9 -1.1 -1.0 -0.4 
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Suppl. Table 5.3.1 Proteome data of E. coli BL21 (DE3) growing in different media 
Name1 Protein name1 Uniprot ID1 
Molecular 
mass2 
(Da) 
Calculated 
pI value2 
Mascot 
score2 
Expect2 
Mascot 
seq. 
cover.2 
Defind medium Complex medium 
Log2 
(DNB 
/TB) 
Log2 
(DNB 
/LB) 
Log2 
(defined/ 
complex) 
Log2(stationary phase 
/exp. phase) DNB medium TB medium LB medium 
exp. stationary exp. stationary exp. stationary 
in 
TB 
medium 
in 
LB 
medium 
in 
complex 
media 
in 
defined 
medium 
phase phase phase phase phase phase 
Whole Cell Protein Mass (WCPM) - % At exp. phase 
IleS Isoleucyl-tRNA synthetase P00956 105042 5.7 169 1.1E-12 33% 0.16 0.14 0.32 0.22 0.33 0.16 -1.0 -1.0 -1.0 -0.5 -1.0 -0.8 -0.2 
LeuS Leucyl-tRNA synthetase B3I479 97801 5.11 132 5.3E-09 26% 0.19 0.21 0.35 0.17 0.27 0.16 -0.9 -0.5 -0.7 -1.0 -0.8 -0.9 0.1 
LysS Lysyl-tRNA synthetase Q8XD57 57614 5.11 159 1.1E-11 42% 0.13 0.11 0.25 0.16 0.26 0.13 -0.9 -1.0 -1.0 -0.6 -1.0 -0.8 -0.2 
MetG Methionyl-tRNA synthetase A8A1X8 76675 5.56 64 3.7E-02 14% 0.11 0.09 0.18 0.11 0.19 0.09 -0.7 -0.8 -0.7 -0.7 -1.1 -0.9 -0.3 
PheT Phenylalanyl-tRNA synthetase subunit beta Q8XE32 88119 5.12 181 6.6E-14 31% 0.19 0.21 0.20 0.13 0.23 0.11 -0.1 -0.3 -0.2 -0.6 -1.1 -0.8 0.1 
ProS Prolyl-tRNA synthetase A7ZHT6 63622 5.08 139 1.0E-09 36% 0.20 0.21 0.35 0.26 0.31 0.19 -0.8 -0.6 -0.7 -0.4 -0.7 -0.6 0.1 
SerS Seryl-tRNA synthetase P0A8L3 48669 5.34 119 1.1E-07 33% 0.13 0.14 0.23 0.22 0.23 0.16 -0.8 -0.8 -0.8 -0.1 -0.5 -0.3 0.1 
ThrS Threonyl-tRNA synthetase Q8XE27 74722 5.8 52 5.8E-01 17% 0.15 0.15 0.27 0.34 0.27 0.21 -0.8 -0.8 -0.8 0.3 -0.4 0.0 0.0 
TyrS Tyrosyl-tRNA synthetase P0AGK0 48382 5.49 125 2.7E-08 40% 0.17 0.12 0.28 0.16 0.23 0.13 -0.7 -0.4 -0.6 -0.8 -0.8 -0.8 -0.5 
LysU Lysyl-tRNA synthetase, heat inducible P0A8N5 57847 5.1 166 5.7E-13 40% 0.13 0.09 0.29 1.00 0.21 0.24 -1.2 -0.7 -0.9 1.8 0.2 1.0 -0.5 
MnmA tRNA-Specific 2-thiouridylase mnmA A7ZKS3 41333 4.94 69 2.9E-03 33% 0.049 0.044 0.05 0.036 0.042 0.031 0.0 0.2 0.1 -0.5 -0.4 -0.5 -0.2 
YgfZ tRNA-modifying protein ygfZ C5A0H0 36185 5.17 211 1.8E-17 54% 0.044 0.06 0.06 0.08 0.036 0.08 -0.4 0.3 -0.1 0.4 1.2 0.8 0.4 
Fmt Methionyl-tRNA formyltransferase P23882 34318 5.56 65 7.8E-03 22% 0.07 0.05 0.017 0.026 0.016 0.048 2.0 2.1 2.1 0.6 1.6 1.1 -0.5 
                     
Elongation factors (6 proteins) Total WCPM: 5.66 6.45 8.93 7.12 9.21 5.77 -0.7 -0.7 -0.7 -0.3 -0.7 -0.5 0.2 
                     
InfB Initiation factor IF2-gamma P0A705 78978 5.65 79 1.1E-03 26% 0.13 0.11 0.28 0.13 0.29 0.14 -1.1 -1.2 -1.1 -1.1 -1.1 -1.1 -0.2 
FusA Elongation factor G A7ZSL5 77704 5.24 102 1.4E-06 23% 1.39 1.55 2.03 1.66 2.14 1.22 -0.5 -0.6 -0.6 -0.3 -0.8 -0.6 0.2 
TufA Elongation factor Tu 1 A7ZSL4 43427 5.3 109 2.9E-07 28% 3.32 3.99 5.30 4.58 5.54 3.58 -0.7 -0.7 -0.7 -0.2 -0.6 -0.4 0.3 
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Suppl. Table 5.3.1 Proteome data of E. coli BL21 (DE3) growing in different media 
Name1 Protein name1 Uniprot ID1 
Molecular 
mass2 
(Da) 
Calculated 
pI value2 
Mascot 
score2 
Expect2 
Mascot 
seq. 
cover.2 
Defind medium Complex medium 
Log2 
(DNB 
/TB) 
Log2 
(DNB 
/LB) 
Log2 
(defined/ 
complex) 
Log2(stationary phase 
/exp. phase) DNB medium TB medium LB medium 
exp. stationary exp. stationary exp. stationary 
in 
TB 
medium 
in 
LB 
medium 
in 
complex 
media 
in 
defined 
medium 
phase phase phase phase phase phase 
Whole Cell Protein Mass (WCPM) - % At exp. phase 
Tsf 
Chain B, Elongation Factor Complex Ef-
TuEF-Ts 
P0A6P1 30387 5.22 245 2.6E-20 73% 0.75 0.74 1.18 0.67 1.12 0.76 -0.7 -0.6 -0.6 -0.8 -0.6 -0.7 0.0 
LepA GTP-binding protein LepA P60787 67099 5.4 193 4.2E-15 40% 0.032 0.026 0.07 0.045 0.07 0.024 -1.1 -1.1 -1.1 -0.6 -1.5 -1.1 -0.3 
PrfC Peptide chain release factor 3 Q1R270 59632 5.66 75 2.9E-03 20% 0.036 0.035 0.07 0.038 0.045 0.041 -1.0 -0.3 -0.6 -0.9 -0.1 -0.5 0.0 
                     
RNA degradation (3 proteins) Total WCPM: 0.51 0.34 0.75 0.34 0.66 0.38 -0.6 -0.4 -0.5 -1.1 -0.8 -1.0 -0.6 
                     
Pnp Polyribonucleotide nucleotidyltransferase B1IQV7 77093 5.09 100 2.6E-06 15% 0.38 0.26 0.53 0.27 0.48 0.28 -0.5 -0.3 -0.4 -1.0 -0.8 -0.9 -0.5 
Rnb Exoribonuclease II B3XC13 72829 5.44 136 2.1E-09 30% 0.09 0.06 0.17 0.06 0.12 0.07 -0.9 -0.4 -0.7 -1.5 -0.8 -1.1 -0.6 
RhlB ATP-dependent RNA helicase P0A8J8 47325 7.29 104 3.4E-06 29% 0.035 0.015 0.045 0.013 0.06 0.031 -0.4 -0.8 -0.6 -1.8 -1.0 -1.4 -1.2 
                     
Isomerases (5 proteins) Total WCPM: 0.51 0.62 0.64 0.66 0.49 0.69 -0.3 0.1 -0.1 0.0 0.5 0.3 0.3 
                     
PpiB 
Peptidyl-prolyl cis-trans isomerase B 
(rotamase B) 
Q8XCU0 18270 5.52 62 5.5E-02 38% 0.08 0.17 0.09 0.24 0.12 0.18 -0.2 -0.6 -0.4 1.4 0.6 1.0 1.1 
SurA Peptidyl-prolyl cis-trans isomerase SurA P0ABZ8 47254 6.48 135 2.7E-09 28% 0.08 0.11 0.11 0.10 0.05 0.11 -0.5 0.7 0.1 -0.1 1.1 0.5 0.5 
FklB 
FKBP-type 22 kDa peptidyl-prolyl cis-trans 
isomerase 
P0A9L3 22203 4.85 146 4.7E-11 37% 0.047 0.06 0.07 0.06 0.048 0.06 -0.6 0.0 -0.3 -0.2 0.3 0.0 0.4 
FkpA 
FKBP-type peptidyl-prolyl cis-trans 
isomerase 
P65765 28894 8.39 94 3.3E-05 44% 0.21 0.23 0.24 0.15 0.16 0.21 -0.2 0.4 0.1 -0.7 0.4 -0.1 0.1 
SlyD 
FKBP-type peptidyl-prolyl cis-trans 
isomerase slyD 
P0A9L1 21182 4.86 100 2.6E-06 31% 0.09 0.05 0.13 0.11 0.11 0.13 -0.5 -0.3 -0.4 -0.2 0.2 0.0 -0.8 
                     
Chaperones (9 proteins) Total WCPM: 2.67 3.05 3.79 4.52 3.89 4.01 -0.5 -0.5 -0.5 0.3 0.0 0.1 0.2 
                     
DnaK Molecular chaperone DnaK P0A6Z0 69130 4.83 192 5.3E-15 39% 0.65 0.84 1.12 1.27 1.06 1.15 -0.8 -0.7 -0.7 0.2 0.1 0.1 0.4 
GrpE Heat shock protein GrpE A7ZQ54 21727 4.68 54 3.3E-01 32% 0.09 0.10 0.15 0.17 0.17 0.14 -0.7 -0.9 -0.8 0.2 -0.3 0.0 0.2 
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Suppl. Table 5.3.1 Proteome data of E. coli BL21 (DE3) growing in different media 
Name1 Protein name1 Uniprot ID1 
Molecular 
mass2 
(Da) 
Calculated 
pI value2 
Mascot 
score2 
Expect2 
Mascot 
seq. 
cover.2 
Defind medium Complex medium 
Log2 
(DNB 
/TB) 
Log2 
(DNB 
/LB) 
Log2 
(defined/ 
complex) 
Log2(stationary phase 
/exp. phase) DNB medium TB medium LB medium 
exp. stationary exp. stationary exp. stationary 
in 
TB 
medium 
in 
LB 
medium 
in 
complex 
media 
in 
defined 
medium 
phase phase phase phase phase phase 
Whole Cell Protein Mass (WCPM) - % At exp. phase 
GroL 60 kDa chaperonin (GroEL protein) P0A6F5 55224 4.84 219 1.0E-17 52% 1.05 1.37 1.55 1.90 1.75 1.66 -0.6 -0.7 -0.6 0.3 -0.1 0.1 0.4 
GroS Co-chaperonin GroES P0A6G1 10381 5.15 100 8.3E-06 64% 0.29 0.29 0.31 0.43 0.24 0.48 -0.1 0.3 0.1 0.5 1.0 0.7 0.0 
HtpG Heat shock protein 90 P0A6Z5 71378 5.09 262 5.3E-22 50% 0.26 0.22 0.41 0.31 0.35 0.26 -0.7 -0.4 -0.5 -0.4 -0.4 -0.4 -0.2 
HscA Fe-S protein assembly chaperone HscA B3XDI5 65726 5.02 85 2.9E-04 21% 0.043 0.018 0.07 0.026 0.05 0.023 -0.7 -0.2 -0.5 -1.4 -1.1 -1.3 -1.3 
ClpA 
ATP-dependent Clp protease ATP-binding 
subunit 
P0ABI1 84326 5.91 87 1.6E-04 21% 0.046 0.019 0.06 0.037 0.09 0.05 -0.4 -1.0 -0.7 -0.7 -0.8 -0.8 -1.3 
ClpB Protein disaggregation chaperone P63285 95697 5.37 160 8.3E-12 27% 0.12 0.09 0.08 0.19 0.08 0.10 0.6 0.6 0.6 1.2 0.3 0.8 -0.4 
IbpA Small heat shock protein ibpA A7ZTP1 15764 5.57 168 8.4E-12 70% 0.12 0.10 0.039 0.19 0.10 0.15 1.6 0.3 0.9 2.3 0.6 1.4 -0.3 
                     
Proteases (13 proteins) Total WCPM: 1.15 1.05 1.50 1.93 1.30 1.73 -0.4 -0.2 -0.3 0.4 0.4 0.4 -0.1 
                     
DegP Serine endoprotease P0C0V1 49438 8.65 119 1.1E-07 31% 0.028 0.024 0.00 0.020 0.00 0.040 >5 >5 >5 >5 >5 >5 -0.2 
PepQ Proline dipeptidase Q8FBI1 50328 5.6 132 5.3E-09 36% 0.12 0.13 0.11 0.23 0.08 0.19 0.1 0.6 0.4 1.1 1.2 1.2 0.1 
PepD Aminoacyl-histidine dipeptidase P15288 53110 5.2 78 8.0E-03 27% 0.18 0.14 0.26 0.62 0.18 0.39 -0.5 0.0 -0.3 1.3 1.1 1.2 -0.4 
PepN Aminopeptidase N B7UN18 99343 5.09 131 6.7E-09 22% 0.12 0.12 0.12 0.17 0.11 0.22 0.0 0.1 0.1 0.5 1.0 0.8 0.0 
Dcp Dipeptidyl carboxypeptidase II Q8XB30 77516 5.35 189 1.1E-14 33% 0.031 0.044 0.05 0.09 0.024 0.11 -0.7 0.4 -0.2 0.8 2.2 1.5 0.5 
Prc Carboxy-terminal protease Q321Y5 76514 6.38 105 2.7E-06 28% 0.048 0.024 0.040 0.022 0.046 0.036 0.3 0.1 0.2 -0.9 -0.4 -0.6 -1.0 
PmbA Protein pmbA P0AFK0 48625 5.4 124 9.1E-09 35% 0.046 0.035 0.05 0.06 0.048 0.05 -0.1 -0.1 -0.1 0.3 0.1 0.2 -0.4 
ClpP 
ATP-dependent Clp protease proteolytic 
subunit 
P0A6G9 23286 5.52 63 4.6E-02 30% 0.09 0.09 0.10 0.11 0.12 0.12 -0.2 -0.4 -0.3 0.1 0.0 0.1 0.0 
HslV ATP-dependent protease peptidase subunit P0A7C0 19138 5.96 79 1.0E-03 46% 0.06 0.044 0.07 0.047 0.08 0.08 -0.2 -0.4 -0.3 -0.6 0.0 -0.3 -0.4 
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Suppl. Table 5.3.1 Proteome data of E. coli BL21 (DE3) growing in different media 
Name1 Protein name1 Uniprot ID1 
Molecular 
mass2 
(Da) 
Calculated 
pI value2 
Mascot 
score2 
Expect2 
Mascot 
seq. 
cover.2 
Defind medium Complex medium 
Log2 
(DNB 
/TB) 
Log2 
(DNB 
/LB) 
Log2 
(defined/ 
complex) 
Log2(stationary phase 
/exp. phase) DNB medium TB medium LB medium 
exp. stationary exp. stationary exp. stationary 
in 
TB 
medium 
in 
LB 
medium 
in 
complex 
media 
in 
defined 
medium 
phase phase phase phase phase phase 
Whole Cell Protein Mass (WCPM) - % At exp. phase 
HslU ATP-dependent protease ATP-binding subunit P0A6H6 49677 5.24 166 2.3E-10 48% 0.11 0.16 0.18 0.14 0.18 0.14 -0.7 -0.7 -0.7 -0.4 -0.4 -0.4 0.5 
PepB Peptidase B B7UGW9 46483 5.49 69 2.6E-03 29% 0.18 0.07 0.22 0.16 0.18 0.12 -0.3 0.0 -0.1 -0.5 -0.6 -0.5 -1.4 
PepP Proline aminopeptidase P II A7ZR18 50000 5.2 69 1.1E-02 27% 0.08 0.11 0.16 0.14 0.16 0.11 -1.0 -1.0 -1.0 -0.2 -0.5 -0.4 0.5 
PrlC Oligopeptidase A P27298 77461 5.15 209 2.9E-17 41% 0.06 0.06 0.14 0.12 0.09 0.12 -1.2 -0.6 -0.9 -0.2 0.4 0.1 0.0 
                     
Other dehydrogenases (9 proteins) Total WCPM: 0.87 0.79 0.76 0.89 0.76 1.00 0.2 0.2 0.2 0.2 0.4 0.3 -0.1 
                     
YdfG 3-Hydroxy acid dehydrogenase Q8X505 27360 5.65 86 2.1E-04 40% 0.10 0.11 0.06 0.11 0.045 0.08 0.7 1.2 0.9 0.9 0.8 0.9 0.1 
YqhD Alcohol dehydrogenase, NAD(P)-dependent Q46856 42128 5.72 83 4.5E-04 32% 0.19 0.16 0.19 0.19 0.15 0.16 0.0 0.3 0.2 0.0 0.1 0.0 -0.2 
AldB Aldehyde dehydrogenase B P37685 56670 5.44 62 1.3E-02 17% 0.07 0.05 0.041 0.045 0.06 0.13 0.8 0.2 0.5 0.1 1.1 0.6 -0.5 
AldA Lactaldehyde dehydrogenase B3XAH7 52362 5.02 132 5.3E-09 32% 0.07 0.05 0.07 0.06 0.08 0.18 0.0 -0.2 -0.1 -0.2 1.2 0.5 -0.5 
YhhX 
Predicted oxidoreductase with NAD(P)-
binding Rossmann-fold domain 
P46853 38912 6.07 131 6.7E-09 32% 0.033 0.025 0.029 0.035 0.043 0.042 0.2 -0.4 -0.1 0.3 0.0 0.1 -0.4 
Ugd UDP-Glucose 6-dehydrogenase P76373 43744 6.06 76 1.5E-02 33% 0.17 0.20 0.11 0.18 0.15 0.16 0.6 0.2 0.4 0.7 0.1 0.4 0.2 
HdhA 7-Alpha-hydroxysteroid dehydrogenase P0AET8 26990 5.22 67 4.3E-03 36% 0.045 0.044 0.036 0.07 0.045 0.07 0.3 0.0 0.2 1.0 0.6 0.8 0.0 
HybC Hydrogenase-2 large chain P0ACE0 62908 5.84 60 2.3E-02 25% 0.05 0.06 0.06 0.08 0.07 0.09 -0.3 -0.5 -0.4 0.4 0.4 0.4 0.3 
TrxB Thioredoxin reductase P0A9P4 34829 5.3 128 3.6E-09 48% 0.14 0.09 0.16 0.12 0.12 0.09 -0.2 0.2 0.0 -0.4 -0.4 -0.4 -0.6 
                     
Oxidoreductases (8 proteins) Total WCPM: 0.49 0.68 0.47 0.82 0.49 0.91 0.1 0.0 0.0 0.8 0.9 0.8 0.5 
                     
Gor Glutathione reductase P06715 49084 5.64 78 8.4E-03 29% 0.06 0.049 0.08 0.09 0.07 0.07 -0.4 -0.2 -0.3 0.2 0.0 0.1 -0.3 
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Suppl. Table 5.3.1 Proteome data of E. coli BL21 (DE3) growing in different media 
Name1 Protein name1 Uniprot ID1 
Molecular 
mass2 
(Da) 
Calculated 
pI value2 
Mascot 
score2 
Expect2 
Mascot 
seq. 
cover.2 
Defind medium Complex medium 
Log2 
(DNB 
/TB) 
Log2 
(DNB 
/LB) 
Log2 
(defined/ 
complex) 
Log2(stationary phase 
/exp. phase) DNB medium TB medium LB medium 
exp. stationary exp. stationary exp. stationary 
in 
TB 
medium 
in 
LB 
medium 
in 
complex 
media 
in 
defined 
medium 
phase phase phase phase phase phase 
Whole Cell Protein Mass (WCPM) - % At exp. phase 
NfsA Oxygen-insensitive NADPH nitroreductase P17117 27069 6.45 117 4.6E-08 40% 0.07 0.049 0.15 0.09 0.14 0.08 -1.1 -1.0 -1.0 -0.7 -0.8 -0.8 -0.5 
QueF 
NADPH-dependent 7-cyano-7-deazaguanine 
reductase 
C4ZZU9 32909 5.73 131 1.8E-09 39% 0.06 0.08 0.06 0.036 0.035 0.043 0.0 0.8 0.4 -0.7 0.3 -0.2 0.4 
NemA N-Ethylmaleimide reductase P77258 39492 5.8 90 2.2E-05 38% 0.046 0.040 0.05 0.048 0.035 0.043 -0.1 0.4 0.1 -0.1 0.3 0.1 -0.2 
SthA Soluble pyridine nucleotide transhydrogenase A7ZUI2 51984 6.08 109 6.6E-06 22% 0.11 0.06 0.06 0.12 0.10 0.21 0.9 0.1 0.5 1.0 1.1 1.0 -0.9 
CueO Blue copper oxidase CueO P36649 53557 6.07 63 4.4E-02 18% 0.040 0.06 0.036 0.06 0.037 0.043 0.2 0.1 0.1 0.7 0.2 0.5 0.6 
Bfr 
Bacterioferritin, iron storage and 
detoxification protein 
P0ABD3 18483 4.69 156 2.1E-11 60% 0.06 0.25 0.032 0.29 0.07 0.22 0.9 -0.2 0.3 3.2 1.7 2.4 2.1 
WrbA Flavoprotein wrbA C4ZQD2 20832 5.59 85 7.6E-05 53% 0.047 0.09 0.00 0.09 0.00 0.20 >5 >5 >5 >5 >5 >5 0.9 
                     
Hydroperoxide reductases and superoxide dismutase (5 proteins) Total WCPM: 1.38 2.16 1.50 3.48 1.22 2.04 -0.1 0.2 0.0 1.2 0.7 1.0 0.6 
                     
AhpF Alkyl hydroperoxide reductase subunit F B3XD66 56496 5.47 101 6.7E-06 28% 0.10 0.08 0.12 0.10 0.09 0.07 -0.3 0.2 -0.1 -0.3 -0.4 -0.3 -0.3 
AhpC Alkyl hydroperoxide reductase subunit C P0AE08 20862 5.03 108 3.6E-07 70% 0.85 1.19 0.97 1.40 0.84 1.12 -0.2 0.0 -0.1 0.5 0.4 0.5 0.5 
Tpx Thiol peroxidase P0A864 17995 4.75 103 1.1E-06 48% 0.08 0.15 0.06 0.15 0.05 0.16 0.4 0.7 0.5 1.3 1.7 1.5 0.9 
SodB Superoxide dismutase [Fe] P0AGD5 21310 5.58 125 2.6E-08 87% 0.13 0.63 0.11 1.52 0.11 0.30 0.2 0.2 0.2 3.8 1.4 2.6 2.3 
KatG Catalase/hydroperoxidase HPI(I) P13029 80031 5.14 76 2.1E-03 18% 0.22 0.11 0.24 0.31 0.13 0.39 -0.1 0.8 0.3 0.4 1.6 1.0 -1.0 
                     
DNA protection and repair (7 proteins) Total WCPM: 0.83 1.37 0.72 1.23 0.76 1.74 0.2 0.1 0.2 0.8 1.2 1.0 0.7 
                     
Ssb Single-stranded DNA-binding protein P0AGE0 18963 5.44 132 1.4E-09 41% 0.00 0.033 0.00 0.041 0.06 0.08 0.0 <-5 <-2.5 >5 0.4 >2.6 >5 
Dps 
DNA starvation/stationary phase protection 
protein Dps 
P0ABT3 18684 5.72 142 5.3E-10 66% 0.028 0.47 0.034 0.59 0.05 0.74 -0.3 -0.8 -0.6 4.1 3.9 4.0 4.1 
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Suppl. Table 5.3.1 Proteome data of E. coli BL21 (DE3) growing in different media 
Name1 Protein name1 Uniprot ID1 
Molecular 
mass2 
(Da) 
Calculated 
pI value2 
Mascot 
score2 
Expect2 
Mascot 
seq. 
cover.2 
Defind medium Complex medium 
Log2 
(DNB 
/TB) 
Log2 
(DNB 
/LB) 
Log2 
(defined/ 
complex) 
Log2(stationary phase 
/exp. phase) DNB medium TB medium LB medium 
exp. stationary exp. stationary exp. stationary 
in 
TB 
medium 
in 
LB 
medium 
in 
complex 
media 
in 
defined 
medium 
phase phase phase phase phase phase 
Whole Cell Protein Mass (WCPM) - % At exp. phase 
CbpA Curved DNA-binding protein C4ZQC8 34434 6.33 82 1.4E-04 24% 0.00 0.019 0.00 0.029 0.00 0.034 0.0 0.0 0.0 >5 >5 >5 >5 
UspA Universal stress protein A P0AED2 16113 5.11 110 8.3E-07 79% 0.11 0.25 0.07 0.17 0.06 0.20 0.7 0.9 0.8 1.3 1.7 1.5 1.2 
UspG Universal stress protein G P39177 15925 6.03 101 1.8E-06 52% 0.11 0.11 0.07 0.044 0.030 0.05 0.7 1.9 1.3 -0.7 0.7 0.0 0.0 
SodA Chain A, Manganese Superoxide Dismutase P00448 22952 6.44 64 3.6E-02 44% 0.54 0.45 0.49 0.30 0.49 0.59 0.1 0.1 0.1 -0.7 0.3 -0.2 -0.3 
PolA DNA polymerase I P00582 103168 5.4 119 2.4E-08 25% 0.043 0.034 0.06 0.06 0.07 0.045 -0.5 -0.7 -0.6 0.0 -0.6 -0.3 -0.3 
                     
Unclassified proteins (7 proteins) Total WCPM: 0.55 0.30 0.43 0.33 0.51 0.36 0.4 0.1 0.2 -0.4 -0.5 -0.4 -0.9 
                     
GyrB DNA gyrase subunit B P0AES6 90153 5.68 135 2.7E-09 24% 0.14 0.043 0.13 0.06 0.14 0.06 0.1 0.0 0.1 -1.1 -1.2 -1.2 -1.7 
MreB 
Regulator of ftsI, penicillin binding protein 3, 
septation function 
Q8X9C9 37140 5.19 101 6.7E-06 34% 0.047 0.07 0.042 0.05 0.06 0.06 0.2 -0.4 -0.1 0.3 0.0 0.1 0.6 
FtsZ Cell division protein FtsZ P0A9A8 40299 4.65 138 1.3E-09 39% 0.043 0.025 0.06 0.06 0.05 0.047 -0.5 -0.2 -0.3 0.0 -0.1 0.0 -0.8 
RsmC 
Ribosomal RNA small subunit 
methyltransferase C 
B1XFI0 37829 6 156 5.7E-12 51% 0.025 0.016 0.030 0.025 0.041 0.028 -0.3 -0.7 -0.5 -0.3 -0.6 -0.4 -0.6 
Can Carbonic anhydrase P61517 25366 6.16 89 9.8E-05 35% 0.15 0.09 0.13 0.10 0.18 0.09 0.2 -0.3 0.0 -0.4 -1.0 -0.7 -0.7 
FrsA Fermentation/respiration switch protein Q8FKM5 47336 6.47 75 2.5E-03 24% 0.032 0.018 0.034 0.033 0.035 0.028 -0.1 -0.1 -0.1 0.0 -0.3 -0.2 -0.8 
YeaG Uncharacterized protein yeaG P0ACY3 74776 5.63 66 5.2E-03 10% 0.11 0.041 0.00 0.00 0.00 0.047 >5 >5 >5 0.0 >5 >2.5 -1.4 
                     
Uncharacterized proteins (13 proteins) Total WCPM: 0.82 0.71 0.57 0.92 0.59 1.12 0.5 0.5 0.5 0.7 0.9 0.8 -0.2 
                     
YhbW Uncharacterized protein yhbW P0ADV5 37163 5.99 89 2.9E-05 33% 0.023 0.026 0.06 0.026 0.06 0.037 -1.4 -1.4 -1.4 -1.2 -0.7 -1.0 0.2 
GalF UTP-glucose-1-phosphate uridylyltransferase P0AAB6 32979 5.73 61 1.9E-02 26% 0.019 0.019 0.032 0.044 0.032 0.028 -0.8 -0.8 -0.8 0.5 -0.2 0.1 0.0 
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Suppl. Table 5.3.1 Proteome data of E. coli BL21 (DE3) growing in different media 
Name1 Protein name1 Uniprot ID1 
Molecular 
mass2 
(Da) 
Calculated 
pI value2 
Mascot 
score2 
Expect2 
Mascot 
seq. 
cover.2 
Defind medium Complex medium 
Log2 
(DNB 
/TB) 
Log2 
(DNB 
/LB) 
Log2 
(defined/ 
complex) 
Log2(stationary phase 
/exp. phase) DNB medium TB medium LB medium 
exp. stationary exp. stationary exp. stationary 
in 
TB 
medium 
in 
LB 
medium 
in 
complex 
media 
in 
defined 
medium 
phase phase phase phase phase phase 
Whole Cell Protein Mass (WCPM) - % At exp. phase 
YbeZ Putative ATP-binding protein in pho regulon Q0T6R9 39129 5.71 84 3.8E-04 41% 0.08 0.09 0.08 0.05 0.08 0.07 0.0 0.0 0.0 -0.7 -0.2 -0.4 0.2 
YicC UPF0701 protein yicC P23839 33211 5.1 86 6.2E-05 43% 0.05 0.038 0.06 0.039 0.041 0.032 -0.3 0.3 0.0 -0.6 -0.4 -0.5 -0.4 
YajQ UPF0234 protein yajQ C4ZTI3 18333 5.96 178 3.6E-14 64% 0.033 0.041 0.039 0.08 0.05 0.048 -0.2 -0.6 -0.4 1.0 -0.1 0.5 0.3 
YbgI UPF0135 protein ybgI P0AFP6 26990 5.07 89 2.7E-05 46% 0.05 0.044 0.042 0.033 0.037 0.05 0.3 0.4 0.3 -0.3 0.4 0.0 -0.2 
YjgR Uncharacterized protein yjgR P39342 54355 5.91 84 9.3E-05 28% 0.015 0.017 0.012 0.021 0.013 0.030 0.3 0.2 0.3 0.8 1.2 1.0 0.2 
YdcJ Uncharacterized protein ydcJ P76097 51353 5.35 58 3.6E-02 34% 0.06 0.06 0.00 0.07 0.035 0.07 >5 0.8 >2.9 >5 1.0 >3 0.0 
YcgB Uncharacterized protein ycgB P29013 61117 5.66 69 2.7E-03 15% 0.032 0.029 0.014 0.024 0.00 0.08 1.2 >5 >3.1 0.8 >5 >2.9 -0.1 
YgaU Uncharacterized protein ygaU P0ADE6 16053 5.71 70 2.1E-03 36% 0.11 0.07 0.026 0.09 0.06 0.28 2.1 0.9 1.5 1.8 2.2 2.0 -0.7 
YfbU Hypothetical protein P0A8W8 19638 6.06 111 6.6E-07 50% 0.12 0.12 0.06 0.12 0.07 0.09 1.0 0.8 0.9 1.0 0.4 0.7 0.0 
LfiI Lateral flagellar export/assembly protein LfiI B1LHP6 48085 6.53 77 1.6E-03 32% 0.15 0.07 0.08 0.25 0.08 0.23 0.9 0.9 0.9 1.6 1.5 1.6 -1.1 
YhdH Putative quinone oxidoreductase YhdH P26646 34873 5.63 111 1.8E-07 33% 0.08 0.09 0.06 0.07 0.030 0.07 0.4 1.4 0.9 0.2 1.2 0.7 0.2 
1
 Name, protein name and Uniprot ID are according to Uniprot database (http://www.uniprot.org/). Functional classifications are mostly according to EcoCyc database 
(http://ecocyc.org/). The classifications are confirmed by KEGG database (http://www.genome.jp/kegg/). 
2
 Molecular mass, calculated pI, Mascot score, expect and sequence coverage are from MASCOT search program (Matrix Science, UK, http://www.matrixscience.com/), based 
on the annotated E. coli genome [Uniprot (http://www.uniprot.org/) serving as database]. 
3
 A truncated outer membrane protein A is identified in the NCBI database (http://www.ncbi.nlm.nih.gov/).  
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Suppl. Table 5.3.2 Summary of proteome data of E. coli BL21 (DE3) growing in different media 
Cat.  
Nr. 
 Nr. Name 
Defined medium Complex medium 
Log2 
(DNB 
/TB) 
Log2 
(DNB 
/LB) 
Log2 
(defined/ 
complex) 
Log2 (stationary phase/exponential phase) 
DNB medium TB medium LB medium 
exp. stationary exp. stationary exp. stationary 
in TB 
medium 
in LB 
medium 
in 
complex 
media 
in 
defined 
medium 
phase phase phase phase phase phase 
Whole Cell Protein Mass (WCPM) - % At exp. phase 
I 
 
Carbohydrate metabolism (51 proteins) Sum 1 ~ 4 15.80 17.30 15.51 25.26 16.94 21.83 0.0 -0.1 0.0 0.7 0.4 0.5 0.1 
                
 
1 Central carbon metabolism (24 proteins) Sum 1.1 ~ 1.4 6.64 9.15 9.73 14.22 9.67 9.24 -0.6 -0.5 -0.5 0.5 -0.1 0.2 0.5 
                
 
1.1 Sub-group: Upper glycolysis (5 proteins) 1.35 1.76 1.21 2.16 1.18 1.51 0.2 0.2 0.2 0.8 0.4 0.6 0.4 
 
1.2 Sub-group: Lower glycolysis (to Acetyl-CoA)  (11 proteins) 4.20 6.06 7.08 9.44 7.01 5.73 -0.8 -0.7 -0.7 0.4 -0.3 0.1 0.5 
 
1.3 Sub-group: Glycerol metabolism (2 proteins) 0.09 0.20 0.16 1.06 0.17 0.37 -0.8 -0.9 -0.9 2.8 1.1 2.0 1.1 
 
1.4 Sub-group: Pentose phosphate pathway (PPP) (6 proteins) 1.00 1.14 1.29 1.56 1.31 1.63 -0.4 -0.4 -0.4 0.3 0.3 0.3 0.2 
 
2 By-product metabolism (9 proteins) 1.48 1.40 1.77 1.59 2.69 2.27 -0.3 -0.9 -0.6 -0.2 -0.2 -0.2 -0.1 
 
3 TCA cycle (14 proteins) 6.94 5.89 3.45 8.55 4.16 9.49 1.0 0.7 0.9 1.3 1.2 1.3 -0.2 
 
4 Connection between glycolysis and TCA cycle (4 proteins) 0.74 0.86 0.56 0.89 0.43 0.82 0.4 0.8 0.6 0.7 0.9 0.8 0.2 
                II 5 Oxidative phosphorylation (7 proteins) 2.54 2.50 2.25 2.72 2.74 2.41 0.2 -0.1 0.0 0.3 -0.2 0.0 0.0 
                III 
 
Biomass blocks biosynthesis (121 proteins): Sum 9 ~ 14 23.93 24.18 13.19 14.51 12.79 15.49 0.9 0.9 0.9 0.1 0.3 0.2 0.0 
                
 
6 Amino acid biosynthesis and metabolism (68 proteins). Sum 6.1 ~ 6.2 18.08 18.27 5.95 8.60 6.09 10.03 1.6 1.6 1.6 0.5 0.7 0.6 0.0 
                
 
6.1 Sub-group: Amino acid biosynthesis (57 proteins) 17.18 17.29 5.25 6.39 5.17 6.82 1.7 1.7 1.7 0.3 0.4 0.3 0.0 
 
6.2 Sub-group: Amino acid degradation (11 proteins) 0.90 0.98 0.70 2.21 0.92 3.20 0.4 0.0 0.2 1.6 1.8 1.7 0.1 
 
7.1 IMP biosynthesis (for nucleotide) (7 proteins) 1.19 1.36 0.41 0.51 0.39 0.61 1.5 1.6 1.6 0.3 0.6 0.5 0.2 
 
7.2 Nucleotide biosynthesis (start from IMP) (13 proteins) 1.66 1.74 2.83 2.05 2.46 1.91 -0.8 -0.6 -0.7 -0.5 -0.4 -0.4 0.1 
 
8 Fatty acid biosynthesis (7 proteins) 1.21 0.96 1.72 1.14 2.05 1.12 -0.5 -0.8 -0.6 -0.6 -0.9 -0.7 -0.3 
 
9 Lipopolysaccharide  biosynthesis (10 proteins) 0.81 0.88 1.22 1.24 0.93 0.91 -0.6 -0.2 -0.4 0.0 0.0 0.0 0.1 
 
10 Synthesis of other cellular components (16 proteins) 0.98 0.96 1.06 0.99 0.87 0.93 -0.1 0.2 0.0 -0.1 0.1 0.0 0.0 
                IV 11 (Metabolite) degradation (19 proteins) 1.48 1.44 1.32 3.97 1.27 2.61 0.2 0.2 0.2 1.6 1.0 1.3 0.0 
                V 
 
Transportation (28 proteins): Sum 28 ~ 30 6.25 9.96 6.15 6.42 6.51 7.68 0.0 -0.1 0.0 0.1 0.2 0.2 0.7 
                
 
12 Sugar transport (7 proteins) 1.02 1.60 0.92 1.30 0.81 1.38 0.2 0.3 0.2 0.5 0.8 0.6 0.6 
 
13 Amino acid and peptide transport (7 proteins) 0.72 1.26 0.43 0.58 0.28 1.12 0.8 1.4 1.1 0.4 2.0 1.2 0.8 
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Suppl. Table 5.3.2 Summary of proteome data of E. coli BL21 (DE3) growing in different media 
Cat.  
Nr. 
 Nr. Name 
Defined medium Complex medium 
Log2 
(DNB 
/TB) 
Log2 
(DNB 
/LB) 
Log2 
(defined/ 
complex) 
Log2 (stationary phase/exponential phase) 
DNB medium TB medium LB medium 
exp. stationary exp. stationary exp. stationary 
in TB 
medium 
in LB 
medium 
in 
complex 
media 
in 
defined 
medium 
phase phase phase phase phase phase 
Whole Cell Protein Mass (WCPM) - % At exp. phase 
 
14 Other transport proteins (14 proteins) 4.51 7.10 4.81 4.54 5.42 5.19 -0.1 -0.3 -0.2 -0.1 -0.1 -0.1 0.7 
                VI 
 
Transcription and translation (66 proteins): Sum 16 ~ 23 17.02 16.72 26.07 18.81 27.23 16.41 -0.6 -0.7 -0.6 -0.5 -0.7 -0.6 0.0 
                
 
15 RNA polymerases (3 proteins) 1.16 1.02 1.47 0.76 1.65 0.73 -0.3 -0.5 -0.4 -1.0 -1.2 -1.1 -0.2 
 
16 RNA polymerase binding proteins (7 proteins) 0.90 0.84 1.35 0.97 1.49 0.91 -0.6 -0.7 -0.7 -0.5 -0.7 -0.6 -0.1 
 
17 Transcription factors (12 proteins) 1.73 1.66 1.75 1.51 2.01 2.12 0.0 -0.2 -0.1 -0.2 0.1 -0.1 -0.1 
 
18 Ribosomal proteins (5 proteins) 2.82 2.67 5.10 2.45 5.73 2.25 -0.9 -1.0 -0.9 -1.1 -1.3 -1.2 -0.1 
 
19 Ribosome-associated proteins (8 proteins) 0.85 0.95 1.58 1.02 1.60 0.98 -0.9 -0.9 -0.9 -0.6 -0.7 -0.7 0.2 
 
20 Aminoacyl-tRNA synthetases (23 proteins) 3.40 2.79 5.14 4.63 4.89 3.27 -0.6 -0.5 -0.6 -0.1 -0.6 -0.4 -0.3 
 
21 Elongation factors (6 proteins) 5.66 6.45 8.93 7.12 9.21 5.77 -0.7 -0.7 -0.7 -0.3 -0.7 -0.5 0.2 
 
22 RNA degradation (3 proteins) 0.51 0.34 0.75 0.34 0.66 0.38 -0.6 -0.4 -0.5 -1.1 -0.8 -1.0 -0.6 
                VII 
 
Protein folding and degradation (28 proteins): Sum 24 ~ 26 4.33 4.72 5.93 7.11 5.68 6.43 -0.5 -0.4 -0.4 0.3 0.2 0.2 0.1 
                
 
23 Isomerases (5 proteins) 0.51 0.62 0.64 0.66 0.49 0.69 -0.3 0.1 -0.1 0.0 0.5 0.3 0.3 
 
24 Chaperones (9 proteins) 2.67 3.05 3.79 4.52 3.89 4.01 -0.5 -0.5 -0.5 0.3 0.0 0.2 0.2 
 
25 Proteases (13 proteins) 1.15 1.05 1.50 1.93 1.30 1.73 -0.4 -0.2 -0.3 0.4 0.4 0.4 -0.1 
                VIII 
 
Cell redox balance (22 proteins): Sum 6 ~ 8 2.74 3.63 2.72 5.19 2.47 3.95 0.0 0.2 0.1 0.9 0.7 0.8 0.4 
                
 
26.1 Other dehydrogenases (9 proteins) 0.87 0.79 0.76 0.89 0.76 1.00 0.2 0.2 0.2 0.2 0.4 0.3 -0.1 
 
26.2 Oxidoreductases (8 proteins) 0.49 0.68 0.47 0.82 0.49 0.91 0.1 0.0 0.0 0.8 0.9 0.9 0.5 
 
26.3 Hydroperoxide reductases and superoxide dismutase (5 proteins) 1.38 2.16 1.50 3.48 1.22 2.04 -0.1 0.2 0.0 1.2 0.7 1.0 0.6 
                IX 27 DNA protection and repair (7 proteins) 0.83 1.37 0.72 1.23 0.76 1.74 0.2 0.1 0.2 0.8 1.2 1.0 0.7 
                X 28 Unclassified proteins (7 proteins) 0.55 0.30 0.43 0.33 0.51 0.36 0.4 0.1 0.2 -0.4 -0.5 -0.4 -0.9 
                XI 29 Uncharacterized proteins (13 proteins) 0.82 0.71 0.57 0.92 0.59 1.12 0.5 0.5 0.5 0.7 0.9 0.8 -0.2 
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Suppl. Table 5.3.3 Sigma and transcription factors of the glycolysis and TCA cycle genes 
Pathway Genes 
Identified in this 
study? 
Promoter1 Sigma factor1, 2 Transcription factor1, 3 Function1 
Binding 
sites1, 3 
Binding sequence1, 3 
Upper 
glycolysis 
pgi No pgip sigmaS, sigmaD SoxS activator 1 cattacgctaACGGCACTAAAACCATCACAtttttctgtg 
pfkA Yes pfkAp2 sigmaS, sigmaD Cra (FruR) repressor 1 atttggcctgACCTGAATCAATTCAGCAggaagtgatt 
   pfkAp1 sigmaS, sigmaD     
 pfkB Yes pfkBp2 sigmaS     
   pfkBp1 sigmaS     
 fbaA Yes epdp sigmaS, sigmaD CRP-cAMP activator 1 aagaagacatTTATCTGACTCACATCACACTTttatcccctt 
     Cra (FruR) repressor 1 acatttaatcGACTGAAACGCTTCAGCTaggataagcg 
   pgkp13 sigmaD     
   pgkp2      
 fbaB Yes fbaBp sigmaS Cra (FruR) repressor 1 cagcgttttcTGTTGGCTCGATTCATCAgaaaaaatgt 
 tpiA Yes tpiAp2 sigmaS, sigmaD Cra (FruR) repressor 1 agatagcgccAGCTTAATCGGTTCAACAgcgaaggtca 
   tpiAp1      
         
Lower 
glycolysis 
gapA Yes gapAp3 sigmaD CRP-cAMP activator 1 gctgcacctaAATCGTGATGAAAATCACATTTttatcgtaat 
  gapAp1 sigmaS, sigmaD Cra (FruR) repressor   
   gapAp2 sigmaS     
   gapAp4 sigmaD     
 pgk Yes epdp sigmaS, sigmaD CRP-cAMP activator 1 aagaagacatTTATCTGACTCACATCACACTTttatcccctt 
     Cra (FruR) repressor 1 acatttaatcGACTGAAACGCTTCAGCTaggataagcg 
   pgkp13 sigmaD     
   pgkp2      
 gpmA Yes gpmAp sigmaS, sigmaD Fur repressor 2 atcatcttttAATGATAATAATTCTCATTatattgccgc 
        caaatcatctTTTAATGATAATAATTCTCattatattgc 
   pmAp2 sigmaS, sigmaD     
 gpmM No gpmMp  Cra (FruR) repressor 1 cttcagaggcTATTTTATCGATTCAGCTgtagtaaaat 
   gpmMp2 sigmaS     
 eno Yes enop123  Cra (FruR) repressor   
 
  enop47 sigmaS, sigmaD     
  enop6      
   pyrGp      
 
  pyrGp2      
  pyrGp1      
 pykA Yes pykAp12 sigmaS, sigmaD     
         
         
 A
-7
5
 
A
p
p
en
d
ix
 
 
Suppl. Table 5.3.3 Sigma and transcription factors of the glycolysis and TCA cycle genes 
Pathway Genes 
Identified in this 
study? 
Promoter1 Sigma factor1, 2 Transcription factor1, 3 Function1 
Binding 
sites1, 3 
Binding sequence1, 3 
Lower 
glycolysis 
pykF Yes pykFp sigmaD Cra (FruR) repressor 1 gccaattgacTCTTGAATGGTTTCAGCActttggactg 
  pykFp12 sigmaS, sigmaD     
   pykFp3      
 ppsA Yes ppsp sigmaD Cra (FruR) repressor 1 tgaaaaaaacGGTGAATCGTTCAAGCaaatatattt 
 aceEF Yes pdhRp sigmaS, sigmaD CRP-cAMP activator 6 atgtgcacagTTTCATGATTTCAATCAAAACCtgtatggaca 
        caagttgttaAAATGTGCACAGTTTCATGATTtcaatcaaaa 
        taaagtctacATTTGTGCATAGTTACAACTTTgaaacgttat 
        tacatcaaagAAGTTTGAATTGTTACAAAAAGacttccgtca 
        ctttgaaacgTTATATATGTCAAGTTGTTAAAatgtgcacag 
        atatatgtcaAGTTGTTAAAATGTGCACAGTTtcatgatttc 
     Cra (FruR) repressor 1 caaaattggtAAGTGAATCGGTTCAATTcggattttta 
     PdhR repressor 1 cacagacatgAAATTGGTAAGACCAATtgacttcggc 
     FNR dual 1 gcacagtttcATGATTTCAATCAAaacctgtatg 
   aceEp sigmaS, sigmaD Phospho-AcrA repressor   
     FNR repressor   
     NsrR-nitric oxide repressor 1 aattatccagAAGATGTTGTAaatcaagcgc 
 lpdA Yes pdhRp sigmaS, sigmaD CRP-cAMP activator 6 atgtgcacagTTTCATGATTTCAATCAAAACCtgtatggaca 
        caagttgttaAAATGTGCACAGTTTCATGATTtcaatcaaaa 
        taaagtctacATTTGTGCATAGTTACAACTTTgaaacgttat 
        tacatcaaagAAGTTTGAATTGTTACAAAAAGacttccgtca 
        ctttgaaacgTTATATATGTCAAGTTGTTAAAatgtgcacag 
        atatatgtcaAGTTGTTAAAATGTGCACAGTTtcatgatttc 
     Cra (FruR) repressor 1 caaaattggtAAGTGAATCGGTTCAATTcggattttta 
     PdhR repressor 1 cacagacatgAAATTGGTAAGACCAATtgacttcggc 
     FNR dual 1 gcacagtttcATGATTTCAATCAAaacctgtatg 
   lpdAp sigmaD Phospho-AcrA repressor 2 tttaaaaattGTTAACAATTTTGTAaaataccgac 
        cgtttgttgtTTAAAAATTGTTAACaattttgtaa 
     CRP-cAMP repressor ? 1 gttgtttaaaAATTGTTAACAATTTTGTAAAAtaccgacgga 
     FNR dual   
     Fis activator 1 gccgtttgttGTTTAAAAATTGTTAacaattttgt 
     Fur dual   
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Suppl. Table 5.3.3 Sigma and transcription factors of the glycolysis and TCA cycle genes 
Pathway Genes 
Identified in this 
study? 
Promoter1 Sigma factor1, 2 Transcription factor1, 3 Function1 
Binding 
sites1, 3 
Binding sequence1, 3 
TCA cycle gltA Yes gltAp1 sigmaD Phospho-AcrA repressor 1 gtaatgtttgTAACAACTTTGTTGAatgattgtca 
     CRP-cAMP activator 1 taaatgttgtTATCGTGACCTGGATCACTGTTcaggataaaa 
     IHF activator 1 aatgattgtcAAATTAGATGATTaaaaattaaa 
   gltAp2      
 acnA Yes acnAp2 sigmaD Phospho-AcrA repressor 1 aatttgggttGTTATCAAATCGTTAcgcgatgttt 
     CRP-cAMP activator 1 ctcttttatcAATTTGGGTTGTTATCAAATCGttacgcgatg 
     FNR repressor 1 tttatcaattTGGGTTGTTATCAAatcgttacgc 
     Cra (FruR) activator   
     MarA activator 1 aaggtttctcCTCTTTTATCAATTTGGGTTgttatcaaat 
     Rob activator 1 aaggtttctcCTCTTTTATCAATTTGGGTTgttatcaaat 
     SoxS activator 1 aaggtttctcCTCTTTTATCAATTTGGGTTgttatcaaat 
   acnAp1 sigmaS, sigmaD     
 acnB Yes acnBp sigmaD Phospho-AcrA repressor 7 gaggcggtagTTTAAATTTTGACTAatcttgggat 
        cttgggattcGTTGAGAAAGGTGATtatcaccatg 
        ggattcgttgAGAAAGGTGATTATCaccatgcgaa 
        ccatgcgaatTAACGAAGTTTTTACggagggaaac 
        ttatcaccatGCGAATTAACGAAGTttttacggag 
        gattcagccaCTTTTTTATGTTGCTtttttgtaaa 
        acttttttatGTTGCTTTTTTGTAAacagattaac 
     CRP-cAMP activator 1 acttttttatGTTGCTTTTTTGTAAacagattaac 
     Fis repressor 3 aagaggcggtAGTTTAAATTTTGACtaatcttggg 
        tctagaccatCCTTAACGATTCAGCcactttttta 
        tttgtaaacaGATTAACACCTCGTCaaaatcctgc 
     Cra (FruR) repressor   
   acnBp2      
 icd Yes icdAp1 sigmaD Phospho-AcrA repressor 2 gggtagtattGACAAGCCAATTACAaatcattaac 
        attgacaagcCAATTACAAATCATTaacaaaaaat 
   icdAp2 sigmaD Cra (FruR) repressor 1 gaacgttgcgAGCTGAATCGCTTAACCTggtgatttct 
 sucABCD Yes sdhCp sigmaD Phospho-AcrA repressor 5 ttgtaacaacTTTGTTGAATGATTGtcaaattaga 
        tgttacataaGTTAATCTTAGGTGAaataccgact 
        acaaagacctGTTAATCTGGACCTAcagaccatcc 
        atgtaggttaATTGTAATGATTTTGtgaacagcct 
        ggttaattgtAATGATTTTGTGAACagcctatact 
     CRP-cAMP activator 1 taaatgttgtTATCGTGACCTGGATCACTGTTcaggataaaa 
     FNR repressor   
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Suppl. Table 5.3.3 Sigma and transcription factors of the glycolysis and TCA cycle genes 
Pathway Genes 
Identified in this 
study? 
Promoter1 Sigma factor1, 2 Transcription factor1, 3 Function1 
Binding 
sites1, 3 
Binding sequence1, 3 
TCA cycle     Fur activator 1 ctatatgtagGTTAATTGTAATGATTTTGtgaacagcct 
   sucAp sigmaS Phospho-AcrA repressor   
     FNR repressor   
     IHF repressor   
 sdhAB Yes sdhCp sigmaD Phospho-AcrA repressor 5 ttgtaacaacTTTGTTGAATGATTGtcaaattaga 
 sdhCD No      tgttacataaGTTAATCTTAGGTGAaataccgact 
        acaaagacctGTTAATCTGGACCTAcagaccatcc 
        atgtaggttaATTGTAATGATTTTGtgaacagcct 
        ggttaattgtAATGATTTTGTGAACagcctatact 
     CRP-cAMP activator 1 taaatgttgtTATCGTGACCTGGATCACTGTTcaggataaaa 
     FNR repressor   
     Fur activator 1 ctatatgtagGTTAATTGTAATGATTTTGtgaacagcct 
   sdhDp2 sigmaD CRP-cAMP activator 1 tgggcagcttCTTCGTCAAATTTATCATGTGGggcatcctta 
 fumA Yes fumAp sigmaD Phospho-AcrA repressor   
     CRP-cAMP activator 1 ttcctgttcaAAGTATTATGCGCAGCACAGCCactctccatt 
     FNR repressor   
 fumB No fumBp sigmaD Phospho-AcrA activator   
     FNR activator 3 gcacgatacgCTCACACCAATCAAccccggcaga 
        gcacgcaaagTGCATTTATAAGAAcccgtacatc 
        gcaaagtgcaTTTATAAGAACCCGtacatcgcgg 
     Fis repressor   
     Fur activator   
   dcuBp  CRP-cAMP activator 1 tcgttaccggCTTTAGCAAATACCTCACAGTGaatattggct 
     FNR activator 1 cagtcacgttCTGTTTTGTATGAActgttttcag 
     NarL-Phosphorylated repressor 6 tggatagtaaATAACATgtgtgaaccc 
        tatcagtattATGATAAgttggatagt 
        agtaaataacATGTGTGaaccctcgcg 
        aaccctcgcgATAATCCtatttaaatt 
        tcacgttctgTTTTGTAtgaactgttt 
        ctttagcaaaTACCTCAcagtgaatat 
   dcuBp2  DcuR-Phosphorylated activator 2 ggtgacataaTAGTTAATTAACTTTTGttagcgtttt 
        ttttgttagcGTTTTGAAATTAAAAACaccgttcacc 
 fumC Yes fumCp  Phospho-AcrA repressor   
     FNR repressor   
     Fur repressor   
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Suppl. Table 5.3.3 Sigma and transcription factors of the glycolysis and TCA cycle genes 
Pathway Genes 
Identified in this 
study? 
Promoter1 Sigma factor1, 2 Transcription factor1, 3 Function1 
Binding 
sites1, 3 
Binding sequence1, 3 
TCA cycle     MarA activator 1 ttcacacagcGGGTGCATTGTGTGAGTTGTAtctgctggaa 
     Rob activator   
     SoxR activator   
     SoxS activator 1 ataacaaatgTTTGGTCTTTCGTGCCATgtaaaaaaac 
 mdh Yes mdhp1 sigmaD Phospho-AcrA repressor 1 ctaaactcctTATTATATTGATAAActaagatatg 
     CRP-cAMP activator 1 ccacatctcaAGAATGTGTAGTCACGCAAGTTtagcgtttat 
     DpiA-Pasp activator   
     FlhDC repressor   
   mdhp2  DpiA-Pasp activator   
 glcB Yes glcDp sigmaD Phospho-AcrA repressor 2 tcttggttaaCTCAATGTTAAATTGatgtaacata 
        taactcaatgTTAAATTGATGTAACataatcactt 
     GlcC-Glycolate activator 1 cagaaaaattGGTCCTACCTGTGCAcgaggtccgg 
     IHF activator 1 ggttaactcaATGTTAAATTGATgtaacataat 
   glcBp      
1
 The information in Suppl. Table 5.3.3 is from RegulonDB Version 7.0 [1] (http://regulondb.ccg.unam.mx).  
2
 Sigma factor σS (sigmaS) is marked as bold letter.  
3
 When a predicted binding site exists, three major transcription factors [Cra (FruR), CRP-cAMP and Phospho-AcrA] are marked as bold letter. 
[1] Gama-Castro, S., et al., RegulonDB version 7.0: transcriptional regulation of Escherichia coli K-12 integrated within genetic sensory response units (Gensor Units). Nucleic 
Acids Res, 2011. 39(Database issue): p. D98-105. 
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Suppl. Table 5.4.4 Amino acids feedback inhibition 
Suppl. Table 5.3.4 Amino acid feedback inhibition 
Protein(s) Involved pathways [1] Inhibitor References 
HisG Histidine biosynthesis Histidine [2] 
SerA Superpathway of serine and glycine biosynthesis Serine [3] 
AroF Superpathway of phenylalanine, tyrosine, and tryptophan biosynthesis Tyrosine [4] 
TrpDE Tryptophan biosynthesis Tryptophan [5] 
PheA Phenylalanine and tyrosine biosynthesis Phenylalanine [6] 
CysE Cysteine biosynthesis Cysteine [7] 
ProB Proline biosynthesis Proline [8] 
ArgA Arginine biosynthesis Arginine [9] 
AsnA Asparagine biosynthesis Asparagine [10] 
LysC Superpathway of lysine, threonine and methionine biosynthesis Lysine [11] 
ThrAB Threonine and methionine biosynthesis Threonine [12] 
MetA Methionine biosynthesis Methionine [13] 
DapA Lysine biosynthesis Lysine [14] 
IlvBHIN Superpathway of leucine, valine, and isoleucine biosynthesis Leucine [15-17] 
IlvA Superpathway of leucine, valine, and isoleucine biosynthesis Leucine [18] 
leuA Superpathway of leucine, valine, and isoleucine biosynthesis Leucine [16] 
References: 
1. Keseler, I.M., Collado-Vides, J., Gama-Castro, S., Ingraham, J., Paley, S., Paulsen, I.T., 
Peralta-Gil, M. and Karp, P.D., EcoCyc: a comprehensive database resource for Escherichia 
coli. Nucleic Acids Res, 2005. 33(Database issue): D334-7. 
2. Tebar, A.R. and Ballesteros, A.O., Kinetic properties of ATP phosphoribosyltransferase of 
Escherichia coli. Mol Cell Biochem, 1976. 11(3): 131-6. 
3. Grant, G.A., Schuller, D.J. and Banaszak, L.J., A model for the regulation of D-3-
phosphoglycerate dehydrogenase, a Vmax-type allosteric enzyme. Protein Sci, 1996. 5(1): 34-
41. 
4. Shultz, J., Hermodson, M.A., Garner, C.C. and Herrmann, K.M., The nucleotide sequence of 
the aroF gene of Escherichia coli and the amino acid sequence of the encoded protein, the 
tyrosine-sensitive 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase. J Biol Chem, 1984. 
259(15): 9655-61. 
5. Pabst, M.J., Kuhn, J.C. and Somerville, R.L., Feedback regulation in the anthranilate aggregate 
from wild type and mutant strains of Escherichia coli. J Biol Chem, 1973. 248(3): 901-14. 
6. Dopheide, T.A., Crewther, P. and Davidson, B.E., Chorismate mutase-prephenate dehydratase 
from Escherichia coli K-12. II. Kinetic properties. J Biol Chem, 1972. 247(14): 4447-52. 
7. Hindson, V.J., Serine acetyltransferase of Escherichia coli: substrate specificity and feedback 
control by cysteine. Biochem J, 2003. 375(Pt 3): 745-52. 
8. Perez-Arellano, I., Rubio, V. and Cervera, J., Dissection of Escherichia coli glutamate 5-kinase: 
functional impact of the deletion of the PUA domain. FEBS Lett, 2005. 579(30): 6903-8. 
9. Marvil, D.K. and Leisinger, T., N-acetylglutamate synthase of Escherichia coli: purification, 
characterization, and molecular properties. J Biol Chem, 1977. 252(10): 3295-303. 
10. Cedar, H. and Schwartz, J.H., The asparagine synthetase of Escherichia coli. II. Studies on 
mechanism. J Biol Chem, 1969. 244(15): 4122-7. 
11. Kotaka, M., Ren, J., Lockyer, M., Hawkins, A.R. and Stammers, D.K., Structures of R- and T-
state Escherichia coli aspartokinase III. Mechanisms of the allosteric transition and inhibition 
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by lysine. J Biol Chem, 2006. 281(42): 31544-52. 
12. Chassagnole, C., Rais, B., Quentin, E., Fell, D.A. and Mazat, J.P., An integrated study of 
threonine-pathway enzyme kinetics in Escherichia coli. Biochem J, 2001. 356(Pt 2): 415-23. 
13. Born, T.L. and Blanchard, J.S., Enzyme-catalyzed acylation of homoserine: mechanistic 
characterization of the Escherichia coli metA-encoded homoserine transsuccinylase. 
Biochemistry, 1999. 38(43): 14416-23. 
14. Shedlarski, J.G. and Gilvarg, C., The pyruvate-aspartic semialdehyde condensing enzyme of 
Escherichia coli. J Biol Chem, 1970. 245(6): 1362-73. 
15. Barak, Z., Calvo, J.M. and Schloss, J.V., Acetolactate synthase isozyme III from Escherichia 
coli. Methods Enzymol, 1988. 166: 455-8. 
16. Stieglitz, B.I. and Calvo, J.M., Distribution of the isopropylmalate pathway to leucine among 
diverse bacteria. J Bacteriol, 1974. 118(3): 935-41. 
17. Gollop, N., Tavori, H. and Barak, Z., Acetohydroxy acid synthase is a target for leucine 
containing peptide toxicity in Escherichia coli. J Bacteriol, 1982. 149(1): 387-90. 
18. Vonder Haar, R.A. and Umbarger, H.E., Isoleucine and valine metabolism in Escherichia coli. 
XIX. Inhibition of isoleucine biosynthesis by glycyl-leucine. J Bacteriol, 1972. 112(1): 142-7. 
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Suppl. Table 5.3.5 Proteome data of E. coli BL21 (DE3) during hFGF-2 production in 
defined and complex media 
Whole Cell Protein Mass (WCPM) - %: Each spot’s intensity was normalized by the 
whole spots intensity on each 2D gel. The corresponding average from two duplicated 
gels was used indicating each spot’s protein portion (%) of whole cell protein mass 
(WCPM). The total “WCPM %” of all spots representing the same protein was used for 
indicating the abundance of the corresponding protein.   
For each protein's WCPM (%), number with two digits after the decimal point is given. 
But for a better comparision of the low abundance protein (WCPM <0.05 %), three 
digits after the decimal point are given.  
Log2(1h after IPTG/exp. before IPTG): Log2(1h after IPTG induction/exponential 
phase before IPTG induction)  
Log2(5h or 3.5h after IPTG/exp. before IPTG): Log2(5h or 3.5 after IPTG 
induction/exponential phase before IPTG induction) 
Log2(5h or 3.5h after IPTG/stationary without IPTG): Log2(5h or 3.5h after IPTG 
induction/stationary phase without IPTG induction) 
Log2(stationary without IPTG/exp. before IPTG): Log2(stationary phase without 
IPTG induction/exponential phase before IPTG induction) 
Log2(DNB medium/LB Medium) exp. before IPTG: Log2(exponential phase before 
IPTG induction in DNB medium/exponential phase before IPTG induction in LB 
medium) 
If WCPM (%) of a protein is zero, an artificial Log2 ratio: ">5" or "<-5" was given, 
indicating the corresponing Log2 ratio is larger than 5 or smaller than -5, respectively.  
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Suppl. Table 5.3.5 Proteome data of hFGF-2 production in E. coli BL21 (DE3) using defined and complex media 
Name1 Protein name1 
Defind (DNB) medium Complex (LB) medium Log2(Ratio in Defind (DNB) medium) Log2(Ratio in Complex (LB) medium) Log2(DNB 
exp. 1h 5h stationary exp. 1h 3.5h stationary (1h after (5h after (5h after (stationary (1h after (3.5h after (3.5h after (stationary medium/ 
phase after after phase phase after after phase IPTG/ IPTG/ IPTG/ without IPTG/ IPTG/ IPTG/ without LB 
before IPTG IPTG without before IPTG IPTG without exp. exp. stationary IPTG/ exp. exp. stationary IPTG/ medium) 
IPTG induction induction IPTG IPTG induction induction IPTG before before without exp. before before before without exp. before exp.before 
Whole Cell Protein Mass (WCPM) - % IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG 
                   Central carbon metabolism (24 proteins): Upper 
and lower glycolysis, glycerol metabolism and 
pentose phosphate pathway. 
6.59 6.61 5.29 7.01 7.36 7.70 6.14 8.26 0.0 -0.3 -0.4 0.1 0.1 -0.3 -0.4 0.2 -0.2 
                  
  
Sub-group: Upper glycolysis (5 proteins) 1.26 1.28 0.93 1.50 0.91 0.98 0.75 1.35 0.0 -0.4 -0.7 0.3 0.1 -0.3 -0.8 0.6 0.5 
                   
PfkA 6-Phosphofructokinase 0.12 0.12 0.08 0.14 0.09 0.08 0.06 0.10 0.0 -0.6 -0.8 0.2 -0.2 -0.6 -0.7 0.2 0.4 
PfkB 6-Phosphofructokinase isozyme 2  0.038 0.039 0.024 0.039 0.00 0.00 0.00 0.044 0.0 -0.7 -0.7 0.0 0.0 0.0 <-5 >5 >5 
FbaA Fructose-bisphosphate aldolase class 2 0.86 0.87 0.62 1.03 0.67 0.77 0.51 0.85 0.0 -0.5 -0.7 0.3 0.2 -0.4 -0.7 0.3 0.4 
FbaB Fructose-bisphosphate aldolase class 1 0.019 0.024 0.00 0.030 0.018 0.00 0.033 0.07 0.3 <-5 <-5 0.7 <-5 0.9 -1.1 2.0 0.1 
TpiA Triosephosphate isomerase 0.23 0.23 0.21 0.26 0.14 0.12 0.14 0.29 0.0 -0.1 -0.3 0.2 -0.2 0.0 -1.1 1.1 0.7 
                                      
Sub-group: Lower glycolysis  
(to Acetyl-CoA) (11 proteins) 
4.21 4.24 3.49 4.28 5.18 5.05 3.95 5.05 0.0 -0.3 -0.3 0.0 0.0 -0.4 -0.4 0.0 -0.3 
                   
GapA 
Glyceraldehyde-3-phosphate 
dehydrogenase A 
0.64 0.63 0.53 0.58 0.64 0.56 0.48 0.72 0.0 -0.3 -0.1 -0.1 -0.2 -0.4 -0.6 0.2 0.0 
Pgk Phosphoglycerate kinase 0.58 0.60 0.47 0.73 0.55 0.58 0.45 0.69 0.0 -0.3 -0.6 0.3 0.1 -0.3 -0.6 0.3 0.1 
GpmA Phosphoglyceromutase 0.18 0.21 0.17 0.26 0.18 0.25 0.16 0.37 0.2 -0.1 -0.6 0.5 0.5 -0.2 -1.2 1.0 0.0 
Eno Enolase 0.49 0.59 0.40 0.61 0.37 0.48 0.34 0.56 0.3 -0.3 -0.6 0.3 0.4 -0.1 -0.7 0.6 0.4 
PykA Pyruvate kinase 0.06 0.05 0.049 0.047 0.09 0.027 0.033 0.08 -0.3 -0.3 0.1 -0.4 -1.7 -1.4 -1.3 -0.2 -0.6 
PykF Pyruvate kinase I 0.18 0.16 0.17 0.19 0.25 0.17 0.12 0.24 -0.2 -0.1 -0.2 0.1 -0.6 -1.1 -1.0 -0.1 -0.5 
PpsA Phosphoenolpyruvate synthase 0.12 0.06 0.05 0.07 0.24 0.33 0.30 0.41 -1.0 -1.3 -0.5 -0.8 0.5 0.3 -0.5 0.8 -1.0 
YdbK 
Pyruvate flavodoxin/ferredoxin 
oxidoreductase domain protein 
0.07 0.06 0.043 0.050 0.05 0.043 0.033 0.06 -0.2 -0.7 -0.2 -0.5 -0.2 -0.6 -0.9 0.3 0.5 
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Suppl. Table 5.3.5 Proteome data of hFGF-2 production in E. coli BL21 (DE3) using defined and complex media 
Name1 Protein name1 
Defind (DNB) medium Complex (LB) medium Log2(Ratio in Defind (DNB) medium) Log2(Ratio in Complex (LB) medium) Log2(DNB 
exp. 1h 5h stationary exp. 1h 3.5h stationary (1h after (5h after (5h after (stationary (1h after (3.5h after (3.5h after (stationary medium/ 
phase after after phase phase after after phase IPTG/ IPTG/ IPTG/ without IPTG/ IPTG/ IPTG/ without LB 
before IPTG IPTG without before IPTG IPTG without exp. exp. stationary IPTG/ exp. exp. stationary IPTG/ medium) 
IPTG induction induction IPTG IPTG induction induction IPTG before before without exp. before before before without exp. before exp.before 
Whole Cell Protein Mass (WCPM) - % IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG 
AceE 
Pyruvate dehydrogenase (acetyl-
transferring), homodimeric type 
0.87 0.96 0.82 0.76 1.51 1.35 1.02 0.92 0.1 -0.1 0.1 -0.2 -0.2 -0.6 0.1 -0.7 -0.8 
AceF 
Pyruvate dehydrogenase, 
dihydrolipoyltransacetylase component E2 
0.35 0.28 0.21 0.36 0.47 0.38 0.23 0.08 -0.3 -0.7 -0.8 0.0 -0.3 -1.0 1.5 -2.6 -0.4 
LpdA Dihydrolipoamide dehydrogenase 0.64 0.63 0.57 0.62 0.83 0.89 0.80 0.93 0.0 -0.2 -0.1 0.0 0.1 -0.1 -0.2 0.2 -0.4 
                                      
Sub-group: Glycerol metabolism  
(2 proteins) 
0.13 0.06 0.08 0.14 0.15 0.47 0.32 0.29 -1.1 -0.7 -0.8 0.1 1.6 1.1 0.1 1.0 -0.2 
                   
GlpK Glycerol kinase 0.10 0.032 0.026 0.09 0.12 0.43 0.29 0.20 -1.6 -1.9 -1.8 -0.2 1.8 1.3 0.5 0.7 -0.3 
Dhak Dihydroxyacetone kinase subunit DhaK 0.030 0.030 0.05 0.042 0.027 0.036 0.031 0.09 0.0 0.7 0.3 0.5 0.4 0.2 -1.5 1.7 0.2 
                    
Sub-group: Pentose phosphate pathway (PPP) (6 
proteins) 
0.99 1.03 0.79 1.09 1.12 1.21 1.13 1.57 0.1 -0.3 -0.5 0.1 0.1 0.0 -0.5 0.5 -0.2 
                   
Gnd 6-Phosphogluconate dehydrogenase 0.30 0.30 0.27 0.32 0.39 0.42 0.36 0.42 0.0 -0.2 -0.2 0.1 0.1 -0.1 -0.2 0.1 -0.4 
TktA Transketolase 0.46 0.45 0.38 0.42 0.53 0.57 0.58 0.65 0.0 -0.3 -0.1 -0.1 0.1 0.1 -0.2 0.3 -0.2 
TktB Transketolase 2 0.017 0.028 0.00 0.011 0.013 0.00 0.00 0.05 0.7 <-5 <-5 -0.6 <-5 <-5 <-5 1.9 0.4 
TalB Chain A, Structure Of Transaldolase B 0.13 0.15 0.07 0.21 0.15 0.18 0.16 0.37 0.2 -0.9 -1.6 0.7 0.3 0.1 -1.2 1.3 -0.2 
TalA Transaldolase A 0.048 0.06 0.045 0.07 0.00 0.00 0.00 0.06 0.3 -0.1 -0.6 0.5 0.0 0.0 <-5 >5 >5 
Eda KHG/KDPG aldolase 0.032 0.039 0.031 0.06 0.029 0.035 0.029 0.041 0.3 0.0 -1.0 0.9 0.3 0.0 -0.5 0.5 0.1 
                   
By-product metabolism (9 proteins) 1.20 1.12 0.89 0.95 1.06 1.13 0.96 2.12 -0.1 -0.4 -0.1 -0.3 0.1 -0.1 -1.1 1.0 0.2 
                   
Acs Acetyl-coenzyme A synthetase 0.10 0.10 0.10 0.09 0.05 0.10 0.13 0.71 0.0 0.0 0.2 -0.2 1.0 1.4 -2.4 3.8 1.0 
PoxB Pyruvate dehydrogenase [ubiquinone] 0.012 0.037 0.00 0.025 0.00 0.00 0.00 0.047 1.6 <-5 <-5 1.1 0.0 0.0 <-5 >5 >5 
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Suppl. Table 5.3.5 Proteome data of hFGF-2 production in E. coli BL21 (DE3) using defined and complex media 
Name1 Protein name1 
Defind (DNB) medium Complex (LB) medium Log2(Ratio in Defind (DNB) medium) Log2(Ratio in Complex (LB) medium) Log2(DNB 
exp. 1h 5h stationary exp. 1h 3.5h stationary (1h after (5h after (5h after (stationary (1h after (3.5h after (3.5h after (stationary medium/ 
phase after after phase phase after after phase IPTG/ IPTG/ IPTG/ without IPTG/ IPTG/ IPTG/ without LB 
before IPTG IPTG without before IPTG IPTG without exp. exp. stationary IPTG/ exp. exp. stationary IPTG/ medium) 
IPTG induction induction IPTG IPTG induction induction IPTG before before without exp. before before before without exp. before exp.before 
Whole Cell Protein Mass (WCPM) - % IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG 
Pta Phosphate acetyltransferase 0.13 0.16 0.15 0.11 0.17 0.30 0.14 0.12 0.3 0.2 0.4 -0.2 0.8 -0.3 0.2 -0.5 -0.4 
AckA Acetate kinase 0.08 0.08 0.08 0.09 0.21 0.17 0.14 0.11 0.0 0.0 -0.2 0.2 -0.3 -0.6 0.3 -0.9 -1.4 
AdhE 
Bifunctional acetaldehyde-CoA/alcohol 
dehydrogenase 
0.33 0.31 0.18 0.29 0.21 0.09 0.15 0.46 -0.1 -0.9 -0.7 -0.2 -1.2 -0.5 -1.6 1.1 0.7 
PflB Formate acetyltransferase 1 0.41 0.32 0.26 0.20 0.32 0.38 0.32 0.55 -0.4 -0.7 0.4 -1.0 0.2 0.0 -0.8 0.8 0.4 
LldD L-Lactate dehydrogenase 0.05 0.05 0.039 0.05 0.049 0.029 0.042 0.031 0.0 -0.4 -0.4 0.0 -0.8 -0.2 0.4 -0.7 0.0 
Dld D-Lactate dehydrogenase 0.047 0.044 0.031 0.039 0.031 0.016 0.029 0.05 -0.1 -0.6 -0.3 -0.3 -1.0 -0.1 -0.8 0.7 0.6 
LdhA D-Lactate dehydrogenase 0.032 0.018 0.043 0.042 0.017 0.036 0.017 0.033 -0.8 0.4 0.0 0.4 1.1 0.0 -1.0 1.0 0.9 
                    
TCA cycle (14 proteins) 5.50 4.84 3.74 4.70 3.61 4.78 4.84 8.42 -0.2 -0.6 -0.3 -0.2 0.4 0.4 -0.8 1.2 0.6 
                   
GltA Citrate synthase 0.69 0.65 0.43 0.55 0.29 0.37 0.61 1.36 -0.1 -0.7 -0.4 -0.3 0.4 1.1 -1.2 2.2 1.3 
AcnA Aconitate hydratase 1 0.15 0.10 0.16 0.17 0.21 0.26 0.20 0.41 -0.6 0.1 -0.1 0.2 0.3 -0.1 -1.0 1.0 -0.5 
AcnB Aconitate hydratase 2 0.86 0.76 0.55 0.59 0.61 0.93 0.85 1.21 -0.2 -0.6 -0.1 -0.5 0.6 0.5 -0.5 1.0 0.5 
Icd Isocitrate dehydrogenase 0.94 0.93 0.82 1.02 0.59 0.79 0.79 1.35 0.0 -0.2 -0.3 0.1 0.4 0.4 -0.8 1.2 0.7 
SucA 
2-Oxoglutarate dehydrogenase E1 
component 
0.47 0.41 0.22 0.27 0.45 0.37 0.54 0.56 -0.2 -1.1 -0.3 -0.8 -0.3 0.3 -0.1 0.3 0.1 
SucB Dihydrolipoamide succinyltransferase 0.48 0.37 0.37 0.38 0.43 0.57 0.46 0.54 -0.4 -0.4 0.0 -0.3 0.4 0.1 -0.2 0.3 0.2 
SucC Succinyl-CoA synthetase subunit beta 0.44 0.43 0.30 0.44 0.28 0.44 0.39 0.59 0.0 -0.6 -0.6 0.0 0.7 0.5 -0.6 1.1 0.7 
SucD 
Succinyl-CoA ligase [ADP-forming] 
subunit alpha 
0.39 0.30 0.22 0.27 0.28 0.29 0.33 0.66 -0.4 -0.8 -0.3 -0.5 0.1 0.2 -1.0 1.2 0.5 
SdhA 
Succinate dehydrogenase flavoprotein 
subunit 
0.40 0.33 0.31 0.39 0.18 0.36 0.33 0.46 -0.3 -0.4 -0.3 0.0 1.0 0.9 -0.5 1.4 1.2 
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Suppl. Table 5.3.5 Proteome data of hFGF-2 production in E. coli BL21 (DE3) using defined and complex media 
Name1 Protein name1 
Defind (DNB) medium Complex (LB) medium Log2(Ratio in Defind (DNB) medium) Log2(Ratio in Complex (LB) medium) Log2(DNB 
exp. 1h 5h stationary exp. 1h 3.5h stationary (1h after (5h after (5h after (stationary (1h after (3.5h after (3.5h after (stationary medium/ 
phase after after phase phase after after phase IPTG/ IPTG/ IPTG/ without IPTG/ IPTG/ IPTG/ without LB 
before IPTG IPTG without before IPTG IPTG without exp. exp. stationary IPTG/ exp. exp. stationary IPTG/ medium) 
IPTG induction induction IPTG IPTG induction induction IPTG before before without exp. before before before without exp. before exp.before 
Whole Cell Protein Mass (WCPM) - % IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG 
SdhB 
Succinate dehydrogenase and fumarate 
reductase iron-sulfur protein 
0.16 0.12 0.09 0.11 0.07 0.06 0.06 0.11 -0.4 -0.8 -0.3 -0.5 -0.2 -0.2 -0.9 0.7 1.2 
FumA 
Fumarate hydratase (fumarase A), aerobic 
Class I 
0.029 0.030 0.021 0.032 0.025 0.035 0.044 0.08 0.0 -0.5 -0.6 0.1 0.5 0.8 -0.9 1.7 0.2 
FumC 
Fumarate hydratase (fumarase C), aerobic 
Class II 
0.16 0.11 0.06 0.10 0.08 0.08 0.06 0.27 -0.5 -1.4 -0.7 -0.7 0.0 -0.4 -2.2 1.8 1.0 
Mdh Malate dehydrogenase 0.32 0.28 0.14 0.35 0.07 0.18 0.15 0.74 -0.2 -1.2 -1.3 0.1 1.4 1.1 -2.3 3.4 2.2 
GlcB Malate synthase G 0.015 0.022 0.041 0.034 0.039 0.05 0.024 0.07 0.6 1.5 0.3 1.2 0.4 -0.7 -1.5 0.8 -1.4 
                    
Connection between glycolysis and TCA cycle (4 
proteins) 
0.67 0.61 0.60 0.72 0.36 0.43 0.40 0.83 -0.1 -0.2 -0.3 0.1 0.3 0.2 -1.1 1.2 0.9 
                   
Ppc Phosphoenolpyruvate carboxylase 0.46 0.42 0.36 0.42 0.24 0.23 0.20 0.20 -0.1 -0.4 -0.2 -0.1 -0.1 -0.3 0.0 -0.3 0.9 
PckA Phosphoenolpyruvate carboxykinase 0.09 0.07 0.16 0.18 0.046 0.08 0.08 0.43 -0.4 0.8 -0.2 1.0 0.8 0.8 -2.4 3.2 1.0 
MaeB 
Malate dehydrogenase (Oxaloacetate-
decarboxylating) (NADP(+)) 
0.09 0.08 0.048 0.06 0.040 0.08 0.07 0.17 -0.2 -0.9 -0.3 -0.6 1.0 0.8 -1.3 2.1 1.2 
SfcA NAD-dependent malic enzyme 0.034 0.041 0.033 0.07 0.033 0.035 0.037 0.026 0.3 0.0 -1.1 1.0 0.1 0.2 0.5 -0.3 0.0 
                    
Oxidative phosphorylation (7 proteins) 2.44 2.31 1.89 2.65 2.53 2.61 2.22 2.39 -0.1 -0.4 -0.5 0.1 0.0 -0.2 -0.1 -0.1 -0.1 
                   
AtpA F0F1 ATP synthase subunit alpha 1.13 1.12 0.91 1.38 1.06 1.19 0.90 1.06 0.0 -0.3 -0.6 0.3 0.2 -0.2 -0.2 0.0 0.1 
AtpD F0F1 ATP synthase subunit beta 0.59 0.60 0.48 0.67 0.80 0.94 0.78 0.70 0.0 -0.3 -0.5 0.2 0.2 0.0 0.2 -0.2 -0.4 
AtpH F0F1 ATP synthase subunit delta 0.07 0.07 0.06 0.08 0.09 0.09 0.06 0.06 0.0 -0.2 -0.4 0.2 0.0 -0.6 0.0 -0.6 -0.4 
NuoF NADH dehydrogenase I subunit F 0.14 0.11 0.12 0.11 0.14 0.08 0.08 0.14 -0.3 -0.2 0.1 -0.3 -0.8 -0.8 -0.8 0.0 0.0 
NuoG NADH dehydrogenase subunit G 0.24 0.16 0.13 0.17 0.21 0.12 0.19 0.21 -0.6 -0.9 -0.4 -0.5 -0.8 -0.1 -0.1 0.0 0.2 
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Suppl. Table 5.3.5 Proteome data of hFGF-2 production in E. coli BL21 (DE3) using defined and complex media 
Name1 Protein name1 
Defind (DNB) medium Complex (LB) medium Log2(Ratio in Defind (DNB) medium) Log2(Ratio in Complex (LB) medium) Log2(DNB 
exp. 1h 5h stationary exp. 1h 3.5h stationary (1h after (5h after (5h after (stationary (1h after (3.5h after (3.5h after (stationary medium/ 
phase after after phase phase after after phase IPTG/ IPTG/ IPTG/ without IPTG/ IPTG/ IPTG/ without LB 
before IPTG IPTG without before IPTG IPTG without exp. exp. stationary IPTG/ exp. exp. stationary IPTG/ medium) 
IPTG induction induction IPTG IPTG induction induction IPTG before before without exp. before before before without exp. before exp.before 
Whole Cell Protein Mass (WCPM) - % IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG 
NuoC 
Bifunctional NADH:ubiquinone 
oxidoreductase subunit C/D 
0.18 0.18 0.13 0.14 0.16 0.12 0.14 0.15 0.0 -0.5 -0.1 -0.4 -0.4 -0.2 -0.1 -0.1 0.2 
NuoB NADH-quinone oxidoreductase subunit B 0.10 0.07 0.07 0.09 0.07 0.07 0.07 0.07 -0.5 -0.5 -0.4 -0.2 0.0 0.0 0.0 0.0 0.5 
                   Amino acid biosynthesis and metabolism (68 
proteins): Amino acid biosynthesis and amino acid 
degradation 
13.15 12.08 10.89 12.82 5.21 5.62 5.67 10.65 -0.1 -0.3 -0.2 0.0 0.1 0.1 -0.9 1.0 1.3 
                    
Sub-group: Amino acid biosynthesis  
(57 proteins) 
12.37 11.37 10.17 11.93 4.42 4.60 4.43 6.91 -0.1 -0.3 -0.2 -0.1 0.1 0.0 -0.6 0.6 1.5 
                   
AroD 3-Dehydroquinate dehydratase 0.14 0.15 0.15 0.16 0.10 0.14 0.09 0.11 0.1 0.1 -0.1 0.2 0.5 -0.2 -0.3 0.1 0.5 
AroB 3-Dehydroquinate synthase 0.024 0.036 0.034 0.019 0.014 0.00 0.029 0.030 0.6 0.5 0.8 -0.3 <-5 1.1 0.0 1.1 0.8 
AroF 
Phospho-2-dehydro-3-deoxyheptonate 
aldolase 
0.16 0.19 0.13 0.18 0.07 0.09 0.10 0.38 0.2 -0.3 -0.5 0.2 0.4 0.5 -1.9 2.4 1.2 
AroG 
Phospho-2-dehydro-3-deoxyheptonate 
aldolase, Phe-sensitive 
0.21 0.22 0.18 0.19 0.07 0.06 0.08 0.048 0.1 -0.2 -0.1 -0.1 -0.2 0.2 0.7 -0.5 1.6 
TrpD Anthranilate synthase, component II 0.09 0.08 0.047 0.08 0.00 0.00 0.00 0.022 -0.2 -0.9 -0.8 -0.2 0.0 0.0 <-5 >5 >5 
TrpE Component I of anthranilate synthase 0.16 0.12 0.10 0.10 0.00 0.00 0.00 0.00 -0.4 -0.7 0.0 -0.7 0.0 0.0 0.0 0.0 >5 
TrpC Anthranilate isomerase 0.10 0.13 0.07 0.12 0.09 0.12 0.10 0.13 0.4 -0.5 -0.8 0.3 0.4 0.2 -0.4 0.5 0.2 
TrpA Tryptophan synthase alpha chain 0.030 0.035 0.07 0.046 0.00 0.00 0.017 0.031 0.2 1.2 0.6 0.6 0.0 >5 -0.9 >5 >5 
PheA P-protein 0.06 0.06 0.06 0.05 0.042 0.027 0.033 0.027 0.0 0.0 0.3 -0.3 -0.6 -0.3 0.3 -0.6 0.5 
TyrA T-protein 0.12 0.10 0.08 0.11 0.020 0.039 0.043 0.036 -0.3 -0.6 -0.5 -0.1 1.0 1.1 0.3 0.8 2.6 
AspC 
Aspartate aminotransferase, PLP-
dependent 
0.19 0.22 0.15 0.30 0.14 0.14 0.12 0.19 0.2 -0.3 -1.0 0.7 0.0 -0.2 -0.7 0.4 0.4 
SerA D-3-Phosphoglycerate dehydrogenase 0.58 0.59 0.54 0.69 0.23 0.22 0.27 0.64 0.0 -0.1 -0.4 0.3 -0.1 0.2 -1.2 1.5 1.3 
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Suppl. Table 5.3.5 Proteome data of hFGF-2 production in E. coli BL21 (DE3) using defined and complex media 
Name1 Protein name1 
Defind (DNB) medium Complex (LB) medium Log2(Ratio in Defind (DNB) medium) Log2(Ratio in Complex (LB) medium) Log2(DNB 
exp. 1h 5h stationary exp. 1h 3.5h stationary (1h after (5h after (5h after (stationary (1h after (3.5h after (3.5h after (stationary medium/ 
phase after after phase phase after after phase IPTG/ IPTG/ IPTG/ without IPTG/ IPTG/ IPTG/ without LB 
before IPTG IPTG without before IPTG IPTG without exp. exp. stationary IPTG/ exp. exp. stationary IPTG/ medium) 
IPTG induction induction IPTG IPTG induction induction IPTG before before without exp. before before before without exp. before exp.before 
Whole Cell Protein Mass (WCPM) - % IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG 
SerC Phosphoserine aminotransferase 0.31 0.23 0.18 0.27 0.10 0.14 0.11 0.15 -0.4 -0.8 -0.6 -0.2 0.5 0.1 -0.4 0.6 1.6 
GdhA Glutamate dehydrogenase, NADP-specific 0.09 0.12 0.17 0.14 0.030 0.045 0.05 0.06 0.4 0.9 0.3 0.6 0.6 0.7 -0.3 1.0 1.6 
GlnA Glutamine synthetase 0.41 0.35 0.25 0.31 0.19 0.13 0.15 0.16 -0.2 -0.7 -0.3 -0.4 -0.5 -0.3 -0.1 -0.2 1.1 
GltB Glutamate synthase subunit alpha 0.15 0.12 0.17 0.16 0.037 0.00 0.00 0.00 -0.3 0.2 0.1 0.1 <-5 <-5 0.0 <-5 2.0 
HisG ATP phosphoribosyltransferase 0.10 0.05 0.06 0.09 0.07 0.06 0.07 0.06 -1.0 -0.7 -0.6 -0.2 -0.2 0.0 0.2 -0.2 0.5 
HisF 
Imidazole glycerol phosphate synthase 
subunit hisF 
0.09 0.07 0.06 0.08 0.08 0.09 0.05 0.10 -0.4 -0.6 -0.4 -0.2 0.2 -0.7 -1.0 0.3 0.2 
HisC Histidinol-phosphate aminotransferase 0.06 0.035 0.07 0.05 0.038 0.048 0.025 0.11 -0.8 0.2 0.5 -0.3 0.3 -0.6 -2.1 1.5 0.7 
HisD Histidinol dehydrogenase 0.022 0.031 0.016 0.046 0.030 0.019 0.024 0.032 0.5 -0.5 -1.5 1.1 -0.7 -0.3 -0.4 0.1 -0.4 
GlyA Serine hydroxymethyltransferase 0.71 0.68 0.59 0.75 0.32 0.31 0.28 0.67 -0.1 -0.3 -0.3 0.1 0.0 -0.2 -1.3 1.1 1.1 
CysK Cysteine synthase A 0.41 0.35 0.28 0.49 0.11 0.10 0.13 0.40 -0.2 -0.6 -0.8 0.3 -0.1 0.2 -1.6 1.9 1.9 
CysN Sulfate adenylyltransferase, subunit 1 0.12 0.12 0.09 0.12 0.020 0.035 0.013 0.019 0.0 -0.4 -0.4 0.0 0.8 -0.6 -0.5 -0.1 2.6 
CysJ Sulfite reductase subunit alpha 0.07 0.08 0.10 0.07 0.024 0.05 0.041 0.020 0.2 0.5 0.5 0.0 1.1 0.8 1.0 -0.3 1.5 
CysI Sulfite reductase subunit beta 0.05 0.049 0.031 0.037 0.00 0.00 0.00 0.00 0.0 -0.7 -0.3 -0.4 0.0 0.0 0.0 0.0 >5 
LysC Aspartokinase III 0.034 0.06 0.039 0.06 0.00 0.00 0.00 0.00 0.8 0.2 -0.6 0.8 0.0 0.0 0.0 0.0 >5 
Asd Maltose-binding periplasmic protein 0.25 0.27 0.21 0.29 0.13 0.13 0.11 0.26 0.1 -0.3 -0.5 0.2 0.0 -0.2 -1.2 1.0 0.9 
DapA Dihydrodipicolinate synthase 0.10 0.09 0.06 0.08 0.08 0.08 0.07 0.10 -0.2 -0.7 -0.4 -0.3 0.0 -0.2 -0.5 0.3 0.3 
DapD 
2,3,4,5-Tetrahydropyridine-2-carboxylate 
N-succinyltransferase 
0.18 0.16 0.13 0.25 0.13 0.13 0.09 0.10 -0.2 -0.5 -0.9 0.5 0.0 -0.5 -0.2 -0.4 0.5 
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Suppl. Table 5.3.5 Proteome data of hFGF-2 production in E. coli BL21 (DE3) using defined and complex media 
Name1 Protein name1 
Defind (DNB) medium Complex (LB) medium Log2(Ratio in Defind (DNB) medium) Log2(Ratio in Complex (LB) medium) Log2(DNB 
exp. 1h 5h stationary exp. 1h 3.5h stationary (1h after (5h after (5h after (stationary (1h after (3.5h after (3.5h after (stationary medium/ 
phase after after phase phase after after phase IPTG/ IPTG/ IPTG/ without IPTG/ IPTG/ IPTG/ without LB 
before IPTG IPTG without before IPTG IPTG without exp. exp. stationary IPTG/ exp. exp. stationary IPTG/ medium) 
IPTG induction induction IPTG IPTG induction induction IPTG before before without exp. before before before without exp. before exp.before 
Whole Cell Protein Mass (WCPM) - % IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG 
LysA Diaminopimelate decarboxylase 0.06 0.05 0.06 0.05 0.10 0.09 0.08 0.13 -0.3 0.0 0.3 -0.3 -0.2 -0.3 -0.7 0.4 -0.7 
ThrB Homoserine kinase 0.039 0.045 0.039 0.05 0.00 0.00 0.00 0.037 0.2 0.0 -0.4 0.4 0.0 0.0 <-5 >5 >5 
MetA Homoserine O-succinyltransferase 0.036 0.034 0.042 0.040 0.00 0.00 0.035 0.025 -0.1 0.2 0.1 0.2 0.0 >5 0.5 >5 >5 
MetH Methionine synthase 0.12 0.09 0.07 0.08 0.06 0.06 0.05 0.038 -0.4 -0.8 -0.2 -0.6 0.0 -0.3 0.4 -0.7 1.0 
MetE 
5-Methyltetrahydropteroyltriglutamate-
homocysteine S-methyltransferase 
3.00 2.58 2.71 2.38 0.09 0.07 0.12 0.24 -0.2 -0.1 0.2 -0.3 -0.4 0.4 -1.0 1.4 5.1 
IlvA Threonine dehydratase biosynthetic 0.15 0.18 0.13 0.16 0.08 0.09 0.07 0.16 0.3 -0.2 -0.3 0.1 0.2 -0.2 -1.2 1.0 0.9 
IlvB Acetolactate synthase I, large subunit 0.05 0.05 0.030 0.045 0.00 0.00 0.05 0.018 0.0 -0.7 -0.6 -0.2 0.0 >5 1.5 >5 >5 
IlvC 
Ketol-acid reductoisomerase, NAD(P)-
binding 
1.01 0.91 0.78 1.06 0.06 0.07 0.07 0.13 -0.2 -0.4 -0.4 0.1 0.2 0.2 -0.9 1.1 4.1 
IlvD Dihydroxyacid dehydratase 0.31 0.26 0.20 0.25 0.07 0.06 0.048 0.07 -0.3 -0.6 -0.3 -0.3 -0.2 -0.5 -0.5 0.0 2.1 
IlvE 
Chain A, Branched-Chain Amino Acid 
Aminotransferase 
0.33 0.33 0.24 0.33 0.048 0.07 0.07 0.23 0.0 -0.5 -0.5 0.0 0.5 0.5 -1.7 2.3 2.8 
IlvI 
Acetolactate synthase isozyme 3 large 
subunit 
0.06 0.048 0.040 0.049 0.020 0.012 0.023 0.026 -0.3 -0.6 -0.3 -0.3 -0.7 0.2 -0.2 0.4 1.6 
LeuA 2-Isopropylmalate synthase 0.18 0.21 0.12 0.15 0.00 0.07 0.00 0.00 0.2 -0.6 -0.3 -0.3 >5 0.0 0.0 0.0 >5 
LeuB 3-Isopropylmalate dehydrogenase 0.10 0.11 0.12 0.13 0.07 0.13 0.048 0.10 0.1 0.3 -0.1 0.4 0.9 -0.5 -1.1 0.5 0.5 
LeuC Isopropylmalate isomerase large subunit 0.12 0.13 0.08 0.16 0.00 0.00 0.015 0.018 0.1 -0.6 -1.0 0.4 0.0 >5 -0.3 >5 >5 
LeuD 3-Isopropylmalate isomerase subunit 0.06 0.08 0.06 0.10 0.00 0.00 0.00 0.00 0.4 0.0 -0.7 0.7 0.0 0.0 0.0 0.0 >5 
AsnA Aspartate--ammonia ligase 0.09 0.08 0.08 0.08 0.036 0.020 0.032 0.11 -0.2 -0.2 0.0 -0.2 -0.8 -0.2 -1.8 1.6 1.3 
AsnB Asparagine synthase 0.10 0.10 0.13 0.12 0.045 0.023 0.048 0.08 0.0 0.4 0.1 0.3 -1.0 0.1 -0.7 0.8 1.2 
 A
-89 
A
ppendix 
 
Suppl. Table 5.3.5 Proteome data of hFGF-2 production in E. coli BL21 (DE3) using defined and complex media 
Name1 Protein name1 
Defind (DNB) medium Complex (LB) medium Log2(Ratio in Defind (DNB) medium) Log2(Ratio in Complex (LB) medium) Log2(DNB 
exp. 1h 5h stationary exp. 1h 3.5h stationary (1h after (5h after (5h after (stationary (1h after (3.5h after (3.5h after (stationary medium/ 
phase after after phase phase after after phase IPTG/ IPTG/ IPTG/ without IPTG/ IPTG/ IPTG/ without LB 
before IPTG IPTG without before IPTG IPTG without exp. exp. stationary IPTG/ exp. exp. stationary IPTG/ medium) 
IPTG induction induction IPTG IPTG induction induction IPTG before before without exp. before before before without exp. before exp.before 
Whole Cell Protein Mass (WCPM) - % IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG 
CarA 
Carbamoyl phosphate synthase small 
subunit 
0.15 0.15 0.11 0.14 0.15 0.14 0.15 0.13 0.0 -0.4 -0.3 -0.1 -0.1 0.0 0.2 -0.2 0.0 
CarB 
Carbamoyl phosphate synthase large 
subunit 
0.38 0.26 0.22 0.20 0.42 0.27 0.33 0.28 -0.5 -0.8 0.1 -0.9 -0.6 -0.3 0.2 -0.6 -0.1 
ArgC 
N-Acetyl-gamma-glutamyl-phosphate 
reductase 
0.06 0.043 0.034 0.05 0.07 0.06 0.042 0.047 -0.5 -0.8 -0.6 -0.3 -0.2 -0.7 -0.2 -0.6 -0.2 
ArgD 
Acetylornithine/succinyldiaminopimelate 
aminotransferase 
0.25 0.18 0.16 0.19 0.09 0.14 0.12 0.10 -0.5 -0.6 -0.2 -0.4 0.6 0.4 0.3 0.2 1.5 
ArgE Acetylornithine deacetylase  0.043 0.039 0.040 0.047 0.045 0.046 0.035 0.048 -0.1 -0.1 -0.2 0.1 0.0 -0.4 -0.5 0.1 -0.1 
ArgI Ornithine carbamoyltransferase chain I 0.041 0.031 0.05 0.037 0.06 0.06 0.038 0.049 -0.4 0.3 0.4 -0.1 0.0 -0.7 -0.4 -0.3 -0.5 
ArgG Argininosuccinate synthase 0.20 0.21 0.19 0.25 0.22 0.23 0.25 0.18 0.1 -0.1 -0.4 0.3 0.1 0.2 0.5 -0.3 -0.1 
ArgH Argininosuccinate lyase 0.16 0.17 0.15 0.18 0.25 0.27 0.21 0.15 0.1 -0.1 -0.3 0.2 0.1 -0.3 0.5 -0.7 -0.6 
AspA Aspartate ammonia-lyase 0.12 0.08 0.06 0.17 0.14 0.30 0.24 0.50 -0.6 -1.0 -1.5 0.5 1.1 0.8 -1.1 1.8 -0.2 
ProA Gamma-glutamyl phosphate reductase 0.06 0.06 0.037 0.05 0.039 0.039 0.032 0.043 0.0 -0.7 -0.4 -0.3 0.0 -0.3 -0.4 0.1 0.6 
IscS 
(Yfho) 
Cysteine desulfurase  0.07 0.07 0.06 0.05 0.10 0.09 0.10 0.08 0.0 -0.2 0.3 -0.5 -0.2 0.0 0.3 -0.3 -0.5 
                   
Sub-group: Amino acid degradation  
(11 proteins) 
0.78 0.71 0.72 0.89 0.79 1.02 1.24 3.74 -0.1 -0.1 -0.3 0.2 0.4 0.7 -1.6 2.2 0.0 
                   
DadX Alanine racemase, catabolic 0.038 0.035 0.026 0.037 0.039 0.028 0.036 0.08 -0.1 -0.5 -0.5 0.0 -0.5 -0.1 -1.2 1.0 0.0 
TnaA Tryptophanase 0.06 0.05 0.06 0.05 0.16 0.34 0.57 2.59 -0.3 0.0 0.3 -0.3 1.1 1.8 -2.2 4.0 -1.4 
MetF 5,10-Methylenetetrahydrofolate reductase 0.17 0.13 0.09 0.11 0.00 0.00 0.00 0.00 -0.4 -0.9 -0.3 -0.6 0.0 0.0 0.0 0.0 >5 
MetK 
Chain A, S-Adenosylmethionine 
Synthetase 
0.27 0.21 0.24 0.32 0.19 0.18 0.17 0.11 -0.4 -0.2 -0.4 0.2 -0.1 -0.2 0.6 -0.8 0.5 
GcvT Glycine cleavage system T protein 0.036 0.07 0.00 0.09 0.00 0.00 0.00 0.00 1.0 <-5 <-5 1.3 0.0 0.0 0.0 0.0 >5 
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Suppl. Table 5.3.5 Proteome data of hFGF-2 production in E. coli BL21 (DE3) using defined and complex media 
Name1 Protein name1 
Defind (DNB) medium Complex (LB) medium Log2(Ratio in Defind (DNB) medium) Log2(Ratio in Complex (LB) medium) Log2(DNB 
exp. 1h 5h stationary exp. 1h 3.5h stationary (1h after (5h after (5h after (stationary (1h after (3.5h after (3.5h after (stationary medium/ 
phase after after phase phase after after phase IPTG/ IPTG/ IPTG/ without IPTG/ IPTG/ IPTG/ without LB 
before IPTG IPTG without before IPTG IPTG without exp. exp. stationary IPTG/ exp. exp. stationary IPTG/ medium) 
IPTG induction induction IPTG IPTG induction induction IPTG before before without exp. before before before without exp. before exp.before 
Whole Cell Protein Mass (WCPM) - % IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG 
AstA Arginine N-succinyltransferase 0.030 0.031 0.031 0.045 0.015 0.00 0.032 0.10 0.0 0.0 -0.5 0.6 <-5 1.1 -1.6 2.7 1.0 
AstB N-Succinylarginine dihydrolase  0.033 0.017 0.035 0.036 0.026 0.038 0.027 0.040 -1.0 0.1 0.0 0.1 0.5 0.1 -0.6 0.6 0.3 
AstD 
N-Succinylglutamate 5-semialdehyde 
dehydrogenase 
0.00 0.00 0.031 0.05 0.022 0.08 0.06 0.15 0.0 >5 -0.7 >5 1.9 1.4 -1.3 2.8 <-5 
Tdh L-threonine 3-dehydrogenase 0.021 0.031 0.037 0.029 0.08 0.05 0.048 0.12 0.6 0.8 0.4 0.5 -0.7 -0.7 -1.3 0.6 -1.9 
Kbl 
2-Amino-3-ketobutyrate coenzyme A 
ligase 
0.11 0.09 0.14 0.09 0.18 0.17 0.16 0.37 -0.3 0.3 0.6 -0.3 -0.1 -0.2 -1.2 1.0 -0.7 
PutA Bifunctional protein putA 0.007 0.035 0.033 0.026 0.08 0.13 0.14 0.18 2.3 2.2 0.3 1.9 0.7 0.8 -0.4 1.2 -3.5 
                            
IMP biosynthesis (for nucleotide) (7 proteins) 1.27 1.23 1.17 1.39 0.59 0.59 0.60 1.00 0.0 -0.1 -0.2 0.1 0.0 0.0 -0.7 0.8 1.1 
                   
PurF Amidophosphoribosyltransferase 0.07 0.09 0.08 0.039 0.019 0.029 0.017 0.033 0.4 0.2 1.0 -0.8 0.6 -0.2 -1.0 0.8 1.9 
PurD Phosphoribosylamine--glycine ligase 0.23 0.21 0.18 0.39 0.14 0.21 0.15 0.18 -0.1 -0.4 -1.1 0.8 0.6 0.1 -0.3 0.4 0.7 
PurT 
Phosphoribosylglycinamide 
formyltransferase 2 
0.09 0.06 0.07 0.08 0.05 0.047 0.05 0.19 -0.6 -0.4 -0.2 -0.2 -0.1 0.0 -1.9 1.9 0.8 
PurL 
Phosphoribosylformyl-glycineamide 
synthetase 
0.36 0.36 0.36 0.28 0.13 0.08 0.15 0.19 0.0 0.0 0.4 -0.4 -0.7 0.2 -0.3 0.5 1.5 
PurC 
Phosphoribosylaminoimidazole-
succinocarboxamide synthase 
0.12 0.14 0.10 0.22 0.036 0.05 0.029 0.10 0.2 -0.3 -1.1 0.9 0.5 -0.3 -1.8 1.5 1.7 
PurB Adenylosuccinate lyase 0.14 0.11 0.11 0.12 0.11 0.09 0.09 0.09 -0.3 -0.3 -0.1 -0.2 -0.3 -0.3 0.0 -0.3 0.3 
PurH 
Bifunctional purine biosynthesis protein 
PurH 
0.26 0.25 0.26 0.27 0.10 0.08 0.11 0.21 -0.1 0.0 -0.1 0.1 -0.3 0.1 -0.9 1.1 1.4 
                            
Nucleotide biosynthesis (start from IMP) (13 
proteins) 
1.53 1.64 1.48 1.87 1.90 1.83 1.59 1.88 0.1 0.0 -0.3 0.3 -0.1 -0.3 -0.2 0.0 -0.3 
                   
PurA Adenylosuccinate synthetase 0.41 0.45 0.35 0.48 0.42 0.46 0.38 0.43 0.1 -0.2 -0.5 0.2 0.1 -0.1 -0.2 0.0 0.0 
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Suppl. Table 5.3.5 Proteome data of hFGF-2 production in E. coli BL21 (DE3) using defined and complex media 
Name1 Protein name1 
Defind (DNB) medium Complex (LB) medium Log2(Ratio in Defind (DNB) medium) Log2(Ratio in Complex (LB) medium) Log2(DNB 
exp. 1h 5h stationary exp. 1h 3.5h stationary (1h after (5h after (5h after (stationary (1h after (3.5h after (3.5h after (stationary medium/ 
phase after after phase phase after after phase IPTG/ IPTG/ IPTG/ without IPTG/ IPTG/ IPTG/ without LB 
before IPTG IPTG without before IPTG IPTG without exp. exp. stationary IPTG/ exp. exp. stationary IPTG/ medium) 
IPTG induction induction IPTG IPTG induction induction IPTG before before without exp. before before before without exp. before exp.before 
Whole Cell Protein Mass (WCPM) - % IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG 
GuaA 
GMP synthetase (glutamine 
aminotransferase) 
0.14 0.15 0.14 0.20 0.14 0.15 0.12 0.12 0.1 0.0 -0.5 0.5 0.1 -0.2 0.0 -0.2 0.0 
GuaB Inositol-5-monophosphate dehydrogenase 0.16 0.19 0.15 0.17 0.22 0.15 0.14 0.13 0.2 -0.1 -0.2 0.1 -0.6 -0.7 0.1 -0.8 -0.5 
Add Adenosine deaminase 0.037 0.028 0.07 0.031 0.00 0.00 0.031 0.026 -0.4 0.9 1.2 -0.3 0.0 >5 0.3 >5 >5 
DeoB Phosphopentomutase 0.042 0.030 0.041 0.045 0.046 0.07 0.07 0.10 -0.5 0.0 -0.1 0.1 0.6 0.6 -0.5 1.1 -0.1 
DeoD 
Chain A, Purine Nucleoside 
Phosphorylase 
0.048 0.09 0.10 0.10 0.21 0.15 0.10 0.12 0.9 1.1 0.0 1.1 -0.5 -1.1 -0.3 -0.8 -2.1 
Hpt Hypoxanthine phosphoribosyltransferase 0.15 0.16 0.14 0.16 0.07 0.09 0.09 0.16 0.1 -0.1 -0.2 0.1 0.4 0.4 -0.8 1.2 1.1 
Apt Adenine phosphoribosyltransferase 0.06 0.07 0.06 0.09 0.10 0.07 0.06 0.049 0.2 0.0 -0.6 0.6 -0.5 -0.7 0.3 -1.0 -0.7 
                   
Udp Uridine phosphorylase 0.07 0.06 0.042 0.09 0.11 0.12 0.07 0.16 -0.2 -0.7 -1.1 0.4 0.1 -0.7 -1.2 0.5 -0.7 
PyrG CTP synthase 0.19 0.17 0.16 0.21 0.37 0.36 0.28 0.25 -0.2 -0.2 -0.4 0.1 0.0 -0.4 0.2 -0.6 -1.0 
Tmk Thymidylate kinase 0.046 0.06 0.040 0.08 0.07 0.06 0.042 0.06 0.4 -0.2 -1.0 0.8 -0.2 -0.7 -0.5 -0.2 -0.6 
Ndk Nucleoside diphosphate kinase 0.15 0.15 0.17 0.15 0.11 0.15 0.13 0.21 0.0 0.2 0.2 0.0 0.4 0.2 -0.7 0.9 0.4 
Amn AMP nucleosidase 0.031 0.05 0.024 0.06 0.034 0.00 0.07 0.08 0.7 -0.4 -1.3 1.0 <-5 1.0 -0.2 1.2 -0.1 
                             
Fatty acid biosynthesis (7 proteins) 1.13 1.09 1.10 1.17 1.62 1.31 1.08 1.12 -0.1 0.0 -0.1 0.1 -0.3 -0.6 -0.1 -0.5 -0.5 
                   
AccA 
Acetyl-coenzyme A carboxylase carboxyl 
transferase subunit alpha 
0.09 0.08 0.09 0.10 0.14 0.11 0.11 0.08 -0.2 0.0 -0.2 0.2 -0.3 -0.3 0.5 -0.8 -0.6 
AccC 
Acetyl-CoA carboxylase, biotin 
carboxylase subunit 
0.14 0.13 0.10 0.12 0.25 0.13 0.15 0.14 -0.1 -0.5 -0.3 -0.2 -0.9 -0.7 0.1 -0.8 -0.8 
FabH 
3-Oxoacyl-[acyl-carrier-protein] synthase 
3 
0.045 0.045 0.047 0.043 0.07 0.07 0.041 0.029 0.0 0.1 0.1 -0.1 0.0 -0.8 0.5 -1.3 -0.6 
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Suppl. Table 5.3.5 Proteome data of hFGF-2 production in E. coli BL21 (DE3) using defined and complex media 
Name1 Protein name1 
Defind (DNB) medium Complex (LB) medium Log2(Ratio in Defind (DNB) medium) Log2(Ratio in Complex (LB) medium) Log2(DNB 
exp. 1h 5h stationary exp. 1h 3.5h stationary (1h after (5h after (5h after (stationary (1h after (3.5h after (3.5h after (stationary medium/ 
phase after after phase phase after after phase IPTG/ IPTG/ IPTG/ without IPTG/ IPTG/ IPTG/ without LB 
before IPTG IPTG without before IPTG IPTG without exp. exp. stationary IPTG/ exp. exp. stationary IPTG/ medium) 
IPTG induction induction IPTG IPTG induction induction IPTG before before without exp. before before before without exp. before exp.before 
Whole Cell Protein Mass (WCPM) - % IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG 
FabB 
3-Oxoacyl-[acyl-carrier-protein] synthase 
I 
0.18 0.25 0.33 0.36 0.36 0.30 0.22 0.33 0.5 0.9 -0.1 1.0 -0.3 -0.7 -0.6 -0.1 -1.0 
FabF 
3-Oxoacyl-(acyl carrier protein) synthase 
II 
0.28 0.22 0.21 0.20 0.35 0.32 0.26 0.23 -0.3 -0.4 0.1 -0.5 -0.1 -0.4 0.2 -0.6 -0.3 
FabI 
Enoyl-[acyl-carrier-protein] reductase 
[NADH] FabI 
0.28 0.22 0.21 0.26 0.32 0.30 0.22 0.25 -0.3 -0.4 -0.3 -0.1 -0.1 -0.5 -0.2 -0.4 -0.2 
FabZ 
(3R)-Hydroxymyristoyl-[acyl-carrier-
protein] dehydratase 
0.12 0.14 0.11 0.10 0.14 0.07 0.08 0.06 0.2 -0.1 0.1 -0.3 -1.0 -0.8 0.4 -1.2 -0.2 
                             
Lipopolysaccharide  biosynthesis  
(10 proteins) 
0.82 0.55 0.71 0.67 0.91 1.10 0.89 1.00 -0.6 -0.2 0.1 -0.3 0.3 0.0 -0.2 0.1 -0.2 
                   
GmhA Phosphoheptose isomerase 0.037 0.040 0.029 0.046 0.023 0.024 0.024 0.06 0.1 -0.4 -0.7 0.3 0.1 0.1 -1.3 1.4 0.7 
HldE Bifunctional protein hldE 0.039 0.045 0.042 0.06 0.025 0.05 0.05 0.046 0.2 0.1 -0.5 0.6 1.0 1.0 0.1 0.9 0.6 
HldD 
ADP-L-glycero-D-manno-heptose-6-
epimerase 
0.31 0.11 0.15 0.18 0.20 0.49 0.26 0.34 -1.5 -1.0 -0.3 -0.8 1.3 0.4 -0.4 0.8 0.6 
                   
LpxA 
Acyl-[acyl-carrier-protein]--UDP-N-
acetylglucosamine O-acyltransferase 
0.10 0.07 0.10 0.045 0.06 0.032 0.08 0.05 -0.5 0.0 1.2 -1.2 -0.9 0.4 0.7 -0.3 0.7 
ArnA 
Bifunctional polymyxin resistance protein 
ArnA 
0.06 0.06 0.039 0.048 0.08 0.043 0.043 0.08 0.0 -0.6 -0.3 -0.3 -0.9 -0.9 -0.9 0.0 -0.4 
                   
GlmS 
Glucosamine--fructose-6-phosphate 
aminotransferase [isomerizing] 
0.14 0.11 0.19 0.12 0.27 0.22 0.22 0.16 -0.3 0.4 0.7 -0.2 -0.3 -0.3 0.5 -0.8 -0.9 
GlmM Phosphoglucosamine mutase 0.042 0.035 0.039 0.047 0.05 0.05 0.045 0.08 -0.3 -0.1 -0.3 0.2 0.0 -0.2 -0.8 0.7 -0.3 
GlmU Bifunctional protein GlmU 0.00 0.00 0.00 0.00 0.06 0.05 0.049 0.047 0.0 0.0 0.0 0.0 -0.3 -0.3 0.1 -0.4 <-5 
RmlA 
Glucose-1-phosphate 
thymidylyltransferase 
0.049 0.042 0.05 0.049 0.05 0.033 0.038 0.040 -0.2 0.0 0.0 0.0 -0.6 -0.4 -0.1 -0.3 0.0 
RfbB dTDP-glucose 4,6-dehydratase 0.032 0.039 0.07 0.08 0.09 0.09 0.08 0.09 0.3 1.1 -0.2 1.3 0.0 -0.2 -0.2 0.0 -1.5 
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Suppl. Table 5.3.5 Proteome data of hFGF-2 production in E. coli BL21 (DE3) using defined and complex media 
Name1 Protein name1 
Defind (DNB) medium Complex (LB) medium Log2(Ratio in Defind (DNB) medium) Log2(Ratio in Complex (LB) medium) Log2(DNB 
exp. 1h 5h stationary exp. 1h 3.5h stationary (1h after (5h after (5h after (stationary (1h after (3.5h after (3.5h after (stationary medium/ 
phase after after phase phase after after phase IPTG/ IPTG/ IPTG/ without IPTG/ IPTG/ IPTG/ without LB 
before IPTG IPTG without before IPTG IPTG without exp. exp. stationary IPTG/ exp. exp. stationary IPTG/ medium) 
IPTG induction induction IPTG IPTG induction induction IPTG before before without exp. before before before without exp. before exp.before 
Whole Cell Protein Mass (WCPM) - % IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG 
Synthesis of other cellular components  
(16 proteins) 
0.86 0.88 0.81 1.02 0.71 0.74 0.72 0.96 0.0 -0.1 -0.3 0.2 0.1 0.0 -0.4 0.4 0.3 
                   
HemB Delta-aminolevulinic acid dehydratase 0.11 0.12 0.09 0.19 0.05 0.06 0.06 0.15 0.1 -0.3 -1.1 0.8 0.3 0.3 -1.3 1.6 1.1 
HemL 
Glutamate-1-semialdehyde 2,1-
aminomutase 
0.12 0.09 0.08 0.09 0.08 0.11 0.09 0.09 -0.4 -0.6 -0.2 -0.4 0.5 0.2 0.0 0.2 0.6 
IspG 
4-Hydroxy-3-methylbut-2-en-1-yl 
diphosphate synthase 
0.06 0.06 0.07 0.05 0.09 0.08 0.06 0.047 0.0 0.2 0.5 -0.3 -0.2 -0.6 0.4 -0.9 -0.6 
IspE 
4-Diphosphocytidyl-2-C-methyl-D-
erythritol kinase 
0.042 0.06 0.035 0.06 0.031 0.07 0.019 0.05 0.5 -0.3 -0.8 0.5 1.2 -0.7 -1.4 0.7 0.4 
Mpl 
UDP-N-acetylmuramate:L-alanyl-gamma-
D-glutamyl-meso-diaminopimelate ligase  
0.035 0.034 0.032 0.05 0.043 0.06 0.07 0.15 0.0 -0.1 -0.6 0.5 0.5 0.7 -1.1 1.8 -0.3 
GshB Glutathione synthetase 0.046 0.045 0.034 0.05 0.05 0.048 0.037 0.05 0.0 -0.4 -0.6 0.1 -0.1 -0.4 -0.4 0.0 -0.1 
MdoG Glucan biosynthesis protein, periplasmic 0.045 0.048 0.032 0.043 0.06 0.035 0.05 0.041 0.1 -0.5 -0.4 -0.1 -0.8 -0.3 0.3 -0.5 -0.4 
SpeA Biosynthetic arginine decarboxylase 0.08 0.09 0.07 0.11 0.15 0.17 0.14 0.08 0.2 -0.2 -0.7 0.5 0.2 -0.1 0.8 -0.9 -0.9 
SpeE Spermidine synthase 0.044 0.047 0.043 0.05 0.031 0.00 0.00 0.042 0.1 0.0 -0.2 0.2 <-5 <-5 <-5 0.4 0.5 
LuxS S-ribosylhomocysteine lyase 0.035 0.043 0.00 0.06 0.00 0.00 0.00 0.047 0.3 <-5 <-5 0.8 0.0 0.0 <-5 >5 >5 
NadE NH(3)-dependent NAD(+) synthetase 0.034 0.046 0.024 0.05 0.020 0.036 0.015 0.040 0.4 -0.5 -1.1 0.6 0.8 -0.4 -1.4 1.0 0.8 
PanB 
3-Methyl-2-oxobutanoate 
hydroxymethyltransferase 
0.026 0.037 0.07 0.032 0.026 0.037 0.026 0.039 0.5 1.4 1.1 0.3 0.5 0.0 -0.6 0.6 0.0 
PanC Pantothenate synthetase 0.028 0.038 0.06 0.039 0.026 0.00 0.034 0.046 0.4 1.1 0.6 0.5 <-5 0.4 -0.4 0.8 0.1 
ThiC Phosphomethylpyrimidine synthase 0.13 0.12 0.09 0.06 0.022 0.027 0.07 0.040 -0.1 -0.5 0.6 -1.1 0.3 1.7 0.8 0.9 2.6 
GlgB 1,4-Alpha-glucan branching enzyme 0.017 0.012 0.031 0.036 0.010 0.00 0.010 0.022 -0.5 0.9 -0.2 1.1 <-5 0.0 -1.1 1.1 0.8 
OtsA 
Alpha,alpha-trehalose-phosphate synthase 
[UDP-forming] 
0.00 0.00 0.045 0.043 0.023 0.00 0.043 0.026 0.0 >5 0.1 >5 <-5 0.9 0.7 0.2 <-5 
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Suppl. Table 5.3.5 Proteome data of hFGF-2 production in E. coli BL21 (DE3) using defined and complex media 
Name1 Protein name1 
Defind (DNB) medium Complex (LB) medium Log2(Ratio in Defind (DNB) medium) Log2(Ratio in Complex (LB) medium) Log2(DNB 
exp. 1h 5h stationary exp. 1h 3.5h stationary (1h after (5h after (5h after (stationary (1h after (3.5h after (3.5h after (stationary medium/ 
phase after after phase phase after after phase IPTG/ IPTG/ IPTG/ without IPTG/ IPTG/ IPTG/ without LB 
before IPTG IPTG without before IPTG IPTG without exp. exp. stationary IPTG/ exp. exp. stationary IPTG/ medium) 
IPTG induction induction IPTG IPTG induction induction IPTG before before without exp. before before before without exp. before exp.before 
Whole Cell Protein Mass (WCPM) - % IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG 
(Metabolite) degradation (19 proteins) 1.67 1.46 1.14 1.64 1.52 1.51 1.33 3.45 -0.2 -0.6 -0.5 0.0 0.0 -0.2 -1.4 1.2 0.1 
                   
MalP Maltodextrin phosphorylase 0.11 0.09 0.07 0.10 0.22 0.13 0.05 0.18 -0.3 -0.7 -0.5 -0.1 -0.8 -2.1 -1.8 -0.3 -1.0 
MalQ 4-Alpha-glucanotransferase 0.13 0.09 0.06 0.12 0.40 0.28 0.19 0.21 -0.5 -1.1 -1.0 -0.1 -0.5 -1.1 -0.1 -0.9 -1.6 
Pgm Phosphoglucomutase 0.15 0.15 0.12 0.12 0.09 0.14 0.09 0.12 0.0 -0.3 0.0 -0.3 0.6 0.0 -0.4 0.4 0.7 
BglX Periplasmic beta-glucosidase precursor 0.06 0.041 0.037 0.046 0.05 0.042 0.032 0.045 -0.5 -0.7 -0.3 -0.4 -0.3 -0.6 -0.5 -0.2 0.3 
GatZ 
D-Tagatose-1,6-bisphosphate aldolase 
subunit gatZ 
0.54 0.48 0.28 0.57 0.18 0.31 0.34 1.16 -0.2 -0.9 -1.0 0.1 0.8 0.9 -1.8 2.7 1.6 
GatD Galactitol-1-phosphate 5-dehydrogenase 0.14 0.13 0.10 0.14 0.07 0.11 0.10 0.60 -0.1 -0.5 -0.5 0.0 0.7 0.5 -2.6 3.1 1.0 
XylA Xylose isomerase  0.022 0.038 0.042 0.031 0.00 0.00 0.00 0.037 0.8 0.9 0.4 0.5 0.0 0.0 <-5 >5 >5 
TreA Periplasmic trehalase 0.037 0.046 0.027 0.039 0.014 0.016 0.013 0.045 0.3 -0.5 -0.5 0.1 0.2 -0.1 -1.8 1.7 1.4 
TreC Trehalose-6-phosphate hydrolase 0.05 0.026 0.08 0.09 0.11 0.10 0.10 0.07 -0.9 0.7 -0.2 0.8 -0.1 -0.1 0.5 -0.7 -1.1 
MelA Alpha-galactosidase 0.030 0.037 0.035 0.08 0.06 0.07 0.13 0.23 0.3 0.2 -1.2 1.4 0.2 1.1 -0.8 1.9 -1.0 
GabT 4-Aminobutyrate aminotransferase GabT  0.16 0.09 0.14 0.047 0.00 0.00 0.022 0.09 -0.8 -0.2 1.6 -1.8 0.0 >5 -2.0 >5 >5 
GabD 
Succinate-semialdehyde dehydrogenase 
[NADP+] GabD 
0.07 0.07 0.049 0.045 0.10 0.11 0.10 0.12 0.0 -0.5 0.1 -0.6 0.1 0.0 -0.3 0.3 -0.5 
Prr 
Gamma-aminobutyraldehyde 
dehydrogenase  
0.034 0.038 0.043 0.03 0.020 0.00 0.00 0.20 0.2 0.3 0.3 0.0 <-5 <-5 <-5 3.3 0.8 
UidA Beta-glucuronidase 0.05 0.05 0.046 0.05 0.05 0.06 0.06 0.07 0.0 -0.1 -0.1 0.0 0.3 0.3 -0.2 0.5 0.0 
CpdB 
2',3'-Cyclic-nucleotide 2'-
phosphodiesterase/3'-nucleotidase  
0.026 0.020 0.016 0.025 0.021 0.025 0.015 0.040 -0.4 -0.7 -0.6 -0.1 0.3 -0.5 -1.4 0.9 0.3 
DkgA 2,5-Diketo-D-gluconic acid reductase A 0.024 0.028 0.00 0.06 0.045 0.00 0.00 0.05 0.2 <-5 <-5 1.3 <-5 <-5 <-5 0.2 -0.9 
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Suppl. Table 5.3.5 Proteome data of hFGF-2 production in E. coli BL21 (DE3) using defined and complex media 
Name1 Protein name1 
Defind (DNB) medium Complex (LB) medium Log2(Ratio in Defind (DNB) medium) Log2(Ratio in Complex (LB) medium) Log2(DNB 
exp. 1h 5h stationary exp. 1h 3.5h stationary (1h after (5h after (5h after (stationary (1h after (3.5h after (3.5h after (stationary medium/ 
phase after after phase phase after after phase IPTG/ IPTG/ IPTG/ without IPTG/ IPTG/ IPTG/ without LB 
before IPTG IPTG without before IPTG IPTG without exp. exp. stationary IPTG/ exp. exp. stationary IPTG/ medium) 
IPTG induction induction IPTG IPTG induction induction IPTG before before without exp. before before before without exp. before exp.before 
Whole Cell Protein Mass (WCPM) - % IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG 
NanA N-Acetylneuraminate lyase 0.00 0.00 0.00 0.00 0.042 0.09 0.05 0.043 0.0 0.0 0.0 0.0 1.1 0.3 0.2 0.0 <-5 
FadB 
Multifunctional fatty acid oxidation 
complex subunit alpha 
0.023 0.028 0.00 0.043 0.013 0.018 0.016 0.09 0.3 <-5 <-5 0.9 0.5 0.3 -2.5 2.8 0.8 
FadH 2,4-Dienoyl-CoA reductase [NADPH] 0.011 0.011 0.00 0.008 0.020 0.00 0.014 0.029 0.0 <-5 <-5 -0.5 <-5 -0.5 -1.1 0.5 -0.9 
                                  
Sugar transport (7 proteins) 2.05 2.00 1.43 2.92 1.37 1.77 1.37 4.17 0.0 -0.5 -1.0 0.5 0.4 0.0 -1.6 1.6 0.6 
                   
PtsI 
Phosphoenolpyruvate-protein 
phosphotransferase 
0.56 0.54 0.42 0.54 0.22 0.25 0.16 0.16 -0.1 -0.4 -0.4 -0.1 0.2 -0.5 0.0 -0.5 1.3 
PtsH Phosphocarrier protein HPr 0.33 0.45 0.30 0.37 0.10 0.13 0.13 0.12 0.4 -0.1 -0.3 0.2 0.4 0.4 0.1 0.3 1.7 
Crr 
Glucose-specific enzyme IIA component 
of PTS 
0.18 0.22 0.10 0.33 0.031 0.08 0.041 0.29 0.3 -0.8 -1.7 0.9 1.4 0.4 -2.8 3.2 2.5 
ManX 
PTS system mannose-specific EIIAB 
component 
0.12 0.07 0.06 0.13 0.045 0.05 0.031 0.17 -0.8 -1.0 -1.1 0.1 0.2 -0.5 -2.5 1.9 1.4 
MalE Maltose-binding periplasmic protein 0.28 0.31 0.25 0.76 0.13 0.23 0.17 1.37 0.1 -0.2 -1.6 1.4 0.8 0.4 -3.0 3.4 1.1 
MalK 
Maltose/maltodextrin import ATP-binding 
protein MalK 
0.07 0.05 0.029 0.07 0.13 0.09 0.09 0.25 -0.5 -1.3 -1.3 0.0 -0.5 -0.5 -1.5 0.9 -0.9 
LamB Chain A, Maltoporin Maltose Complex 0.50 0.36 0.26 0.73 0.71 0.94 0.75 1.80 -0.5 -0.9 -1.5 0.5 0.4 0.1 -1.3 1.3 -0.5 
                            
Amino acid and peptide transport  
(7 proteins) 
0.79 0.78 0.50 1.00 0.26 0.29 0.35 1.45 0.0 -0.7 -1.0 0.3 0.2 0.4 -2.1 2.5 1.6 
                   
GlnH 
Glutamine ABC transporter periplasmic 
protein 
0.11 0.18 0.07 0.06 0.07 0.046 0.07 0.05 0.7 -0.7 0.2 -0.9 -0.6 0.0 0.5 -0.5 0.7 
ArtJ Arginine transporter subunit 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
ArgT 
Lysine-arginine-ornithine-binding 
periplasmic protein 
0.08 0.07 0.11 0.12 0.027 0.06 0.07 0.12 -0.2 0.5 -0.1 0.6 1.2 1.4 -0.8 2.2 1.6 
LivJ 
Leucine/isoleucine/valine transporter 
subunit 
0.26 0.31 0.19 0.55 0.05 0.09 0.10 0.12 0.3 -0.5 -1.5 1.1 0.8 1.0 -0.3 1.3 2.4 
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Suppl. Table 5.3.5 Proteome data of hFGF-2 production in E. coli BL21 (DE3) using defined and complex media 
Name1 Protein name1 
Defind (DNB) medium Complex (LB) medium Log2(Ratio in Defind (DNB) medium) Log2(Ratio in Complex (LB) medium) Log2(DNB 
exp. 1h 5h stationary exp. 1h 3.5h stationary (1h after (5h after (5h after (stationary (1h after (3.5h after (3.5h after (stationary medium/ 
phase after after phase phase after after phase IPTG/ IPTG/ IPTG/ without IPTG/ IPTG/ IPTG/ without LB 
before IPTG IPTG without before IPTG IPTG without exp. exp. stationary IPTG/ exp. exp. stationary IPTG/ medium) 
IPTG induction induction IPTG IPTG induction induction IPTG before before without exp. before before before without exp. before exp.before 
Whole Cell Protein Mass (WCPM) - % IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG 
DppA 
Chain A, Dipeptide Binding Protein 
Complex With Glycyl-L-Leucine 
0.17 0.00 0.00 0.00 0.00 0.00 0.00 0.43 <-5 <-5 0.0 <-5 0.0 0.0 <-5 >5 >5 
OppA Periplasmic oligopeptide-binding protein 0.12 0.17 0.13 0.23 0.11 0.10 0.10 0.70 0.5 0.1 -0.8 0.9 -0.1 -0.1 -2.8 2.7 0.1 
OppD 
Oligopeptide transport ATP-binding 
protein OppD 
0.040 0.045 0.00 0.038 0.00 0.00 0.00 0.031 0.2 <-5 <-5 -0.1 0.0 0.0 <-5 >5 >5 
                   
Other transport proteins (14 proteins) 5.45 5.51 4.93 5.66 5.58 7.53 4.56 5.04 0.0 -0.1 -0.2 0.1 0.4 -0.3 -0.1 -0.1 0.0 
                   
CusB 
Copper/silver efflux system, membrane 
fusion protein 
0.07 0.06 0.06 0.06 0.00 0.00 0.00 0.00 -0.2 -0.2 0.0 -0.2 0.0 0.0 0.0 0.0 >5 
GsiB 
Glutathione ABC transporter, periplasmic 
glutathione-binding protein GsiB 
0.042 0.034 0.022 0.036 0.040 0.016 0.019 0.038 -0.3 -0.9 -0.7 -0.2 -1.3 -1.1 -1.0 -0.1 0.1 
LptD 
Exported protein required for envelope 
biosynthesis and integrity 
0.06 0.08 0.047 0.10 0.08 0.08 0.044 0.06 0.4 -0.4 -1.1 0.7 0.0 -0.9 -0.4 -0.4 -0.4 
FadL Long-chain fatty acid transport protein 0.10 0.05 0.06 0.06 0.06 0.09 0.09 0.20 -1.0 -0.7 0.0 -0.7 0.6 0.6 -1.2 1.7 0.7 
OmpF Outer membrane porin 1a (Ia;b;F) 2.63 2.89 2.33 2.65 2.93 4.70 2.51 2.55 0.1 -0.2 -0.2 0.0 0.7 -0.2 0.0 -0.2 -0.2 
OmpA Outer membrane protein A 0.69 0.61 0.62 0.99 0.47 0.65 0.49 0.59 -0.2 -0.2 -0.7 0.5 0.5 0.1 -0.3 0.3 0.6 
OmpA 
(2) 
Outer membrane protein A 1.10 1.01 1.01 0.95 0.76 0.73 0.57 0.80 -0.1 -0.1 0.1 -0.2 -0.1 -0.4 -0.5 0.1 0.5 
TolB Translocation protein TolB 0.05 0.06 0.032 0.10 0.06 0.048 0.023 0.11 0.3 -0.6 -1.6 1.0 -0.3 -1.4 -2.3 0.9 -0.3 
TolC Outer membrane protein TolC 0.08 0.08 0.06 0.09 0.10 0.09 0.021 0.038 0.0 -0.4 -0.6 0.2 -0.2 -2.3 -0.9 -1.4 -0.3 
OmpX Outer membrane protein X 0.30 0.30 0.40 0.31 0.54 0.51 0.31 0.18 0.0 0.4 0.4 0.0 -0.1 -0.8 0.8 -1.6 -0.8 
YbiT 
Putative ATP-binding component of a 
transport system 
0.05 0.047 0.027 0.038 0.06 0.06 0.09 0.036 -0.1 -0.9 -0.5 -0.4 0.0 0.6 1.3 -0.7 -0.3 
YjjK 
Uncharacterized ABC transporter ATP-
binding protein YjjK 
0.047 0.06 0.042 0.047 0.11 0.09 0.09 0.12 0.4 -0.2 -0.2 0.0 -0.3 -0.3 -0.4 0.1 -1.2 
SecA Preprotein translocase subunit, ATPase 0.09 0.09 0.09 0.07 0.17 0.15 0.15 0.11 0.0 0.0 0.4 -0.4 -0.2 -0.2 0.4 -0.6 -0.9 
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Suppl. Table 5.3.5 Proteome data of hFGF-2 production in E. coli BL21 (DE3) using defined and complex media 
Name1 Protein name1 
Defind (DNB) medium Complex (LB) medium Log2(Ratio in Defind (DNB) medium) Log2(Ratio in Complex (LB) medium) Log2(DNB 
exp. 1h 5h stationary exp. 1h 3.5h stationary (1h after (5h after (5h after (stationary (1h after (3.5h after (3.5h after (stationary medium/ 
phase after after phase phase after after phase IPTG/ IPTG/ IPTG/ without IPTG/ IPTG/ IPTG/ without LB 
before IPTG IPTG without before IPTG IPTG without exp. exp. stationary IPTG/ exp. exp. stationary IPTG/ medium) 
IPTG induction induction IPTG IPTG induction induction IPTG before before without exp. before before before without exp. before exp.before 
Whole Cell Protein Mass (WCPM) - % IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG 
YaeT 
Outer membrane protein assembly factor 
yaeT 
0.14 0.15 0.12 0.16 0.19 0.31 0.15 0.19 0.1 -0.2 -0.4 0.2 0.7 -0.3 -0.3 0.0 -0.4 
                                  
RNA polymerases (3 proteins) 1.06 1.00 1.06 0.88 1.36 1.20 1.00 0.80 -0.1 0.0 0.3 -0.3 -0.2 -0.4 0.3 -0.8 -0.4 
                   
RpoA 
DNA-directed RNA polymerase subunit 
alpha 
0.54 0.54 0.60 0.61 0.71 0.74 0.57 0.44 0.0 0.2 0.0 0.2 0.1 -0.3 0.4 -0.7 -0.4 
RpoB 
DNA-directed RNA polymerase subunit 
beta 
0.49 0.44 0.44 0.26 0.57 0.46 0.43 0.36 -0.2 -0.2 0.8 -0.9 -0.3 -0.4 0.3 -0.7 -0.2 
RpoC 
DNA-directed RNA polymerase subunit 
beta' 
0.043 0.020 0.021 0.017 0.07 0.00 0.00 0.008 -1.1 -1.0 0.3 -1.3 <-5 <-5 <-5 -3.1 -0.7 
                   
RNA polymerase binding proteins (7 proteins) 0.83 0.91 0.87 0.88 1.24 1.07 1.04 0.77 0.1 0.1 0.0 0.1 -0.2 -0.3 0.4 -0.7 -0.6 
                   
RapA RNA polymerase-associated protein rapA 0.029 0.018 0.031 0.015 0.08 0.043 0.048 0.020 -0.7 0.1 1.0 -1.0 -0.9 -0.7 1.3 -2.0 -1.5 
NusA Transcription elongation protein nusA 0.12 0.16 0.14 0.13 0.19 0.21 0.22 0.10 0.4 0.2 0.1 0.1 0.1 0.2 1.1 -0.9 -0.7 
NusG 
Transcription antitermination protein 
NusG 
0.09 0.08 0.06 0.07 0.09 0.06 0.06 0.042 -0.2 -0.6 -0.2 -0.4 -0.6 -0.6 0.5 -1.1 0.0 
Rho Transcription termination factor Rho 0.37 0.38 0.40 0.34 0.62 0.55 0.42 0.29 0.0 0.1 0.2 -0.1 -0.2 -0.6 0.5 -1.1 -0.7 
RpoD RNA polymerase sigma-subunit 0.05 0.09 0.11 0.039 0.15 0.08 0.21 0.10 0.8 1.1 1.5 -0.4 -0.9 0.5 1.1 -0.6 -1.6 
SspA Stringent starvation protein A 0.08 0.09 0.08 0.12 0.07 0.08 0.05 0.11 0.2 0.0 -0.6 0.6 0.2 -0.5 -1.1 0.7 0.2 
DksA DnaK transcriptional regulator DksA 0.08 0.10 0.06 0.17 0.031 0.044 0.039 0.12 0.3 -0.4 -1.5 1.1 0.5 0.3 -1.6 2.0 1.4 
                   
Transcription factors (12 proteins) 1.78 1.84 1.74 1.79 1.65 1.69 1.68 2.03 0.0 0.0 0.0 0.0 0.0 0.0 -0.3 0.3 0.1 
                   
LacI Lactose operon repressor 0.00 0.00 0.00 0.00 0.11 0.022 0.033 0.042 0.0 0.0 0.0 0.0 -2.3 -1.7 -0.3 -1.4 <-5 
Hns 
Global DNA-binding transcriptional dual 
regulator H-NS 
0.71 0.73 0.77 0.80 0.75 0.90 0.75 0.85 0.0 0.1 -0.1 0.2 0.3 0.0 -0.2 0.2 -0.1 
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Suppl. Table 5.3.5 Proteome data of hFGF-2 production in E. coli BL21 (DE3) using defined and complex media 
Name1 Protein name1 
Defind (DNB) medium Complex (LB) medium Log2(Ratio in Defind (DNB) medium) Log2(Ratio in Complex (LB) medium) Log2(DNB 
exp. 1h 5h stationary exp. 1h 3.5h stationary (1h after (5h after (5h after (stationary (1h after (3.5h after (3.5h after (stationary medium/ 
phase after after phase phase after after phase IPTG/ IPTG/ IPTG/ without IPTG/ IPTG/ IPTG/ without LB 
before IPTG IPTG without before IPTG IPTG without exp. exp. stationary IPTG/ exp. exp. stationary IPTG/ medium) 
IPTG induction induction IPTG IPTG induction induction IPTG before before without exp. before before before without exp. before exp.before 
Whole Cell Protein Mass (WCPM) - % IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG 
ArcA Aerobic respiration control protein ArcA 0.09 0.07 0.07 0.08 0.08 0.08 0.08 0.14 -0.4 -0.4 -0.2 -0.2 0.0 0.0 -0.8 0.8 0.2 
KdgR Transcriptional regulator kdgR 0.031 0.034 0.048 0.043 0.029 0.037 0.027 0.032 0.1 0.6 0.2 0.5 0.4 -0.1 -0.2 0.1 0.1 
OxyR 
Hydrogen peroxide-inducible genes 
activator 
0.038 0.05 0.039 0.043 0.029 0.06 0.046 0.037 0.4 0.0 -0.1 0.2 1.0 0.7 0.3 0.4 0.4 
BasR Transcriptional regulatory protein BasR 0.06 0.06 0.06 0.07 0.042 0.06 0.06 0.08 0.0 0.0 -0.2 0.2 0.5 0.5 -0.4 0.9 0.5 
CspC CspC 0.55 0.61 0.42 0.43 0.34 0.43 0.33 0.62 0.1 -0.4 0.0 -0.4 0.3 0.0 -0.9 0.9 0.7 
StpA DNA binding protein, nucleoid-associated 0.06 0.06 0.06 0.07 0.07 0.00 0.22 0.06 0.0 0.0 -0.2 0.2 <-5 1.7 1.9 -0.2 -0.2 
PspA Phage shock protein A 0.028 0.040 0.043 0.041 0.027 0.00 0.034 0.018 0.5 0.6 0.1 0.6 <-5 0.3 0.9 -0.6 0.1 
OmpR Transcriptional regulatory protein ompR 0.11 0.10 0.11 0.12 0.10 0.06 0.08 0.10 -0.1 0.0 -0.1 0.1 -0.7 -0.3 -0.3 0.0 0.1 
CpxR Transcriptional regulatory protein CpxR 0.044 0.038 0.046 0.041 0.026 0.05 0.00 0.035 -0.2 0.1 0.2 -0.1 0.9 <-5 <-5 0.4 0.8 
PhoP Transcriptional regulatory protein phoP 0.06 0.045 0.07 0.05 0.031 0.00 0.020 0.028 -0.4 0.2 0.5 -0.3 <-5 -0.6 -0.5 -0.1 1.0 
                            
Ribosomal proteins (5 proteins) 3.55 3.78 4.32 3.76 5.41 4.75 4.47 2.74 0.1 0.3 0.2 0.1 -0.2 -0.3 0.7 -1.0 -0.6 
                   
RplL 50S ribosomal protein L7/L12 0.51 0.66 0.82 0.87 0.91 1.17 1.00 0.65 0.4 0.7 -0.1 0.8 0.4 0.1 0.6 -0.5 -0.8 
RplI 50S ribosomal protein L9 0.54 0.53 0.55 0.53 0.78 0.76 0.59 0.37 0.0 0.0 0.1 0.0 0.0 -0.4 0.7 -1.1 -0.5 
RpsA 30S ribosomal protein S1 1.38 1.42 1.63 1.49 1.99 2.04 1.75 1.16 0.0 0.2 0.1 0.1 0.0 -0.2 0.6 -0.8 -0.5 
RpsB 30S ribosomal protein S2 0.66 0.74 0.87 0.54 1.28 0.40 0.87 0.41 0.2 0.4 0.7 -0.3 -1.7 -0.6 1.1 -1.6 -1.0 
RpsF 30S ribosomal protein S6 0.45 0.43 0.45 0.33 0.46 0.38 0.27 0.15 -0.1 0.0 0.4 -0.4 -0.3 -0.8 0.8 -1.6 0.0 
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Suppl. Table 5.3.5 Proteome data of hFGF-2 production in E. coli BL21 (DE3) using defined and complex media 
Name1 Protein name1 
Defind (DNB) medium Complex (LB) medium Log2(Ratio in Defind (DNB) medium) Log2(Ratio in Complex (LB) medium) Log2(DNB 
exp. 1h 5h stationary exp. 1h 3.5h stationary (1h after (5h after (5h after (stationary (1h after (3.5h after (3.5h after (stationary medium/ 
phase after after phase phase after after phase IPTG/ IPTG/ IPTG/ without IPTG/ IPTG/ IPTG/ without LB 
before IPTG IPTG without before IPTG IPTG without exp. exp. stationary IPTG/ exp. exp. stationary IPTG/ medium) 
IPTG induction induction IPTG IPTG induction induction IPTG before before without exp. before before before without exp. before exp.before 
Whole Cell Protein Mass (WCPM) - % IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG 
Ribosome-associated proteins (8 proteins) 1.05 1.16 1.16 1.56 1.67 1.71 1.37 1.20 0.1 0.1 -0.4 0.6 0.0 -0.3 0.2 -0.5 -0.7 
                   
EngA Predicted GTP-binding protein 0.039 0.036 0.032 0.027 0.035 0.00 0.023 0.023 -0.1 -0.3 0.2 -0.5 <-5 -0.6 0.0 -0.6 0.2 
YcaO UPF0142 protein ycaO 0.021 0.027 0.024 0.017 0.06 0.08 0.049 0.031 0.4 0.2 0.5 -0.3 0.4 -0.3 0.7 -1.0 -1.5 
EngD 
(YchF) 
GTP-dependent nucleic acid-binding 
protein EngD 
0.06 0.09 0.06 0.09 0.10 0.13 0.09 0.08 0.6 0.0 -0.6 0.6 0.4 -0.2 0.2 -0.3 -0.7 
TypA GTP-binding protein typA/BipA 0.20 0.27 0.23 0.16 0.31 0.34 0.26 0.15 0.4 0.2 0.5 -0.3 0.1 -0.3 0.8 -1.0 -0.6 
HflX GTP-binding protein hflX 0.021 0.027 0.039 0.043 0.037 0.05 0.06 0.05 0.4 0.9 -0.1 1.0 0.4 0.7 0.3 0.4 -0.8 
Tig Trigger factor 0.65 0.66 0.69 0.72 0.98 1.12 0.85 0.63 0.0 0.1 -0.1 0.1 0.2 -0.2 0.4 -0.6 -0.6 
Frr Ribosome recycling factor 0.05 0.00 0.09 0.14 0.030 0.00 0.034 0.11 <-5 0.8 -0.6 1.5 <-5 0.2 -1.7 1.9 0.7 
RaiA Ribosome-associated inhibitor A 0.00 0.06 0.00 0.36 0.11 0.00 0.00 0.12 >5 0.0 <-5 >5 <-5 <-5 <-5 0.1 <-5 
                                     
Aminoacyl-tRNA synthetases  
(23 proteins) 
2.80 2.75 3.04 2.49 3.69 3.67 3.35 3.06 0.0 0.1 0.3 -0.2 0.0 -0.1 0.1 -0.3 -0.4 
                   
AlaS Alanyl-tRNA synthetase 0.22 0.24 0.21 0.15 0.45 0.33 0.36 0.60 0.1 -0.1 0.5 -0.6 -0.4 -0.3 -0.7 0.4 -1.0 
ArgS Arginyl-tRNA synthetase 0.049 0.05 0.05 0.049 0.08 0.08 0.06 0.033 0.0 0.0 0.0 0.0 0.0 -0.4 0.9 -1.3 -0.7 
AsnS Asparaginyl tRNA synthetase 0.22 0.18 0.19 0.22 0.28 0.25 0.25 0.17 -0.3 -0.2 -0.2 0.0 -0.2 -0.2 0.6 -0.7 -0.3 
AspS Aspartyl-tRNA synthetase 0.18 0.18 0.19 0.18 0.20 0.18 0.15 0.17 0.0 0.1 0.1 0.0 -0.2 -0.4 -0.2 -0.2 -0.2 
CysS Cysteinyl-tRNA synthetase 0.12 0.08 0.08 0.09 0.09 0.16 0.14 0.09 -0.6 -0.6 -0.2 -0.4 0.8 0.6 0.6 0.0 0.4 
GlnS Glutaminyl-tRNA synthetase 0.09 0.09 0.11 0.08 0.13 0.18 0.16 0.08 0.0 0.3 0.5 -0.2 0.5 0.3 1.0 -0.7 -0.5 
GltX Glutamyl-tRNA synthetase 0.10 0.09 0.09 0.09 0.10 0.10 0.07 0.16 -0.2 -0.2 0.0 -0.2 0.0 -0.5 -1.2 0.7 0.0 
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Suppl. Table 5.3.5 Proteome data of hFGF-2 production in E. coli BL21 (DE3) using defined and complex media 
Name1 Protein name1 
Defind (DNB) medium Complex (LB) medium Log2(Ratio in Defind (DNB) medium) Log2(Ratio in Complex (LB) medium) Log2(DNB 
exp. 1h 5h stationary exp. 1h 3.5h stationary (1h after (5h after (5h after (stationary (1h after (3.5h after (3.5h after (stationary medium/ 
phase after after phase phase after after phase IPTG/ IPTG/ IPTG/ without IPTG/ IPTG/ IPTG/ without LB 
before IPTG IPTG without before IPTG IPTG without exp. exp. stationary IPTG/ exp. exp. stationary IPTG/ medium) 
IPTG induction induction IPTG IPTG induction induction IPTG before before without exp. before before before without exp. before exp.before 
Whole Cell Protein Mass (WCPM) - % IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG 
GlyQ Glycyl-tRNA synthetase alpha subunit 0.12 0.05 0.07 0.044 0.08 0.10 0.09 0.11 -1.3 -0.8 0.7 -1.4 0.3 0.2 -0.3 0.5 0.6 
GlyS Glycyl-tRNA synthetase beta subunit 0.15 0.12 0.13 0.09 0.21 0.24 0.18 0.09 -0.3 -0.2 0.5 -0.7 0.2 -0.2 1.0 -1.2 -0.5 
HisS Histidyl-tRNA synthetase 0.08 0.06 0.08 0.06 0.017 0.08 0.044 0.06 -0.4 0.0 0.4 -0.4 2.2 1.4 -0.4 1.8 2.2 
IleS Isoleucyl-tRNA synthetase 0.16 0.13 0.14 0.09 0.35 0.15 0.25 0.18 -0.3 -0.2 0.6 -0.8 -1.2 -0.5 0.5 -1.0 -1.1 
LeuS Leucyl-tRNA synthetase 0.26 0.24 0.36 0.21 0.30 0.40 0.34 0.21 -0.1 0.5 0.8 -0.3 0.4 0.2 0.7 -0.5 -0.2 
LysS Lysyl-tRNA synthetase 0.13 0.12 0.14 0.11 0.25 0.20 0.17 0.12 -0.1 0.1 0.3 -0.2 -0.3 -0.6 0.5 -1.1 -0.9 
MetG Methionyl-tRNA synthetase 0.12 0.10 0.10 0.10 0.14 0.10 0.11 0.11 -0.3 -0.3 0.0 -0.3 -0.5 -0.3 0.0 -0.3 -0.2 
PheT 
Phenylalanyl-tRNA synthetase subunit 
beta 
0.17 0.20 0.19 0.18 0.15 0.14 0.13 0.11 0.2 0.2 0.1 0.1 -0.1 -0.2 0.2 -0.4 0.2 
ProS Prolyl-tRNA synthetase 0.11 0.24 0.22 0.17 0.19 0.23 0.22 0.07 1.1 1.0 0.4 0.6 0.3 0.2 1.7 -1.4 -0.8 
SerS Seryl-tRNA synthetase 0.11 0.11 0.10 0.09 0.14 0.14 0.11 0.10 0.0 -0.1 0.2 -0.3 0.0 -0.3 0.1 -0.5 -0.3 
ThrS Threonyl-tRNA synthetase 0.12 0.11 0.14 0.13 0.19 0.10 0.14 0.15 -0.1 0.2 0.1 0.1 -0.9 -0.4 -0.1 -0.3 -0.7 
TyrS Tyrosyl-tRNA synthetase  0.13 0.12 0.15 0.09 0.18 0.16 0.19 0.14 -0.1 0.2 0.7 -0.5 -0.2 0.1 0.4 -0.4 -0.5 
LysU Lysyl-tRNA synthetase, heat inducible  0.036 0.035 0.09 0.041 0.07 0.09 0.08 0.07 0.0 1.3 1.1 0.2 0.4 0.2 0.2 0.0 -1.0 
MnmA tRNA-Specific 2-thiouridylase mnmA  0.05 0.09 0.042 0.08 0.043 0.12 0.036 0.05 0.8 -0.3 -0.9 0.7 1.5 -0.3 -0.5 0.2 0.2 
YgfZ tRNA-modifying protein ygfZ 0.040 0.06 0.07 0.06 0.016 0.13 0.045 0.08 0.6 0.8 0.2 0.6 3.0 1.5 -0.8 2.3 1.3 
Fmt Methionyl-tRNA formyltransferase 0.046 0.036 0.10 0.06 0.018 0.032 0.029 0.09 -0.4 1.1 0.7 0.4 0.8 0.7 -1.6 2.3 1.4 
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Suppl. Table 5.3.5 Proteome data of hFGF-2 production in E. coli BL21 (DE3) using defined and complex media 
Name1 Protein name1 
Defind (DNB) medium Complex (LB) medium Log2(Ratio in Defind (DNB) medium) Log2(Ratio in Complex (LB) medium) Log2(DNB 
exp. 1h 5h stationary exp. 1h 3.5h stationary (1h after (5h after (5h after (stationary (1h after (3.5h after (3.5h after (stationary medium/ 
phase after after phase phase after after phase IPTG/ IPTG/ IPTG/ without IPTG/ IPTG/ IPTG/ without LB 
before IPTG IPTG without before IPTG IPTG without exp. exp. stationary IPTG/ exp. exp. stationary IPTG/ medium) 
IPTG induction induction IPTG IPTG induction induction IPTG before before without exp. before before before without exp. before exp.before 
Whole Cell Protein Mass (WCPM) - % IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG 
Elongation factors (6 proteins) 4.93 6.01 5.55 6.09 6.74 8.11 7.35 6.17 0.3 0.2 -0.1 0.3 0.3 0.1 0.3 -0.1 -0.5 
                   
InfB Initiation factor IF2-gamma 0.15 0.11 0.16 0.08 0.28 0.09 0.24 0.15 -0.4 0.1 1.0 -0.9 -1.6 -0.2 0.7 -0.9 -0.9 
FusA Elongation factor G 1.30 1.72 1.58 1.38 1.67 2.15 2.12 1.49 0.4 0.3 0.2 0.1 0.4 0.3 0.5 -0.2 -0.4 
TufA Elongation factor Tu 1 2.77 3.48 3.08 3.76 3.72 4.70 4.12 3.89 0.3 0.2 -0.3 0.4 0.3 0.1 0.1 0.1 -0.4 
Tsf 
Chain B, Elongation Factor Complex Ef-
TuEF-Ts 
0.65 0.62 0.64 0.80 0.97 1.08 0.76 0.58 -0.1 0.0 -0.3 0.3 0.2 -0.4 0.4 -0.7 -0.6 
LepA GTP-binding protein LepA 0.041 0.048 0.045 0.029 0.05 0.06 0.06 0.037 0.2 0.1 0.6 -0.5 0.3 0.3 0.7 -0.4 -0.3 
PrfC Peptide chain release factor 3 0.022 0.026 0.031 0.028 0.046 0.039 0.041 0.037 0.2 0.5 0.1 0.3 -0.2 -0.2 0.1 -0.3 -1.1 
                                
RNA degradation (3 proteins) 0.52 0.56 0.51 0.42 0.68 0.98 0.64 0.53 0.1 0.0 0.3 -0.3 0.5 -0.1 0.3 -0.4 -0.4 
                   
Pnp Polyribonucleotide nucleotidyltransferase 0.44 0.48 0.43 0.36 0.56 0.88 0.53 0.44 0.1 0.0 0.3 -0.3 0.7 -0.1 0.3 -0.3 -0.3 
Rnb Exoribonuclease II 0.05 0.05 0.048 0.047 0.09 0.07 0.09 0.07 0.0 -0.1 0.0 -0.1 -0.4 0.0 0.4 -0.4 -0.8 
RhlB ATP-dependent RNA helicase 0.020 0.030 0.028 0.021 0.032 0.032 0.021 0.018 0.6 0.5 0.4 0.1 0.0 -0.6 0.2 -0.8 -0.7 
                             
Isomerases (5 proteins) 0.72 0.79 0.62 0.80 0.55 0.56 0.38 0.86 0.1 -0.2 -0.4 0.2 0.0 -0.5 -1.2 0.6 0.4 
                   
PpiB 
Peptidyl-prolyl cis-trans isomerase B 
(rotamase B) 
0.07 0.10 0.08 0.15 0.08 0.047 0.048 0.12 0.5 0.2 -0.9 1.1 -0.8 -0.7 -1.3 0.6 -0.2 
SurA Peptidyl-prolyl cis-trans isomerase SurA 0.09 0.09 0.08 0.09 0.07 0.10 0.10 0.11 0.0 -0.2 -0.2 0.0 0.5 0.5 -0.1 0.7 0.4 
FklB 
FKBP-type 22 kDa peptidyl-prolyl cis-
trans isomerase 
0.10 0.12 0.06 0.13 0.06 0.07 0.06 0.15 0.3 -0.7 -1.1 0.4 0.2 0.0 -1.3 1.3 0.7 
FkpA 
FKBP-type peptidyl-prolyl cis-trans 
isomerase 
0.15 0.17 0.16 0.10 0.17 0.17 0.043 0.20 0.2 0.1 0.7 -0.6 0.0 -2.0 -2.2 0.2 -0.2 
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Suppl. Table 5.3.5 Proteome data of hFGF-2 production in E. coli BL21 (DE3) using defined and complex media 
Name1 Protein name1 
Defind (DNB) medium Complex (LB) medium Log2(Ratio in Defind (DNB) medium) Log2(Ratio in Complex (LB) medium) Log2(DNB 
exp. 1h 5h stationary exp. 1h 3.5h stationary (1h after (5h after (5h after (stationary (1h after (3.5h after (3.5h after (stationary medium/ 
phase after after phase phase after after phase IPTG/ IPTG/ IPTG/ without IPTG/ IPTG/ IPTG/ without LB 
before IPTG IPTG without before IPTG IPTG without exp. exp. stationary IPTG/ exp. exp. stationary IPTG/ medium) 
IPTG induction induction IPTG IPTG induction induction IPTG before before without exp. before before before without exp. before exp.before 
Whole Cell Protein Mass (WCPM) - % IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG 
SlyD 
FKBP-type peptidyl-prolyl cis-trans 
isomerase slyD 
0.31 0.31 0.25 0.32 0.18 0.18 0.13 0.28 0.0 -0.3 -0.4 0.0 0.0 -0.5 -1.1 0.6 0.8 
                   
Chaperones (9 proteins) 1.94 2.63 5.46 1.95 2.92 5.92 7.12 2.75 0.4 1.5 1.5 0.0 1.0 1.3 1.4 -0.1 -0.6 
                   
DnaK Molecular chaperone DnaK 0.56 0.87 2.19 0.56 0.89 2.10 2.53 0.81 0.6 2.0 2.0 0.0 1.2 1.5 1.6 -0.1 -0.7 
GrpE Heat shock protein GrpE 0.08 0.09 0.19 0.07 0.14 0.27 0.27 0.10 0.2 1.2 1.4 -0.2 0.9 0.9 1.4 -0.5 -0.8 
GroL 60 kDa chaperonin (GroEL protein) 0.83 1.13 1.71 0.88 1.22 2.26 2.28 1.32 0.4 1.0 1.0 0.1 0.9 0.9 0.8 0.1 -0.6 
GroS Co-chaperonin GroES 0.11 0.14 0.26 0.13 0.15 0.36 0.54 0.14 0.3 1.2 1.0 0.2 1.3 1.8 1.9 -0.1 -0.4 
HtpG Heat shock protein 90 0.16 0.21 0.62 0.13 0.28 0.48 0.66 0.14 0.4 2.0 2.3 -0.3 0.8 1.2 2.2 -1.0 -0.8 
HscA Fe-S protein assembly chaperone HscA 0.040 0.036 0.029 0.042 0.05 0.05 0.040 0.027 -0.2 -0.5 -0.5 0.1 0.0 -0.3 0.6 -0.9 -0.3 
ClpA 
ATP-dependent Clp protease ATP-binding 
subunit 
0.05 0.049 0.039 0.06 0.037 0.025 0.038 0.06 0.0 -0.4 -0.6 0.3 -0.6 0.0 -0.7 0.7 0.4 
ClpB Protein disaggregation chaperone 0.021 0.027 0.08 0.021 0.06 0.11 0.14 0.042 0.4 1.9 1.9 0.0 0.9 1.2 1.7 -0.5 -1.5 
IbpA Small heat shock protein ibpA 0.09 0.09 0.33 0.06 0.10 0.27 0.61 0.10 0.0 1.9 2.5 -0.6 1.4 2.6 2.6 0.0 -0.2 
                   
Proteases (13 proteins) 0.88 0.85 1.01 0.83 1.03 1.28 1.55 1.38 -0.1 0.2 0.3 -0.1 0.3 0.6 0.2 0.4 -0.2 
                   
DegP Serine endoprotease 0.017 0.025 0.030 0.037 0.00 0.00 0.00 0.027 0.6 0.8 -0.3 1.1 0.0 0.0 <-5 >5 >5 
PepQ Proline dipeptidase 0.08 0.08 0.07 0.10 0.08 0.10 0.13 0.16 0.0 -0.2 -0.5 0.3 0.3 0.7 -0.3 1.0 0.0 
PepD Aminoacyl-histidine dipeptidase 0.11 0.12 0.09 0.10 0.13 0.22 0.20 0.24 0.1 -0.3 -0.2 -0.1 0.8 0.6 -0.3 0.9 -0.2 
PepN Aminopeptidase N 0.12 0.09 0.05 0.08 0.17 0.13 0.14 0.20 -0.4 -1.3 -0.7 -0.6 -0.4 -0.3 -0.5 0.2 -0.5 
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Suppl. Table 5.3.5 Proteome data of hFGF-2 production in E. coli BL21 (DE3) using defined and complex media 
Name1 Protein name1 
Defind (DNB) medium Complex (LB) medium Log2(Ratio in Defind (DNB) medium) Log2(Ratio in Complex (LB) medium) Log2(DNB 
exp. 1h 5h stationary exp. 1h 3.5h stationary (1h after (5h after (5h after (stationary (1h after (3.5h after (3.5h after (stationary medium/ 
phase after after phase phase after after phase IPTG/ IPTG/ IPTG/ without IPTG/ IPTG/ IPTG/ without LB 
before IPTG IPTG without before IPTG IPTG without exp. exp. stationary IPTG/ exp. exp. stationary IPTG/ medium) 
IPTG induction induction IPTG IPTG induction induction IPTG before before without exp. before before before without exp. before exp.before 
Whole Cell Protein Mass (WCPM) - % IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG 
Dcp Dipeptidyl carboxypeptidase II 0.037 0.016 0.034 0.017 0.00 0.00 0.025 0.00 -1.2 -0.1 1.0 -1.1 0.0 >5 >5 0.0 >5 
Prc Carboxy-terminal protease 0.031 0.025 0.021 0.028 0.043 0.029 0.032 0.032 -0.3 -0.6 -0.4 -0.1 -0.6 -0.4 0.0 -0.4 -0.5 
PmbA Protein pmbA  0.039 0.030 0.033 0.034 0.041 0.045 0.08 0.10 -0.4 -0.2 0.0 -0.2 0.1 1.0 -0.3 1.3 -0.1 
ClpP 
ATP-dependent Clp protease proteolytic 
subunit 
0.08 0.07 0.11 0.08 0.09 0.10 0.09 0.10 -0.2 0.5 0.5 0.0 0.2 0.0 -0.2 0.2 -0.2 
HslV ATP-dependent protease peptidase subunit 0.030 0.05 0.14 0.035 0.06 0.09 0.14 0.032 0.7 2.2 2.0 0.2 0.6 1.2 2.1 -0.9 -1.0 
HslU 
ATP-dependent protease ATP-binding 
subunit 
0.10 0.14 0.30 0.12 0.18 0.29 0.38 0.13 0.5 1.6 1.3 0.3 0.7 1.1 1.5 -0.5 -0.8 
PepB Peptidase B 0.12 0.09 0.10 0.08 0.12 0.14 0.20 0.17 -0.4 -0.3 0.3 -0.6 0.2 0.7 0.2 0.5 0.0 
PepP Proline aminopeptidase P II 0.047 0.048 0.037 0.06 0.06 0.05 0.06 0.08 0.0 -0.3 -0.7 0.4 -0.3 0.0 -0.4 0.4 -0.4 
PrlC Oligopeptidase A 0.08 0.06 0.00 0.05 0.049 0.08 0.07 0.11 -0.4 <-5 <-5 -0.7 0.7 0.5 -0.7 1.2 0.7 
                   
Other dehydrogenases (9 proteins) 0.69 0.66 0.66 0.75 0.61 0.74 0.67 1.13 -0.1 -0.1 -0.2 0.1 0.3 0.1 -0.8 0.9 0.2 
                   
YdfG 3-Hydroxy acid dehydrogenase 0.10 0.09 0.11 0.11 0.049 0.10 0.044 0.07 -0.2 0.1 0.0 0.1 1.0 -0.2 -0.7 0.5 1.0 
YqhD 
Alcohol dehydrogenase, NAD(P)-
dependent 
0.11 0.10 0.12 0.09 0.14 0.14 0.12 0.18 -0.1 0.1 0.4 -0.3 0.0 -0.2 -0.6 0.4 -0.3 
AldB Aldehyde dehydrogenase B 0.031 0.027 0.029 0.11 0.037 0.022 0.06 0.16 -0.2 -0.1 -1.9 1.8 -0.8 0.7 -1.4 2.1 -0.3 
AldA Lactaldehyde dehydrogenase  0.10 0.10 0.09 0.10 0.047 0.10 0.12 0.36 0.0 -0.2 -0.2 0.0 1.1 1.4 -1.6 2.9 1.1 
YhhX 
Predicted oxidoreductase with NAD(P)-
binding Rossmann-fold domain 
0.046 0.044 0.023 0.038 0.033 0.06 0.044 0.049 -0.1 -1.0 -0.7 -0.3 0.9 0.4 -0.2 0.6 0.5 
Ugd UDP-Glucose 6-dehydrogenase 0.16 0.12 0.11 0.14 0.12 0.13 0.13 0.13 -0.4 -0.5 -0.3 -0.2 0.1 0.1 0.0 0.1 0.4 
HdhA 7-Alpha-hydroxysteroid dehydrogenase 0.030 0.048 0.05 0.033 0.05 0.08 0.05 0.07 0.7 0.7 0.6 0.1 0.7 0.0 -0.5 0.5 -0.7 
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Suppl. Table 5.3.5 Proteome data of hFGF-2 production in E. coli BL21 (DE3) using defined and complex media 
Name1 Protein name1 
Defind (DNB) medium Complex (LB) medium Log2(Ratio in Defind (DNB) medium) Log2(Ratio in Complex (LB) medium) Log2(DNB 
exp. 1h 5h stationary exp. 1h 3.5h stationary (1h after (5h after (5h after (stationary (1h after (3.5h after (3.5h after (stationary medium/ 
phase after after phase phase after after phase IPTG/ IPTG/ IPTG/ without IPTG/ IPTG/ IPTG/ without LB 
before IPTG IPTG without before IPTG IPTG without exp. exp. stationary IPTG/ exp. exp. stationary IPTG/ medium) 
IPTG induction induction IPTG IPTG induction induction IPTG before before without exp. before before before without exp. before exp.before 
Whole Cell Protein Mass (WCPM) - % IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG 
HybC Hydrogenase-2 large chain 0.028 0.038 0.042 0.041 0.041 0.041 0.038 0.040 0.4 0.6 0.0 0.6 0.0 -0.1 -0.1 0.0 -0.6 
TrxB Thioredoxin reductase 0.08 0.09 0.08 0.08 0.09 0.08 0.07 0.06 0.2 0.0 0.0 0.0 -0.2 -0.4 0.2 -0.6 -0.2 
                   
Oxidoreductases (8 proteins) 0.39 0.36 0.43 0.65 0.34 0.34 0.38 0.54 -0.1 0.1 -0.6 0.7 0.0 0.2 -0.5 0.7 0.2 
                   
Gor Glutathione reductase 0.028 0.034 0.026 0.07 0.047 0.022 0.028 0.07 0.3 -0.1 -1.4 1.3 -1.1 -0.7 -1.3 0.6 -0.7 
NfsA 
Oxygen-insensitive NADPH 
nitroreductase 
0.09 0.07 0.039 0.06 0.09 0.07 0.05 0.043 -0.4 -1.2 -0.6 -0.6 -0.4 -0.8 0.2 -1.1 0.0 
QueF 
NADPH-dependent 7-cyano-7-
deazaguanine reductase 
0.05 0.041 0.046 0.08 0.019 0.046 0.05 0.041 -0.3 -0.1 -0.8 0.7 1.3 1.4 0.3 1.1 1.4 
NemA N-Ethylmaleimide reductase 0.031 0.030 0.039 0.012 0.023 0.00 0.00 0.025 0.0 0.3 1.7 -1.4 <-5 <-5 <-5 0.1 0.4 
SthA 
Soluble pyridine nucleotide 
transhydrogenase 
0.08 0.07 0.07 0.06 0.07 0.09 0.10 0.13 -0.2 -0.2 0.2 -0.4 0.4 0.5 -0.4 0.9 0.2 
CueO Blue copper oxidase CueO 0.033 0.028 0.016 0.034 0.025 0.030 0.029 0.049 -0.2 -1.0 -1.1 0.0 0.3 0.2 -0.8 1.0 0.4 
Bfr 
Bacterioferritin, iron storage and 
detoxification protein 
0.044 0.05 0.13 0.28 0.06 0.08 0.10 0.13 0.2 1.6 -1.1 2.7 0.4 0.7 -0.4 1.1 -0.4 
WrbA Flavoprotein wrbA 0.031 0.038 0.06 0.05 0.00 0.00 0.028 0.05 0.3 1.0 0.3 0.7 0.0 >5 -0.8 >5 >5 
                            
Hydroperoxide reductases and superoxide 
dismutase (5 proteins) 
1.26 1.45 1.17 1.92 0.83 0.88 0.75 1.83 0.2 -0.1 -0.7 0.6 0.1 -0.1 -1.3 1.1 0.6 
                   
AhpF Alkyl hydroperoxide reductase subunit F 0.08 0.11 0.10 0.10 0.11 0.10 0.08 0.15 0.5 0.3 0.0 0.3 -0.1 -0.5 -0.9 0.4 -0.5 
AhpC Alkyl hydroperoxide reductase subunit C 0.79 0.89 0.65 1.10 0.53 0.57 0.46 1.10 0.2 -0.3 -0.8 0.5 0.1 -0.2 -1.3 1.1 0.6 
Tpx Thiol peroxidase 0.13 0.18 0.11 0.20 0.044 0.049 0.07 0.22 0.5 -0.2 -0.9 0.6 0.2 0.7 -1.7 2.3 1.6 
SodB Superoxide dismutase [Fe] 0.13 0.19 0.21 0.45 0.030 0.028 0.06 0.21 0.5 0.7 -1.1 1.8 -0.1 1.0 -1.8 2.8 2.1 
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Suppl. Table 5.3.5 Proteome data of hFGF-2 production in E. coli BL21 (DE3) using defined and complex media 
Name1 Protein name1 
Defind (DNB) medium Complex (LB) medium Log2(Ratio in Defind (DNB) medium) Log2(Ratio in Complex (LB) medium) Log2(DNB 
exp. 1h 5h stationary exp. 1h 3.5h stationary (1h after (5h after (5h after (stationary (1h after (3.5h after (3.5h after (stationary medium/ 
phase after after phase phase after after phase IPTG/ IPTG/ IPTG/ without IPTG/ IPTG/ IPTG/ without LB 
before IPTG IPTG without before IPTG IPTG without exp. exp. stationary IPTG/ exp. exp. stationary IPTG/ medium) 
IPTG induction induction IPTG IPTG induction induction IPTG before before without exp. before before before without exp. before exp.before 
Whole Cell Protein Mass (WCPM) - % IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG 
KatG Catalase/hydroperoxidase HPI(I) 0.13 0.09 0.09 0.07 0.12 0.13 0.08 0.16 -0.5 -0.5 0.4 -0.9 0.1 -0.6 -1.0 0.4 0.1 
                              
DNA protection and repair (6 proteins) 0.83 0.86 0.58 0.84 0.51 0.27 0.36 1.29 0.1 -0.5 -0.5 0.0 -0.9 -0.5 -1.8 1.3 0.7 
                   
Ssb Single-stranded DNA-binding protein 0.046 0.045 0.037 0.047 0.024 0.00 0.044 0.06 0.0 -0.3 -0.3 0.0 <-5 0.9 -0.4 1.3 0.9 
Dps 
DNA starvation/stationary phase 
protection protein Dps 
0.032 0.015 0.09 0.21 0.031 0.00 0.020 0.42 -1.1 1.5 -1.2 2.7 <-5 -0.6 -4.4 3.8 0.0 
UspA Universal stress protein A 0.07 0.06 0.05 0.15 0.09 0.07 0.08 0.16 -0.2 -0.5 -1.6 1.1 -0.4 -0.2 -1.0 0.8 -0.4 
UspG Universal stress protein G 0.06 0.041 0.09 0.10 0.10 0.00 0.00 0.00 -0.5 0.6 -0.2 0.7 <-5 <-5 0.0 <-5 -0.7 
SodA 
Chain A, Manganese Superoxide 
Dismutase 
0.57 0.64 0.19 0.29 0.18 0.12 0.17 0.59 0.2 -1.6 -0.6 -1.0 -0.6 -0.1 -1.8 1.7 1.7 
PolA DNA polymerase I 0.06 0.049 0.12 0.045 0.09 0.08 0.048 0.06 -0.3 1.0 1.4 -0.4 -0.2 -0.9 -0.3 -0.6 -0.6 
                   
Unclassified proteins (7 proteins) 0.63 0.57 0.53 0.59 0.46 0.36 0.39 0.36 -0.1 -0.2 -0.2 -0.1 -0.4 -0.2 0.1 -0.4 0.5 
                   
GyrB DNA gyrase subunit B 0.29 0.23 0.24 0.27 0.12 0.07 0.08 0.046 -0.3 -0.3 -0.2 -0.1 -0.8 -0.6 0.8 -1.4 1.3 
MreB 
Regulator of ftsI, penicillin binding 
protein 3, septation function 
0.05 0.08 0.07 0.07 0.09 0.08 0.08 0.08 0.7 0.5 0.0 0.5 -0.2 -0.2 0.0 -0.2 -0.8 
FtsZ Cell division protein FtsZ 0.07 0.07 0.044 0.06 0.06 0.09 0.07 0.09 0.0 -0.7 -0.4 -0.2 0.6 0.2 -0.4 0.6 0.2 
RsmC 
Ribosomal RNA small subunit 
methyltransferase C 
0.017 0.019 0.029 0.034 0.040 0.034 0.042 0.05 0.2 0.8 -0.2 1.0 -0.2 0.1 -0.3 0.3 -1.2 
Can Carbonic anhydrase 0.10 0.10 0.06 0.08 0.13 0.09 0.10 0.05 0.0 -0.7 -0.4 -0.3 -0.5 -0.4 1.0 -1.4 -0.4 
FrsA Fermentation/respiration switch protein 0.030 0.021 0.015 0.016 0.029 0.00 0.018 0.032 -0.5 -1.0 -0.1 -0.9 <-5 -0.7 -0.8 0.1 0.0 
YeaG Uncharacterized protein yeaG 0.07 0.06 0.07 0.06 0.00 0.00 0.00 0.00 -0.2 0.0 0.2 -0.2 0.0 0.0 0.0 0.0 >5 
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Suppl. Table 5.3.5 Proteome data of hFGF-2 production in E. coli BL21 (DE3) using defined and complex media 
Name1 Protein name1 
Defind (DNB) medium Complex (LB) medium Log2(Ratio in Defind (DNB) medium) Log2(Ratio in Complex (LB) medium) Log2(DNB 
exp. 1h 5h stationary exp. 1h 3.5h stationary (1h after (5h after (5h after (stationary (1h after (3.5h after (3.5h after (stationary medium/ 
phase after after phase phase after after phase IPTG/ IPTG/ IPTG/ without IPTG/ IPTG/ IPTG/ without LB 
before IPTG IPTG without before IPTG IPTG without exp. exp. stationary IPTG/ exp. exp. stationary IPTG/ medium) 
IPTG induction induction IPTG IPTG induction induction IPTG before before without exp. before before before without exp. before exp.before 
Whole Cell Protein Mass (WCPM) - % IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG 
Uncharacterized proteins (13 proteins) 0.44 0.42 0.45 0.52 0.41 0.44 0.39 0.76 -0.1 0.0 -0.2 0.2 0.1 -0.1 -1.0 0.9 0.1 
                   
YhbW Uncharacterized protein yhbW 0.028 0.028 0.019 0.027 0.049 0.041 0.036 0.047 0.0 -0.6 -0.5 -0.1 -0.3 -0.4 -0.4 -0.1 -0.8 
GalF 
UTP-glucose-1-phosphate 
uridylyltransferase 
0.00 0.00 0.00 0.00 0.035 0.040 0.027 0.026 0.0 0.0 0.0 0.0 0.2 -0.4 0.1 -0.4 <-5 
YbeZ 
Putative ATP-binding protein in pho 
regulon 
0.06 0.06 0.11 0.06 0.07 0.10 0.11 0.044 0.0 0.9 0.9 0.0 0.5 0.7 1.3 -0.7 -0.2 
YicC UPF0701 protein yicC 0.036 0.033 0.029 0.042 0.045 0.040 0.028 0.032 -0.1 -0.3 -0.5 0.2 -0.2 -0.7 -0.2 -0.5 -0.3 
YajQ UPF0234 protein yajQ  0.00 0.034 0.00 0.031 0.00 0.00 0.00 0.00 >5 0.0 <-5 >5 0.0 0.0 0.0 0.0 0.0 
YbgI UPF0135 protein ybgI 0.041 0.038 0.049 0.043 0.05 0.09 0.047 0.041 -0.1 0.3 0.2 0.1 0.8 -0.1 0.2 -0.3 -0.3 
YjgR Uncharacterized protein yjgR  0.016 0.011 0.037 0.012 0.012 0.00 0.00 0.024 -0.5 1.2 1.6 -0.4 <-5 <-5 <-5 1.0 0.4 
YdcJ Uncharacterized protein ydcJ 0.08 0.031 0.08 0.039 0.018 0.031 0.022 0.10 -1.4 0.0 1.0 -1.0 0.8 0.3 -2.2 2.5 2.2 
YcgB Uncharacterized protein ycgB 0.00 0.00 0.00 0.028 0.00 0.00 0.00 0.046 0.0 0.0 <-5 >5 0.0 0.0 <-5 >5 0.0 
YgaU Uncharacterized protein ygaU 0.00 0.00 0.00 0.07 0.00 0.00 0.00 0.16 0.0 0.0 <-5 >5 0.0 0.0 <-5 >5 0.0 
YfbU Hypothetical protein 0.08 0.07 0.05 0.09 0.037 0.00 0.00 0.028 -0.2 -0.7 -0.8 0.2 <-5 <-5 <-5 -0.4 1.1 
LfiI 
Lateral flagellar export/assembly protein 
LfiI 
0.07 0.07 0.032 0.06 0.07 0.07 0.08 0.16 0.0 -1.1 -0.9 -0.2 0.0 0.2 -1.0 1.2 0.0 
YhdH Putative quinone oxidoreductase YhdH 0.031 0.044 0.05 0.026 0.019 0.034 0.035 0.06 0.5 0.7 0.9 -0.3 0.8 0.9 -0.8 1.7 0.7 
1
 Name, protein name and Uniprot ID are according to Uniprot database (http://www.uniprot.org/). Functional classifications are mostly according to EcoCyc database 
(http://ecocyc.org/). The classifications are confirmed by KEGG database (http://www.genome.jp/kegg/). 
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Suppl. Table 5.3.6 Summary of proteome data of hFGF-2 production in E. coli BL21 (DE3) using defined and complex media 
Cat.  
Nr. 
 Nr. Name 
Defind (DNB) medium Complex (LB) medium Log2 (Ratio in Defind (DNB) medium) Log2 (Ratio in Complex (LB) medium) Log2(DNB 
exp.  1h 5h stationary exp. 1h 3.5h stationary (1h after (5h after (5h after (stationary (1h after (5h after (5h after (stationary medium/ 
phase after after phase phase after after phase IPTG/ IPTG/ IPTG/ without IPTG/ IPTG/ IPTG/ without LB 
before IPTG IPTG without before IPTG IPTG without exp. exp. stationary IPTG/ exp. exp. stationary IPTG/ medium) 
IPTG induction induction IPTG IPTG induction induction IPTG before before without exp. before before before without exp. before exp. before 
Whole Cell Protein Mass (WCPM) - % IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG 
I 
 
Carbohydrate Metabolism  
(51 proteins) Sum 1 ~ 4 
13.95 13.17 10.51 13.38 12.39 14.03 12.34 19.63 -0.1 -0.4 -0.3 -0.1 0.2 0.0 -0.7 0.7 0.2 
                    
 
1 
Central carbon metabolism  
(24 proteins) Sum 1.1 ~ 1.4 
6.59 6.61 5.29 7.01 7.36 7.70 6.14 8.26 0.0 -0.3 -0.4 0.1 0.1 -0.3 -0.4 0.2 -0.2 
                    
 
1.1 Sub-group: Upper glycolysis (5 proteins) 1.26 1.28 0.93 1.50 0.91 0.98 0.75 1.35 0.0 -0.4 -0.7 0.3 0.1 -0.3 -0.8 0.6 0.5 
 
1.2 
Sub-group: Lower glycolysis  
(to Acetyl-CoA)  (11 proteins) 
4.21 4.24 3.49 4.28 5.18 5.05 3.95 5.05 0.0 -0.3 -0.3 0.0 0.0 -0.4 -0.4 0.0 -0.3 
 
1.3 
Sub-group: Glycerol metabolism  
(2 proteins) 
0.13 0.06 0.08 0.14 0.15 0.47 0.32 0.29 -1.1 -0.7 -0.8 0.1 1.6 1.1 0.1 1.0 -0.2 
 
1.4 
Sub-group: Pentose phosphate pathway 
(PPP) (6 proteins) 
0.99 1.03 0.79 1.09 1.12 1.21 1.13 1.57 0.1 -0.3 -0.5 0.1 0.1 0.0 -0.5 0.5 -0.2 
 
2 
By-product metabolism  
(9 proteins) 
1.20 1.12 0.89 0.95 1.06 1.13 0.96 2.12 -0.1 -0.4 -0.1 -0.3 0.1 -0.1 -1.1 1.0 0.2 
 
3 TCA cycle (14 proteins) 5.50 4.84 3.74 4.70 3.61 4.78 4.84 8.42 -0.2 -0.6 -0.3 -0.2 0.4 0.4 -0.8 1.2 0.6 
 
4 
Connection between glycolysis and TCA 
cycle (4 proteins) 
0.67 0.61 0.60 0.72 0.36 0.43 0.40 0.83 -0.1 -0.2 -0.3 0.1 0.3 0.2 -1.1 1.2 0.9 
                    
II 5 Oxidative phosphorylation (7 proteins) 2.44 2.31 1.89 2.65 2.53 2.61 2.22 2.39 -0.1 -0.4 -0.5 0.1 0.0 -0.2 -0.1 -0.1 -0.1 
                    
III 
 
Synthesis of biomass building blocks  
(121 proteins): Sum 6 ~ 10 
18.76 17.47 16.15 18.95 10.96 11.18 10.55 16.60 -0.1 -0.2 -0.2 0.0 0.0 -0.1 -0.7 0.6 0.8 
                    
 
6 
Amino acid biosynthesis and metabolism 
(68 proteins). Sum 6.1 ~ 6.2 
13.15 12.08 10.89 12.82 5.21 5.62 5.67 10.65 -0.1 -0.3 -0.2 0.0 0.1 0.1 -0.9 1.0 1.3 
                    
 
6.1 
Sub-group: Amino acid biosynthesis  
(57 proteins) 
12.37 11.37 10.17 11.93 4.42 4.60 4.43 6.91 -0.1 -0.3 -0.2 -0.1 0.1 0.0 -0.6 0.6 1.5 
 
6.2 
Sub-group: Amino acid degradation  
(11 proteins) 
0.78 0.71 0.72 0.89 0.79 1.02 1.24 3.74 -0.1 -0.1 -0.3 0.2 0.4 0.7 -1.6 2.2 0.0 
 
7.1 
IMP biosynthesis (for nucleotide) (7 
proteins) 
1.27 1.23 1.17 1.39 0.59 0.59 0.60 1.00 0.0 -0.1 -0.2 0.1 0.0 0.0 -0.7 0.8 1.1 
 
7.2 
Nucleotide biosynthesis (start from IMP) 
(13 proteins) 
1.53 1.64 1.48 1.87 1.90 1.83 1.59 1.88 0.1 0.0 -0.3 0.3 -0.1 -0.3 -0.2 0.0 -0.3 
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Suppl. Table 5.3.6 Summary of proteome data of hFGF-2 production in E. coli BL21 (DE3) using defined and complex media 
Cat.  
Nr. 
 Nr. Name 
Defind (DNB) medium Complex (LB) medium Log2 (Ratio in Defind (DNB) medium) Log2 (Ratio in Complex (LB) medium) Log2(DNB 
exp.  1h 5h stationary exp. 1h 3.5h stationary (1h after (5h after (5h after (stationary (1h after (5h after (5h after (stationary medium/ 
phase after after phase phase after after phase IPTG/ IPTG/ IPTG/ without IPTG/ IPTG/ IPTG/ without LB 
before IPTG IPTG without before IPTG IPTG without exp. exp. stationary IPTG/ exp. exp. stationary IPTG/ medium) 
IPTG induction induction IPTG IPTG induction induction IPTG before before without exp. before before before without exp. before exp. before 
Whole Cell Protein Mass (WCPM) - % IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG 
 
8 Fatty acid biosynthesis (7 proteins) 1.13 1.09 1.10 1.17 1.62 1.31 1.08 1.12 -0.1 0.0 -0.1 0.1 -0.3 -0.6 -0.1 -0.5 -0.5 
 
9 
Lipopolysaccharide  biosynthesis  
(10 proteins) 
0.82 0.55 0.71 0.67 0.91 1.10 0.89 1.00 -0.6 -0.2 0.1 -0.3 0.3 0.0 -0.2 0.1 -0.2 
 
10 
Synthesis of other cellular components  
(16 proteins) 
0.86 0.88 0.81 1.02 0.71 0.74 0.72 0.96 0.0 -0.1 -0.3 0.2 0.1 0.0 -0.4 0.4 0.3 
                    
IV 11 (Metabolite) degradation (19 proteins) 1.67 1.46 1.14 1.64 1.52 1.51 1.33 3.45 -0.2 -0.6 -0.5 0.0 0.0 -0.2 -1.4 1.2 0.1 
                    
V 
 
Transportation (28 proteins): Sum 12 ~ 14 8.29 8.28 6.86 9.59 7.21 9.59 6.28 10.66 0.0 -0.3 -0.5 0.2 0.4 -0.2 -0.8 0.6 0.2 
                    
 
12 Sugar transport (7 proteins) 2.05 2.00 1.43 2.92 1.37 1.77 1.37 4.17 0.0 -0.5 -1.0 0.5 0.4 0.0 -1.6 1.6 0.6 
 
13 
Amino acid and peptide transport  
(7 proteins) 
0.79 0.78 0.50 1.00 0.26 0.29 0.35 1.45 0.0 -0.7 -1.0 0.3 0.2 0.4 -2.1 2.5 1.6 
 
14 Other transport proteins (14 proteins) 5.45 5.51 4.93 5.66 5.58 7.53 4.56 5.04 0.0 -0.1 -0.2 0.1 0.4 -0.3 -0.1 -0.1 0.0 
                    
VI 
 
Transcription and translation  
(66 proteins): Sum 15 ~ 22 
16.51 18.02 18.25 17.88 22.43 23.18 20.91 17.31 0.1 0.1 0.0 0.1 0.0 -0.1 0.3 -0.4 -0.4 
                    
 
15 RNA polymerases (3 proteins) 1.06 1.00 1.06 0.88 1.36 1.20 1.00 0.80 -0.1 0.0 0.3 -0.3 -0.2 -0.4 0.3 -0.8 -0.4 
 
16 
RNA polymerase binding proteins  
(7 proteins) 
0.83 0.91 0.87 0.88 1.24 1.07 1.04 0.77 0.1 0.1 0.0 0.1 -0.2 -0.3 0.4 -0.7 -0.6 
 
17 Transcription factors (12 proteins) 1.78 1.84 1.74 1.79 1.65 1.69 1.68 2.03 0.0 0.0 0.0 0.0 0.0 0.0 -0.3 0.3 0.1 
 
18 Ribosomal proteins (5 proteins) 3.55 3.78 4.32 3.76 5.41 4.75 4.47 2.74 0.1 0.3 0.2 0.1 -0.2 -0.3 0.7 -1.0 -0.6 
 
19 Ribosome-associated proteins (8 proteins) 1.05 1.16 1.16 1.56 1.67 1.71 1.37 1.20 0.1 0.1 -0.4 0.6 0.0 -0.3 0.2 -0.5 -0.7 
 
20 
Aminoacyl-tRNA synthetases  
(23 proteins) 
2.80 2.75 3.04 2.49 3.69 3.67 3.35 3.06 0.0 0.1 0.3 -0.2 0.0 -0.1 0.1 -0.3 -0.4 
 
21 Elongation factors (6 proteins) 4.93 6.01 5.55 6.09 6.74 8.11 7.35 6.17 0.3 0.2 -0.1 0.3 0.3 0.1 0.3 -0.1 -0.5 
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Suppl. Table 5.3.6 Summary of proteome data of hFGF-2 production in E. coli BL21 (DE3) using defined and complex media 
Cat.  
Nr. 
 Nr. Name 
Defind (DNB) medium Complex (LB) medium Log2 (Ratio in Defind (DNB) medium) Log2 (Ratio in Complex (LB) medium) Log2(DNB 
exp.  1h 5h stationary exp. 1h 3.5h stationary (1h after (5h after (5h after (stationary (1h after (5h after (5h after (stationary medium/ 
phase after after phase phase after after phase IPTG/ IPTG/ IPTG/ without IPTG/ IPTG/ IPTG/ without LB 
before IPTG IPTG without before IPTG IPTG without exp. exp. stationary IPTG/ exp. exp. stationary IPTG/ medium) 
IPTG induction induction IPTG IPTG induction induction IPTG before before without exp. before before before without exp. before exp. before 
Whole Cell Protein Mass (WCPM) - % IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG) IPTG 
 
22 RNA degradation (3 proteins) 0.52 0.56 0.51 0.42 0.68 0.98 0.64 0.53 0.1 0.0 0.3 -0.3 0.5 -0.1 0.3 -0.4 -0.4 
                    
VII 
 
Protein folding and degradation  
(28 proteins): Sum 23 ~ 25 
3.54 4.27 7.09 3.57 4.50 7.76 9.05 4.99 0.3 1.0 1.0 0.0 0.8 1.0 0.9 0.1 -0.3 
                    
 
23 Isomerases (5 proteins) 0.72 0.79 0.62 0.80 0.55 0.56 0.38 0.86 0.1 -0.2 -0.4 0.2 0.0 -0.5 -1.2 0.6 0.4 
 
24 Chaperones (9 proteins) 1.94 2.63 5.46 1.95 2.92 5.92 7.12 2.75 0.4 1.5 1.5 0.0 1.0 1.3 1.4 -0.1 -0.6 
 
25 Proteases (13 proteins) 0.88 0.85 1.01 0.83 1.03 1.28 1.55 1.38 -0.1 0.2 0.3 -0.1 0.3 0.6 0.2 0.4 -0.2 
                    
VIII 
 
Cell redox balance  
(22 proteins): Sum 26.1 ~ 26.3 
2.35 2.46 2.26 3.32 1.78 1.95 1.81 3.50 0.1 -0.1 -0.6 0.5 0.1 0.0 -1.0 1.0 0.4 
                    
 
26.1 Other dehydrogenases (9 proteins) 0.69 0.66 0.66 0.75 0.61 0.74 0.67 1.13 -0.1 -0.1 -0.2 0.1 0.3 0.1 -0.8 0.9 0.2 
 
26.2 Oxidoreductases (8 proteins) 0.39 0.36 0.43 0.65 0.34 0.34 0.38 0.54 -0.1 0.1 -0.6 0.7 0.0 0.2 -0.5 0.7 0.2 
 
26.3 
Hydroperoxide reductases and superoxide 
dismutase (5 proteins) 
1.26 1.45 1.17 1.92 0.83 0.88 0.75 1.83 0.2 -0.1 -0.7 0.6 0.1 -0.1 -1.3 1.1 0.6 
                    
IX 27 DNA protection and repair (6 proteins) 0.83 0.86 0.58 0.84 0.51 0.27 0.36 1.29 0.1 -0.5 -0.5 0.0 -0.9 -0.5 -1.8 1.3 0.7 
                    
X 28 Unclassified proteins (7 proteins) 0.63 0.57 0.53 0.59 0.46 0.36 0.39 0.36 -0.1 -0.2 -0.2 -0.1 -0.4 -0.2 0.1 -0.4 0.5 
                    
XI 29 Uncharacterized proteins (13 proteins) 0.44 0.42 0.45 0.52 0.41 0.44 0.39 0.76 -0.1 0.0 -0.2 0.2 0.1 -0.1 -1.0 0.9 0.1 
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5.3.3 Suppl. Methods - Determination of NADPH turn-over involved in 
amino acid biosynthesis 
Starting from a genome-scale reconstruction of the metabolic network of E. coli [1] flux 
balance analysis [2] was used to compute a flux distribution that maximizes growth yield 
in the given conditions (constraints were set as described before [1]). To determine the 
relative cellular NADPH production that is oxidized in amino acid metabolism, we first 
determined the total NADPH turnover, NADPHtot, by summing across all reactions with 
non-zero flux, the flux of the reaction multiplied with the molar amount of NADPH 
consumed by this reaction. For NADPHtot we obtained a value of 12.27 mmol h
−1 
g
−1 
DCW 
(Dry Cell Weight). Second, we calculated the amount of NADPH oxidized in amino acid 
metabolism, aaNADPH , by performing the same calculations but only summing up 
reactions annotated as belonging to amino acid metabolism. For NADPHaa we obtained a 
value of 10.08 mmol h
−1 
g
−1 
DCW. To take into account reducing equivalents in terms of 
NADH produced during amino acid biosynthesis, we calculated the level of NADH 
produced during amino acid biosynthesis, NADHpaa, which is 1.84 mmol h
−1 
g
−1 
DCW. 
Subsequently, we determined the relative fraction of reducing equivalent consumed in 
amino acid metabolism through the following equation: 
%79
84.127.12
84.108.10
 Equivalent Reducing 
 Equivalent Reducing
tot
aa







paatot
paaaa
NADHNADPH
NADHNADPH
 
References: 
1. Feist, A. M., Henry, C. S., Reed, J. L., Krummenacker, M., Joyce, A. R., Karp, P. D., 
Broadbelt, L. J., Hatzimanikatis, V., and Palsson, B. O. (2007) A genome-scale 
metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 
ORFs and thermodynamic information. Mol Syst Biol 3, 121. 
2. Orth, J. D., Thiele, I., and Palsson, B. O. (2010) What is flux balance analysis? Nat 
Biotechnol 28, 245-248. 
* The calculation was carried out by Dr. Christoph Kaleta: Friedrich Schiller University of 
Jena, School of Biology and Pharmaceutics, Department of Bioinformatics and Research 
Group Theoretical Systems Biology, Jena, Germany 
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5.4 Chemicals 
Chemicals, commercial buffers, kits and other materials used in current study are listed in 
Suppl. Tables 5.4.1 and 5.4.2 
Suppl. Table 5.4.1 Chemicals 
Name Chemical MW:  Manufacturer Country 
Acetic acid CH3COOH 60.05 
Carl Roth GmbH + Co. 
KG.  
Germany 
Acetonitrile CH3CN 41.05 
Carl Roth GmbH + Co. 
KG.  
Germany 
Acrylamide and 
bisacrylamide stock 
solution 
Rotiphorese® Gel 30 (37,5:1)  
 
Carl Roth GmbH + Co. 
KG.  
Germany 
Agar BactoTM Agar 
 
Becton, Dickinson and 
Company (BD) 
USA 
Agarose Biozym LE GP Agarose 
 
Biozym Scientific GmbH Germany 
Ammonium hydrogen 
carbonate  
NH4HCO3 79.06 Merck KGaA Germany 
Ammonium persulfate (NH4)2S2O8 228.2 
Sigma-Aldrich 
Laborchemikalien GmbH 
Germany 
Ammonium phosphate 
dibasic 
(NH4)2HPO4 132.06 
Sigma-Aldrich 
Laborchemikalien GmbH 
Germany 
ammonium phosphate 
monobasic 
NH4H2PO4 115.02 Merck KGaA Germany 
Ammonium sulfate  (NH4)2SO4 132.14 
Carl Roth GmbH + Co. 
KG.  
Germany 
Boric acid H3BO3 61.83 Merck KGaA Germany 
Bromophenol Blue 
C19H10Br4O5S 
3′,3′′,5′,5′′-
Tetrabromophenolsulfonephthalein 
669.96 
Sigma-Aldrich 
Laborchemikalien GmbH 
Germany 
CHAPS 
C32H58N2O7S 
3-((3-Cholamidopropyl)-di- 
methylammonio)-1-propane- 
sulfonate 
614.89 Biomol GmbH Germany 
Citric acid 
monohydrate 
C6H8O7·H2O 210.14 
Sigma-Aldrich 
Laborchemikalien GmbH 
Germany 
Cobalt(II) chloride 
hexahydrate 
CoCl2·6H2O 237.9 Merck KGaA Germany 
Coomassie Blue G250 
C47H50N3NaO7S2 
Coomassie Brilliant Blue G-250 
854.02 Merck KGaA Germany 
Copper(II) chloride 
dihydrate 
CuCl2·2H2O 170.48 
Sigma-Aldrich 
Laborchemikalien GmbH 
Germany 
DTT 
C4H10O2S2  
DL-Dithiothreitol  
154.25 Fermentas GmbH Germany 
Ethanol  
C2H6O 
Ethanol (96%) 
46.07 Merck KGaA Germany 
Fe(III) Citrate FeC6H5O7 244.94 
Sigma-Aldrich 
Laborchemikalien GmbH 
Germany 
Formic acid HCOOH 46.03 
J.T.Baker Chemical 
Company 
USA 
Glucose monohydrate 
C6H12O6·2H2O  
D-(+)-Glucose monohydrate 
198.17 
Sigma-Aldrich 
Laborchemikalien GmbH 
Germany 
Glycerol  
C3H8O3  
Glycerol (86%) 
92.1 
Carl Roth GmbH + Co. 
KG.  
Germany 
Glycine C2H5NO2 75.07 
Carl Roth GmbH + Co. 
KG.  
Germany 
Iodoacetamide ICH2CONH2 184.96 GE Healthcare 
United 
Kingdom 
IPG Buffer pH 3-10 
NL   
GE Healthcare 
United 
Kingdom 
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Name Chemical MW:  Manufacturer Country 
IPG strip pH 3-10 NL 
Immobiline DryStrip pH 3-10 NL, 
18 cm  
GE Healthcare 
United 
Kingdom 
Magnesium sulfate 
heptahydrate 
MgSO4·7H2O 246.47 
Carl Roth GmbH + Co. 
KG.  
Germany 
Manganese(II) 
chloride tetrahydrate 
MnCl2·4H2O 197.91 Merck KGaA Germany 
Methanol CH3OH  32.04 
Carl Roth GmbH + Co. 
KG.  
Germany 
Phosphoric acid  H3PO4 (85%) 98 
Carl Roth GmbH + Co. 
KG.  
Germany 
Potassium phosphate 
dibasic 
K2HPO4 174.18 
Carl Roth GmbH + Co. 
KG.  
Germany 
Potassium phosphate 
monobasic 
KH2PO4 136.09 
Carl Roth GmbH + Co. 
KG.  
Germany 
SDS 
NaC12H25SO4 
Sodium Dodecyl Sulfate 
288.38 
Bio-Rad Laboratories 
GmbH 
Germany 
Sodium chloride NaCl 58.44 
Carl Roth GmbH + Co. 
KG.  
Germany 
Sodium molybdate 
dihydrate  
Na2MoO4·2H2O  241.95 Merck KGaA Germany 
TEMED 
C6H16N2 N,N,N′,N′-
Tetramethylethylenediamine  
116.2 
Sigma-Aldrich 
Laborchemikalien GmbH 
Germany 
TFA 
C2HF3O2 
Trifluoroacetic acid 
114.02 Merck KGaA Germany 
Thiourea 
CH4N2S 
Thiocarbamide 
76.12 
Sigma-Aldrich 
Laborchemikalien GmbH 
Germany 
Titriplex III 
C10H14N2Na2O8·2H2O 
Ethylenedinitrilotetraacetic acid 
disodium salt dihydrate 
372.24 Merck KGaA Germany 
TRIS 
NH2C(CH2OH)3 
Tris(hydroxymethyl) 
aminomethane 
121.14 Molekula GmbH Germany 
Tryptone BactoTM Tryptone 
 
Becton, Dickinson and 
Company (BD) 
USA 
Urea 
NH2CONH2 
Carbamide 
60.06 
Sigma-Aldrich 
Laborchemikalien GmbH 
Germany 
Yeast Extract BactoTM Yeast Extract 
 
Becton, Dickinson and 
Company (BD) 
USA 
Zinc acetate dihydrate Zn(CH3COO)2·2H2O 219.51 Merck KGaA Germany 
α-Cyano-4-
hydroxycinnamic acid  
189.17 
Sigma-Aldrich 
Laborchemikalien GmbH 
Germany 
Suppl. Table 5.4.2 Commercial buffers, kits and other materials 
Chemical Annotation Manufacturer Country 
Acetic Acid kit Acetate Kinase Manual Format 
Megazyme International 
Ireland 
Ireland 
Benzonase 250 U/µL (>99% purity) Merck KGaA Germany 
BugBuster 
BugBuster® Protein Extraction 
Reagent 
Novagen (Merck KGaA) Germany 
IPG Buffer pH 3-10 NL 
 
GE Healthcare 
United 
Kingdom 
IPG strip pH 3-10 NL 
Immobiline DryStrip pH 3-10 NL, 
18 cm 
GE Healthcare 
United 
Kingdom 
rLysozyme 27–33 KU/µL Novagen (Merck KGaA) Germany 
Trypsin Sequencing grade modified trypsin Promega Corporation USA 
ZiptipsC18  
Millipore Corporation USA 
PAC target Prespotted AnchorChip target Bruker Daltonik GmbH Germany 
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5.5 List of Abbreviations 
Abbreviations of identified protein are given in Suppl. Table 5.3.1 or 5.3.5. 
Abbreviation Full name 
2D gel Two-Dimensional Gel 
Acetyl-CoA Acetyl Coenzyme A 
ATP Adenosine Triphosphate 
C(CAM)  Carbamidomethyl Cysteine 
cAMP Cyclic Adenosine Monophosphate 
CMPs Central Metabolic Pathways 
Cra Catabolite repressor activator  
CRP cAMP Receptor Protein  
DAB Defined Autoinduction Broth  
DCM Cell Dry Mass  
DNB Defined Non-inducing Broth  
EIICB
Glc
 
Membrane-bound subunit of the glucosespecific PTS transporter encoded by 
ptsG 
Exp. Exponential 
F1P Fructose-1-Phosphate  
FBP Fructose-1,6-Bisphosphate  
GFP Green Fluorescent Protein 
GlcNAc N-Acetylglucosamine 
GlcNAc-6-P N-Acetylglucosamine-6-Phosphate 
GST Glutathion-S-Transferase 
hFGF-2 Human Basic Fibroblast Growth Factor 
His Histidine 
HNC High Nitrogen Content 
IEF Isoelectric Focusing  
IMP Inosine Monophosphate 
IPG  Immobiline DryStrip Gel 
IPTG Isopropyl β-D-1-Thiogalactopyranoside 
LB Luria Bertani  
L-DNB Labeling Defined Non-inducing Broth 
LPS Lipopolysaccharides 
MALDI-TOF MS 
Matrix-Assisted Laser Desorption Ionization Time-Of-Flight Mass 
Spectrometry 
Met  Methionine 
Metox Oxidized Methionine 
Mlc Making Large Colonies 
MW Molecular Weight 
NADH Nicotinamide Adenine Dinucleotide 
NADPH Nicotinamide Adenine Dinucleotide Phosphate 
NagC N-Acetylglucosamine Repressor 
NMR Nuclear Magnetic Resonance 
P-ArcA Phosphorylated-ArcA 
PEP Phosphoenolpyruvate 
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Abbreviation Full name 
PPP Pentose Phosphate Pathway 
PTS Phosphotransferase System 
rL-DNB Reduced Labeling-Defined Non-inducing Broth 
RNAP RNA polymerase 
RNAP RNA Polymerase 
ROS Reactive Oxygen Species 
S-DAB Smart-Defined Autoinduction Broth  
SDS-PAGE  Sodium Dodecyl Sulfate PolyAcrylamide Gel Electrophoresis 
Se-Met Selenomethionine 
SL-DAB Smart Labeling-Defined Autoinduction Broth 
TAL Transaldolase 
TB Terrific-Broth  
TCA cycle Tricarboxylic Acid Cycle 
TKT Transketolase  
WCPM Whole Cell Protein Mass  
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